Microbial metabolites in tumor epigenetic regulation

Abstract

With an increasing global cancer burden, the regulatory function of the human microbiome and its metabolites in tumor epigenetics has garnered significant interest. Microbial metabolites are not merely passive byproducts but serve as signaling molecules and epigenetic modulators, contributing to tumor progression through multiple overlapping pathways. Short-chain fatty acids (SCFAs) such as butyrate directly inhibit histone deacetylases to reactivate tumor suppressor genes, while secondary bile acids (BAs) induce gene silencing via DNA methylation remodeling by altering the FXR/TGR5 signaling pathway. Folate and vitamin B12 serve as substrates for DNA and histone methylation through one-carbon metabolism. A complex bidirectional feedback loop exists between microbial metabolism and tumor epigenetics: reprogramming driven by hypoxia or oncogenes alters metabolite flux, generating molecules such as lactate and succinate that not only remodel chromatin and the tumor microenvironment (TME) but also selectively promote the growth of metabolically adapted microbial species, thereby reinforcing epigenetic dysregulation. Despite growing mechanistic insights, establishing causality and correlating spatiotemporal dynamics and dose responses within the highly heterogeneous TME remain major challenges. Data integration across multi-omics remains limited by methodological and computational constraints. Resolving these issues will be critical for understanding the microbe–metabolite–epigenetic axis and advancing personalized precision oncology.

Keywords

bidirectional feedback loop / epigenetic modulation / microbial metabolites / precision oncology / tumor epigenetics / tumor microenvironment

References

[1] Chen, Qi, Xi Liang, Tianzhou Wu, Jing Jiang, Yongpo Jiang, Sheng Zhang, Yanyun Ruan, et al. 2022. “Integrative Analysis of Metabolomics and Proteomics Reveals Amino Acid Metabolism Disorder in Sepsis.” Journal of Translational Medicine 20: 123. https://doi.org/10.1186/s12967-022-03320-y

[2] Argaw-Denboba, Ayele, Thomas S. B. Schmidt, Monica Di Giacomo, Bobby Ranjan, Saravanan Devendran, Eleonora Mastrorilli, Catrin T. Lloyd, et al. 2024. “Paternal Microbiome Perturbations Impact Offspring Fitness.” Nature 629: 652–9. https://doi.org/10.1038/s41586-024-07336-w

[3] Kim, Myunghoo, Yaqing Qie, Jeongho Park, and Chang H. Kim. 2016. “Gut Microbial Metabolites Fuel Host Antibody Responses.” Cell Host & Microbe 20: 202–14. https://doi.org/10.1016/j.chom.2016.07.001

[4] Qin, Mingjian, Zigui Huang, Yongqi Huang, Xiaoliang Huang, Chuanbin Chen, Yongzhi Wu, Zhen Wang, et al. 2024. “Association Analysis of Gut Microbiota With LDL-C Metabolism and Microbial Pathogenicity in Colorectal Cancer Patients.” Lipids in Health and Disease 23: 367. https://doi.org/10.1186/s12944-024-02333-4

[5] Cong, Jingjing, Pianpian Liu, Zili Han, Wei Ying, Chaoliang Li, Yifei Yang, Shuling Wang, et al. 2024. “Bile Acids Modified by the Intestinal Microbiota Promote Colorectal Cancer Growth by Suppressing CD8⁺ T Cell Effector Functions.” Immunity 57: 876–89. https://doi.org/10.1016/j.immuni.2024.02.014

[6] Chowdhury, Snehanshu, Anwesha Kar, Debaleena Bhowmik, Anupam Gautam, Debashree Basak, Ishita Sarkar, Puspendu Ghosh, et al. 2022. “Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8⁺ T Cells.” Cancer Research 82: 2640–55. https://doi.org/10.1158/0008-5472.Can-21-4052

[7] Bernard, Matthew J., and Andrew S. Goldstein. 2024. “A Metabolic–Epigenetic Mechanism Directs Cell Fate and Therapeutic Sensitivity in Breast Cancer.” Cancer Research 84: 1382–3. https://doi.org/10.1158/0008-5472.CAN-24-0460

[8] Su, Anthony Chin Yang, Xiao Ding, Harry Cheuk Hay Lau, Xing Kang, Qing Li, Xueliang Wang, Yali Liu, et al. 2024. “Lactococcus lactis HkyuLL 10 Suppresses Colorectal Tumourigenesis and Restores Gut Microbiota Through Its Generated Alpha-Mannosidase.” Gut 73: 1478–88. https://doi.org/10.1136/gutjnl-2023-330835

[9] Desouky, E.M., A. K. Khaliefa, W. G. Hozayen, S. M. Shaaban, and N. A. Hasona. 2023. “Signature of miR-21 and MEG-2 and Their Correlation With TGF-β Signaling in Breast Cancer.” Human & Experimental Toxicology 42: 09603271231159799. https://doi.org/10.1177/09603271231159799

[10] Ubachs, Jorne, Janine Ziemons, Zita Soons, Romy Aarnoutse, David P. J. van Dijk, John Penders, Ardy van Helvoort, et al. 2021. “Gut Microbiota and Short-Chain Fatty Acid Alterations in Cachectic Cancer Patients.” Journal of Cachexia, Sarcopenia and Muscle 12: 2007–21. https://doi.org/10.1002/jcsm.12804

[11] Chen, Danfeng, Duochen Jin, Shumin Huang, Jingyi Wu, Mengque Xu, Tianyu Liu, Wenxiao Dong, et al. 2020. “Clostridium butyricum, a Butyrate-Producing Probiotic, Inhibits Intestinal Tumor Development Through Modulating Wnt Signaling and Gut Microbiota.” Cancer Letters 469: 456–67. https://doi.org/10.1016/j.canlet.2019.11.019

[12] Ma, Hang, Yang Yu, Meimei Wang, Zhaoxing Li, Heshan Xu, Cheng Tian, Jian Zhang, Xiaoli Ye, and Xuegang Li. 2019. “Correlation Between Microbes and Colorectal Cancer: Tumor Apoptosis Is Induced by Sitosterols Through Promoting Gut Microbiota to Produce Short-Chain Fatty Acids.” Apoptosis 24: 168–83. https://doi.org/10.1007/s10495-018-1500-9

[13] Li, Fei, Wenzhe Si, Li Xia, Deshan Yin, Tianjiao Wei, Ming Tao, Xiaona Cui, et al. 2024. “Positive Feedback Regulation Between Glycolysis and Histone Lactylation Drives Oncogenesis in Pancreatic Ductal Adenocarcinoma.” Molecular Cancer 23: 90. https://doi.org/10.1186/s12943-024-02008-9

[14] Huang, An, Zhuang Sun, Haopeng Hong, Yong Yang, Jiajia Chen, Zhaoya Gao, and Jin Gu. 2024. “Novel Hypoxia-and Lactate Metabolism-Related Molecular Subtyping and Prognostic Signature for Colorectal Cancer.” Journal of Translational Medicine 22: 587. https://doi.org/10.1186/s12967-024-05391-5

[15] Han, Shulan, Xueying Bao, Yifang Zou, Lingzhi Wang, Yutong Li, Leilei Yang, Anqi Liao, et al. 2023. “D-Lactate Modulates M2 Tumor-Associated Macrophages and Remodels Immunosuppressive Tumor Microenvironment for Hepatocellular Carcinoma.” Science Advances 9: eadg2697. https://doi.org/10.1126/sciadv.adg2697

[16] Huang, Huixia, Keji Chen, Yifei Zhu, Zijuan Hu, Yaxian Wang, Jiayu Chen, Yuxue Li, Dawei Li, and Ping Wei. 2024. “A Multi-Dimensional Approach to Unravel the Intricacies of Lactylation Related Signature for Prognostic and Therapeutic Insight in Colorectal Cancer.” Journal of Translational Medicine 22: 211. https://doi.org/10.1186/s12967-024-04955-9

[17] Wang, Hai, Xingyu Rong, Gan Zhao, Yifan Zhou, Yi Xiao, Ding Ma, Xi Jin, et al. 2022. “The Microbial Metabolite Trimethylamine N-Oxide Promotes Antitumor Immunity in Triple-Negative Breast Cancer.” Cell Metabolism 34: 581–94, e588. https://doi.org/10.1016/j.cmet.2022.02.010

[18] Mirji, Gauri, Alison Worth, Sajad Ahmad Bhat, Mohamed El Sayed, Toshitha Kannan, Aaron R. Goldman, Hsin-Yao Tang, et al. 2022. “The Microbiome-Derived Metabolite TMAO Drives Immune Activation and Boosts Responses to Immune Checkpoint Blockade in Pancreatic Cancer.” Science Immunology 7: eabn0704. https://doi.org/10.1126/sciimmunol.abn0704

[19] Luu, Maik, Zeno Riester, Adrian Baldrich, Nicole Reichardt, Samantha Yuille, Alessandro Busetti, Matthias Klein, et al. 2021. “Microbial Short-Chain Fatty Acids Modulate CD8⁺ T Cell Responses and Improve Adoptive Immunotherapy for Cancer.” Nature Communications 12: 4077. https://doi.org/10.1038/s41467-021-24331-1

[20] Chen, Jian, Deping Zhao, Yupeng Wang, Ming Liu, Yuan Zhang, Tingting Feng, Chao Xiao, et al. 2024. “Lactylated Apolipoprotein C-II Induces Immunotherapy Resistance by Promoting Extracellular Lipolysis.” Advanced Science 11: e2406333. https://doi.org/10.1002/advs.202470226

[21] Fong, Winnie, Qing Li, Fenfen Ji, Wei Liang, Harry Cheuk Hay Lau, Xing Kang, Weixin Liu, et al. 2023. “Lactobacillus gallinarum-Derived Metabolites Boost anti-PD1 Efficacy in Colorectal Cancer by Inhibiting Regulatory T Cells Through Modulating IDO1/Kyn/AHR Axis.” Gut 72: 2272–85. https://doi.org/10.1136/gutjnl-2023-329543

[22] Cui, Jian-Xin, Xian-Hui Xu, Tao He, Jia-Jia Liu, Tian-Yu Xie, Wen Tian, and Jun-Yan Liu. 2023. “L-Kynurenine Induces NK Cell Loss in Gastric Cancer Microenvironment via Promoting Ferroptosis.” Journal of Experimental & Clinical Cancer Research 42: 52. https://doi.org/10.1186/s13046-023-02629-w

[23] Zhang, Xin-Yu, Jian-Bo Shi, Shu-Fang Jin, Rui-Jie Wang, Ming-Yu Li, Zhi-Yuan Zhang, Xi Yang, and Hai-Long Ma. 2024. “Metabolic Landscape of Head and Neck Squamous Cell Carcinoma Informs a Novel kynurenine/Siglec-15 Axis in Immune Escape.” Cancer Communications 44: 670–94. https://doi.org/10.1002/cac2.12545

[24] Campesato, Luis Felipe, Sadna Budhu, Jeremy Tchaicha, Chien-Huan Weng, Mathieu Gigoux, Ivan Jose Cohen, David Redmond, et al. 2020. “Blockade of the AHR Restricts a Treg-Macrophage Suppressive Axis Induced by L-Kynurenine.” Nature Communications 11: 4011. https://doi.org/10.1038/s41467-020-17750-z

[25] Fang, Yuan, Weiren Liu, Zheng Tang, Xiang Ji, Yufu Zhou, Shushu Song, Mengxin Tian, et al. 2023. “Monocarboxylate Transporter 4 Inhibition Potentiates Hepatocellular Carcinoma Immunotherapy Through Enhancing T Cell Infiltration and Immune Attack.” Hepatology 77: 109–23. https://doi.org/10.1002/hep.32348

[26] Cai, Jialiang, Peiling Zhang, Yufan Cai, Guiqi Zhu, Shiping Chen, Lina Song, Junxian Du, et al. 2025. “Lactylation-Driven NUPR1 Promotes Immunosuppression of Tumor-Infiltrating Macrophages in Hepatocellular Carcinoma.” Advanced Science 12: e2413095. https://doi.org/10.1002/advs.202413095

[27] Nan, Han, Pengkun Guo, Jianing Fan, Wen Zeng, Chonghan Hu, Can Zheng, Bujian Pan, et al. 2023. “Comprehensive Analysis of the Prognosis, Tumor Microenvironment, and Immunotherapy Response of SDHs in Colon Adenocarcinoma.” Frontiers in Immunology 14: 1093974. https://doi.org/10.3389/fimmu.2023.1093974

[28] Zhang, Shi-long, Yu-qin Mao, Zheng-yan Zhang, Zhan-ming Li, Chao-yue Kong, Hui-Ling Chen, Pei-ran Cai, et al. 2021. “Pectin Supplement Significantly Enhanced the anti-PD-1 Efficacy in Tumor-Bearing Mice Humanized With Gut Microbiota From Patients With Colorectal Cancer.” Theranostics 11: 4155–70. https://doi.org/10.7150/thno.54476

[29] Zhang, Menghan, Xuefeng Huang, Yanlong Zhang, Minghang Yu, Xiaoxue Yuan, Yifan Xu, Lei Ma, Xi Wang, and Huichun Xing. 2025. “Gut Microbial Metabolite Butyrate Suppresses Hepatocellular Carcinoma Growth via CXCL11-Dependent Enhancement of Natural Killer Cell Infiltration.” Gut Microbes 17: 2519706. https://doi.org/10.1080/19490976.2025.2519706

[30] Mowat, Courtney, Jasmine Dhatt, Ilsa Bhatti, Angela Hamie, and Kristi Baker. 2023. “Short Chain Fatty Acids Prime Colorectal Cancer Cells to Activate Antitumor Immunity.” Frontiers in Immunology 14: 1190810. https://doi.org/10.3389/fimmu.2023.1190810

[31] Guo, Yinglin, Qing Peng, Liyuan Hao, Jingmin Ji, Zhiqin Zhang, Yu Xue, Yiwei Liu, et al. 2022. “Dihydroartemisinin Promoted FXR Expression Independent of YAP1 in Hepatocellular Carcinoma.” FASEB Journal 36: e22361. https://doi.org/10.1096/fj.202200171R

[32] Liu, Yufei, Quan Zhou, Fangdie Ye, Chen Yang, and Haowen Jiang. 2023. “Gut Microbiota-Derived Short-Chain Fatty Acids Promote Prostate Cancer Progression via Inducing Cancer Cell Autophagy and M2 Macrophage Polarization.” Neoplasia 43: 100928. https://doi.org/10.1016/j.neo.2023.100928

[33] Yang, Wenjing, Tianming Yu, Xiangsheng Huang, Anthony J. Bilotta, Leiqi Xu, Yao Lu, Jiaren Sun, et al. 2020. “Intestinal Microbiota-Derived Short-Chain Fatty Acids Regulation of Immune Cell IL-22 Production and Gut Immunity.” Nature Communications 11: 4457. https://doi.org/10.1038/s41467-020-18262-6

[34] Dupraz, Louise, Aurélie Magniez, Nathalie Rolhion, Mathias L. Richard, Grégory Da Costa, Sothea Touch, Camille Mayeur, et al. 2021. “Gut Microbiota-Derived Short-Chain Fatty Acids Regulate IL-17 Production by Mouse and Human Intestinal γδ T Cells.” Cell Reports 36: 109332. https://doi.org/10.1016/j.celrep.2021.109332

[35] Ikeda, Takako, Akari Nishida, Mayu Yamano, and Ikuo Kimura. 2022. “Short-Chain Fatty Acid Receptors and Gut Microbiota as Therapeutic Targets in Metabolic, Immune, and Neurological Diseases.” Pharmacology & Therapeutics 239: 108273. https://doi.org/10.1016/j.pharmthera.2022.108273

[36] Wegner, Valentin D., Adrian Feile, Miriam Alb, Michael Hudecek, Philip Hewitt, and Alexander S. Mosig. 2025. “Short-Chain Fatty Acids Modulate Anti-ROR1 CAR T-Cell Function and Exhaustion in an Intestinal Adenocarcinoma-on-Chip Model.” Advanced Healthcare Materials 14: 2405003. https://doi.org/10.1002/adhm.202405003

[37] Cui, Bai, Huandong Luo, Bin He, Xinyu Liu, Dekang Lv, Xiaoyu Zhang, Keyu Su, et al. 2025. “Gut Dysbiosis Conveys Psychological Stress to Activate LRP5/β-Catenin Pathway Promoting Cancer Stemness.” Signal Transduction and Targeted Therapy 10: 79. https://doi.org/10.1038/s41392-025-02159-1

[38] Li, Gengfeng, Jian Lin, Cui Zhang, Han Gao, Huiying Lu, Xiang Gao, Ruixin Zhu, et al. 2021. “Microbiota Metabolite Butyrate Constrains Neutrophil Functions and Ameliorates Mucosal Inflammation in Inflammatory Bowel Disease.” Gut Microbes 13: 1968257. https://doi.org/10.1080/19490976.2021.1968257

[39] Wu, Shu-en, Seika Hashimoto-Hill, Vivienne Woo, Emily M. Eshleman, Jordan Whitt, Laura Engleman, Rebekah Karns, et al. 2020. “Microbiota-Derived Metabolite Promotes HDAC3 Activity in the Gut.” Nature 586: 108–12. https://doi.org/10.1038/s41586-020-2604-2

[40] Yunusbaeva, Milyausha, Liliya Borodina, Darya Terentyeva, Anna Bogdanova, Aigul Zakirova, Shamil Bulatov, Radick Altinbaev, Fanil Bilalov, and Bayazit Yunusbayev. 2024. “Excess Fermentation and Lactic Acidosis as Detrimental Functions of the Gut Microbes in Treatment-Naive TB Patients.” Frontiers in Cellular and Infection Microbiology 14: 1331521. https://doi.org/10.3389/fcimb.2024.1331521

[41] Huertas-Díaz, Lucía, Rikke Kyhnau, Eugenio Ingribelli, Vera Neuzil-Bunesova, Qing Li, Mari Sasaki, Roger P. Lauener, et al. 2023. “Breastfeeding and the Major Fermentation Metabolite Lactate Determine Occurrence of Peptostreptococcaceae in Infant Feces.” Gut Microbes 15: 2241209. https://doi.org/10.1080/19490976.2023.2241209

[42] Zhu, Xinhai, Ke Li, Guichao Liu, Ruan Wu, Yan Zhang, Siying Wang, Meng Xu, Ligong Lu, and Peng Li. 2023. “Microbial Metabolite Butyrate Promotes anti-PD-1 Antitumor Efficacy by Modulating T Cell Receptor Signaling of Cytotoxic CD8 T Cell.” Gut Microbes 15: 2249143. https://doi.org/10.1080/19490976.2023.2249143

[43] Tanes, Ceylan, Kyle Bittinger, Yuan Gao, Elliot S. Friedman, Lisa Nessel, Unmesha Roy Paladhi, Lillian Chau, et al. 2021. “Role of Dietary Fiber in the Recovery of the Human Gut Microbiome and Its Metabolome.” Cell Host & Microbe 29: 394–407, e395. https://doi.org/10.1016/j.chom.2020.12.012

[44] Adachi, Yusuke, Ana Luisa De Sousa-Coelho, Ikue Harata, Charlie Aoun, Sandra Weimer, Xu Shi, Karina N. Gonzalez Herrera, et al. 2018. “L-Alanine Activates Hepatic AMP-Activated Protein Kinase and Modulates Systemic Glucose Metabolism.” Molecular Metabolism 17: 61–70. https://doi.org/10.1016/j.molmet.2018.08.002

[45] Huang, Yumei, Yinhuan Ding, Huiyuan Xu, Cheng Shen, Xia Chen, and Changping Li. 2026 2021. “Effects of Sodium Butyrate Supplementation on Inflammation, Gut Microbiota, and Short-Chain Fatty Acids in Helicobacter pylori-Infected Mice.” Helicobacter 26: e12785. https://doi.org/10.1111/hel.12785

[46] Wrzosek, Laura, Dragos Ciocan, Cindy Hugot, Madeleine Spatz, Margot Dupeux, Camille Houron, Vanessa Lievin-Le Moal, et al. 2021. “Microbiota Tryptophan Metabolism Induces Aryl Hydrocarbon Receptor Activation and Improves Alcohol-Induced Liver Injury.” Gut 70: 1299–308. https://doi.org/10.1136/gutjnl-2020-321565

[47] Li, Xue-Song, Jun-Ze Xue, Yu Qi, Inam Muhammad, Hao Wang, Xuan-Yu Li, Yi-Jia Luo, et al. 2023. “Citric Acid Confers Broad Antibiotic Tolerance Through Alteration of Bacterial Metabolism and Oxidative Stress.” International Journal of Molecular Sciences 24: 9089. https://doi.org/10.3390/ijms24109089

[48] Zhang, Fang-Ling, Xiao-Wei Chen, Yi-Fan Wang, Zhen Hu, Wen-Juan Zhang, Bo-Wei Zhou, Peng-Fei Ci, and Ke-Xuan Liu. 2023. “Microbiota-Derived Tryptophan Metabolites Indole-3-Lactic Acid Is Associated With Intestinal Ischemia/Reperfusion Injury via Positive Regulation of YAP and Nrf2.” Journal of Translational Medicine 21: 264. https://doi.org/10.1186/s12967-023-04109-3

[49] Bhowmick, Krishanu, Xiaochun Yang, Taj Mohammad, Xiyan Xiang, Christine L. Molmenti, Bibhuti Mishra, Srinivasan Dasarathy, et al. 2025. “Microbial Metabolite Ammonia Disrupts TGF-β Signaling to Promote Colon Cancer.” Journal of Biological Chemistry 301: 108559. https://doi.org/10.1016/j.jbc.2025.108559

[50] Eetemadi, Ameen, and Ilias Tagkopoulos. 2021. “Methane and Fatty Acid Metabolism Pathways Are Predictive of Low-FODMAP Diet Efficacy for Patients With Irritable Bowel Syndrome.” Clinical Nutrition 40: 4414–21. https://doi.org/10.1016/j.clnu.2020.12.041

[51] Niu, Yuguo, Xiaoming Hu, Yali Song, Cunchuan Wang, Peixiang Luo, Shihong Ni, Fuxin Jiao, et al. 2024. “Blautia coccoides Is a Newly Identified Bacterium Increased by Leucine Deprivation and Has a Novel Function in Improving Metabolic Disorders.” Advanced Science 11: e2309255. https://doi.org/10.1002/advs.202309255

[52] Gheorghe, Cassandra E., Sarah-Jane Leigh, Gabriel S. S. Tofani, Thomaz F. S. Bastiaanssen, Joshua M. Lyte, Elisa Gardellin, Ashokkumar Govindan, et al. 2024. “The Microbiota Drives Diurnal Rhythms in Tryptophan Metabolism in the Stressed Gut.” Cell Reports 43: 114079. https://doi.org/10.1016/j.celrep.2024.114079

[53] Wang, Gang, Yuxin Fan, Guolong Zhang, Shuang Cai, Yonghang Ma, Lijie Yang, Yuming Wang, et al. 2024. “Microbiota-Derived Indoles Alleviate Intestinal Inflammation and Modulate Microbiome by Microbial Cross-Feeding.” Microbiome 12: 59. https://doi.org/10.1186/s40168-024-01750-y

[54] Dong, Fangcong, Fuhua Hao, Iain A. Murray, Philip B. Smith, Imhoi Koo, Alyssa M. Tindall, Penny M. Kris-Etherton, et al. 2020. “Intestinal Microbiota-Derived Tryptophan Metabolites Are Predictive of Ah Receptor Activity.” Gut Microbes 12: 1788899. https://doi.org/10.1080/19490976.2020.1788899

[55] Hu, Hai, Wentao Shao, Qian Liu, Ning Liu, Qihan Wang, Jin Xu, Xin Zhang, et al. 2022. “Gut Microbiota Promotes Cholesterol Gallstone Formation by Modulating Bile Acid Composition and Biliary Cholesterol Secretion.” Nature Communications 13: 252. https://doi.org/10.1038/s41467-021-27758-8

[56] Boutte, Harold J., Jacqueline Chen, Todd N. Wylie, Kristine M. Wylie, Yan Xie, Mackenzie Geisman, Anirudh Prabu, et al. 2022. “Fecal Microbiome and Bile Acid Metabolome in Adult Short Bowel Syndrome.” American Journal of Physiology-Gastrointestinal and Liver Physiology 322: G154–68. https://doi.org/10.1152/ajpgi.00091.2021

[57] Ghias, Emaan, Mette Glavind Bülow Pedersen, Camilla Bak Nielsen, Louise Vase Bech, Ida Marie Modvig, Natasa Brkovic Zubanovic, Jacob Marthinsen Seefeldt, et al. 2025. “Gut Lactate Increases Circulating l-Lac-Phe and Key Metabolites Linked to GLP-1 and Human Health.” American Journal of Physiology-Endocrinology and Metabolism 329: E143–50. https://doi.org/10.1152/ajpendo.00037.2025

[58] Taubenheim, Jan, A. Samer Kadibalban, Johannes Zimmermann, Claudia Taubenheim, Florian Tran, Stefan Schreiber, Philip Rosenstiel, Konrad Aden, and Christoph Kaleta. 2025. “Metabolic Modeling Reveals a Multi-Level Deregulation of Host-Microbiome Metabolic Networks in IBD.” Nature Communications 16: 5120. https://doi.org/10.1038/s41467-025-60233-2

[59] Park, Sun-Yang, Chitong Rao, Katharine Z. Coyte, Gavin A. Kuziel, Yancong Zhang, Wentao Huang, Eric A. Franzosa, et al. 2022. “Strain-Level Fitness in the Gut Microbiome Is an Emergent Property of Glycans and a Single Metabolite.” Cell 185: 513–29.e21. e521. https://doi.org/10.1016/j.cell.2022.01.002

[60] Luo, Ying, Taha Majid Mahmood Sheikh, Xin Li, Yu-Meng Yuan, Fen Yao, Meimei Wang, Xiaoling Guo, et al. 2024. “Exploring the Dynamics of Gut Microbiota, Antibiotic Resistance, and Chemotherapy Impact in Acute Leukemia Patients: A Comprehensive Metagenomic Analysis.” Virulence 15: 2428843. https://doi.org/10.1080/21505594.2024.2428843

[61] Zhuang, Xin, Qingning Yin, Rong Yang, Xiaoying Man, Ruochen Wang, Hui Geng, and Yifen Shi. 2024. “Causal Pathways in Lymphoid Leukemia: The Gut Microbiota, Immune Cells, and Serum Metabolites.” Frontiers in Immunology 15: 1437869. https://doi.org/10.3389/fimmu.2024.1437869

[62] Zünd, Janina N., Denisa Mujezinovic, Markus Reichlin, Serafina Plüss, Marina Caflisch, Serina Robinson, Christophe Lacroix, and Benoit Pugin. 2025. “Novel Cross-Feeding Human Gut Microbes Metabolizing Tryptophan to Indole-3-Propionate.” Gut Microbes 17: 2501195. https://doi.org/10.1080/19490976.2025.2501195

[63] Oliver, Andrew, Zeynep Alkan, Charles B. Stephensen, John W. Newman, Mary E. Kable, Danielle G. Lemay, et al. 2024. “Diet, Microbiome, and Inflammation Predictors of Fecal and Plasma Short-Chain Fatty Acids in Humans.” Journal of Nutrition 154: 3298–311. https://doi.org/10.1016/j.tjnut.2024.08.012

[64] Aggarwal, Hobby, Jyoti Gautam, Deepika Kumari, Sonu Kumar Gupta, Sneh Bajpai, Kartikey Chaturvedi, Yashwant Kumar, and Madhu Dikshit. 2024. “Comparative Profiling of Gut Microbiota and Metabolome in Diet-Induced Obese and Insulin-Resistant C57BL/6J Mice.” Biochimica et Biophysica Acta (BBA)—Molecular Cell Research 1871: 119643. https://doi.org/10.1016/j.bbamcr.2023.119643

[65] Behrens, Luiza Marques Prates, Juciano Gasparotto, Pabulo Henrique Rampelotto, Manuel Adrian Riveros Escalona, Lucas Dos Santos da Silva, Flávio Gabriel Carazza-Kessler, Camila Pocharski Barbosa, et al. 2024. “Sodium Propionate Oral Supplementation Ameliorates Depressive-Like Behavior Through Gut Microbiome and Histone 3 Epigenetic Regulation.” Journal of Nutritional Biochemistry 130: 109660. https://doi.org/10.1016/j.jnutbio.2024.109660

[66] Johnson, Kelsey E., Nelmary Hernandez-Alvarado, Mark Blackstad, Timothy Heisel, Mattea Allert, David A. Fields, Elvira Isganaitis, et al. 2024. “Human Cytomegalovirus in Breast Milk Is Associated With Milk Composition and the Infant Gut Microbiome and Growth.” Nature Communications 15: 6216. https://doi.org/10.1038/s41467-024-50282-4

[67] Nagineni, Chandrasekharam N., Sarwat Naz, Rajani Choudhuri, Gadisetti V. R. Chandramouli, Murali C. Krishna, Jeffrey R. Brender, John A. Cook, and James B. Mitchell. 2021. “Radiation-Induced Senescence Reprograms Secretory and Metabolic Pathways in Colon Cancer HCT-116 Cells.” International Journal of Molecular Sciences 22: 4835. https://doi.org/10.3390/ijms22094835

[68] Hernández, M.A. González, E. E. Canfora, and E. E. Blaak. 2021. “Faecal Microbial Metabolites of Proteolytic and Saccharolytic Fermentation in Relation to Degree of Insulin Resistance in Adult Individuals.” Beneficial Microbes 12: 259–66. https://doi.org/10.3920/bm2020.0179

[69] Brown, Timothy P., Pushpak Bhattacharjee, Sabarish Ramachandran, Sathish Sivaprakasam, Bojana Ristic, Mohd Omar F. Sikder, and Vadivel Ganapathy. 2020. “The Lactate Receptor GPR81 Promotes Breast Cancer Growth via a Paracrine Mechanism Involving Antigen-Presenting Cells in the Tumor Microenvironment.” Oncogene 39: 3292–304. https://doi.org/10.1038/s41388-020-1216-5

[70] Kalafati, Lydia, Ioannis Kourtzelis, Jonas Schulte-Schrepping, Xiaofei Li, Aikaterini Hatzioannou, Tatyana Grinenko, Eman Hagag, et al. 2020. “Innate Immune Training of Granulopoiesis Promotes Anti-Tumor Activity.” Cell 183: 771–85. https://doi.org/10.1016/j.cell.2020.09.058

[71] Wang, Yun, Ge Liu, Rui Liu, Maosheng Wei, Jinxiang Zhang, and Chaomin Sun. 2021. “EPS364, a Novel Deep-Sea Bacterial Exopolysaccharide, Inhibits Liver Cancer Cell Growth and Adhesion.” Marine Drugs 19: 171. https://doi.org/10.3390/md19030171

[72] Fan, Jun, Fang Guo, Ran Mo, Liang-Yu Chen, Jia-Wen Mo, Cheng-Lin Lu, Jing Ren, et al. 2023. “O-GlcNAc Transferase in Astrocytes Modulates Depression-Related Stress Susceptibility through Glutamatergic Synaptic Transmission.” Journal of Clinical Investigation 133: e160016. https://doi.org/10.1172/JCI160016

[73] Frau, Maddalena, Francesco Feo, and Rosa M. Pascale. 2013. “Pleiotropic Effects of Methionine Adenosyltransferases Deregulation as Determinants of Liver Cancer Progression and Prognosis.” Journal of Hepatology 59: 830–41. https://doi.org/10.1016/j.jhep.2013.04.031

[74] Pascale, Rosa M., Maria M. Simile, Maria R. De Miglio, and Francesco Feo. 2002. “Chemoprevention of Hepatocarcinogenesis.” Alcohol 27: 193–8. https://doi.org/10.1016/s0741-8329(02)00227-6

[75] Calvisi, Diego F., Maria M. Simile, Sara Ladu, Rossella Pellegrino, Valentina De Murtas, Federico Pinna, Maria L. Tomasi, et al. 2007. “Altered Methionine Metabolism and Global DNA Methylation in Liver Cancer: Relationship With Genomic Instability and Prognosis.” International Journal of Cancer 121: 2410–20. https://doi.org/10.1002/ijc.22940

[76] Karouzakis, Emmanuel, Renate E. Gay, Steffen Gay, and Michel Neidhart. 2012. “Increased Recycling of Polyamines Is Associated With Global DNA Hypomethylation in Rheumatoid Arthritis Synovial Fibroblasts.” Arthritis & Rheumatism 64: 1809–17. https://doi.org/10.1002/art.34340

[77] Pascale, Rosa M., Claudio F. Feo, Diego F. Calvisi, and Francesco Feo. 2018. “Deregulation of Methionine Metabolism as Determinant of Progression and Prognosis of Hepatocellular Carcinoma.” Translational Gastroenterology and Hepatology 3: 36. https://doi.org/10.21037/tgh.2018.06.04

[78] Jaiswal, Shivani, Vivek Mishra, Srija Majumder, Pramod P. Wangikar, and Shinjinee Sengupta. 2025. “Metabolomic Profiling Reveals Grade-Specific Niacinamide Accumulation and Its Therapeutic Potential via SIRT1-CD38-EMT Axis Modulation in Cervical Cancer Progression.” Biochimica et Biophysica Acta (BBA)—Molecular Cell Research 1872: 119994. https://doi.org/10.1016/j.bbamcr.2025.119994

[79] Yang, Yunshu, Yang Liu, Yunwei Wang, Yongyi Chao, Jinxin Zhang, Yanhui Jia, Jun Tie, et al. 2022. “Regulation of SIRT1 and Its Roles in Inflammation.” Frontiers in Immunology 13: 831168. https://doi.org/10.3389/fimmu.2022.831168

[80] Cantó, Carles, Riekelt H. Houtkooper, Eija Pirinen, Dou Y. Youn, Maaike H. Oosterveer, Yana Cen, Pablo J. Fernandez-Marcos, et al. 2012. “The NAD⁺ Precursor Nicotinamide Riboside Enhances Oxidative Metabolism and Protects Against High-Fat Diet-Induced Obesity.” Cell Metabolism 15: 838–47. https://doi.org/10.1016/j.cmet.2012.04.022

[81] Challa, Sridevi, Beman R. Khulpateea, Tulip Nandu, Cristel V. Camacho, Keun W. Ryu, Hao Chen, Yan Peng, Jayanthi S. Lea, and W. Lee Kraus. 2021. “Ribosome ADP-Ribosylation Inhibits Translation and Maintains Proteostasis in Cancers.” Cell 184: 4531–46.e26. https://doi.org/10.1016/j.cell.2021.07.005

[82] Linares, Juan F., Tania Cid-Diaz, Angeles Duran, Marta Osrodek, Anxo Martinez-Ordoñez, Miguel Reina-Campos, Hui-Hsuan Kuo, et al. 2022. “The Lactate-NAD⁺ Axis Activates Cancer-Associated Fibroblasts by Downregulating p62.” Cell Reports 39: 110792. https://doi.org/10.1016/j.celrep.2022.110792

[83] Yang, Shu-Xian, Tian-Tian Wu, Ci-Hang Ding, Peng-Cheng Zhou, Zhong-Zhong Chen, and Jin-Ying Gou. 2019. “SAHH and SAMS Form a Methyl Donor Complex With CCoAOMT7 for Methylation of Phenolic Compounds.” Biochemical and Biophysical Research Communications 520: 122–7. https://doi.org/10.1016/j.bbrc.2019.09.101

[84] Geng, Yanqing, Rufei Gao, Xueqing Liu, Xuemei Chen, Shangjing Liu, Yubin Ding, Xinyi Mu, Yingxiong Wang, and Junlin He. 2018. “Folate Deficiency Inhibits the PCP Pathway and Alters Genomic Methylation Levels During Embryonic Development.” Journal of Cellular Physiology 233: 7333–42. https://doi.org/10.1002/jcp.26564

[85] Oster, M., W. Nuchchanart, N. Trakooljul, E. Muráni, A. Zeyner, E. Wirthgen, A. Hoeflich, S. Ponsuksili, and K. Wimmers. 2016. “Methylating Micronutrient Supplementation During Pregnancy Influences Foetal Hepatic Gene Expression and IGF Signalling and Increases Foetal Weight.” European Journal of Nutrition 55: 1717–27. https://doi.org/10.1007/s00394-015-0990-2

[86] Kovatcheva, Marta, Elena Melendez, Dafni Chondronasiou, Federico Pietrocola, Raquel Bernad, Adrià Caballe, Alexandra Junza, et al. 2023. “Vitamin B12 Is a Limiting Factor for Induced Cellular Plasticity and Tissue Repair.” Nature Metabolism 5: 1911–30. https://doi.org/10.1038/s42255-023-00916-6

[87] Owen, Manon D., Bernadette C. Baker, Eleanor M. Scott, and Karen Forbes. 2021. “Interaction Between Metformin, Folate and Vitamin B12 and the Potential Impact on Fetal Growth and Long-Term Metabolic Health in Diabetic Pregnancies.” International Journal of Molecular Sciences 22: 5759. https://doi.org/10.3390/ijms22115759

[88] Williamson, Jessica M., Anya L. Arthurs, Melanie D. Smith, Claire T. Roberts, and Tanja Jankovic-Karasoulos. 2022. “High Folate, Perturbed One-Carbon Metabolism and Gestational Diabetes Mellitus.” Nutrients 14: 3930. https://doi.org/10.3390/nu14193930

[89] Sahu, Prashant, Harish Thippeswamy, and Santosh K. Chaturvedi. 2022. “Neuropsychiatric Manifestations in Vitamin B12 Deficiency.” Vitamins and Hormones 119: 457–70. https://doi.org/10.1016/bs.vh.2022.01.001

[90] Simonenko, Sergey Yu, Daria A. Bogdanova, and Nikita A. Kuldyushev. 2024. “Emerging Roles of Vitamin B12 in Aging and Inflammation.” International Journal of Molecular Sciences 25: 5044. https://doi.org/10.3390/ijms25095044

[91] Zheng, Yuxiang, Ting-Yu Lin, Gina Lee, Marcia N. Paddock, Jessica Momb, Zhe Cheng, Qian Li, et al. 2018. “Mitochondrial One-Carbon Pathway Supports Cytosolic Folate Integrity in Cancer Cells.” Cell 175: 1546–60. https://doi.org/10.1016/j.cell.2018.09.041

[92] Zhong, Kun, Xiaojun Liu, Weihua Ding, Lizhong Peng, Xuhui Zeng, and Yayun Gu. 2023. “TRAF Inhibition Drives Cancer Cell Apoptosis and Improves Retinoic Acid Sensitivity in Multiple Cancers Models.” Discover Oncology 14: 117. https://doi.org/10.1007/s12672-023-00703-5

[93] Cabezas-Wallscheid, Nina, Florian Buettner, Pia Sommerkamp, Daniel Klimmeck, Luisa Ladel, Frederic B. Thalheimer, Daniel Pastor-Flores, et al. 2017. “Vitamin A-Retinoic Acid Signaling Regulates Hematopoietic Stem Cell Dormancy.” Cell 169: 807–23.e19. https://doi.org/10.1016/j.cell.2017.04.018

[94] Yang, Ruhui, Zhe Wei, and Songquan Wu. 2019. “Lumiflavin Increases the Sensitivity of Ovarian Cancer Stem-Like Cells to Cisplatin by Interfering With Riboflavin.” Journal of Cellular and Molecular Medicine 23: 5329–39. https://doi.org/10.1111/jcmm.14409

[95] Beltrà, Marc, Noora Pöllänen, Claudia Fornelli, Kialiina Tonttila, Myriam Y. Hsu, Sandra Zampieri, Lucia Moletta, et al. 2023. “NAD(+) Repletion With Niacin Counteracts Cancer Cachexia.” Nature Communications 14: 1849. https://doi.org/10.1038/s41467-023-37595-6

[96] Graziani, Claudio, Anna Barile, Lorenzo Antonelli, Annarita Fiorillo, Andrea Ilari, Fabrizio Vetica, Martino Luigi di Salvo, et al. 2024. “The Z Isomer of Pyridoxilidenerhodanine 5′-Phosphate Is an Efficient Inhibitor of Human Pyridoxine 5′-Phosphate Oxidase, a Crucial Enzyme in Vitamin B(6) Salvage Pathway and a Potential Chemotherapeutic Target.” FEBS Journal 291: 4984–5001. https://doi.org/10.1111/febs.17274

[97] Gylling, Björn, Robin Myte, Jörn Schneede, Göran Hallmans, Jenny Häggström, Ingegerd Johansson, Arve Ulvik, et al. 2017. “Vitamin B-6 and Colorectal Cancer Risk: A Prospective Population-Based Study Using 3 Distinct Plasma Markers of Vitamin B-6 Status.” American Journal of Clinical Nutrition 105: 897–904. https://doi.org/10.3945/ajcn.116.139337

[98] Wu, Tsai-Ming, Shu-Ting Liu, Ssu-Yu Chen, Gunng-Shinng Chen, Chia-Chun Wu, and Shih-Ming Huang. 2020. “Mechanisms and Applications of the Anti-Cancer Effect of Pharmacological Ascorbic Acid in Cervical Cancer Cells.” Frontiers in Oncology 10: 1483. https://doi.org/10.3389/fonc.2020.01483

[99] Ratsma, Danielle M. A., Max Muller, Marijke Koedam, M. Carola Zillikens, and Bram C. J. van der Eerden. 2023. “In Vitro Regulation of Fibroblast Growth Factor 23 by 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Synthesized by Osteocyte-Like MC3T3-E1 Cells.” European Journal of Endocrinology 189: 448–59. https://doi.org/10.1093/ejendo/lvad131

[100] O'Mahony, Caitlin, Adam Clooney, Siobhan F. Clarke, Mònica Aguilera, Aisling Gavin, Donjete Simnica, Mary Ahern, et al. 2023. “Dietary-Induced Bacterial Metabolites Reduce Inflammation and Inflammation-Associated Cancer via Vitamin D Pathway.” International Journal of Molecular Sciences 24: 1864. https://doi.org/10.3390/ijms24031864

[101] Elimrani, Ihsan, Jamie Koenekoop, Serge Dionne, Valerie Marcil, Edgar Delvin, Emile Levy, and Ernest G. Seidman. 2017. “Vitamin D Reduces Colitis- and Inflammation-Associated Colorectal Cancer in Mice Independent of NOD2.” Nutrition and Cancer 69: 276–88. https://doi.org/10.1080/01635581.2017.1263346

[102] Wang, Zheng, Lingjuan Jiang, Xiaoyin Bai, Mingyue Guo, Runing Zhou, Qingyang Zhou, Hong Yang, and Jiaming Qian. 2025. “Vitamin D Receptor Regulates Methyltransferase Like 14 to Mitigate Colitis-Associated Colorectal Cancer.” Journal of Genetics and Genomics 52: 1011–20. https://doi.org/10.1016/j.jgg.2024.12.020

[103] Liao, Sijia, Lisa Börmel, Anke Katharina Müller, Luisa Gottschalk, Nadine Pritsch, Lara Zoé Preisner, Oleksandra Samokhina, et al. 2024. “α-Tocopherol Long-Chain Metabolite α-T-13′-COOH Exhibits Biphasic Effects on Cell Viability, Induces ROS-Dependent DNA Damage, and Modulates Redox Status in Murine RAW264.7 Macrophages.” Molecular Nutrition & Food Research 68: e2400455. https://doi.org/10.1002/mnfr.202400455

[104] Duan, Fengsen, Chunlei Mei, Luhao Yang, Junyan Zheng, Huiai Lu, Yanzhi Xia, Stacy Hsu, Huageng Liang, and Ling Hong. 2020. “Vitamin K2 Promotes PI3K/AKT/HIF-1α-Mediated Glycolysis That Leads to AMPK-Dependent Autophagic Cell Death in Bladder Cancer Cells.” Scientific Reports 10: 7714. https://doi.org/10.1038/s41598-020-64880-x

[105] Yang, Kun, Min Fan, Xiaohui Wang, Jingjing Xu, Yana Wang, Fei Tu, P Spencer Gill, et al. 2022. “Lactate Promotes Macrophage HMGB1 Lactylation, Acetylation, and Exosomal Release in Polymicrobial Sepsis.” Cell Death & Differentiation 29: 133–46. https://doi.org/10.1038/s41418-021-00841-9

[106] Zhang, Dan, Yong-Ping Jian, Yu-Ning Zhang, Yao Li, Li-Ting Gu, Hui-Hui Sun, Ming-Di Liu, et al. 2023. “Short-Chain Fatty Acids in Diseases.” Cell Communication and Signaling 21: 212. https://doi.org/10.1186/s12964-023-01219-9

[107] Chen, Rui, Min Xu, Jason S. Nagati, Richard T. Hogg, Alok Das, Robert D. Gerard, et al. 2015. “The Acetate/ACSS2 Switch Regulates HIF-2 Stress Signaling in the Tumor Cell Microenvironment.” PloS One 10: e0116515. https://doi.org/10.1371/journal.pone.0123612

[108] Arpaia, Nicholas, Clarissa Campbell, Xiying Fan, Stanislav Dikiy, Joris Van Der Veeken, Paul Deroos, Hui Liu, et al. 2013. “Metabolites Produced by Commensal Bacteria Promote Peripheral Regulatory T-Cell Generation.” Nature 504: 451–5. https://doi.org/10.1038/nature12726

[109] Guo, Jian, Fanqi Meng, Ruixue Hu, Lei Chen, Jiang Chang, Ke Zhao, Honglin Ren, et al. 2024. “Inhibition of the NF-κB/HIF-1α Signaling Pathway in Colorectal Cancer by Tyrosol: A Gut Microbiota-Derived Metabolite.” Journal for ImmunoTherapy of Cancer 12: e008831. https://doi.org/10.1136/jitc-2024-008831

[110] Jia, Dingjiacheng, Qiwen Wang, Yadong Qi, Yao Jiang, Jiamin He, Yifeng Lin, Yong Sun, et al. 2024. “Microbial Metabolite Enhances Immunotherapy Efficacy by Modulating T Cell Stemness in Pan-Cancer.” Cell 187: 1651–65. https://doi.org/10.1016/j.cell.2024.02.022

[111] Meng, Qing, Jianshuang Guo, Ke Lv, Yang Liu, Jin Zhang, Mingyue Li, Xirui Cheng, et al. 2024. “5S-Heudelotinone Alleviates Experimental Colitis by Shaping the Immune System and Enhancing the Intestinal Barrier in a Gut Microbiota-Dependent Manner.” Acta Pharmaceutica Sinica B 14: 2153–76. https://doi.org/10.1016/j.apsb.2024.02.020

[112] Tsai, Min-Ling, Cheng-Chieh Yen, Fung-Jou Lu, Hung-Chih Ting, and Horng-Rong Chang. 2016. “Environmentally Relevant Concentration of Arsenic Trioxide and Humic Acid Promoted Tumor Progression of Human Cervical Cancer Cells: in Vivo and In Vitro Studies.” Environmental Toxicology 31: 1121–32. https://doi.org/10.1002/tox.22121

[113] Anantharaju, Preethi G., Bandi Deepa Reddy, Mahesh A. Padukudru, Ch M. Kumari Chitturi, Manjunath G. Vimalambike, and SubbaRao V. Madhunapantula. 2017. “Naturally Occurring Benzoic Acid Derivatives Retard Cancer Cell Growth by Inhibiting Histone Deacetylases (HDAC).” Cancer Biology & Therapy 18: 492–504. https://doi.org/10.1080/15384047.2017.1324374

[114] Li, Qingran, Lijuan Cao, Yang Tian, Pei Zhang, Chujie Ding, Wenjie Lu, Chenxi Jia, et al. 2018. “Butyrate Suppresses the Proliferation of Colorectal Cancer Cells via Targeting Pyruvate Kinase M2 and Metabolic Reprogramming.” Molecular & Cellular Proteomics 17: 1531–45. https://doi.org/10.1074/mcp.RA118.000752

[115] Zhang, Chen, Yiying Wang, Mengdi He, Chenyang Wang, Kankan Cao, Yujing Zhong, Xueling Wang, et al. 2025. “Mannose Enhances Immunotherapy Efficacy in Ovarian Cancer by Modulating Gut Microbial Metabolites.” Cancer Research 85: 2468–84. https://doi.org/10.1158/0008-5472.Can-24-3209

[116] Yang, Yang, Tianduo Pei, Xiaolin Hu, Yu Lu, Yanqiu Huang, Tingya Wan, Chaobao Liu, et al. 2024. “Dietary Vitamin B3 Supplementation Induces the Antitumor Immunity Against Liver Cancer via Biased GPR109A Signaling in Myeloid Cell.” Cell Reports Medicine 5: 101718. https://doi.org/10.1016/j.xcrm.2024.101718

[117] Huang, Wen-Shih, Jen-Tsung Yang, Chien-Chang Lu, Shun-Fu Chang, Cheng-Nan Chen, Yu-Ping Su, and Ko-Chao Lee. 2015. “Fulvic Acid Attenuates Resistin-Induced Adhesion of HCT-116 Colorectal Cancer Cells to Endothelial Cells.” International Journal of Molecular Sciences 16: 29370–82. https://doi.org/10.3390/ijms161226174

[118] Yang, Haochi, Binghuo Wu, Qi Yang, Tian Tan, Dan Shang, Jie Chen, Chenhui Cao, Chuan Xu, et al. 2024. “Urolithin C Suppresses Colorectal Cancer Progression via the AKT/mTOR Pathway.” Journal of Natural Medicines 78: 887–900. https://doi.org/10.1007/s11418-024-01821-2

[119] Murayama, Masakazu, Masahiro Hosonuma, Atsuo Kuramasu, Sei Kobayashi, Akiko Sasaki, Yuta Baba, Yoichiro Narikawa, et al. 2024. “Isobutyric Acid Enhances the Anti-Tumour Effect of Anti-PD-1 Antibody.” Scientific Reports 14: 11325. https://doi.org/10.1038/s41598-024-59677-1

[120] Li, Qingran, Chujie Ding, Tuo Meng, Wenjie Lu, Wenyue Liu, Haiping Hao, and Lijuan Cao. 2017. “Butyrate Suppresses Motility of Colorectal Cancer Cells via Deactivating Akt/ERK Signaling in Histone Deacetylase Dependent Manner.” Journal of Pharmacological Sciences 135: 148–55. https://doi.org/10.1016/j.jphs.2017.11.004

[121] Lofft, Zoe, Amel Taibi, Paraskevi Massara, Tomas Tokar, Inke Paetau-Robinson, Christina Khoo, and Elena M. Comelli. 2022. “Cranberry Proanthocyanidin and Its Microbial Metabolite 3,4-Dihydroxyphenylacetic Acid, but Not 3-(4-Hydroxyphenyl)-Propionic Acid, Partially Reverse Pro-Inflammatory microRNA Responses in Human Intestinal Epithelial Cells.” Molecular Nutrition & Food Research 66: e2100853. https://doi.org/10.1002/mnfr.202100853

[122] Kang, Xing, Changan Liu, Yanqiang Ding, Yunbi Ni, Fenfen Ji, Harry Cheuk Hay Lau, Lanping Jiang, et al. 2023. “Roseburia Intestinalis Generated Butyrate Boosts Anti-PD-1 Efficacy in Colorectal Cancer by Activating Cytotoxic CD8⁺ T Cells.” Gut 72: 2112–22. https://doi.org/10.1136/gutjnl-2023-330291

[123] Colbert, Lauren E., Molly B. El Alam, Rui Wang, Tatiana Karpinets, David Lo, Erica J. Lynn, Timothy A. Harris, et al. 2023. “Tumor-Resident Lactobacillus Iners Confer Chemoradiation Resistance Through Lactate-Induced Metabolic Rewiring.” Cancer Cell 41: 1945–62.e11. https://doi.org/10.1016/j.ccell.2023.09.012

[124] Wang, Ying, Jiarui Chen, Weiqing Tang, Yanping Zhang, and Xiaoyan Li. 2017. “Rapamycin Inhibits the Proliferation of Endothelial Cells in Hemangioma by Blocking the mTOR-FABP4 Pathway.” Biomedicine & Pharmacotherapy 85: 272–9. https://doi.org/10.1016/j.biopha.2016.11.021

[125] Liu, Xiao-Min, Wen-Ting Zhu, Meng-Lei Jia, Yu-Ting Li, Ye Hong, Zhong-Qiu Liu, and Peng-Ke Yan. 2022. “Rapamycin Liposomes Combined With 5-Fluorouracil Inhibits Angiogenesis and Tumor Growth of APC ((Min/+)) Mice and AOM/DSS-Induced Colorectal Cancer Mice.” International Journal of Nanomedicine 17: 5049–61. https://doi.org/10.2147/ijn.S373777

[126] Sugimura, Naoki, Qing Li, Eagle Siu Hong Chu, Harry Cheuk Hay Lau, Winnie Fong, Weixin Liu, Cong Liang, et al. 2021. “Lactobacillus gallinarum Modulates the Gut Microbiota and Produces Anti-Cancer Metabolites to Protect Against Colorectal Tumourigenesis.” Gut 71: 2011–21. https://doi.org/10.1136/gutjnl-2020-323951

[127] Sári, Zsanett, Edit Mikó, Tünde Kovács, Laura Jankó, Tamás Csonka, Gréta Lente, Éva Sebő, et al. 2020. “Indolepropionic Acid, a Metabolite of the Microbiome, Has Cytostatic Properties in Breast Cancer by Activating AHR and PXR Receptors and Inducing Oxidative Stress.” Cancers 12: 2411. https://doi.org/10.3390/cancers12092411

[128] Pham, Chau Ha, Joo-Eun Lee, Jinha Yu, Sung Hoon Lee, Kyung-Rok Yu, Jaewoo Hong, Namki Cho, et al. 2021. “Anticancer Effects of Propionic Acid Inducing Cell Death in Cervical Cancer Cells.” Molecules 26: 4951. https://doi.org/10.3390/molecules26164951

[129] Sharma, Sharada H., Vinothkumar Rajamanickam, and Sangeetha Nagarajan. 2018. “Antiproliferative Effect of P-Coumaric Acid Targets UPR Activation by Downregulating Grp78 in Colon Cancer.” Chemico-Biological Interactions 291: 16–28. https://doi.org/10.1016/j.cbi.2018.06.001

[130] Jaye, Kayla, Muhammad A. Alsherbiny, Dennis Chang, Chun-Guang Li, and Deep Jyoti Bhuyan. 2023. “Mechanistic Insights into the Anti-Proliferative Action of Gut Microbial Metabolites Against Breast Adenocarcinoma Cells.” International Journal of Molecular Sciences 24: 15053. https://doi.org/10.3390/ijms242015053

[131] Al-Khazaleh, Ahmad K., Muhammad A. Alsherbiny, Gerald Münch, Dennis Chang, and Deep Jyoti Bhuyan. 2025. “Gut Microbial Postbiotics as Potential Therapeutics for Lymphoma: Proteomics Insights of the Synergistic Effects of Nisin and Urolithin B Against Human Lymphoma Cells.” International Journal of Molecular Sciences 26: 6829. https://doi.org/10.3390/ijms26146829

[132] Che, Yibin, Guoyu Chen, Qianqian Guo, Yourong Duan, Haizhong Feng, and Qiang Xia. 2023. “Gut Microbial Metabolite Butyrate Improves Anticancer Therapy by Regulating Intracellular Calcium Homeostasis.” Hepatology 78: 88–102. https://doi.org/10.1097/hep.0000000000000047

[133] Kofla, G., C. Radecke, M. Frentsch, W. Walther, S. Stintzing, H. Riess, L. Bullinger, and I.-K. Na. 2022. “Conventional Amphotericin B Elicits Markers of Immunogenic Cell Death on Leukemic Blasts, Mediates Immunostimulatory Effects on Phagocytic Cells, and Synergizes With PD-L1 Blockade.” Oncoimmunology 11: 2068109. https://doi.org/10.1080/2162402x.2022.2068109

[134] Zhang, Jing, Dongqing Cao, Shuangquan Yu, Lingchao Chen, Daolin Wei, Chang Shen, Lin Zhuang, et al. 2018. “Amphotericin B Suppresses M2 Phenotypes and B7-H1 Expression in Macrophages to Prevent Raji Cell Proliferation.” BMC Cancer 18: 467. https://doi.org/10.1186/s12885-018-4266-0

[135] Ma, Hongbin, Liang Yang, Yingchao Liang, Fenghua Liu, Jinxiang Hu, Rui Zhang, Yong Li, Lei Yuan, and Feiling Feng. 2024. “B. Thetaiotaomicron-Derived Acetic Acid Modulate Immune Microenvironment and Tumor Growth in Hepatocellular Carcinoma.” Gut Microbes 16: 2297846. https://doi.org/10.1080/19490976.2023.2297846

[136] Liao, Qing, Ximing Zhou, Ling Wu, Yuyi Yang, Xiaohui Zhu, Hangyu Liao, Yujie Zhang, et al. 2025. “Gut Microbial Metabolite 4-Hydroxybenzeneacetic Acid Drives Colorectal Cancer Progression via Accumulation of Immunosuppressive PMN-MDSCs.” Journal of Clinical Investigation 135: e181243. https://doi.org/10.1172/jci181243

[137] Bohnsack, John Peyton, Vraj K. Patel, and A Leslie Morrow. 2017. “Ethanol Exposure Regulates Gabra1 Expression via Histone Deacetylation at the Promoter in Cultured Cortical Neurons.” Journal of Pharmacology and Experimental Therapeutics 363: 1–11. https://doi.org/10.1124/jpet.117.242446

[138] Sakharkar, Amul J., Huaibo Zhang, Lei Tang, Kathryn Baxstrom, Guangbin Shi, Sachin Moonat, and Subhash C. Pandey. 2014. “Effects of Histone Deacetylase Inhibitors on Amygdaloid Histone Acetylation and Neuropeptide Y Expression: A Role in Anxiety-Like and Alcohol-Drinking Behaviours.” International Journal of Neuropsychopharmacology 17: 1207–20. https://doi.org/10.1017/S1461145714000054

[139] Gao, Xue, Shu-Hai Lin, Feng Ren, Jin-Tao Li, Jia-Jia Chen, Chuan-Bo Yao, Hong-Bin Yang, et al. 2016. “Acetate Functions as an Epigenetic Metabolite to Promote Lipid Synthesis Under Hypoxia.” Nature Communications 7: 11960. https://doi.org/10.1038/ncomms11960

[140] Hu, Yongfeng, Yue Lu, Yu Zhao, and Dao-Xiu Zhou. 2019. “Histone Acetylation Dynamics Integrates Metabolic Activity to Regulate Plant Response to Stress.” Frontiers in Plant Science 10: 1236. https://doi.org/10.3389/fpls.2019.01236

[141] Guidolin, Valeria, Erik S. Carlson, Andrea Carrà, Peter W. Villalta, Laura A. Maertens, Stephen S. Hecht, and Silvia Balbo. 2021. “Identification of New Markers of Alcohol-Derived DNA Damage in Humans.” Biomolecules 11: 366. https://doi.org/10.3390/biom11030366

[142] de Graaf, Bendert, Adam Clore, and Amanda K. McCullough. 2009. “Cellular Pathways for DNA Repair and Damage Tolerance of Formaldehyde-Induced DNA-Protein Crosslinks.” DNA Repair 8: 1207–14. https://doi.org/10.1016/j.dnarep.2009.06.007

[143] Niu, Chunyang, Sujuan Zhang, Guilin Mo, Yilong Jiang, Liang Li, Hengyong Xu, Chunchun Han, et al. 2021. “Effects of ODC on Polyamine Metabolism, Hormone Levels, Cell Proliferation and Apoptosis in Goose Ovarian Granulosa Cells.” Poultry Science 100: 101226. https://doi.org/10.1016/j.psj.2021.101226

[144] Meng, Xiangqi, Jingxuan Peng, Xiaoshan Xie, Fenghai Yu, Wencong Wang, Qihao Pan, Huilin Jin, et al. 2022. “Roles of lncRNA LVBU in Regulating Urea Cycle/Polyamine Synthesis Axis to Promote Colorectal Carcinoma Progression.” Oncogene 41: 4231–43. https://doi.org/10.1038/s41388-022-02413-8

[145] Cui, Hao, Bao Zhu, Huiyan Li, Yuanyuan Meng, Meng Cai, Hui Wang, Min Yuan, et al. 2024. “Malonate Differentially Affects Cell Survival and Confers Chemoresistance in Cancer Cells via the Induction of p115950-Dependent Autophagy.” Biochemical Pharmacology 219: 115950. https://doi.org/10.1016/j.bcp.2023.115950

[146] Zhou, Yi, Liang Hu, Wenqing Tang, Dongping Li, Lijie Ma, Hongchun Liu, Shuncai Zhang, et al. 2021. “Hepatic NOD2 Promotes Hepatocarcinogenesis via a RIP2-Mediated Proinflammatory Response and a Novel Nuclear Autophagy-Mediated DNA Damage Mechanism.” Journal of Hematology & Oncology 14: 1–19. https://doi.org/10.1186/s13045-020-01028-4

[147] Meng, Qingfei, Huihui Sun, Yanghe Zhang, Xiangzhe Yang, Shiming Hao, Bin Liu, Honglan Zhou, Zhi-Xiang Xu, and Yishu Wang. 2024. “Lactylation Stabilizes DCBLD1 Activating the Pentose Phosphate Pathway to Promote Cervical Cancer Progression.” Journal of Experimental & Clinical Cancer Research 43: 36. https://doi.org/10.1186/s13046-024-02943-x

[148] Ma, Yi, Haiming Chen, Haoran Li, Meiling Zheng, Xianglin Zuo, Wenxiang Wang, Shaodong Wang, et al. 2024. “Intratumor Microbiome-Derived Butyrate Promotes Lung Cancer Metastasis.” Cell Reports Medicine 5: 101488. https://doi.org/10.1016/j.xcrm.2024.101488

[149] Liao, Ruocen, Xingyu Chen, Qianhua Cao, Longchang Bai, Chenglong Ma, Zhijun Dai, and Chenfang Dong. 2024. “AMD1 Promotes Breast Cancer Aggressiveness via a Spermidine-eIF5A Hypusination-TCF4 Axis.” Breast Cancer Research 26: 70. https://doi.org/10.1186/s13058-024-01825-6

[150] Plebanek, Michael P., Yue Xue, Y-Van Nguyen, Nicholas C. DeVito, Xueying Wang, Alisha Holtzhausen, Georgia M. Beasley, Balamayooran Theivanthiran, and Brent A. Hanks. 2024. “A lactate-SREBP2 Signaling Axis Drives Tolerogenic Dendritic Cell Maturation and Promotes Cancer Progression.” Science Immunology 9: eadi4191. https://doi.org/10.1126/sciimmunol.adi4191

[151] Zhu, Pingping, Tiankun Lu, Zhenzhen Chen, Benyu Liu, Dongdong Fan, Chong Li, Jiayi Wu, et al. 2022. “5-Hydroxytryptamine Produced by Enteric Serotonergic Neurons Initiates Colorectal Cancer Stem Cell Self-Renewal and Tumorigenesis.” Neuron 110: 2268–82, e64. https://doi.org/10.1016/j.neuron.2022.04.024

[152] Mai, Zongjiong. 2024. “Citraconate Promotes the Malignant Progression of Colorectal Cancer by Inhibiting Ferroptosis.” American Journal of Cancer Research 14: 2790–804. https://doi.org/10.62347/lwrs3363

[153] Su, Jin, Xinyuan Mao, Lingzhi Wang, Zhian Chen, Weisheng Wang, Cuiyin Zhao, Guoxin Li, Weihong Guo, and Yanfeng Hu. 2024. “Lactate/GPR81 Recruits Regulatory T Cells by Modulating CX3CL1 to Promote Immune Resistance in a Highly Glycolytic Gastric Cancer.” Oncoimmunology 13: 2320951. https://doi.org/10.1080/2162402x.2024.2320951

[154] Yang, Shuyan, Hui Dai, Yimei Lu, Rui Li, Chengjin Gao, and Shuming Pan. 2022. “Trimethylamine N-Oxide Promotes Cell Proliferation and Angiogenesis in Colorectal Cancer.” Journal of Immunology Research 2022: 7043856. https://doi.org/10.1155/2022/7043856

[155] Yan, Chaolong, Zijiang Yang, Pin Chen, Yuyang Yeh, Chongjing Sun, Tao Xie, Wei Huang, and Xiaobiao Zhang. 2024. “GPR65 Sensing Tumor-Derived Lactate Induces HMGB1 Release From TAM via the cAMP/PKA/CREB Pathway to Promote Glioma Progression.” Journal of Experimental & Clinical Cancer Research 43: 105. https://doi.org/10.1186/s13046-024-03025-8

[156] Liu, Li, Wenxiao Dong, Sinan Wang, Yujie Zhang, Tianyu Liu, Runxiang Xie, Bangmao Wang, and Hailong Cao. 2018. “Deoxycholic Acid Disrupts the Intestinal Mucosal Barrier and Promotes Intestinal Tumorigenesis.” Food & Function 9: 5588–97. https://doi.org/10.1039/c8fo01143e

[157] Sun, Jiwei, Qingming Tang, Shaoling Yu, Mengru Xie, Wenhao Zheng, Guangjin Chen, Ying Yin, et al. 2023. “F. nucleatum Facilitates Oral Squamous Cell Carcinoma Progression via GLUT1-Driven Lactate Production.” EBioMedicine 88: 104444. https://doi.org/10.1016/j.ebiom.2023.104444

[158] Liu, Xueqing, Bi Chen, Wenjie You, Shan Xue, Hui Qin, and Handong Jiang. 2018. “The Membrane Bile Acid Receptor TGR5 Drives Cell Growth and Migration via Activation of the JAK2/STAT3 Signaling Pathway in Non-Small Cell Lung Cancer.” Cancer Letters 412: 194–207. https://doi.org/10.1016/j.canlet.2017.10.017

[159] Shao, Xinyu, Luojie Liu, Yuqing Zhou, Kaiqiang Zhong, Jinrong Gu, Tong Hu, Yizhou Yao, Chunli Zhou, and Weichang Chen. 2023. “High-Fat Diet Promotes Colitis-Associated Tumorigenesis by Altering Gut Microbial Butyrate Metabolism.” International Journal of Biological Sciences 19: 5004–19. https://doi.org/10.7150/ijbs.86717

[160] Zhao, Yupeng, Jiang Jiang, Peng Zhou, Kaiyuan Deng, Ziyuan Liu, Mengqi Yang, Xiao Yang, et al. 2024. “H3K18 Lactylation-Mediated VCAM1 Expression Promotes Gastric Cancer Progression and Metastasis via AKT-mTOR-CXCL1 Axis.” Biochemical Pharmacology 222: 116120. https://doi.org/10.1016/j.bcp.2024.116120

[161] Rao, Keqiang, Xinchao Zhang, Yi Luo, Qiang Xia, Yuting Jin, and Jing He. 2025. “Lactylation Orchestrates Ubiquitin-Independent Degradation of cGAS and Promotes Tumor Growth.” Cell Reports 44: 115441. https://doi.org/10.1016/j.celrep.2025.115441

[162] Tajpara, Poojabahen, Michał Jacek Sobkowiak, Katie Healy, Sabrina Naud, Beate Gündel, Asif Halimi, Zara Ahmad Khan, et al. 2025. “Patient-Derived Pancreatic Tumor Bacteria Exhibit Oncogenic Properties and Are Recognized by MAIT Cells in Tumor Spheroids.” Frontiers in Immunology 16: 1553034. https://doi.org/10.3389/fimmu.2025.1553034

[163] Yang, Jing, Xuhui Tong, Wei Wang, Xianjun Yu, Jin Xu, and Si Shi. 2024. “Targeting CA9 Restricts Pancreatic Cancer Progression through Ph Regulation and ROS Production.” Cell Oncol 47: 2367–82. https://doi.org/10.1007/s13402-024-01022-9

[164] Glymenaki, Maria, Sophie Curio, Smeeta Shrestha, Qi Zhong, Laura Rushton, Rachael Barry, Mona El-Bahrawy, et al. 2025. “Roux-en-Y Gastric Bypass-Associated Fecal Tyramine Promotes Colon Cancer Risk via Increased DNA Damage, Cell Proliferation, and Inflammation.” Microbiome 13: 60. https://doi.org/10.1186/s40168-025-02049-2

[165] Hezaveh, Kebria, Rahul S. Shinde, Andreas Klötgen, Marie Jo Halaby, Sara Lamorte, M. Teresa Ciudad, Rene Quevedo, et al. 2022. “Tryptophan-Derived Microbial Metabolites Activate the Aryl Hydrocarbon Receptor in Tumor-Associated Macrophages to Suppress Anti-Tumor Immunity.” Immunity 55: 324–40. https://doi.org/10.1016/j.immuni.2022.01.006

[166] Gu, Xuyu, Yifei Zhu, Jincheng Su, Sheng Wang, Xiangyu Su, Xu Ding, Lei Jiang, Xiang Fei, and Wentian Zhang. 2024. “Lactate-Induced Activation of Tumor-Associated Fibroblasts and IL-8-Mediated Macrophage Recruitment Promote Lung Cancer Progression.” Redox Biology 74: 103209. https://doi.org/10.1016/j.redox.2024.103209

[167] Song, Qi, Zhiliang Jin, Han Zhang, Kunqiao Hong, Beibei Zhu, Haisen Yin, and Baoping Yu. 2025. “Fusobacterium Nucleatum-Derived 3-Indolepropionic Acid Promotes Colorectal Cancer Progression via Aryl Hydrocarbon Receptor Activation in Macrophages.” Chemico-Biological Interactions 414: 111495. https://doi.org/10.1016/j.cbi.2025.111495

[168] Pandkar, Madhura R., Sommya Sinha, Atul Samaiya, and Sanjeev Shukla. 2023. “Oncometabolite Lactate Enhances Breast Cancer Progression by Orchestrating Histone Lactylation-Dependent C-Myc Expression.” Translational Oncology 37: 101758. https://doi.org/10.1016/j.tranon.2023.101758

[169] Zhou, Yuhua, Jing Lv, Shengkai Jin, Chaowei Fu, Bo Liu, Yang Shen, Menglu Li, Yuwei Zhang, and Ninghan Feng. 2024. “Gut Microbiota Derived Metabolite Trimethylamine N-Oxide Influences Prostate Cancer Progression via the p38/HMOX1 Pathway.” Frontiers in Pharmacology 15: 1526051. https://doi.org/10.3389/fphar.2024.1526051

[170] Wu, Jing-Yiing, Tsai-Wang Huang, Yi-Ting Hsieh, Yi-Fu Wang, Chia-Chien Yen, Guan-Lin Lee, Chang-Ching Yeh, et al. 2020. “Cancer-Derived Succinate Promotes Macrophage Polarization and Cancer Metastasis via Succinate Receptor.” Molecular Cell 77: 213–27. https://doi.org/10.1016/j.molcel.2019.10.023

[171] Varanasi, Siva Karthik, Dan Chen, Yingluo Liu, Melissa A. Johnson, Cayla M. Miller, Souradipta Ganguly, Kathryn Lande, et al. 2025. “Bile Acid Synthesis Impedes Tumor-Specific T Cell Responses During Liver Cancer.” Science 387: 192–201. https://doi.org/10.1126/science.adl4100

[172] Varma, Gopal, Pankaj Seth, Patricia Coutinho de Souza, Cody Callahan, Jocelin Pinto, Manushka Vaidya, Olmo Sonzogni, et al. 2021. “Visualizing the Effects of Lactate Dehydrogenase (LDH) Inhibition and LDH-A Genetic Ablation in Breast and Lung Cancer With Hyperpolarized Pyruvate NMR.” NMR in Biomedicine 34: e4560. https://doi.org/10.1002/nbm.4560

[173] Khajah, Maitham A., Sarah Khushaish, and Yunus A. Luqmani. 2021. “Lactate Dehydrogenase A or B Knockdown Reduces Lactate Production and Inhibits Breast Cancer Cell Motility In Vitro.” Frontiers in Pharmacology 12: 747001. https://doi.org/10.3389/fphar.2021.747001

[174] Yang, Qingzhuoma, Shengtao Guo, Qi Lu, Yong Tao, Decong Zheng, Qinmao Zhou, and Jun Liu. 2021. “Butyryl/Caproyl-CoA: Acetate CoA-Transferase: Cloning, Expression and Characterization of the Key Enzyme Involved in Medium-Chain Fatty Acid Biosynthesis.” Bioscience Reports 41: BSR20211135. https://doi.org/10.1042/BSR20211135

[175] Ortega, Juliana Festa, Renato Heidor, Ana Paula Auriemo, Juliana Marques Affonso, Thais Pereira D’ Amico, Corinna Herz, Aline de Conti, et al. 2021. “Butyrate-Containing Structured Lipids Act on HDAC4, HDAC6, DNA Damage and Telomerase Activity During Promotion of Experimental Hepatocarcinogenesis.” Carcinogenesis 42: 1026–36. https://doi.org/10.1093/carcin/bgab039

[176] More, Tushar H., Sourav RoyChoudhury, Joel Christie, Khushman Taunk, Anupama Mane, Manas K. Santra, Koel Chaudhury, and Srikanth Rapole. 2017. “Metabolomic Alterations in Invasive Ductal Carcinoma of Breast: A Comprehensive Metabolomic Study Using Tissue and Serum Samples.” Oncotarget 9: 2678–96. https://doi.org/10.18632/oncotarget.23626

[177] Beksac, Kemal, Tuba Reçber, Bahadır Çetin, Orkun Alp, Volkan Kaynaroğlu, Sedef Kır, and Emirhan Nemutlu. 2023. “GC-MS Based Metabolomics Analysis to Evaluate Short-Term Effect of Tumor Removal on Patients With Early-Stage Breast Cancer.” Journal of Chromatographic Science 61: 612–8. https://doi.org/10.1093/chromsci/bmac035

[178] Katsaounou, Kyriaki, Danae Yiannakou, Elpiniki Nikolaou, Cameron Brown, Paris Vogazianos, Aristos Aristodimou, Jianxiang Chi, et al. 2023. “Fecal Microbiota and Associated Volatile Organic Compounds Distinguishing No-Adenoma From High-Risk Colon Adenoma Adults.” Metabolites 13: 819. https://doi.org/10.3390/metabo13070819

[179] Casadei-Gardini, Andrea, Laura Del Coco, Giorgia Marisi, Fabio Conti, Giulia Rovesti, Paola Ulivi, Matteo Canale, et al. 2020. “1H-NMR Based Serum Metabolomics Highlights Different Specific Biomarkers Between Early and Advanced Hepatocellular Carcinoma Stages.” Cancers 12: 241. https://doi.org/10.3390/cancers12010241

[180] Li, Yuting, Bicheng Wang, Shihong Fei, and You Qin. 2024. “Predictive Value of Direct Bilirubin and Total Bile Acid in Lung Adenocarcinoma Patients Treated With EGFR-TKIs.” BMC Pulmonary Medicine 24: 583. https://doi.org/10.1186/s12890-024-03367-1

[181] Xu, Yanjun, Kaibo Ding, Zhongsheng Peng, Ling Ding, Hui Li, and Yun Fan. 2024. “Evaluating for Correlations Between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts.” Molecular Cancer Therapeutics 23: 733–42. https://doi.org/10.1158/1535-7163.MCT-23-0459

[182] Wang, Daguang, Wei Li, Qi Zou, Lei Yin, Yechao Du, Jingkai Gu, and Jian Suo. 2017. “Serum Metabolomic Profiling of Human Gastric Cancer and Its Relationship With the Prognosis.” Oncotarget 8: 110000–15. https://doi.org/10.18632/oncotarget.21314

[183] Wang, Pan Pan, Xin Song, Xue Ke Zhao, Meng Xia Wei, She Gan Gao, Fu You Zhou, Xue Na Han, et al. 2022. “Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma.” Frontiers in Oncology 12: 790933. https://doi.org/10.3389/fonc.2022.790933

[184] Yang, Jie, Yunyun Zhu, Yijian Zhou, Jiaying Zhang, Yuxuan Wei, Yongpan Liu, Bo Zhang, et al. 2025. “Potential Biomarkers Develop for Predicting the Prognosis of Patients With Esophageal Squamous Cell Carcinoma After Optimized Chemoradiotherapy Using Serum Metabolomics.” BMC Cancer 25: 438. https://doi.org/10.1186/s12885-025-13866-x

[185] Blyuss, Oleg, Alex Gentry-Maharaj, Evangelia-Orania Fourkala, Andy Ryan, Alexey Zaikin, Usha Menon, Ian Jacobs, and John F. Timms. 2015. “Serial Patterns of Ovarian Cancer Biomarkers in a Prediagnosis Longitudinal Dataset.” BioMed Research International 2015: 681416. https://doi.org/10.1155/2015/681416

[186] Matsushita, Makoto, Kazutoshi Fujita, Daisuke Motooka, Koji Hatano, Shota Fukae, Norihiko Kawamura, Eisuke Tomiyama, et al. 2021. “The Gut Microbiota Associated With High-Gleason Prostate Cancer.” Cancer Science 112: 3125–35. https://doi.org/10.1111/cas.14998

[187] Pinto, Joana, Ângela Carapito, Filipa Amaro, Ana Rita Lima, Carina Carvalho-Maia, Maria Conceição Martins, Carmen Jerónimo, et al. 2021. “Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging Through Urine Metabolomics.” Metabolites 11: 199. https://doi.org/10.3390/metabo11040199

[188] Zheng, Hong, Jiansong Ji, Liangcai Zhao, Minjiang Chen, An Shi, Linlin Pan, Yiran Huang, et al. 2016. “Prediction and Diagnosis of Renal Cell Carcinoma Using Nuclear Magnetic Resonance-Based Serum Metabolomics and Self-Organizing Maps.” Oncotarget 7: 59189–98. https://doi.org/10.18632/oncotarget.10830

[189] Obukhova, Larisa, Natalia Shchelchkova, Igor Medyanik, Konstantin Yashin, Artem Grishin, Oksana Bezvuglyak, and Ilkhom Abdullaev. 2025. “Brain Tumor-Induced Changes in Routine Parameters of the Lipid Spectrum of Blood Plasma and Its Short-Chain Fatty Acids.” Current Issues in Molecular Biology 47: 228. https://doi.org/10.3390/cimb47040228

[190] Kosmopoulou, Mariangela, Aikaterini F. Giannopoulou, Aikaterini Iliou, Dimitra Benaki, Aristeidis Panagiotakis, Athanassios D. Velentzas, Eumorphia G. Konstantakou, et al. 2020. “Human Melanoma-Cell Metabolic Profiling: Identification of Novel Biomarkers Indicating Metastasis.” International Journal of Molecular Sciences 21: 2436. https://doi.org/10.3390/ijms21072436

[191] Khan, Imran, Miso Nam, Minji Kwon, Sang-Soo Seo, Sunhee Jung, Ji Soo Han, Geum-Sook Hwang, and Mi Kyung Kim. 2019. “LC/MS-based Polar Metabolite Profiling Identified Unique Biomarker Signatures for Cervical Cancer and Cervical Intraepithelial Neoplasia Using Global and Targeted Metabolomics.” Cancers 11: 511. https://doi.org/10.3390/cancers11040511

[192] Zhong, Xiaocui, Rui Ran, Shanhu Gao, Manlin Shi, Xian Shi, Fei Long, Yanqiu Zhou, et al. 2022. “Complex Metabolic Interactions between Ovary, Plasma, Urine, and Hair in Ovarian Cancer.” Frontiers in Oncology 12: 916375. https://doi.org/10.3389/fonc.2022.916375

[193] Wang, Ke-xin, Guan-hua Du, Xue-mei Qin, and Li Gao. 2022. “1H-NMR-based Metabolomics Reveals the Biomarker Panel and Molecular Mechanism of Hepatocellular Carcinoma Progression.” Analytical and Bioanalytical Chemistry 414: 1525–37. https://doi.org/10.1007/s00216-021-03768-9

[194] Xie, Guoxiang, Lingeng Lu, Yunping Qiu, Quanxing Ni, Wei Zhang, Yu-Tang Gao, Harvey A. Risch, Herbert Yu, and Wei Jia. 2015. “Plasma Metabolite Biomarkers for the Detection of Pancreatic Cancer.” Journal of Proteome Research 14: 1195–202. https://doi.org/10.1021/pr501135f

[195] Li, Tong, Yinfen Qian, Hongling Li, and Jiusheng Deng. 2018. “Combination of Serum Lipids and Cancer Antigens as a Novel Marker for Colon Cancer Diagnosis.” Lipids in Health and Disease 17: 261. https://doi.org/10.1186/s12944-018-0911-5

[196] Chen, Yinan, Jun Zhang, Lei Guo, Lei Liu, Jingran Wen, Lu Xu, Min Yan, et al. 2016. “A Characteristic Biosignature for Discrimination of Gastric Cancer From Healthy Population by High Throughput GC-MS Analysis.” Oncotarget 7: 87496–510. https://doi.org/10.18632/oncotarget.11754

[197] Wang, Zhening, Yan Lin, Jiahao Liang, Yao Huang, Changchun Ma, Xingmu Liu, and Jurong Yang. 2017. “NMR-Based Metabolomic Techniques Identify Potential Urinary Biomarkers for Early Colorectal Cancer Detection.” Oncotarget 8: 105819–31. https://doi.org/10.18632/oncotarget.22402

[198] Amiri-Dashatan, Nasrin, Reyhaneh Farrokhi Yekta, Mehdi Koushki, Afsaneh Arefi Oskouie, Hadi Esfahani, Salman Taheri, and Elham Kazemian. 2022. “Metabolomic Study of Serum in Patients With Invasive Ductal Breast Carcinoma With LC-MS/MS Approach.” International Journal of Biological Markers 37: 349–59. https://doi.org/10.1177/03936155221123343

[199] Wang, Yanzhong, Rui An, Haitao Yu, Yuehong Dai, Luping Lou, Sheng Quan, Rongchang Chen, et al. 2024. “Largescale Multicenter Study of a Serum Metabolite Biomarker Panel for the Diagnosis of Breast Cancer.” iScience 27: 110345. https://doi.org/10.1016/j.isci.2024.110345

[200] Catlett, Jennie L., Jonathan Catazaro, Mikaela Cashman, Sean Carr, Robert Powers, Myra B. Cohen, and Nicole R. Buan. 2020. “Metabolic Feedback Inhibition Influences Metabolite Secretion by the Human Gut Symbiont Bacteroides Thetaiotaomicron.” mSystems 5: e00252–20. https://doi.org/10.1128/mSystems.00252-20

[201] Ayoola, Moses B., Mary F. Nakamya, Leslie A. Shack, Seongbin Park, Juhyeon Lim, Jung Hwa Lee, Matthew K. Ross, Hyungjin Eoh, and Bindu Nanduri. 2020. “SP_0916 Is an Arginine Decarboxylase That Catalyzes the Synthesis of Agmatine, Which Is Critical for Capsule Biosynthesis in Streptococcus Pneumoniae.” Frontiers in Microbiology 11: 578533. https://doi.org/10.3389/fmicb.2020.578533

[202] Pan, Tong, Zhangming Pei, Zhifeng Fang, Hongchao Wang, Jinlin Zhu, Hao Zhang, Jianxin Zhao, Wei Chen, and Wenwei Lu. 2023. “Uncovering the Specificity and Predictability of Tryptophan Metabolism in Lactic Acid Bacteria With Genomics and Metabolomics.” Frontiers in Cellular and Infection Microbiology 13: 1154346. https://doi.org/10.3389/fcimb.2023.1154346

[203] Han, Ziyi, Jian Fu, Aiyan Gong, and Wenkai Ren. 2025. “Bacterial indole-3-propionic Acid Inhibits Macrophage IL-1β Production Through Targeting Methionine Metabolism.” Science China Life Sciences 1–14. https://doi.org/10.1007/s11427-024-2789-1

[204] Nam, Hyeyoung, Anirban Kundu, Suman Karki, Richard L. Kirkman, Darshan S. Chandrashekar, Jeremy B. Foote, Guofang Zhang, et al. 2025. “HDAC7 Promotes Renal Cancer Progression by Reprogramming Branched-Chain Amino Acid Metabolism.” Science Advances 11: eadt3552. https://doi.org/10.1126/sciadv.adt3552

[205] Kikushige, Yoshikane, Toshihiro Miyamoto, Yu Kochi, Yuichiro Semba, Maki Ohishi, Hidetoshi Irifune, Kiwamu Hatakeyama, et al. 2023. “Human Acute Leukemia Uses Branched-Chain Amino Acid Catabolism to Maintain Stemness Through Regulating PRC2 Function.” Blood Advances 7: 3592–603. https://doi.org/10.1182/bloodadvances.2022008242

[206] Li, Na, Xiang Xu, Dan Liu, Jiaxin Gao, Ying Gao, Xufeng Wu, Huiming Sheng, Qun Li, and Jun Mi. 2023. “The Delta Subunit of the GABAA Receptor Is Necessary for the GPT2-Promoted Breast Cancer Metastasis.” Theranostics 13: 1355–69. https://doi.org/10.7150/thno.80544

[207] Lee, Joyce V., Corbett T. Berry, Karla Kim, Payel Sen, Taehyong Kim, Alessandro Carrer, Sophie Trefely, et al. 2018. “Acetyl-CoA Promotes Glioblastoma Cell Adhesion and Migration Through Ca²⁺-NFAT Signaling.” Genes & Development 32: 497–511. https://doi.org/10.1101/gad.311027.117

[208] Zhu, Liming, Gang Chen, Changjing Huang, Huifeng Gao, Yilin Wang, Yehua Shen, et al. 2024. “SUMO3 Inhibition by Butyric Acid Suppresses Cell Viability and Glycolysis and Promotes Gemcitabine Antitumor Activity in Pancreatic Cancer.” Biology Direct 19: 74. https://doi.org/10.1186/s13062-024-00513-x

[209] Sun, Qi, Qiyu Tian, Alejandro Bravo Iniguez, Xiaofei Sun, Hui Zhang, Jeanene Deavila, Min Du, and Mei-Jun Zhu. 2024. “AMPK Deficiency Increases DNA Methylation and Aggravates Colorectal Tumorigenesis in AOM/DSS Mice.” Genes 15: 835. https://doi.org/10.3390/genes15070835

[210] Vander Linden, Catherine, Cyril Corbet, Estelle Bastien, Ruben Martherus, Céline Guilbaud, Laurenne Petit, Loris Wauthier, et al. 2021. “Therapy-Induced DNA Methylation Inactivates MCT1 and Renders Tumor Cells Vulnerable to MCT4 Inhibition.” Cell Reports 35: 109202. https://doi.org/10.1016/j.celrep.2021.109202

[211] Ippolito, Luigi, Giuseppina Comito, Matteo Parri, Marta Iozzo, Assia Duatti, Francesca Virgilio, Nicla Lorito, et al. 2022. “Lactate Rewires Lipid Metabolism and Sustains a Metabolic-Epigenetic Axis in Prostate Cancer.” Cancer Research 82: 1267–82. https://doi.org/10.1158/0008-5472.Can-21-0914

[212] Lin, Kai, Lulu Wei, Ranran Wang, Li Li, Shiyu Song, Fei Wang, Meiwei He, et al. 2025. “Disrupted Methionine Cycle Triggers Muscle Atrophy in Cancer Cachexia Through Epigenetic Regulation of REDD1.” Cell Metabolism 37: 460–76. https://doi.org/10.1016/j.cmet.2024.10.017

[213] Gou, Dongmei, Rui Liu, Xiaoqun Shan, Haijun Deng, Chang Chen, Jin Xiang, Yi Liu, et al. 2023. “Gluconeogenic Enzyme PCK1 Supports S-Adenosylmethionine Biosynthesis and Promotes H3K9me3 Modification to Suppress Hepatocellular Carcinoma Progression.” Journal of Clinical Investigation 133: e161713. https://doi.org/10.1172/JCI161713

[214] Pan, Jun-Jie, Sun-Zhe Xie, Xin Zheng, Jian-Feng Xu, Hao Xu, Rui-Qi Yin, Yun-Ling Luo, et al. 2024. “Acetyl-CoA Metabolic Accumulation Promotes Hepatocellular Carcinoma Metastasis via Enhancing CXCL1-Dependent Infiltration of Tumor-Associated Neutrophils.” Cancer Letters 592: 216903. https://doi.org/10.1016/j.canlet.2024.216903

[215] Morris, John P., Jossie J. Yashinskie, Richard Koche, Rohit Chandwani, Sha Tian, Chi-Chao Chen, Timour Baslan, et al. 2019. “α-Ketoglutarate Links p53 to Cell Fate During Tumour Suppression.” Nature 573: 595–9. https://doi.org/10.1038/s41586-019-1577-5

[216] Wong, Chi Chun, Jiaying Xu, Xiqing Bian, Jian-Lin Wu, Wei Kang, Yun Qian, Weilin Li, et al. 2020. “In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.” Gastroenterology 159: 2163–80. https://doi.org/10.1053/j.gastro.2020.08.016

[217] He, Xuxiao, Deyu Chen, Guijun Liu, Qingang Wu, Hong Zhao, Dong Guo, Xiaoming Jiang, et al. 2025. “PI3Kβ Functions as a Protein Kinase to Promote Cellular Protein O-GlcNAcylation and acetyl-CoA Production for Tumor Growth.” Molecular Cell 85: 1411–25. https://doi.org/10.1016/j.molcel.2025.02.024

[218] Shi, Zhuangzhuang, Min Li, Chen Zhang, Hongwen Li, Yue Zhang, Lei Zhang, Xin Li, et al. 2025. “Butyrate-Producing Faecalibacterium prausnitzii Suppresses Natural Killer/T-Cell Lymphoma by Dampening the JAK-STAT Pathway.” Gut 74: 557–70. https://doi.org/10.1136/gutjnl-2024-333530

[219] Xue, Qianqian, Wenbei Peng, Siyu Zhang, Xiaoshan Wei, Linlin Ye, Zihao Wang, Xuan Xiang, et al. 2024. “Lactylation-Driven TNFR2 Expression in Regulatory T Cells Promotes the Progression of Malignant Pleural Effusion.” Journal for ImmunoTherapy of Cancer 12: e010040. https://doi.org/10.1136/jitc-2024-010040

[220] Li, Lvyuan, Qiling Tang, Junshang Ge, Dan Wang, Yongzhen Mo, Yijie Zhang, Yumin Wang, et al. 2024. “METTL14 Promotes Lipid Metabolism Reprogramming and Sustains Nasopharyngeal Carcinoma Progression via Enhancing m(6)A Modification of ANKRD22 mRNA.” Clinical and Translational Medicine 14: e1766. https://doi.org/10.1002/ctm2.1766

[221] Kim, Ji Hye, Jinyoung Lee, Se Seul Im, Boyun Kim, Eun-Young Kim, Hyo-Jin Min, Jinbeom Heo, et al. 2024. “Glutamine-Mediated Epigenetic Regulation of cFLIP Underlies Resistance to TRAIL in Pancreatic Cancer.” Experimental & Molecular Medicine 56: 1013–26. https://doi.org/10.1038/s12276-024-01231-0

[222] Fortin, Jerome, Ming-Feng Chiang, Cem Meydan, Jonathan Foox, Parameswaran Ramachandran, Julie Leca, François Lemonnier, et al. 2023. “Distinct and Opposite Effects of Leukemogenic Idh and Tet2 Mutations in Hematopoietic Stem and Progenitor Cells.” Proceedings of the National Academy of Sciences of the United States of America 120: e2208176120. https://doi.org/10.1073/pnas.2208176120

[223] Furth, Noa, Niv Cohen, Avishay Spitzer, Tomer-Meir Salame, Bareket Dassa, Tevie Mehlman, Alexander Brandis, et al. 2025. “Oncogenic IDH1(mut) Drives Robust Loss of Histone Acetylation and Increases Chromatin Heterogeneity.” Proceedings of the National Academy of Sciences 122: e2403862122. https://doi.org/10.1073/pnas.2403862122

[224] Karagiota, Angeliki, Amalia Kanoura, Efrosyni Paraskeva, George Simos, and Georgia Chachami. 2023. “Pyruvate Dehydrogenase Phosphatase 1 (PDP1) Stimulates HIF Activity by Supporting Histone Acetylation Under Hypoxia.” FEBS Journal 290: 2165–79. https://doi.org/10.1111/febs.16694

[225] Tian, Yangzi, Jingjing Ma, Hao Wang, Xiuli Yi, Huina Wang, Hengxiang Zhang, Sen Guo, et al. 2023. “BCAT2 Promotes Melanoma Progression by Activating Lipogenesis via the Epigenetic Regulation of FASN and ACLY Expressions.” Cellular and Molecular Life Sciences 80: 315. https://doi.org/10.1007/s00018-023-04965-8

[226] Shi, Chengyu, Ying Wang, Minjie Wu, Yu Chen, Fangzhou Liu, Zheyuan Shen, Yiran Wang, et al. 2022. “Promoting Anti-Tumor Immunity by Targeting TMUB1 to Modulate PD-L1 Polyubiquitination and Glycosylation.” Nature Communications 13: 6951. https://doi.org/10.1038/s41467-022-34346-x

[227] Mathes, Arthur, Merve Busra Duman, Alexander Neumann, Gergana Dobreva, and Thomas Schmidt. 2024. “S-Adenosylmethionine Treatment Affects Histone Methylation in Prostate Cancer Cells.” Gene 893: 147915. https://doi.org/10.1016/j.gene.2023.147915

[228] Shang, Shipeng, Mi-Zhou Wang, Zhiyuan Xing, Ningning He, and Shangyong Li. 2022. “Lactate Regulators Contribute to Tumor Microenvironment and Predict Prognosis in Lung Adenocarcinoma.” Frontiers in Immunology 13: 1024925. https://doi.org/10.3389/fimmu.2022.1024925

[229] Liu, Yanfeng, Fan Wang, Guoquan Yan, Yu Tong, Wenyun Guo, Songling Li, Yifei Qian, et al. 2024. “CPT1A Loss Disrupts BCAA Metabolism to Confer Therapeutic Vulnerability in TP53-mutated Liver Cancer.” Cancer Letters 595: 217006. https://doi.org/10.1016/j.canlet.2024.217006

[230] Matias, Maria I., Carmen S. Yong, Amir Foroushani, Chloe Goldsmith, Cédric Mongellaz, Erdinc Sezgin, Kandice R. Levental, et al. 2021. “Regulatory T Cell Differentiation Is Controlled by αKG-induced Alterations in Mitochondrial Metabolism and Lipid Homeostasis.” Cell Reports 37: 109911. https://doi.org/10.1016/j.celrep.2021.109911

[231] Noronha, Katelyn J., Karlie N. Lucas, Sateja Paradkar, Joseph Edmonds, Sam Friedman, Matthew A. Murray, Samantha Liu, et al. 2024. “NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD⁺ Depletion.” Molecular Cancer Research 22: 973–88. https://doi.org/10.1158/1541-7786.Mcr-23-1003

[232] Li, Yang, Joshua J. Gruber, Ulrike M. Litzenburger, Yiren Zhou, Yu Rebecca Miao, Edward L. LaGory, Albert M. Li, et al. 2020. “Acetate Supplementation Restores Chromatin Accessibility and Promotes Tumor Cell Differentiation Under Hypoxia.” Cell Death & Disease 11: 102. https://doi.org/10.1038/s41419-020-2303-9

[233] Li, Yangbo, Pengzhan He, Ying Chen, Jiaming Hu, Beiying Deng, Chuan Liu, Baoping Yu, and Weiguo Dong. 2024. “Microbial Metabolite Sodium Butyrate Enhances the Anti-Tumor Efficacy of 5-fluorouracil Against Colorectal Cancer by Modulating PINK1/Parkin Signaling and Intestinal Flora.” Scientific Reports 14: 13063. https://doi.org/10.1038/s41598-024-63993-x

[234] Li, Lu, Jinyun Dong, Chunwei Xu, and Shiqun Wang. 2025. “Lactate Drives Senescence-Resistant Lineages in Hepatocellular Carcinoma via Histone H2B Lactylation of NDRG1.” Cancer Letters 616: 217567. https://doi.org/10.1016/j.canlet.2025.217567

[235] Huang, Yumei, Jiali Cao, Mengpei Zhu, Ziwen Wang, Ze Jin, and Zhifan Xiong. 2024. “Bacteroides Fragilis Aggravates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Regulating Lipid Metabolism and Remodeling Gut Microbiota.” Microbiology Spectrum 12: e0339323. https://doi.org/10.1128/spectrum.03393-23

[236] Tejedor-Sanz, Sara, Eric T. Stevens, Siliang Li, Peter Finnegan, James Nelson, Andre Knoesen, Samuel H. Light, Caroline M. Ajo-Franklin, and Maria L. Marco. 2022. “Extracellular Electron Transfer Increases Fermentation in Lactic Acid Bacteria via a Hybrid Metabolism.” Elife 11: e70684. https://doi.org/10.7554/eLife.70684

[237] Lee, Na-Rae, Choong Hwan Lee, Dong-Yup Lee, and Jin-Byung Park. 2020. “Genome-Scale Metabolic Network Reconstruction and in Silico Analysis of Hexanoic Acid Producing Megasphaera Elsdenii.” Microorganisms 8: 539. https://doi.org/10.3390/microorganisms8040539

[238] Edwards, Peter A., Heidi R. Kast, and Andrew M. Anisfeld. 2002. “BAREing It All: the Adoption of LXR and FXR and Their Roles in Lipid Homeostasis.” Journal of Lipid Research 43: 2–12. https://doi.org/10.1016/S0022-2275(20)30180-2

[239] Long, Shengwen, Guixiang Huang, Mi Ouyang, Kai Xiao, Hao Zhou, Anyi Hou, Zhiwei Li, et al. 2023. “Epigenetically Modified AP-2α by DNA Methyltransferase Facilitates Glioma Immune Evasion by Upregulating PD-L1 Expression.” Cell Death & Disease 14: 365. https://doi.org/10.1038/s41419-023-05878-x

[240] Liu, Zongzhi, Xiang Li, Yibo Gao, Jiejie Liu, Yating Feng, Yang Liu, Junyun Wang, et al. 2023. “Epigenetic Reprogramming of Runx3 Reinforces CD8⁺ T-Cell Function and Improves the Clinical Response to Immunotherapy.” Molecular Cancer 22: 84. https://doi.org/10.1186/s12943-023-01768-0

[241] Wang, Qing, Jianzhong Ye, Daiqiong Fang, Longxian Lv, Wenrui Wu, Ding Shi, Yating Li, et al. 2020. “Multi-Omic Profiling Reveals Associations between the Gut Mucosal Microbiome, the Metabolome, and Host DNA Methylation Associated Gene Expression in Patients With Colorectal Cancer.” BMC Microbiology 20: 83. https://doi.org/10.1186/s12866-020-01762-2

[242] Xu, Yuyan, Wei Liao, Qiong Luo, Dinghua Yang, and Mingxin Pan. 2022. “Histone Acetylation Regulator-Mediated Acetylation Patterns Define Tumor Malignant Pathways and Tumor Microenvironment in Hepatocellular Carcinoma.” Frontiers in Immunology 13: 761046. https://doi.org/10.3389/fimmu.2022.761046

[243] Zhao, Zhongliang, Marcel Andre Dammert, Ingrid Grummt, and Holger Bierhoff. 2016. “lncRNA-induced Nucleosome Repositioning Reinforces Transcriptional Repression of rRNA Genes Upon Hypotonic Stress.” Cell Reports 14: 1876–82. https://doi.org/10.1016/j.celrep.2016.01.073

[244] Matson, Vyara, Jessica Fessler, Riyue Bao, Tara Chongsuwat, Yuanyuan Zha, Maria-Luisa Alegre, Jason J. Luke, and Thomas F. Gajewski. 2018. “The Commensal Microbiome Is Associated With Anti-PD-1 Efficacy in Metastatic Melanoma Patients.” Science 359: 104–8. https://doi.org/10.1126/science.aao3290

[245] Jin, Xin, Donglin Ding, Yuqian Yan, Hui Li, Bo Wang, Linlin Ma, Zhenqing Ye, et al. 2019. “Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression.” Molecular Cell 73: 22–35, e26. https://doi.org/10.1016/j.molcel.2018.10.034

[246] Sridaran, Dhivya, Surbhi Chouhan, Kiran Mahajan, Arun Renganathan, Cody Weimholt, Shambhavi Bhagwat, Melissa Reimers, et al. 2022. “Inhibiting ACK1-Mediated Phosphorylation of C-Terminal Src Kinase Counteracts Prostate Cancer Immune Checkpoint Blockade Resistance.” Nature Communications 13: 6929. https://doi.org/10.1038/s41467-022-34724-5

[247] Zhang, Xing, Jian Cao, Xiuting Li, Yan Zhang, Wenjing Yan, Bo Ding, Jing Hu, et al. 2024. “Comprehensive Analysis of the SUMO-related Signature: Implication for Diagnosis, Prognosis, and Immune Therapeutic Approaches in Cervical Cancer.” Biochemical Genetics 62: 4654–78. https://doi.org/10.1007/s10528-024-10728-2

[248] Kumar, Sumit, Mark J. A. Schoonderwoerd, Jessie S. Kroonen, Ilona J. de Graaf, Marjolein Sluijter, Dina Ruano, Román González-Prieto, et al. 2022. “Targeting Pancreatic Cancer by TAK-981: A SUMOylation Inhibitor That Activates the Immune System and Blocks Cancer Cell Cycle Progression in a Preclinical Model.” Gut 71: 2266–83. https://doi.org/10.1136/gutjnl-2021-324834

[249] Di Modica, Martina, Giorgio Gargari, Viola Regondi, Arianna Bonizzi, Stefania Arioli, Beatrice Belmonte, Loris De Cecco, et al. 2021. “Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer.” Cancer Research 81: 2195–206. https://doi.org/10.1158/0008-5472.Can-20-1659

[250] Wang, Qing-Ming, Guang-Yu Lian, Su-Mei Sheng, Jing Xu, Long-Long Ye, Chao Min, and Shu-Fang Guo. 2024. “Exosomal lncRNA NEAT1 Inhibits NK-cell Activity to Promote Multiple Myeloma Cell Immune Escape via an EZH2/PBX1 Axis.” Molecular Cancer Research 22: 125–36. https://doi.org/10.1158/1541-7786.MCR-23-0282

[251] Zhang, Yan, Ruimin Hu, Bixin Xi, Dimin Nie, Hanxiao Xu, and Aiguo Liu. 2022. “Mechanisms of Senescence-Related NKG2D Ligands Release and Immune Escape Induced by Chemotherapy in Neuroblastoma Cells.” Frontiers in Cell and Developmental Biology 10: 829404. https://doi.org/10.3389/fcell.2022.829404

[252] Lv, Ji, Yitao Jia, Jing Li, Wentao Kuai, Yang Li, Fang Guo, Xinjian Xu, et al. 2019. “Gegen Qinlian Decoction Enhances the Effect of PD-1 Blockade in Colorectal Cancer With Microsatellite Stability by Remodelling the Gut Microbiota and the Tumour Microenvironment.” Cell Death & Disease 10: 415. https://doi.org/10.1038/s41419-019-1638-6

[253] Sethi, Vrishketan, Saba Kurtom, Mohammad Tarique, Shweta Lavania, Zoe Malchiodi, Leonor Hellmund, Li Zhang, et al. 2018. “Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response.” Gastroenterology 155: 33–7. https://doi.org/10.1053/j.gastro.2018.04.001

[254] Lin, Yufeng, Mingxu Xie, Harry Cheuk-Hay Lau, Ruijie Zeng, Ruyi Zhang, Luyao Wang, Qing Li, et al. 2025. “Effects of Gut Microbiota on Immune Checkpoint Inhibitors in Multi-Cancer and as Microbial Biomarkers for Predicting Therapeutic Response.” Med 6: 100530. https://doi.org/10.1016/j.medj.2024.10.007

[255] Yang, Huiqin, Jiahao Cai, Xiaolong Huang, Cheng Zhan, Chunlai Lu, Jie Gu, Teng Ma, et al. 2025. “Gram-Negative Microflora Dysbiosis Facilitates Tumor Progression and Immune Evasion by Activating the CCL3/CCL5–CCR1–MAPK–PD-L1 Pathway in Esophageal Squamous Cell Carcinoma.” Molecular Cancer Research 23: 71–85. https://doi.org/10.1158/1541-7786.MCR-24-0451

[256] Noble, Alistair, Edward T. Pring, Lydia Durant, Ripple Man, Stella M. Dilke, Lesley Hoyles, Steve A. James, et al. 2022. “Altered Immunity to Microbiota, B Cell Activation and Depleted γδ/Resident Memory T Cells in Colorectal Cancer.” Cancer Immunology, Immunotherapy 71: 2619–29. https://doi.org/10.1007/s00262-021-03135-8

[257] Yin, Han, Zhuangzhuang Miao, Lu Wang, Beibei Su, Chaofan Liu, Yu Jin, Bili Wu, Hu Han, and Xianglin Yuan. 2022. “Fusobacterium Nucleatum Promotes Liver Metastasis in Colorectal Cancer by Regulating the Hepatic Immune Niche and Altering Gut Microbiota.” Aging 14: 1941–58. https://doi.org/10.18632/aging.203914

[258] Ling, Zongxin, Li Shao, Xia Liu, Yiwen Cheng, Chongxian Yan, Ying Mei, Feng Ji, and Xiaosun Liu. 2019. “Regulatory T Cells and Plasmacytoid Dendritic Cells Within the Tumor Microenvironment in Gastric Cancer Are Correlated With Gastric Microbiota Dysbiosis: A Preliminary Study.” Frontiers in Immunology 10: 533. https://doi.org/10.3389/fimmu.2019.00533

[259] Lam, Khiem C., Romina E. Araya, April Huang, Quanyi Chen, Martina Di Modica, Richard R. Rodrigues, Amélie Lopès, et al. 2021. “Microbiota Triggers STING-Type I IFN-Dependent Monocyte Reprogramming of the Tumor Microenvironment.” Cell 184: 5338–56. https://doi.org/10.1016/j.cell.2021.09.019

[260] Xia, Xiaoxuan, William Ka Kei Wu, Sunny Hei Wong, Dabin Liu, Thomas Ngai Yeung Kwong, Geicho Nakatsu, Pearlly S. Yan, et al. 2020. “Bacteria Pathogens Drive Host Colonic Epithelial Cell Promoter Hypermethylation of Tumor Suppressor Genes in Colorectal Cancer.” Microbiome 8: 108. https://doi.org/10.1186/s40168-020-00847-4

[261] Li, Hui, Tieying Dong, Meng Tao, Haifeng Zhao, Tongtong Lan, Shiyu Yan, Xinyi Gong, et al. 2024. “Fucoidan Enhances the Anti-Tumor Effect of Anti-PD-1 Immunotherapy by Regulating Gut Microbiota.” Food & Function 15: 3463–78. https://doi.org/10.1039/d3fo04807a

[262] Qin, Rui, Chen Zhao, Chen-Ji Wang, Wei Xu, Jian-Yuan Zhao, Yan Lin, Yi-Yuan Yuan, et al. 2021. “Tryptophan Potentiates CD8⁺ T Cells Against Cancer Cells by TRIP12 Tryptophanylation and Surface PD-1 Downregulation.” Journal for Immunotherapy of Cancer 9: e002840. https://doi.org/10.1136/jitc-2021-002840

[263] Sengupta, Isha, Payel Mondal, Amrita Sengupta, Atanu Mondal, Vipin Singh, Swagata Adhikari, Sinjini Dhang, Siddhartha Roy, and Chandrima Das. 2022. “Epigenetic Regulation of Fructose-1, 6-Bisphosphatase 1 by Host Transcription Factor Speckled 110 kDa During Hepatitis B Virus Infection.” FEBS Journal 289: 6694–713. https://doi.org/10.1111/febs.16544

[264] Neubert, Emily N., Julia M. DeRogatis, Sloan A. Lewis, Karla M. Viramontes, Pedro Ortega, Monique L. Henriquez, Rémi Buisson, et al. 2023. “HMGB2 Regulates the Differentiation and Stemness of Exhausted CD8⁺ T Cells During Chronic Viral Infection and Cancer.” Nature Communications 14: 5631. https://doi.org/10.1038/s41467-023-41352-0

[265] Zhang, Xusheng, Xintong Gao, Zhen Liu, Fei Shao, Dou Yu, Min Zhao, Xiwen Qin, and Shuo Wang. 2024. “Microbiota Regulates the TET1-Mediated DNA Hydroxymethylation Program in Innate Lymphoid Cell Differentiation.” Nature Communications 15: 4792. https://doi.org/10.1038/s41467-024-48794-0

[266] Tang, Xiaolong, Yahang Liang, Guorui Sun, Qingsi He, Zhenyu Hou, Xingzhi Jiang, Peng Gao, and Hui Qu. 2022. “Upregulation of CRABP2 by TET1-mediated DNA Hydroxymethylation Attenuates Mitochondrial Apoptosis and Promotes Oxaliplatin Resistance in Gastric Cancer.” Cell Death & Disease 13: 848. https://doi.org/10.1038/s41419-022-05299-2

[267] Yang, Kai, Bing Bai, Xiaomei Li, Wei Rou, Cheng Huang, Meixin Lu, Xueyan Zhang, et al. 2025. “Coordinating Interleukin-2 Encoding circRNA With Immunomodulatory Lipid Nanoparticles to Potentiate Cancer Immunotherapy.” Science Advances 11: eadn7256. https://doi.org/10.1126/sciadv.adn7256

[268] Meng, Jing, Shuang Chen, Jing-Xia Han, Baoxin Qian, Xiao-Rui Wang, Wei-Long Zhong, Yuan Qin, et al. 2018. “Twist1 Regulates Vimentin Through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma.” Cancer Research 78: 4150–62. https://doi.org/10.1158/0008-5472.CAN-17-3009

[269] Kadosh, Eliran, Irit Snir-Alkalay, Avanthika Venkatachalam, Shahaf May, Audrey Lasry, Ela Elyada, Adar Zinger, et al. 2020. “The Gut Microbiome Switches Mutant p53 From Tumour-Suppressive to Oncogenic.” Nature 586: 133–8. https://doi.org/10.1038/s41586-020-2541-0

[270] Naciri, Ikrame, Minzhi Liang, Ying Yang, Heather Karner, Benjamin Lin, Maria De Lourdes Andrade Ludena, Eric A. Hanse, et al. 2024. “Loss of XIST lncRNA Unlocks Stemness and Cellular Plasticity in Ovarian Cancer.” Proceedings of the National Academy of Sciences of the United States of America 121: e2418096121. https://doi.org/10.1073/pnas.2418096121

[271] Sierra, Isabel, Sarah Pyfrom, Aaron Weiner, Gan Zhao, Amanda Driscoll, Xiang Yu, Brian D. Gregory, Andrew E. Vaughan, and Montserrat C. Anguera. 2023. “Unusual X Chromosome Inactivation Maintenance in Female Alveolar Type 2 Cells Is Correlated With Increased Numbers of X-Linked Escape Genes and Sex-Biased Gene Expression.” Stem Cell Reports 18: 489–502. https://doi.org/10.1016/j.stemcr.2022.12.005

[272] Shademan, Milad, Khadijeh Zare, Morteza Zahedi, Hooman Mosannen Mozaffari, Hadi Bagheri Hosseini, Kamran Ghaffarzadegan, Ladan Goshayeshi, Hesam Dehghani, et al. 2020. “Promoter Methylation, Transcription, and Retrotransposition of LINE-1 in Colorectal Adenomas and Adenocarcinomas.” Cancer Cell International 20: 426. https://doi.org/10.1186/s12935-020-01511-5

[273] Zeng, Jianyao, Yan Sun, Yuan Fang, Xiaodie Wang, Qian Huang, Pingjing Zhang, Meiqi Shao, et al. 2025. “Unleashing the Potential of a Low CpG Passer Transposon for Superior CAR-T Cell Therapy.” Frontiers in Immunology 16: 1541653. https://doi.org/10.3389/fimmu.2025.1541653

[274] Yu, TaChung, Fangfang Guo, Yanan Yu, Tiantian Sun, Dan Ma, Jixuan Han, Yun Qian, et al. 2017. “Fusobacterium Nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy.” Cell 170: 548–63. https://doi.org/10.1016/j.cell.2017.07.008

[275] Waidmann, Oliver, Thomas Pleli, Karel Dvorak, Christina Baehr, Ulrich Mondorf, Guido Plotz, Ricardo M. Biondi, Stefan Zeuzem, and Albrecht Piiper. 2009. “Inhibition of the Equilibrative Nucleoside Transporter 1 and Activation of A2A Adenosine Receptors by 8-(4-Chlorophenylthio)-Modified cAMP Analogs and Their Hydrolytic Products.” Journal of Biological Chemistry 284: 32256–63. https://doi.org/10.1074/jbc.M109.056622

[276] Liu, Qiannv, Zhiheng Tang, Yan Qian, Chunlei Wang, Chun Kong, Mengqian Li, Xiangyang Geng, et al. 2025. “Eukaryotic ADCY7 Catalyzes the Production of c-di-AMP to Activate the NLRP3 Inflammasome.” Nature Chemical Biology 21: 1–9. https://doi.org/10.1038/s41589-025-01919-y

[277] Sun, Xudong, Xiaotong Yu, Yaqi Zhao, Lei Xing, Luxin Na, Zhuo Chen, Zhangping Xiao, et al. 2023. “Cyclic Diguanylate Analogues: Facile Synthesis, STING Binding Mode and Anti-Tumor Immunity Delivered by Cytidinyl/Cationic Lipid.” European Journal of Medicinal Chemistry 247: 115053. https://doi.org/10.1016/j.ejmech.2022.115053

[278] Görigk, Sarah, D Margriet Ouwens, Tanja Kuhn, Delsi Altenhofen, Christian Binsch, Mareike Damen, Jenny Minh-An Khuong, et al. 2022. “Nudix Hydrolase NUDT19 Regulates Mitochondrial Function and ATP Production in Murine Hepatocytes.” Biochimica et Biophysica Acta (BBA)–Molecular and Cell Biology of Lipids 1867: 159153. https://doi.org/10.1016/j.bbalip.2022.159153

[279] Dalile, Boushra, Lukas Van Oudenhove, Bram Vervliet, and Kristin Verbeke. 2019. “The Role of Short-Chain Fatty Acids in Microbiota–Gut–Brain Communication.” Nature Reviews Gastroenterology & Hepatology 16: 461–78. https://doi.org/10.1038/s41575-019-0157-3

[280] Huang, Wenjun, Qingyun Zhu, Zhichao Shi, Yao Tu, Qinyuan Li, Wenwen Zheng, Zigao Yuan, et al. 2024. “Dual Inhibitors of DNMT and HDAC Induce Viral Mimicry to Induce Antitumour Immunity in Breast Cancer.” Cell Death Discovery 10: 143. https://doi.org/10.1038/s41420-024-01895-7

[281] Lee, Minjung, Jianfang Li, Jia Li, Shaohai Fang, Joanna Zhang, Anh Tran Tram Vo, Wei Han, et al. 2021. “Tet2 Inactivation Enhances the Antitumor Activity of Tumor-Infiltrating Lymphocytes.” Cancer Research 81: 1965–76. https://doi.org/10.1158/0008-5472.CAN-20-3213

[282] Hu, Jun, Jianwei Chen, Xiaojian Xu, Qiliang Hou, Jing Ren, and Xianghua Yan. 2023. “Gut Microbiota-Derived 3-Phenylpropionic Acid Promotes Intestinal Epithelial Barrier Function via AhR Signaling.” Microbiome 11: 102. https://doi.org/10.1186/s40168-023-01551-9

[283] Boschiero, Clarissa, Yahui Gao, Mei Liu, Ransom L. Baldwin, Li Ma, Cong-Jun Li, and George E. Liu. 2022. “The Dynamics of Chromatin Accessibility Prompted by Butyrate-Induced Chromatin Modification in Bovine Cells.” Ruminants 2: 226–43. https://doi.org/10.3390/ruminants2020015. https://www.mdpi.com/2673-933X/2/2/15

[284] de Miguel, Fernando J., Claudia Gentile, William W. Feng, Shannon J. Silva, Akshay Sankar, Francisco Exposito, Wesley L. Cai, et al. 2023. “Mammalian SWI/SNF Chromatin Remodeling Complexes Promote Tyrosine Kinase Inhibitor Resistance in EGFR-Mutant Lung Cancer.” Cancer Cell 41: 1516–34. https://doi.org/10.1016/j.ccell.2023.07.005

[285] Kumar, Kundan, Aditi Pareek, and Rupinder Kaur. 2024. “SWI/SNF Complex-Mediated Chromatin Remodeling in Candida Glabrata Promotes Immune Evasion.” Iscience 27: 109607. https://doi.org/10.1016/j.isci.2024.109607

[286] Duplaquet, Leslie, Kevin So, Alexander W. Ying, Shreoshi Pal Choudhuri, Xinyue Li, Grace D. Xu, Yixiang Li, et al. 2024. “Mammalian SWI/SNF Complex Activity Regulates POU2F3 and Constitutes a Targetable Dependency in Small Cell Lung Cancer.” Cancer Cell 42: 1352–69. https://doi.org/10.1016/j.ccell.2024.06.012

[287] Zhao, Wenjuan, Jiayi Xin, Xin Yu, Zhifang Li, and Nan Li. 2024. “Recent Advances of Lysine Lactylation in Prokaryotes and Eukaryotes.” Frontiers in Molecular Biosciences 11: 1510975. https://doi.org/10.3389/fmolb.2024.1510975

[288] Wang, Naixin, Weiwei Wang, Weiwei Wang, Xiaoqi Wang, Ge Mang, Jianfeng Chen, Xiangyu Yan, Zhonghua Tong, et al. 2022. “Histone Lactylation Boosts Reparative Gene Activation Post–Myocardial Infarction.” Circulation Research 131: 893–908. https://doi.org/10.1161/CIRCRESAHA.122.320488

[289] Zhang, Yujuan, Guoquan Tao, Ping Liu, Kai Lu, Zhichao Han, Hanting Liu, Mulong Du, et al. 2022. “Evaluation of Genetic Variants in Nucleosome Remodeling and Deacetylase (NuRD) Complex Subunits Encoding Genes and Gastric Cancer Susceptibility.” Archives of Toxicology 96: 1739–49. https://doi.org/10.1007/s00204-022-03275-5

[290] Chen, Xue, Ming-feng Huang, Da-meng Fan, Yao-hui He, Wen-juan Zhang, Jian-cheng Ding, Bing-ling Peng, et al. 2024. “CARM1 Hypermethylates the NuRD Chromatin Remodeling Complex to Promote Cell Cycle Gene Expression and Breast Cancer Development.” Nucleic Acids Research 52: 6811–29. https://doi.org/10.1093/nar/gkae329

[291] Liu, Wei, Yi Zeng, Xinhui Hao, Xin Wang, Jiaxiang Liu, Tianyang Gao, Mengdi Wang, et al. 2023. “JARID2 Coordinates With the NuRD Complex to Facilitate Breast Tumorigenesis Through Response to Adipocyte-Derived Leptin.” Cancer Communications 43: 1117–42. https://doi.org/10.1002/cac2.12479

[292] Gao, Jie, Ruiqiong Liu, Dandan Feng, Wei Huang, Miaomiao Huo, Jingyao Zhang, Shuai Leng, et al. 2021. “Snail/PRMT5/NuRD Complex Contributes to DNA Hypermethylation in Cervical Cancer by TET1 Inhibition.” Cell Death & Differentiation 28: 2818–2136. https://doi.org/10.1038/s41418-021-00786-z

[293] Yang, Yang, Rongfang Qiu, Siyu Zhao, Lin Shen, Bufu Tang, Qiaoyou Weng, Ziwei Xu, et al. 2022. “SMYD3 Associates With the NuRD (MTA1/2) Complex to Regulate Transcription and Promote Proliferation and Invasiveness in Hepatocellular Carcinoma Cells.” BMC Biology 20: 294. https://doi.org/10.1186/s12915-022-01499-6

[294] Yin, Xin, Xu Teng, Tianyu Ma, Tianshu Yang, Jingyao Zhang, Miaomiao Huo, Wei Liu, et al. 2022. “RUNX2 Recruits the NuRD (MTA1)/CRL4B Complex to Promote Breast Cancer Progression and Bone Metastasis.” Cell Death & Differentiation 29: 2203–17. https://doi.org/10.1038/s41418-022-01010-2

[295] Hsieh, Yung-Yu, Ko-Chao Lee, Kung-Chuan Cheng, Kam-Fai Lee, Ya-Ling Yang, Hsin-Tung Chu, Ting-Wei Lin, et al. 2023. “Antrodin C Isolated from Antrodia Cinnamomea Induced Apoptosis Through ROS/AKT/ERK/P38 Signaling Pathway and Epigenetic Histone Acetylation of TNFα in Colorectal Cancer Cells.” Antioxidants 12: 764. https://doi.org/10.3390/antiox12030764

[296] Mady, Leila J., Yan Zhong, Puneet Dhawan, and Sylvia Christakos. 2023. “Role of Coactivator Associated Arginine Methyltransferase 1 (CARM1) in the Regulation of the Biological Function of 1, 25-Dihydroxyvitamin D3.” Cells 12: 1407. https://doi.org/10.3390/cells12101407

[297] Gong, Hao, Yin Yuan, Yongwen Li, Hongbing Zhang, Ying Li, Weiting Li, Pan Wang, et al. 2019. “Role of EZH2 Inhibitor Combined With Gefitinib in EGFR-TKIs Resistant Lung Cancer Cells.” Chinese Journal of Lung Cancer 22: 255–63. https://doi.org/10.3779/j.issn.1009-3419.2019.05.01

[298] Benitz, Simone, Ivonne Regel, Tobias Reinhard, Anna Popp, Isabell Schäffer, Susanne Raulefs, Bo Kong, et al. 2016. “Polycomb Repressor Complex 1 Promotes Gene Silencing Through H2AK119 Mono-Ubiquitination in Acinar-to-Ductal Metaplasia and Pancreatic Cancer Cells.” Oncotarget 7: 11424–33. https://doi.org/10.18632/oncotarget.6717

[299] Song, Yue, Zhao-Xia Li, Xi Liu, Rui Wang, Li-Wei Li, and Qingyu Zhang. 2017. “The Wnt/β-catenin and PI3K/Akt Signaling Pathways Promote EMT in Gastric Cancer by Epigenetic Regulation via H3 Lysine 27 Acetylation.” Tumor Biology 39: 1010428317712617. https://doi.org/10.1177/1010428317712617

[300] Lu, Hang, Xue-Feng Yang, Xiao-Qing Tian, Shou-Long Tang, Lian-Qian Li, Shuang Zhao, and Hua-Chuan Zheng. 2016. “The in Vitro and Vivo Anti-Tumor Effects and Molecular Mechanisms of Suberoylanilide Hydroxamic Acid (SAHA) and MG132 on the Aggressive Phenotypes of Gastric Cancer Cells.” Oncotarget 7: 56508–25. https://doi.org/10.18632/oncotarget.10643

[301] Pan, Lianhong, Fan Feng, Jiaqin Wu, Shibing Fan, Juanjuan Han, Shunxi Wang, Li Yang, et al. 2022. “Demethylzeylasteral Targets Lactate by Inhibiting Histone Lactylation to Suppress the Tumorigenicity of Liver Cancer Stem Cells.” Pharmacological Research 181: 106270. https://doi.org/10.1016/j.phrs.2022.106270

[302] He, Dan, Huijin Feng, Belen Sundberg, Jiaxing Yang, Justin Powers, Alec H. Christian, John E. Wilkinson, et al. 2022. “Methionine Oxidation Activates Pyruvate Kinase M2 to Promote Pancreatic Cancer Metastasis.” Molecular Cell 82: 3045–60.e11. https://doi.org/10.1016/j.molcel.2022.06.005

[303] Dong, Renshun, Tianci Wang, Wei Dong, Haoquan Zhang, Yani Li, Ran Tao, Qiumeng Liu, et al. 2025. “TGM2-Mediated Histone Serotonylation Promotes HCC Progression via MYC Signalling Pathway.” Journal of Hepatology 83: 105–18. https://doi.org/10.1016/j.jhep.2024.12.038

[304] Tian, Hua, Yichen Liu, Songwen Lin, Jialing Deng, Qinghua Zhang, Feng Hao, Yao Tang, et al. 2025. “Design, Synthesis, and Biological Evaluation of Novel Fms-Like Tyrosine Kinase 3/VEGFR2/Histone Deacetylase Inhibitors for the Treatment of Acute Myeloid Leukemia.” Journal of Medicinal Chemistry 68: 5736–59. https://doi.org/10.1021/acs.jmedchem.4c03084

[305] Lin, Sang, Sheng Tan, Yonglin Peng, Aziguli Tulamaiti, Wenfei Du, Keshuo Ding, Changyu Chen, et al. 2025. “Histone Serotonylation Promotes Pancreatic Cancer Development via Lipid Metabolism Remodeling.” Nature Communications 16: 5947. https://doi.org/10.1038/s41467-025-61197-z

[306] Ishi, Yukitomo, Soichiro Takamiya, Toshitaka Seki, Kazuyoshi Yamazaki, Kazutoshi Hida, Kanako C. Hatanaka, Yusuke Ishida, et al. 2020. “Prognostic Role of H3K27M Mutation, Histone H3K27 Methylation Status, and EZH2 Expression in Diffuse Spinal Cord Gliomas.” Brain Tumor Pathology 37: 81–8. https://doi.org/10.1007/s10014-020-00369-9

[307] Shao, Zhenlong, Shutong Liu, Wenshuang Sun, Xuefen Zhuang, Shusha Yin, Ji Cheng, Xiaohong Xia, et al. 2024. “SENP3 Mediates deSUMOylation of SIX1 to Promote Prostate Cancer Proliferation and Migration.” Cellular & Molecular Biology Letters 29: 146. https://doi.org/10.1186/s11658-024-00665-8

[308] Wang, Tian-Yun, Yu-Rong Chai, Yan-Long Jia, Jian-Hui Gao, Xiao-Jun Peng, and Hua-Feng Han. 2016. “Crosstalk Among the Proteome, Lysine Phosphorylation, and Acetylation in Romidepsin-Treated Colon Cancer Cells.” Oncotarget 7: 53471–501. https://doi.org/10.18632/oncotarget.10840

[309] Liao, Meijian, Xiaolin Sun, Wendan Zheng, Mengdi Wu, Yifan Wang, Jia Yao, Yu Ma, Shoucui Gao, and Dongsheng Pei. 2023. “LINC00922 Decoys SIRT3 to Facilitate the Metastasis of Colorectal Cancer Through Up-Regulation the H3K27 Crotonylation of ETS1 Promoter.” Molecular Cancer 22: 163. https://doi.org/10.1186/s12943-023-01859-y

[310] Yamagishi, Makoto, Makoto Hori, Dai Fujikawa, Takeo Ohsugi, Daisuke Honma, Nobuaki Adachi, Harutaka Katano, et al. 2019. “Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas.” Cell Reports 29: 2321–37. https://doi.org/10.1016/j.celrep.2019.10.083

[311] Xu, Xiaolin, Xin Zhu, Feng Liu, Wenlong Lu, Yihan Wang, and Jianjun Yu. 2021. “The Effects of Histone Crotonylation and Bromodomain Protein 4 on Prostate Cancer Cell Lines.” Translational Andrology and Urology 10: 900–14. https://doi.org/10.21037/tau-21-53

[312] Deng, Yilin, Jinjin Gao, Guangying Xu, Yuan Yao, Yan Sun, Yehui Shi, Xishan Hao, Liling Niu, and Hui Li. 2022. “HDAC6-Dependent Deacetylation of AKAP12 Dictates Its Ubiquitination and Promotes Colon Cancer Metastasis.” Cancer Letters 549: 215911. https://doi.org/10.1016/j.canlet.2022.215911

[313] Jiang, Jianping, Leilei Wang, Yiyi Hu, Xin Chen, Pei Li, Jianfeng Zhang, Yixin Zhang, et al. 2025. “Global Emergence of Carbapenem-Resistant Hypervirulent Klebsiella Pneumoniae Driven by an IncFIIK34 KPC-2 Plasmid.” EBioMedicine 113: 105627. https://doi.org/10.1016/j.ebiom.2025.105627

[314] He, Lin, Chunyu Yu, Sen Qin, Enrun Zheng, Xinhua Liu, Yanhua Liu, Shimiao Yu, et al. 2023. “The Proteasome Component PSMD14 Drives Myelomagenesis Through a Histone Deubiquitinase Activity.” Molecular Cell 83: 4000–16. https://doi.org/10.1016/j.molcel.2023.10.019

[315] Zeng, Yuan, Haoran Jiang, Zhoufeng Chen, Jun Xu, Xiangting Zhang, Weimin Cai, Xianjie Zeng, et al. 2025. “Histone Lactylation Promotes Multidrug Resistance in Hepatocellular Carcinoma by Forming a Positive Feedback Loop With PTEN.” Cell Death & Disease 16: 59. https://doi.org/10.1038/s41419-025-07359-9

[316] Yu, Hui, Xianrong Xu, Lirong Zhu, Shengjie Chen, and Jincheng He. 2024. “MELK Aggravates Lung Adenocarcinoma by Regulating EZH2 Ubiquitination and H3K27me3 Histone Methylation of LATS2.” Journal of Cellular and Molecular Medicine 28: e18216. https://doi.org/10.1111/jcmm.18216

[317] Cui, Zhaolei, Yanhong Li, Yingying Lin, Chaoqiang Zheng, Lingqing Luo, Dan Hu, Yan Chen, Zhenzhou Xiao, and Yang Sun. 2024. “Lactylproteome Analysis Indicates Histone H4K12 Lactylation as a Novel Biomarker in Triple-Negative Breast Cancer.” Frontiers in Endocrinology 15: 1328679. https://doi.org/10.3389/fendo.2024.1328679

[318] Wang, Yufeng, Yajing Lyu, Kangsheng Tu, Qiuran Xu, Yongkang Yang, Shaima Salman, Nguyet Le, et al. 2021. “Histone Citrullination by PADI4 Is Required for HIF-Dependent Transcriptional Responses to Hypoxia and Tumor Vascularization.” Science Advances 7: eabe3771. https://doi.org/10.1126/sciadv.abe3771

[319] Ghate, Nikhil Baban, Sangnam Kim, Erin Spiller, Sungmin Kim, Yonghwan Shin, Suhn K. Rhie, Goar Smbatyan, et al. 2021. “VprBP Directs Epigenetic Gene Silencing Through Histone H2A Phosphorylation in Colon Cancer.” Molecular Oncology 15: 2801–17. https://doi.org/10.1002/1878-0261.13068

[320] Deng, Yu, Yujiang Li, Tiantong Wu, Xuyuan Chen, Xiang Li, Kaican Cai, and Xu Wu. 2022. “RAD6 Positively Affects Tumorigenesis of Esophageal Squamous Cell Carcinoma by Regulating Histone Ubiquitination of CCNB1.” Biological Procedures Online 24: 4. https://doi.org/10.1186/s12575-022-00165-z

[321] Li, Qixiang, Hongfei Ci, Pengpeng Zhao, Dongjun Yang, Yi Zou, Panhai Chen, Dongliang Wu, et al. 2025. “NONO Interacts With Nuclear PKM2 and Directs Histone H3 Phosphorylation to Promote Triple-Negative Breast Cancer Metastasis.” Journal of Experimental & Clinical Cancer Research 44: 90. https://doi.org/10.1186/s13046-025-03343-5

[322] Liu, Kaiyuan, Yingchao Zhang, Genyu Du, Xinyu Chen, Lingling Xiao, Luyao Jiang, Na Jing, et al. 2025. “5-HT Orchestrates Histone Serotonylation and Citrullination to Drive Neutrophil Extracellular Traps and Liver Metastasis.” Journal of Clinical Investigation 135: e183544. https://doi.org/10.1172/JCI183544

[323] Gnedina, Olga O., Alisa V. Morshneva, Elena V. Skvortsova, and Maria V. Igotti. 2022. “HDAC Inhibitor Sodium Butyrate Attenuates the DNA Repair in Transformed but Not in Normal Fibroblasts.” International Journal of Molecular Sciences 23: 3517. https://doi.org/10.3390/ijms23073517

[324] Chambers, Laura M., Emily L. Esakov Rhoades, Rashmi Bharti, Chad Braley, Surabhi Tewari, Lexie Trestan, Zahraa Alali, et al. 2022. “Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer.” Cancer Research 82: 4654–69. https://doi.org/10.1158/0008-5472.Can-22-0455

[325] Rivas-Domínguez, Antonio, Nuria Pastor, Laura Martínez-López, Julia Colón-Pérez, Beatriz Bermúdez, and Manuel Luis Orta. 2021. “The Role of DNA Damage Response in Dysbiosis-Induced Colorectal Cancer.” Cells 10: 1934. https://doi.org/10.3390/cells10081934

[326] Luu, Maik, Zeno Riester, Adrian Baldrich, Nicole Reichardt, Samantha Yuille, Alessandro Busetti, Matthias Klein, et al. 2021. “Microbial Short-Chain Fatty Acids Modulate CD8⁺ T Cell Responses and Improve Adoptive Immunotherapy for Cancer.” Nature Communications 12: 4077. https://doi.org/10.1038/s41467-021-24331-1

[327] Hang, Saiyu, Donggi Paik, Lina Yao, Eunha Kim, Jamma Trinath, Jingping Lu, Soyoung Ha, et al. 2019. “Bile Acid Metabolites Control TH17 and Treg Cell Differentiation.” Nature 576: 143–8. https://doi.org/10.1038/s41586-019-1785-z

[328] Wang, Li-Ting, Jing-Ping Liou, Yu-Hsuan Li, Yi-Min Liu, Shiow-Lin Pan, and Che-Ming Teng. 2014. “A Novel Class I HDAC Inhibitor, MPT0G030, Induces Cell Apoptosis and Differentiation in Human Colorectal Cancer Cells via HDAC1/PKCδ and E-Cadherin.” Oncotarget 5: 5651–62. https://doi.org/10.18632/oncotarget.2155. https://www.oncotarget.com/article/2155/text/

[329] Soda, Kuniyasu. 2018. “Polyamine Metabolism and Gene Methylation in Conjunction With One-Carbon Metabolism.” International Journal of Molecular Sciences 19: 3106. https://doi.org/10.3390/ijms19103106. https://www.mdpi.com/1422-0067/19/10/3106

[330] Xu, Bangjun, Yi Liu, Ning Li, and Qing Geng. 2024. “Lactate and Lactylation in Macrophage Metabolic Reprogramming: Current Progress and Outstanding Issues.” Frontiers in Immunology 15: 1395786. https://doi.org/10.3389/fimmu.2024.1395786

[331] Ohta, Akio, Radhika Kini, Akiko Ohta, Meenakshi Subramanian, Manasa Madasu, and Michail Sitkovsky. 2012. “The Development and Immunosuppressive Functions of CD4⁺ CD25⁺ FoxP3⁺ Regulatory T Cells Are Under Influence of the adenosine-A2A Adenosine Receptor Pathway.” Frontiers in Immunology 3: 190. https://doi.org/10.3389/fimmu.2012.00190

[332] Garavaglia, Beatrice, Letizia Vallino, Alessandra Ferraresi, Andrea Esposito, Amreen Salwa, Chiara Vidoni, Sergio Gentilli, and Ciro Isidoro. 2022. “Butyrate Inhibits Colorectal Cancer Cell Proliferation Through Autophagy Degradation of β-Catenin Regardless of APC and β-Catenin Mutational Status.” Biomedicines 10: 1131. https://doi.org/10.3390/biomedicines10051131

[333] Centuori, Sara M., Cecil J. Gomes, Jesse Trujillo, Jamie Borg, Joshua Brownlee, Charles W. Putnam, and Jesse D. Martinez. 2016. “Deoxycholic Acid Mediates Non-Canonical EGFR-MAPK Activation Through the Induction of Calcium Signaling in Colon Cancer Cells.” Biochimica et Biophysica Acta (BBA)—Molecular and Cell Biology of Lipids 1861: 663–70. https://doi.org/10.1016/j.bbalip.2016.04.006

[334] Ye, Zi, Zhirui Zeng, Yiyi Shen, Qiang Yang, Duidui Chen, Zubing Chen, and Shiqiang Shen. 2019. “ODC1 Promotes Proliferation and Mobility via the AKT/GSK3β/β-Catenin Pathway and Modulation of Acidotic Microenvironment in Human Hepatocellular Carcinoma.” OncoTargets and Therapy 12: 4081–92. https://doi.org/10.2147/OTT.S198341

[335] Shiizaki, Kazuhiro, Kenta Kido, and Yasuhiro Mizuta. 2019. “Insight Into the Relationship Between Aryl-Hydrocarbon Receptor and β-Catenin in Human Colon Cancer Cells.” PLoS One 14: e0224613. https://doi.org/10.1371/journal.pone.0224613

[336] Li, Yangbo, Pengzhan He, Ying Chen, Jiaming Hu, Beiying Deng, Chuan Liu, Baoping Yu, et al. 2024. “Microbial Metabolite Sodium Butyrate Enhances the Anti-Tumor Efficacy of 5-fluorouracil Against Colorectal Cancer by Modulating PINK1/Parkin Signaling and Intestinal Flora.” Scientific Reports 14: 13063. https://doi.org/10.1038/s41598-024-63993-x

[337] Loftfield, Erikka, Roni T. Falk, Joshua N. Sampson, Wen-Yi Huang, Autumn Hullings, Gwen Murphy, Stephanie J. Weinstein, et al. 2022. “Prospective Associations of Circulating Bile Acids and Short-Chain Fatty Acids With Incident Colorectal Cancer.” JNCI Cancer Spectrum 6: pkac027. https://doi.org/10.1093/jncics/pkac027

[338] Bailey, Ann M., Le Zhan, Dipen Maru, Imad Shureiqi, Curtis R. Pickering, Galina Kiriakova, Julie Izzo, et al. 2014. “FXR Silencing in Human Colon Cancer by DNA Methylation and KRAS Signaling.” American Journal of Physiology—Gastrointestinal and Liver Physiology 306: G48–58. https://doi.org/10.1152/ajpgi.00234.2013

[339] Kok, Dieuwertje E. G., Rosalie A. M. Dhonukshe-Rutten, Carolien Lute, Sandra G. Heil, André G Uitterlinden, Nathalie van der Velde, Joyce B. J. van Meurs, et al. 2015. “The Effects of Long-Term Daily Folic Acid and Vitamin B12 Supplementation on Genome-Wide DNA Methylation in Elderly Subjects.” Clinical Epigenetics 7: 121. https://doi.org/10.1186/s13148-015-0154-5

[340] Davletgildeeva, Anastasiia T., and Nikita A. Kuznetsov. 2024. “The Role of DNMT Methyltransferases and TET Dioxygenases in the Maintenance of the DNA Methylation Level.” Biomolecules 14: 1117. https://doi.org/10.3390/biom14091117. https://www.mdpi.com/2218-273X/14/9/1117

[341] Cho, Hang Joo, Sin Young Kim, Kee Hwan Kim, Won Kyung Kang, Ji Il kim, Seong Tack Oh, Jeong Soo Kim, and Chang Hyeok An. 2009. “The Combination Effect of Sodium Butyrate and 5-Aza-2′-Deoxycytidine on Radiosensitivity in RKO Colorectal Cancer and MCF-7 Breast Cancer Cell Lines.” World Journal of Surgical Oncology 7: 49. https://doi.org/10.1186/1477-7819-7-49

[342] Chen, Zhangqian, Lin Zhang, Yang Yang, Haiming Liu, Xiaoyu Kang, Yongzhan Nie, and Daiming Fan. 2023. “DNMT1 Expression Partially Dictates 5-Azacytidine Sensitivity and Correlates With RAS/MEK/ERK Activity in Gastric Cancer Cells.” Epigenetics 18: 2254976. https://doi.org/10.1080/15592294.2023.2254976

[343] Munteanu, Raluca Andrada, Cristian Silviu Moldovan, Adrian Bogdan Tigu, Rares Drula, Richard Feder, Lorand Magdo, Ancuta Jurj, et al. 2024. “5-Azacytidine Treatment Inhibits the Development of Lung Cancer Models via Epigenetic Reprogramming and Activation of Cellular Pathways With Anti-Tumor Activity.” Medicine and Pharmacy Reports 97: 488–506. https://doi.org/10.15386/mpr-2777

[344] Sufiyan, Sufiyan, Hira Salam, Sahar Ilyas, Wajiha Amin, Fatima Arshad, Kainaat Fatima, Sana Naeem, et al. 2025. “Prognostic Implications of DNA Methylation Machinery (DNMTs and TETs) Expression in Gliomas: Correlations With Tumor Grading and Patient Survival.” Journal of Neuro-Oncology 12: 1–16. https://doi.org/10.1007/s11060-025-05032-x

[345] Park, Pyoung Hwa, Kelsey Keith, Gennaro Calendo, Jaroslav Jelinek, Jozef Madzo, Raad Z. Gharaibeh, Jayashri Ghosh, et al. 2024. “Association between Gut Microbiota and CpG Island Methylator Phenotype in Colorectal Cancer.” Gut Microbes 16: 2363012. https://doi.org/10.1080/19490976.2024.2363012

[346] Zhang, Xianglin, Wei Zhang, Jinyi Zhang, Xiuhong Lyu, Haoran Pan, Tianwei Jia, Ting Wang, et al. 2025. “Simulation-Guided Pan-Cancer Analysis Identifies a Novel Regulator of CpG Island Hypermethylation Heterogeneity.” Briefings in Bioinformatics 26: bbaf252. https://doi.org/10.1093/bib/bbaf252

[347] Ning, Gang, Yongqiang Li, Wenji Chen, Wenjuan Tang, Diwen Shou, Qingling Luo, Huiting Chen, and Yongjian Zhou. 2021. “CpG Island Methylator Phenotype Modulates the Immune Response of the Tumor Microenvironment and Influences the Prognosis of Pancreatic Cancer Patients.” Journal of Oncology 2021: 2715694. https://doi.org/10.1155/2021/2715694

[348] Gebhard, Claudia, Roger Mulet-Lazaro, Dagmar Glatz, Lucia Schwarzfischer-Pfeilschifter, Peter Schirmacher, Jochen Gaedcke, Wilko Weichert, et al. 2022. “Aberrant DNA Methylation Patterns in Microsatellite Stable Human Colorectal Cancers Define a New Marker Panel for the CpG Island Methylator Phenotype.” International Journal of Cancer 150: 617–25. https://doi.org/10.1002/ijc.33831

[349] Yu, Huichuan, Xiaolin Wang, Liangliang Bai, Guannan Tang, Kelly T. Carter, Ji Cui, Pinzhu Huang, et al. 2023. “DNA Methylation Profile in CpG-depleted Regions Uncovers a High-Risk Subtype of Early-Stage Colorectal Cancer.” JNCI: Journal of the National Cancer Institute 115: 52–61. https://doi.org/10.1093/jnci/djac183

[350] Wang, Jiu, Meng Zhang, Yi-feng Liu, Yan Yao, Yu-sha Ji, Amandine Etcheverry, Kun Chen, et al. 2022. “Potent Predictive CpG Signature for Temozolomide Response in Non-glioma-CpG Island Methylator Phenotype Glioblastomas With Methylated MGMT Promoter.” Epigenomics 14: 1233–47. https://doi.org/10.2217/epi-2022-0344

[351] Kim, Jung Ho, Jiyun Hong, Ji Ae Lee, Minsun Jung, Eunwoo Choi, Nam-Yun Cho, Gyeong Hoon Kang, and Sangwoo Kim. 2024. “Immune Microenvironmental Heterogeneity According to Tumor DNA Methylation Phenotypes in Microsatellite Instability-High Colorectal Cancers.” Cancer Immunology, Immunotherapy 73: 215. https://doi.org/10.1007/s00262-024-03805-3

[352] Liang, Junnan, Tongtong Liu, Jingyu Liao, Lu Zhang, Mi Zhou, Weiqi Xu, Yi He, et al. 2021. “Development and Validation of a CpG Island Methylator Phenotype-Related Prognostic Signature for Cholangiocarcinoma.” Journal of Cellular Physiology 236: 3143–56. https://doi.org/10.1002/jcp.30082

[353] Somuncu, Berna, Aysegul Ekmekcioglu, Fatma Merve Antmen, Tugce Ertuzun, Emre Deniz, Nazli Keskin, Joon Park, et al. 2022. “Targeting Mitochondrial DNA Polymerase Gamma for Selective Inhibition of MLH1 Deficient Colon Cancer Growth.” PloS One 17: e0268391. https://doi.org/10.1371/journal.pone.0268391

[354] Desterke, Christophe, Fanny Jaulin, and Emmanuel Dornier. 2024. “Hypermethylated Colorectal Cancer Tumours Present a Myc-Driven Hypermetabolism With a One-Carbon Signature Associated With Worsen Prognosis.” Biomedicines 12: 590. https://doi.org/10.3390/biomedicines12030590

[355] Durrant, Matthew G., Brayon J. Fremin, Emily Cribas, Stephen Montgomery, and Ami S. Bhatt. 2021. “Chromatin Accessibility Changes Induced by the Microbial Metabolite Butyrate Reveal Possible Mechanisms of Anti-cancer Effects.” bioRxiv 2021.2003.2030.437582. https://doi.org/10.1101/2021.03.30.437582

[356] Delaney, Colin E., Stephen P. Methot, Veronique Kalck, Jan Seebacher, Daniel Hess, Susan M. Gasser, and Jan Padeken. 2022. “SETDB1-like MET-2 Promotes Transcriptional Silencing and Development Independently of Its H3K9me-Associated Catalytic Activity.” Nature Structural & Molecular Biology 29: 85–96. https://doi.org/10.1038/s41594-021-00712-4

[357] Akimoto, Naohiko, Melissa Zhao, Tomotaka Ugai, Rong Zhong, Mai Chan Lau, Kenji Fujiyoshi, Junko Kishikawa, et al. 2021. “Tumor Long Interspersed Nucleotide Element-1 (LINE-1) Hypomethylation in Relation to Age of Colorectal Cancer Diagnosis and Prognosis.” Cancers 13: 2016. https://doi.org/10.3390/cancers13092016

[358] Casarotto, Mariateresa, Valentina Lupato, Giorgio Giurato, Roberto Guerrieri, Sandro Sulfaro, Annamaria Salvati, Elisa D'Angelo, et al. 2022. “LINE-1 Hypomethylation Is Associated With Poor Outcomes in Locoregionally Advanced Oropharyngeal Cancer.” Clinical Epigenetics 14: 171. https://doi.org/10.1186/s13148-022-01386-5

[359] Baba, Yoshifumi, Noriko Yasuda, Miki Bundo, Yutaka Nakachi, Junko Ueda, Takatsugu Ishimoto, Masaaki Iwatsuki, et al. 2024. “LINE-1 Hypomethylation, Increased Retrotransposition and Tumor-Specific Insertion in Upper Gastrointestinal Cancer.” Cancer Science 115: 247–56. https://doi.org/10.1111/cas.16007

[360] McKerrow, Wilson, Xuya Wang, Carlos Mendez-Dorantes, Paolo Mita, Song Cao, Mark Grivainis, Li Ding, et al. 2022. “LINE-1 Expression in Cancer Correlates With p53 Mutation, Copy Number Alteration, and S Phase Checkpoint.” Proceedings of the National Academy of Sciences 119: e2115999119. https://doi.org/10.1073/pnas.2115999119

[361] Xu, Baohong, Xueer Li, Shaoqi Zhang, Meina Lian, Wenbin Huang, Yin Zhang, Yudong Wang, and Zhiquan Huang. 2023. “Pan Cancer Characterization of Genes Whose Expression Has Been Associated With LINE-1 Antisense Promoter Activity.” Mobile DNA 14: 13. https://doi.org/10.1186/s13100-023-00300-x

[362] Sun, Zeguo, Rui Zhang, Xiao Zhang, Yifei Sun, Pengpeng Liu, Nancy Francoeur, Lei Han, et al. 2022. “LINE-1 Promotes Tumorigenicity and Exacerbates Tumor Progression via Stimulating Metabolism Reprogramming in Non-Small Cell Lung Cancer.” Molecular Cancer 21: 147. https://doi.org/10.1186/s12943-022-01618-5

[363] Muse, Meghan E., Drew T. Bergman, Lucas A. Salas, Lisa N. Tom, Jean-Marie Tan, Antonia Laino, Duncan Lambie, et al. 2022. “Genome-Scale DNA Methylation Analysis Identifies Repeat Element Alterations That Modulate the Genomic Stability of Melanocytic Nevi.” Journal of Investigative Dermatology 142: 1893–902.e7. https://doi.org/10.1016/j.jid.2021.11.025

[364] Jiang, Alice C., Lela Buckingham, Faraz Bishehsari, Stephanie Sutherland, Karen Ma, and Joshua E. Melson. 2021. “Correlation of LINE-1 Hypomethylation With Size and Pathologic Extent of Dysplasia in Colorectal Tubular Adenomas.” Clinical and Translational Gastroenterology 12: e00369. https://doi.org/10.14309/ctg.0000000000000369

[365] de Santiago, Pamela R., Sho Sato, Stephanie J. Zhang, Meaghan C. Dougher, Kyle M. Devins, Agnes J. Bilecz, Sagar Rayamajhi, et al. 2025. “LINE-1 ORF1p Expression Occurs in Clear Cell Ovarian Carcinoma Precursors and Is a Candidate Blood Biomarker.” npj Precision Oncology 9: 62. https://doi.org/10.1038/s41698-025-00849-1

[366] Chen, Xuedan, Juan Li, Xingying Guan, Yun Bai, and Kai Wang. 2024. “Abnormal Activation of Genomic LINE1 Elements Caused by DNA Demethylation Contributes to lncRNA CASC9 Overexpression in Esophageal Squamous Cell Carcinoma.” Heliyon 10: e32857. https://doi.org/10.1016/j.heliyon.2024.e32857

[367] Chen, Teng-fei, Hui-fei Hao, Yan Zhang, Xiao-yu Chen, Hua-si Zhao, Rui Yang, Ping Li, et al. 2022. “HBO1 Induces Histone Acetylation and Is Important for Non-Small Cell Lung Cancer Cell Growth.” International Journal of Biological Sciences 18: 3313–23. https://doi.org/10.7150/ijbs.72526

[368] Gu, Hao, Suwan Qi, Jiaying Chen, Hongqin Wu, Jianjuan Xu, and Yaling Feng. 2025. “NOC2L Promotes Paclitaxel Resistance in Various Types of Ovarian Cancers by Decreasing NDUFA4 Through Histone Acetylation Suppression.” Molecular Cancer Therapeutics 24: 942–56. https://doi.org/10.1158/1535-7163.MCT-24-0512

[369] Yang, Guang, Ying Yuan, Hongfeng Yuan, Jiapei Wang, Haolin Yun, Yu Geng, Man Zhao, et al. 2021. “Histone Acetyltransferase 1 Is a Succinyltransferase for Histones and Non-Histones and Promotes Tumorigenesis.” EMBO Reports 22: e50967. https://doi.org/10.15252/embr.202050967

[370] Shi, Yingying, You Wang, Huangang Jiang, Xuehua Sun, Hui Xu, Xue Wei, Yan Wei, et al. 2021. “Mitochondrial Dysfunction Induces Radioresistance in Colorectal Cancer by Activating [Ca²⁺] m-PDP1-PDH-Histone Acetylation Retrograde Signaling.” Cell Death & Disease 12: 837. https://doi.org/10.1038/s41419-021-03984-2

[371] Zheng, Wei, Luisa Tasselli, Tie-mei Li, and Katrin F. Chua. 2021. “Mammalian SIRT6 Represses Invasive Cancer Cell Phenotypes Through ATP Citrate Lyase (ACLY)-Dependent Histone Acetylation.” Genes 12: 1460. https://doi.org/10.3390/genes12091460

[372] Wang, Yingying, Qianying Zhu, Haihong Hu, Hong Zhu, Bo Yang, Qiaojun He, Lushan Yu, and Su Zeng. 2021. “Upregulation of Histone Acetylation Reverses Organic Anion Transporter 2 Repression and Enhances 5-Fluorouracil Sensitivity in Hepatocellular Carcinoma.” Biochemical Pharmacology 188: 114546. https://doi.org/10.1016/j.bcp.2021.114546

[373] Si, Xiaohui, Mi Shao, Xinyi Teng, Yue Huang, Ye Meng, Longyuan Wu, Jieping Wei, et al. 2024. “Mitochondrial Isocitrate Dehydrogenase Impedes CAR T Cell Function by Restraining Antioxidant Metabolism and Histone Acetylation.” Cell Metabolism 36: 176–92.e10. e110. https://doi.org/10.1016/j.cmet.2023.12.010

[374] Sun, Yan, Dianyun Ren, Yingke Zhou, Jian Shen, Heshui Wu, and Xin Jin. 2021. “Histone Acetyltransferase 1 Promotes Gemcitabine Resistance by Regulating the PVT1/EZH2 Complex in Pancreatic Cancer.” Cell Death & Disease 12: 878. https://doi.org/10.1038/s41419-021-04118-4

[375] Liu, Yifan, Eun Ju Yang, Changxiang Shi, Pui Kei Mou, Baoyuan Zhang, Changjie Wu, Junfang Lyu, and Joong Sup Shim. 2020. “Histone Acetyltransferase (HAT) P300/CBP Inhibitors Induce Synthetic Lethality in PTEN-Deficient Colorectal Cancer Cells Through Destabilizing AKT.” International Journal of Biological Sciences 16: 1774–84. https://doi.org/10.7150/ijbs.42197

[376] Kuang, Chaoyuan, Jingshan Tong, Kaylee Ermine, Manbo Cai, Fujun Dai, Suisui Hao, Francis Giles, et al. 2022. “Dual Inhibition of BET and HAT/p300 Suppresses Colorectal Cancer via DR5- and p53/PUMA-Mediated Cell Death.” Frontiers in Oncology 12: 1018775. https://doi.org/10.3389/fonc.2022.1018775

[377] Garcia, Jacqueline S., Yael Flamand, Livius Penter, Michael Keng, Benjamin K. Tomlinson, Lourdes M. Mendez, Paul Koller, et al. 2023. “Ipilimumab Plus Decitabine for Patients With MDS or AML in Posttransplant or Transplant-Naïve Settings.” Blood 141: 1884–8. https://doi.org/10.1182/blood.2022017686

[378] Pawlak, Alicja, Kinga Chybicka, Ewa Zioło, Leon Strządała, and Wojciech Kałas. 2022. “The Contrasting Delayed Effects of Transient Exposure of Colorectal Cancer Cells to Decitabine or Azacitidine.” Cancers 14: 1530. https://doi.org/10.3390/cancers14061530

[379] Kim, S. J., J. H. Kim, C. S. Ki, Y. H. Ko, J. S. Kim, and W. S. Kim. 2016. “Epstein–Barr Virus Reactivation in Extranodal Natural Killer/T-Cell Lymphoma Patients: A Previously Unrecognized Serious Adverse Event in a Pilot Study With Romidepsin.” Annals of Oncology 27: 508–13. https://doi.org/10.1093/annonc/mdv596

[380] Wobser, Marion, Alexandra Weber, Amelie Glunz, Saskia Tauch, Kristina Seitz, Tobias Butelmann, Sonja Hesbacher, et al. 2019. “Elucidating the Mechanism of Action of Domatinostat (4SC-202) in Cutaneous T Cell Lymphoma Cells.” Journal of Hematology & Oncology 12: 30. https://doi.org/10.1186/s13045-019-0719-4

[381] Koseki, Akihito, Natsumi Araya, Makoto Yamagishi, Junji Yamauchi, Naoko Yagishita, Naoki Takao, Katsunori Takahashi, et al. 2023. “EZH1/2 Dual Inhibitors Suppress HTLV-1-Infected Cell Proliferation and Hyperimmune Response in HTLV-1-Associated Myelopathy.” Frontiers in Microbiology 14: 1175762. https://doi.org/10.3389/fmicb.2023.1175762

[382] Lai, Yongwei, Xu Han, Bo Xie, Yan Xu, Zhengyi Yang, Didi Wang, Wei Li, et al. 2024. “EZH2 Suppresses Ferroptosis in Hepatocellular Carcinoma and Reduces Sorafenib Sensitivity Through Epigenetic Regulation of TFR2.” Cancer Science 115: 2220–34. https://doi.org/10.1111/cas.16186

[383] Zhong, Mengjun, Rili Gao, Ruocong Zhao, Youxue Huang, Cunte Chen, Kehan Li, Xibao Yu, et al. 2022. “BET Bromodomain Inhibition Rescues PD-1-Mediated T-Cell Exhaustion in Acute Myeloid Leukemia.” Cell Death & Disease 13: 671. https://doi.org/10.1038/s41419-022-05123-x

[384] Zhang, Xin, Tim Zegar, Anais Lucas, Chevaun Morrison-Smith, Tatiana Knox, Christopher A. French, Stefan Knapp, Susanne Müller, and Jens T. Siveke. 2020. “Therapeutic Targeting of p300/CBP HAT Domain for the Treatment of NUT Midline Carcinoma.” Oncogene 39: 4770–9. https://doi.org/10.1038/s41388-020-1301-9

[385] Thomas, Daniel, Manhong Wu, Yusuke Nakauchi, Ming Zheng, Chloe A. L. Thompson-Peach, Kelly Lim, Niklas Landberg, et al. 2023. “Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability.” Cancer Discovery 13: 496–515. https://doi.org/10.1158/2159-8290.CD-21-0218

[386] Chen, Kuei-An, Wei-Ming Huang, Eric Yi-Ting Chen, Pei-Kuan Ho, Chen-Han Chueh, Yu-Wen Wen, Ming-Huang Chen, Nai-Jung Chiang, and Yi-Wen Tsai. 2024. “Cost-Effectiveness of Ivosidenib Versus Chemotherapy for Previously Treated IDH1-Mutant Advanced Intrahepatic Cholangiocarcinoma in Taiwan.” BMC Cancer 24: 622. https://doi.org/10.1186/s12885-024-12362-y

[387] Shih, Alan H., Cem Meydan, Kaitlyn Shank, Francine E. Garrett-Bakelman, Patrick S. Ward, Andrew M. Intlekofer, Abbas Nazir, et al. 2017. “Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2-and TET2-Mutant Acute Myeloid Leukemia.” Cancer Discovery 7: 494–505. https://doi.org/10.1158/2159-8290.CD-16-1049

[388] Cai, Sheng F., Ying Huang, Jennie R. Lance, Hsiaoyin Charlene Mao, Andrew J. Dunbar, Samantha N. McNulty, Todd Druley, et al. 2024. “A Study to Assess the Efficacy of Enasidenib and Risk-Adapted Addition of Azacitidine in Newly Diagnosed IDH2-Mutant AML.” Blood Advances 8: 429–40. https://doi.org/10.1182/bloodadvances.2023010563

[389] Park, Sungryul, Seung-Hyun Jo, Jong-Hwan Kim, Seon-Young Kim, Jae Du Ha, Jong Yeon Hwang, Myeong Youl Lee, et al. 2020. “Combination Treatment With GSK126 and Pomalidomide Induces B-Cell Differentiation in EZH2 Gain-of-Function Mutant Diffuse Large B-Cell Lymphoma.” Cancers 12: 2541. https://doi.org/10.3390/cancers12092541

[390] Zhou, Liang, Yu Zhang, Mark B. Meads, Yun Dai, Yanxia Ning, Xiaoyan Hu, Lin Li, et al. 2021. “IAP and HDAC Inhibitors Interact Synergistically in Myeloma Cells Through Noncanonical NF-κB–and Caspase-8-Dependent Mechanisms.” Blood Advances 5: 3776–88. https://doi.org/10.1182/bloodadvances.2020003597

[391] Harding, Taylor, Jessica Swanson, and Brian Van Ness. 2018. “EZH2 Inhibitors Sensitize Myeloma Cell Lines to Panobinostat Resulting in Unique Combinatorial Transcriptomic Changes.” Oncotarget 9: 21930–42. https://doi.org/10.18632/oncotarget.25128

[392] Kawashima, Nagako, Yoshiyuki Nishimiya, Shouta Takahata, and Ken-Ichi Nakayama. 2016. “Induction of Glycosphingolipid GM3 Expression by Valproic Acid Suppresses Cancer Cell Growth.” Journal of Biological Chemistry 291: 21424–33. https://doi.org/10.1074/jbc.M116.751503

[393] Barciszewska, Anna-Maria, Agnieszka Belter, Iwona Gawrońska, Małgorzata Giel-Pietraszuk, and Mirosława Z. Naskręt-Barciszewska. 2022. “Cross-Reactivity Between Histone Demethylase Inhibitor Valproic Acid and DNA Methylation in Glioblastoma Cell Lines.” Frontiers in Oncology 12: 1033035. https://doi.org/10.3389/fonc.2022.1033035

[394] Janssens, Derek H., Michael P. Meers, Steven J. Wu, Ekaterina Babaeva, Soheil Meshinchi, Jay F. Sarthy, Kami Ahmad, and Steven Henikoff. 2021. “Automated CUT&Tag Profiling of Chromatin Heterogeneity in Mixed-Lineage Leukemia.” Nature Genetics 53: 1586–96. https://doi.org/10.1038/s41588-021-00941-9

[395] Cardenas, Horacio, Fang Fang, Guanglong Jiang, Susan M. Perkins, Chi Zhang, Robert E. Emerson, George Hutchins, et al. 2021. “Methylomic Signatures of High Grade Serous Ovarian Cancer.” Epigenetics 16: 1201–16. https://doi.org/10.1080/15592294.2020.1853402

[396] Wang, Weini, Fang Fang, Ali Ozes, and Kenneth P. Nephew. 2021. “Targeting Ovarian Cancer Stem Cells by Dual Inhibition of HOTAIR and DNA Methylation.” Molecular Cancer Therapeutics 20: 1092–101. https://doi.org/10.1158/1535-7163.MCT-20-0826

[397] Stein, Eytan M., Courtney D. DiNardo, Daniel A. Pollyea, Amir T. Fathi, Gail J. Roboz, Jessica K. Altman, Richard M. Stone, et al. 2017. “Enasidenib in Mutant IDH2 Relapsed or Refractory Acute Myeloid Leukemia.” Blood 130: 722–31. https://doi.org/10.1182/blood-2017-04-779405

[398] Watts, Justin, Mark D. Minden, Kimo Bachiashvili, Andrew M. Brunner, Sameem Abedin, Timothy Crossman, Magdalena Zajac, et al. 2024. “Phase I/II Study of the Clinical Activity and Safety of GSK3326595 in Patients With Myeloid Neoplasms.” Therapeutic Advances in Hematology 15: 20406207241275376. https://doi.org/10.1177/20406207241275376

[399] Tang, Yixuan, Shihui Huang, Xingxing Chen, Junzhang Huang, Qianwen Lin, Lei Huang, Shuping Wang, et al. 2022. “Design, Synthesis and Biological Evaluation of Novel and Potent Protein Arginine Methyltransferases 5 Inhibitors for Cancer Therapy.” Molecules 27: 6637. https://doi.org/10.3390/molecules27196637

[400] Augert, Arnaud, Emily Eastwood, Ali H. Ibrahim, Nan Wu, Eli Grunblatt, Ryan Basom, Denny Liggitt, et al. 2019. “Targeting NOTCH Activation in Small Cell Lung Cancer Through LSD1 Inhibition.” Science Signaling 12: eaau2922. https://doi.org/10.1126/scisignal.aau2922

[401] Salamero, Olga, Pau Montesinos, Christophe Willekens, José Antonio Pérez-Simón, Arnaud Pigneux, Christian Récher, Rakesh Popat, et al. 2020. “First-In-Human Phase I Study of Iadademstat (ORY-1001): A First-In-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia.” Journal of Clinical Oncology 38: 4260–73. https://doi.org/10.1200/JCO.19.03250

[402] Ciechomska, Iwona Anna, Piotr Przanowski, Judyta Jackl, Bartosz Wojtas, and Bozena Kaminska. 2016. “BIX01294, an Inhibitor of Histone Methyltransferase, Induces Autophagy-Dependent Differentiation of Glioma Stem-Like Cells.” Scientific Reports 6: 38723. https://doi.org/10.1038/srep38723

[403] Bao, Lei, Yan Chen, Hsien-Tsung Lai, Shwu-Yuan Wu, Jennifer E. Wang, Kimmo J. Hatanpaa, Jack M. Raisanen, et al. 2018. “Methylation of Hypoxia-Inducible Factor (HIF)-1α by G9a/GLP Inhibits HIF-1 Transcriptional Activity and Cell Migration.” Nucleic Acids Research 46: 6576–91. https://doi.org/10.1093/nar/gky449

[404] Romani, Massimo, Antonio Daga, Alessandra Forlani, Maria Pia Pistillo, and Barbara Banelli. 2019. “Targeting of Histone Demethylases KDM5A and KDM6B Inhibits the Proliferation of Temozolomide-Resistant Glioblastoma Cells.” Cancers 11: 878. https://doi.org/10.3390/cancers11060878

[405] Bayo, Juan, Tram Anh Tran, Lei Wang, Samuel Peña-Llopis, Amit K. Das, and Elisabeth D. Martinez. 2018. “Jumonji Inhibitors Overcome Radioresistance in Cancer Through Changes in H3K4 Methylation at Double-Strand Breaks.” Cell Reports 25: 1040–50.e5. e45. https://doi.org/10.1016/j.celrep.2018.09.081

[406] Okabe, Seiichi, Yuko Tanaka, and Akihiko Gotoh. 2021. “Targeting Phosphoinositide 3-kinases and Histone Deacetylases in Multiple Myeloma.” Experimental Hematology & Oncology 10: 19. https://doi.org/10.1186/s40164-021-00213-6

[407] Fu, Xu-Hong, Xiong Zhang, Hong Yang, Xiao-Wei Xu, Zong-Long Hu, Juan Yan, Xing-Ling Zheng, et al. 2019. “CUDC-907 Displays Potent Antitumor Activity Against Human Pancreatic Adenocarcinoma In Vitro and in Vivo Through Inhibition of HDAC6 to Downregulate C-Myc Expression.” Acta Pharmacologica Sinica 40: 677–88. https://doi.org/10.1038/s41401-018-0108-5

[408] Saenz, D. T., W. Fiskus, Y. Qian, T. Manshouri, K. Rajapakshe, K. Raina, K. G. Coleman, et al. 2017. “Novel BET Protein Proteolysis-Targeting Chimera Exerts Superior Lethal Activity Than Bromodomain Inhibitor (BETi) Against Post-Myeloproliferative Neoplasm Secondary (S) AML Cells.” Leukemia 31: 1951–61. https://doi.org/10.1038/leu.2016.393

[409] Stathis, Anastasios, Emanuele Zucca, Mohamed Bekradda, Carlos Gomez-Roca, Jean-Pierre Delord, Thibault de La Motte Rouge, Emmanuelle Uro-Coste, et al. 2016. “Clinical Response of Carcinomas Harboring the BRD4–NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628.” Cancer Discovery 6: 492–500. https://doi.org/10.1158/2159-8290.CD-15-1335

[410] Erdreich-Epstein, Anat, Alok R. Singh, Shweta Joshi, Francisco M. Vega, Pinzheng Guo, Jingying Xu, Susan Groshen, et al. 2016. “Association of High Microvessel αvβ3 and Low PTEN With Poor Outcome in Stage 3 Neuroblastoma: Rationale for Using First in Class Dual PI3K/BRD4 Inhibitor, SF1126.” Oncotarget 8: 52193–210. https://doi.org/10.18632/oncotarget.13386

[411] Hay, Jodie F., Katrina Lappin, Fabio Liberante, Laura M. Kettyle, Kyle B. Matchett, Alexander Thompson, and Ken I. Mills. 2017. “Integrated Analysis of the Molecular Action of Vorinostat Identifies Epi-Sensitised Targets for Combination Therapy.” Oncotarget 8: 67891–903. https://doi.org/10.18632/oncotarget.18910

[412] Long, Jun, Bin Li, Jezabel Rodriguez-Blanco, Chiara Pastori, Claude-Henry Volmar, Claes Wahlestedt, Anthony Capobianco, et al. 2014. “The BET Bromodomain Inhibitor I-BET151 Acts Downstream of Smoothened Protein to Abrogate the Growth of Hedgehog Protein-Driven Cancers.” Journal of Biological Chemistry 289: 35494–502. https://doi.org/10.1074/jbc.M114.595348

[413] Lombard, David B., Tomasz Cierpicki, and Jolanta Grembecka. 2019. “Combined MAPK Pathway and HDAC Inhibition Breaks Melanoma.” Cancer Discovery 9: 469–71. https://doi.org/10.1158/2159-8290.CD-19-0069

[414] Chen, Genwen, Danxue Zheng, Yimin Zhou, Shisuo Du, and Zhaochong Zeng. 2024. “Olaparib Enhances Radiation-Induced Systemic Anti-Tumor Effects via Activating STING-Chemokine Signaling in Hepatocellular Carcinoma.” Cancer Letters 582: 216507. https://doi.org/10.1016/j.canlet.2023.216507

[415] Blum, Kristie A., Jeffrey G. Supko, Michael B. Maris, Ian W. Flinn, Andre Goy, Anas Younes, Suresh Bobba, et al. 2022. “A Phase I Study of Pelabresib (CPI-0610), a Small-Molecule Inhibitor of BET Proteins, in Patients With Relapsed or Refractory Lymphoma.” Cancer Research Communications 2: 795–805. https://doi.org/10.1158/2767-9764.CRC-22-0060

[416] Girard, Nicolas, Céline Bazille, Eva Lhuissier, Hervé Benateau, Antonio Llombart-Bosch, Karim Boumediene, and Catherine Bauge. 2014. “3-Deazaneplanocin A (DZNep), an Inhibitor of the Histone Methyltransferase EZH2, Induces Apoptosis and Reduces Cell Migration in Chondrosarcoma Cells.” PLoS One 9: e98176. https://doi.org/10.1371/journal.pone.0098176

[417] Huang, Tianhao, Peng Zhang, Wang Li, Tian Zhao, Zhixiong Zhang, Sujun Chen, Yan Yang, et al. 2017. “G9A Promotes Tumor Cell Growth and Invasion by Silencing CASP1 in Non-Small-Cell Lung Cancer Cells.” Cell Death & Disease 8: e2726. https://doi.org/10.1038/cddis.2017.65

[418] Jia, Dingjiacheng, Zheng Kuang, and Liangjing Wang. 2024. “The Role of Microbial Indole Metabolites in Tumor.” Gut Microbes 16: 2409209. https://doi.org/10.1080/19490976.2024.2409209

[419] Maleknia, Mohsen, Nooshin Ahmadirad, Fereshteh Golab, Yasmina Katebi, and Arsh Haj Mohamad Ebrahim Ketabforoush. 2023. “DNA Methylation in Cancer: Epigenetic View of Dietary and Lifestyle Factors.” Epigenetics Insights 16: 25168657231199893. https://doi.org/10.1177/25168657231199893

[420] Ler, Lian Dee, Sujoy Ghosh, Xiaoran Chai, Aye Aye Thike, Hong Lee Heng, Ee Yan Siew, Sucharita Dey, et al. 2017. “Loss of Tumor Suppressor KDM6A Amplifies PRC2-Regulated Transcriptional Repression in Bladder Cancer and Can be Targeted Through Inhibition of EZH2.” Science Translational Medicine 9: eaai8312. https://doi.org/10.1126/scitranslmed.aai8312

[421] Liu, Lei, Jianfeng Cui, Yajing Zhao, Xiaochen Liu, Lipeng Chen, Yangyang Xia, Yong Wang, et al. 2021. “KDM6A-ARHGDIB Axis Blocks Metastasis of Bladder Cancer by Inhibiting Rac1.” Molecular Cancer 20: 77. https://doi.org/10.1186/s12943-021-01369-9

[422] Chen, Xingxing, Xuehua Lin, Guofu Pang, Jian Deng, Qun Xie, and Zhengrong Zhang. 2021. “Significance of KDM6A Mutation in Bladder Cancer Immune Escape.” BMC cancer 21: 635. https://doi.org/10.1186/s12885-021-08372-9

[423] Ren, Lei, Hong Deng, Yu Jiang, and Chunfeng Liu. 2023. “Dual-Regulated Mechanism of EZH2 and KDM6A on SALL4 Modulates Tumor Progression via Wnt/β-Catenin Pathway in Gastric Cancer.” Digestive Diseases and Sciences 68: 1292–305. https://doi.org/10.1007/s10620-022-07790-4

[424] Chen, Zhiwei, Yuwen Qi, Jie Shen, and Zhen Chen. 2023. “Histone Demethylase KDM6A Coordinating With KMT2B Regulates Self-Renewal and Chemoresistance of Non-Small Cell Lung Cancer Stem Cells.” Translational Oncology 37: 101778. https://doi.org/10.1016/j.tranon.2023.101778

[425] Shokry, Doha, Mehwish W. Khan, Christine Powell, Samantha Johnson, Brayden C. Rennels, Raya I. Boyd, Zhengyang Sun, et al. 2024. “Refractory Testicular Germ Cell Tumors Are Highly Sensitive to the Targeting of Polycomb Pathway Demethylases KDM6A and KDM6B.” Cell Communication and Signaling 22: 528. https://doi.org/10.1186/s12964-024-01912-3

[426] Liu, Jiye, Lijie Xing, Jiang Li, Kenneth Wen, Ning Liu, Yuntong Liu, Gongwei Wu, et al. 2024. “Epigenetic Regulation of CD38/CD48 by KDM6A Mediates NK Cell Response in Multiple Myeloma.” Nature Communications 15: 1367. https://doi.org/10.1038/s41467-024-45561-z

[427] Wang, Yun, Shuzhao Chen, Zhijian Liang, Robert Peter Gale, Shutong Liu, Xiaoqin Chen, Peidong Chi, et al. 2025. “The Bone Marrow Immune Ecosystem Shapes Daratumumab Acquired Resistance in Plasma Cell Myeloma.” Leukemia 39: 2504–15. https://doi.org/10.1038/s41375-025-02712-5

[428] Li, Jing, Elaine M. Richards, Eileen M. Handberg, Carl J. Pepine, Eyad Alakrad, Chris E. Forsmark, and Mohan K. Raizada. 2023. “Influence of Butyrate on Impaired Gene Expression in Colon from Patients With High Blood Pressure.” International Journal of Molecular Sciences 24: 2650. https://doi.org/10.3390/ijms24032650

[429] Zhao, Xiaoliang, Xiaohua Wen, Bin Liu. 2023. “Wee1 Epigenetically Modulates H2B Mono-Ubiquitination at K120 Lysine and DNA Double-Strand Break Repair Through Phosphorylation of H2BY37-Dependent Manner in Small-Cell Lung Cancer.” Thoracic Cancer 14: 1420–9. https://doi.org/10.1111/1759-7714.14862

[430] Xiao, Mingming, Siyue Zhang, Zhuang Liu, Yaqi Mo, Han Wang, Xu Zhao, Xue Yang, et al. 2022. “Dual-Functional Significance of ATM-Mediated Phosphorylation of Spindle Assembly Checkpoint Component Bub3 in Mitosis and the DNA Damage Response.” Journal of Biological Chemistry 298: 101632. https://doi.org/10.1016/j.jbc.2022.101632

[431] He, Jianfeng, Caihu Huang, Yanmin Guo, Rong Deng, Lian Li, Ran Chen, Yanli Wang, et al. 2024. “PTEN-Mediated Dephosphorylation of 53BP1 Confers Cellular Resistance to DNA Damage in Cancer Cells.” Molecular Oncology 18: 580–605. https://doi.org/10.1002/1878-0261.13563

[432] Yang, Xiaotong, Zhengyan Zhang, Xuqing Shen, Junyi Xu, Yawen Weng, Wei Wang, and Jing Xue. 2023. “Clostridium butyricum and Its Metabolite Butyrate Promote Ferroptosis Susceptibility in Pancreatic Ductal Adenocarcinoma.” Cellular Oncology 46: 1645–58. https://doi.org/10.1007/s13402-023-00831-8

[433] Liu, Hao, Yongqin Tang, Anshu Singh, Joaquim Vong, Julio Cordero, Arthur Mathes, Rui Gao, et al. 2025. “RNF20 Links the DNA Damage Response and Metabolic Rewiring in Lung Cancer Through HIF1α.” Nature Communications 16: 1–22. https://doi.org/10.1038/s41467-025-60223-4

[434] Hou, Bo, Ting Chen, He Zhang, Jiatong Li, Peter Wang, and Guanning Shang. 2023. “The E3 Ubiquitin Ligases Regulate PD-1/PD-L1 Protein Levels in Tumor Microenvironment to Improve Immunotherapy.” Frontiers in Immunology 14: 1123244. https://doi.org/10.3389/fimmu.2023.1123244

[435] Zhao, Yan, Xinping Huang, Dan Zhu, Min Wei, Jiechen Luo, Shuyu Yu, Yonglu Tian, et al. 2022. “Deubiquitinase OTUD6A Promotes Breast Cancer Progression by Increasing TopBP1 Stability and Rendering Tumor Cells Resistant to DNA-Damaging Therapy.” Cell Death & Differentiation 29: 2531–44. https://doi.org/10.1038/s41418-022-01036-6

[436] Wei, Min, Xinping Huang, Liming Liao, Yonglu Tian, and Xiaofeng Zheng. 2023. “SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer.” Cancer Research 83: 2908–23. https://doi.org/10.1158/0008-5472.CAN-22-4017

[437] Arnold, Frank, Johann Gout, Heike Wiese, Stephanie E. Weissinger, Elodie Roger, Lukas Perkhofer, Karolin Walter, et al. 2021. “RINT1 Regulates SUMOylation and the DNA Damage Response to Preserve Cellular Homeostasis in Pancreatic Cancer.” Cancer Research 81: 1758–74. https://doi.org/10.1158/0008-5472.CAN-20-2633

[438] Kotani, Hiroshi, Hiroko Oshima, Justin C. Boucher, Tomoyoshi Yamano, Hiroyuki Sakaguchi, Shigeki Sato, Koji Fukuda, et al. 2024. “Dual Inhibition of SUMOylation and MEK Conquers MYC-Expressing KRAS-Mutant Cancers by Accumulating DNA Damage.” Journal of Biomedical Science 31: 68. https://doi.org/10.1186/s12929-024-01060-3

[439] Xavier-Magalhães, Ana, Céline S Gonçalves, Anne Fogli, Tatiana Lourenço, Marta Pojo, Bruno Pereira, Miguel Rocha, et al. 2018. “The Long Non-Coding RNA HOTAIR Is Transcriptionally Activated by HOXA9 and Is an Independent Prognostic Marker in Patients With Malignant Glioma.” Oncotarget 9: 15740–56. https://doi.org/10.18632/oncotarget.24597

[440] Bennett, Joshua, Chiharu Ishikawa, Puneet Agarwal, Jennifer Yeung, Avery Sampson, Emma Uible, Eric Vick, et al. 2023. “Paralog-Specific Signaling by IRAK1/4 Maintains MyD88-independent Functions in MDS/AML.” Blood 142: 989–1007. https://doi.org/10.1182/blood.2022018718

[441] Wang, P., L. Chen, J. Zhang, H. Chen, J. Fan, K. Wang, J. Luo, et al. 2014. “Methylation-Mediated Silencing of the miR-124 Genes Facilitates Pancreatic Cancer Progression and Metastasis by Targeting Rac1.” Oncogene 33: 514–24. https://doi.org/10.1038/onc.2012.598

[442] Hajibabaei, Sara, Fattah Sotoodehnejadnematalahi, Nahid Nafissi, Sirous Zeinali, and Masoumeh Azizi. 2023. “Aberrant Promoter Hypermethylation of miR-335 and miR-145 Is Involved in Breast Cancer PD-L1 Overexpression.” Scientific Reports 13: 1003. https://doi.org/10.1038/s41598-023-27415-8

[443] Supic, Gordana, Debora Stefik, Nemanja Ivkovic, Ahmad Sami, Katarina Zeljic, Sasa Jovic, Ruzica Kozomara, Danilo Vojvodic, and Srboljub Stosic. 2022. “Prognostic Impact of miR-34b/c DNA Methylation, Gene Expression, and Promoter Polymorphism in HPV-Negative Oral Squamous Cell Carcinomas.” Scientific Reports 12: 1296. https://doi.org/10.1038/s41598-022-05399-1

[444] Xu, Qian-Lan, Zan Luo, Bin Zhang, Guan-Jie Qin, Ru-Yun Zhang, Xiang-Yun Kong, Hua-Ying Tang, and Wei Jiang. 2021. “Methylation-Associated Silencing of miR-9-1 Promotes Nasopharyngeal Carcinoma Progression and Glycolysis via HK2.” Cancer Science 112: 4127–38. https://doi.org/10.1111/cas.15103

[445] Namløs, Heidi M., Magne Skårn, Deeqa Ahmed, Iwona Grad, Kim Andresen, Stine H. Kresse, Else Munthe, et al. 2022. “miR-486-5p Expression Is Regulated by DNA Methylation in Osteosarcoma.” BMC Genomics 23: 142. https://doi.org/10.1186/s12864-022-08346-6

[446] Liang, Lu, Wen-yan Xu, Ao Shen, Hui-yu Cen, Zhi-jun Chen, Lin Tan, Ling-min Zhang, et al. 2022. “Promoter Methylation-Regulated miR-148a-3p Inhibits Lung Adenocarcinoma (LUAD) Progression by Targeting MAP3K9.” Acta Pharmacologica Sinica 43: 2946–55. https://doi.org/10.1038/s41401-022-00893-8

[447] Ahmadpour, Fatemeh, Somayeh Igder, Hossein Babaahmadi-Rezaei, Ehsan Khalili, Malek Kanani, Vahid Soleimani, and Ghorban Mohammadzadeh. 2022. “Methylation-Mediated Silencing of miR-125a-5p Facilitates Breast Cancer Progression by Inducing Autophagy.” Molecular Biology Reports 49: 6325–39. https://doi.org/10.1007/s11033-022-07440-y

[448] Li, Yansheng, Yu Ren, Yunfei Wang, Yanli Tan, Qixue Wang, Jinquan Cai, Junhu Zhou, et al. 2019. “A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep.” Theranostics 9: 4608–23. https://doi.org/10.7150/thno.35188

[449] Yan, Shuai, Lizhi Teng, Juntong Du, Liang Ji, Peng Xu, Wenxi Zhao, and Weiyang Tao. 2024. “Long Non-Coding RNA DANCR Aggravates Breast Cancer Through the miR-34c/E2F1 Feedback Loop.” Molecular Medicine Reports 29: 93. https://doi.org/10.3892/mmr.2024.13217

[450] Nasuh, Sedin, Sibel Oguzkan Balci, Ibrahim Bozgeyik, Masa-Aki Ikeda, Muhammetnur Tekayev, and Khandakar A. S. M. Saadat. 2023. “ARID3A and ARID3B Exert Direct Regulatory Control Over the Long Non-Coding RNAs (lncRNAs) MALAT1 and NORAD Within the Context of Non-Small Cell Lung Cancer (NSCLC).” Pathology - Research and Practice 252: 154948. https://doi.org/10.1016/j.prp.2023.154948

[451] Wang, Dan, Suhong Zhang, Min Zhao, and Fengling Chen. 2020. “LncRNA MALAT1 Accelerates Non-Small Cell Lung Cancer Progression via Regulating miR-185-5p/MDM4 Axis.” Cancer Medicine 9: 9138–49. https://doi.org/10.1002/cam4.3570

[452] Chen, Zhiping, Tianyu Zhong, Tao Li, Jinghua Zhong, Yang Tang, Zhanyu Liu, Baodian Ling, and Lanfeng Wang. 2021. “LncRNA SNHG15 Modulates Gastric Cancer Tumorigenesis by Impairing miR-506-5p Expression.” Bioscience Reports 41: BSR20204177. https://doi.org/10.1042/bsr20204177

[453] Liu, Xiaoli, Chunhai Zhang, Xiaomiao Wang, Can Cui, Hanwen Cui, Baishu Zhu, Anqi Chen, et al. 2023. “Long Non-Coding RNA MFSD4A-AS1 Promotes Lymphangiogenesis and Lymphatic Metastasis of Papillary Thyroid Cancer.” Endocrine-Related Cancer 30: e220221. https://doi.org/10.1530/erc-22-0221

[454] Li, Peng, Hongsheng Wang, Ying Tang, Shuo Sun, Yue Ma, Yansong Xu, and Guangyu Chen. 2021. “Knockdown of LINC00657 Inhibits the Viability, Migration and Invasion of Pancreatic Cancer Cells by Regulating the miR-520h/CKS1B Axis.” Experimental and Therapeutic Medicine 22: 1142. https://doi.org/10.3892/etm.2021.10576

[455] Ding, Nan, Haiying Wu, Tao Tao, and Erxuan Peng. 2017. “NEAT1 Regulates Cell Proliferation and Apoptosis of Ovarian Cancer by miR-34a-5p/BCL2.” OncoTargets and Therapy 10: 4905–15. https://doi.org/10.2147/ott.S142446

[456] Li, Yabin, Xirui Wang, Zhihuang Zhao, Jinxing Shang, Gang Li, and Ruijian Zhang. 2021. “LncRNA NEAT1 Promotes Glioma Cancer Progression via Regulation of miR-98-5p/BZW1.” Bioscience Reports 41: BSR20200767. https://doi.org/10.1042/bsr20200767

[457] Wang, Chaoqun. 2024. “LncRNA AFAP1-AS1 Exhibits Oncogenic Characteristics and Promotes Gemcitabine-Resistance of Cervical Cancer Cells Through miR-7-5p/EGFR Axis.” Oncology Research 32: 1867–79. https://doi.org/10.32604/or.2024.044547

[458] Zhou, Zhigang, and Fei Huang. 2019. “Long Non-Coding RNA LINC00152 Regulates Cell Proliferation, Migration and Invasion in Esophageal Squamous Cell Carcinoma via miR-107/Rab10 Axis.” OncoTargets and Therapy 12: 8553–67. https://doi.org/10.2147/ott.S221515

[459] Mou, Exian, and Hao Wang. 2019. “LncRNA LUCAT1 Facilitates Tumorigenesis and Metastasis of Triple-Negative Breast Cancer Through Modulating miR-5702.” Bioscience Reports 39: BSR20190489. https://doi.org/10.1042/bsr20190489

[460] Song, Zaowen, Wencai Wu, Mengyun Chen, Wenzhao Cheng, Juntao Yu, Jinyong Fang, Lingling Xu, et al. 2018. “Long Noncoding RNA ANRIL Supports Proliferation of Adult T-Cell Leukemia Cells Through Cooperation With EZH2.” Journal of Virology 92: e00909–18. https://doi.org/10.1128/jvi.00909-18

[461] Liu, Benquan, Jun-Ichirou Yasunaga, Yi Liang, Ruoning Zhou, Sikai Yang, Xiaoyi Yuan, Jie Liu, et al. 2025. “Identification of AK4 and RHOC as Potential Oncogenes Addicted by Adult T Cell Leukemia.” Proceedings of the National Academy of Sciences of the United States of America 122: e2416412122. https://doi.org/10.1073/pnas.2416412122

[462] Huang, Qing, Deli Zhang, Qingchun Diao, and Mao Lin. 2019. “lncRNA LINC-PINT Is Downregulated in Melanoma and Regulates Cell Proliferation by Downregulating lncRNA BANCR.” Oncology Letters 18: 2917–22. https://doi.org/10.3892/ol.2019.10631

[463] Ma, Aiwei, Wenqi Shi, Liyun Chen, Zijian Huang, Yiwen Zhang, Zixuan Tang, Wenshi Jiang, et al. 2024. “GRASLND Regulates Melanoma Cell Progression by Targeting the miR-218-5p/STAM2 Axis.” Journal of Translational Medicine 22: 684. https://doi.org/10.1186/s12967-024-05397-z

[464] Luo, Junhua, Jing Chen, Hang Li, Yu Yang, Haichao Yun, Shangqi Yang, and Xiangming Mao. 2017. “LncRNA UCA1 Promotes the Invasion and EMT of Bladder Cancer Cells by Regulating the miR-143/HMGB1 Pathway.” Oncology Letters 14: 5556–62. https://doi.org/10.3892/ol.2017.6886

[465] Liu, Lifen, Xin Chen, Ying Zhang, Yanrong Hu, Xiaoqing Shen, and Weipei Zhu. 2017. “Long Non-Coding RNA TUG1 Promotes Endometrial Cancer Development via Inhibiting miR-299 and miR-34a-5p.” Oncotarget 8: 31386–94. https://doi.org/10.18632/oncotarget.15607

[466] Amodio, Nicola, Maria Angelica Stamato, Giada Juli, Eugenio Morelli, Mariateresa Fulciniti, Martina Manzoni, Elisa Taiana, et al. 2018. “Drugging the lncRNA MALAT1 via LNA Gapmer ASO Inhibits Gene Expression of Proteasome Subunits and Triggers Anti-Multiple Myeloma Activity.” Leukemia 32: 1948–57. https://doi.org/10.1038/s41375-018-0067-3

[467] Xu, Yuxiu, Tao Wang, Jiangwei Wan, Dongsheng Ma, Hongyang Zhang, Dongru Cheng, Jing Yang, and Meng Wang. 2024. “Long Non-Coding RNA NEAT1 Promotes Multiple Myeloma Malignant Transformation via Targeting miR-485-5p/ABCB8.” Hematology 29: 2422153. https://doi.org/10.1080/16078454.2024.2422153

[468] Wang, Bin, Kai Zhang, Sen Meng, Xiaofeng Shao, Zhangzhe Zhou, Haiqing Mao, Ziqiang Zhu, et al. 2021. “LncRNA-NONHSAT024778 Promote the Proliferation and Invasion of Chordoma Cell by Regulating miR-1290/Robo1 Axis.” International Journal of Biological Sciences 17: 796–806. https://doi.org/10.7150/ijbs.54091

[469] Zhang, Xiaoming, Wanxiang Niu, Maolin Mu, Shanshan Hu, and Chaoshi Niu. 2020. “Long Non-Coding RNA LPP-AS2 Promotes Glioma Tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC Feedback Loop.” Journal of Experimental & Clinical Cancer Research 39: 196. https://doi.org/10.1186/s13046-020-01695-8

[470] Chen, Muhua, Chunfeng Zhang, Wei Liu, Xiaojuan Du, Xiaofeng Liu, and Baocai Xing. 2022. “Long Noncoding RNA LINC01234 Promotes Hepatocellular Carcinoma Progression Through Orchestrating Aspartate Metabolic Reprogramming.” Molecular Therapy 30: 2354–69. https://doi.org/10.1016/j.ymthe.2022.02.020

[471] Lu, Le, Jingjing Huang, Jiantao Mo, Xuanbo Da, Qiaoxin Li, Meng Fan, and Hongwei Lu. 2022. “Exosomal lncRNA TUG1 from Cancer-Associated Fibroblasts Promotes Liver Cancer Cell Migration, Invasion, and Glycolysis by Regulating the miR-524-5p/SIX1 Axis.” Cellular & Molecular Biology Letters 27: 17. https://doi.org/10.1186/s11658-022-00309-9

[472] Gao, Kun, Shuhua Chen, and Xiangyu Yang. 2021. “HOTTIP Enhances Gemcitabine and Cisplatin Resistance Through Sponging miR-637 in Cholangiocarcinoma.” Frontiers in Oncology 11: 664916. https://doi.org/10.3389/fonc.2021.664916

[473] Zhang, Yajun, Woda Shi, Rongjin Chen, Yan Gu, Mengjie Zhao, Jianxiang Song, Zhan Shi, et al. 2024. “LINC01133 Regulates MARCKS Expression via Sponging miR-30d-5p to Promote the Development of Lung Squamous Cell Carcinoma.” Translational Oncology 44: 101931. https://doi.org/10.1016/j.tranon.2024.101931

[474] Li, Yansheng, Xing Liu, Xiaoteng Cui, Yanli Tan, Qixue Wang, Yunfei Wang, Can Xu, Chuan Fang, and Chunsheng Kang. 2021. “LncRNA PRADX-mediated Recruitment of PRC2/DDX5 Complex Suppresses UBXN1 Expression and Activates NF-κB Activity, Promoting Tumorigenesis.” Theranostics 11: 4516–30. https://doi.org/10.7150/thno.54549

[475] Arratia, Felipe, Cristopher Fierro, Alejandro Blanco, Sebastian Fuentes, Daniela Nahuelquen, Martin Montecino, Adriana Rojas, and Rodrigo Aguilar. 2023. “Selective Concurrence of the Long Non-Coding RNA MALAT1 and the Polycomb Repressive Complex 2 to Promoter Regions of Active Genes in MCF7 Breast Cancer Cells.” Current Issues in Molecular Biology 45: 4735–48. https://doi.org/10.3390/cimb45060301

[476] Wang, Jiajia, Xingzhu Liu, Ping Li, Junrong Wang, Yu Shu, Xinyu Zhong, Zhen Gao, et al. 2022. “Long Noncoding RNA HOTAIR Regulates the Stemness of Breast Cancer Cells via Activation of the NF-κB Signaling Pathway.” Journal of Biological Chemistry 298: 102630. https://doi.org/10.1016/j.jbc.2022.102630

[477] Chu, Dong-xia, Yu Jin, Bing-rong Wang, Yan Jiao, Chao-ke Zhang, Zi-han Guo, Shao-zhuo Hu, and Na Li. 2023. “LncRNA HOTAIR Enhances Epithelial-to-Mesenchymal Transition to Promote the Migration and Invasion of Liver Cancer by Regulating NUAK1 via Epigenetic Inhibition miR-145-5p Expression.” Journal of Cancer 14: 2329–43. https://doi.org/10.7150/jca.85335

[478] Zhang, Yinxin, Changliang Lu, and Haiwei Cui. 2021. “Long Non-Coding RNA SNHG22 Facilitates Hepatocellular Carcinoma Tumorigenesis and Angiogenesis via DNA Methylation of microRNA miR-16-5p.” Bioengineered 12: 7446–58. https://doi.org/10.1080/21655979.2021.1975969

[479] Mimura, Kosaku, Ley-Fang Kua, Jin-Fen Xiao, Bernadette Reyna Asuncion, Yuko Nakayama, Nicholas Syn, Zul Fazreen, et al. 2021. “Combined Inhibition of PD-1/PD-L1, Lag-3, and Tim-3 Axes Augments Antitumor Immunity in Gastric Cancer–T Cell Coculture Models.” Gastric Cancer 24: 611–23. https://doi.org/10.1007/s10120-020-01151-8

[480] Xu, Can, Jixing Zhao, Jia Song, Menglin Xiao, Xiaoteng Cui, Lei Xin, Jianglong Xu, et al. 2022. “lncRNA PRADX Is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted Therapy.” Frontiers in Oncology 12: 888922. https://doi.org/10.3389/fonc.2022.888922

[481] Zhu, Yixiao, Chengmei Huang, Chao Zhang, Yi Zhou, Enen Zhao, Yaxin Zhang, Xingyan Pan, et al. 2023. “LncRNA MIR200CHG Inhibits EMT in Gastric Cancer by Stabilizing miR-200c From Target-Directed miRNA Degradation.” Nature Communications 14: 8141. https://doi.org/10.1038/s41467-023-43974-w

[482] Bi, Xukun, Xiaotian Wu, Jiaqi Chen, Xiaoting Li, Yangjun Lin, Yingying Yu, Xuexian Fang, et al. 2024. “Characterization of Ferroptosis-Triggered Pyroptotic Signaling in Heart Failure.” Signal Transduction and Targeted Therapy 9: 257. https://doi.org/10.1038/s41392-024-01962-6

[483] Liu, Shuochen, Yirui Wang, Tianlin Wang, Kuangheng Shi, Shilong Fan, Chang Li, Ruixiang Chen, et al. 2024. “CircPCNXL2 Promotes Tumor Growth and Metastasis by Interacting With STRAP to Regulate ERK Signaling in Intrahepatic Cholangiocarcinoma.” Molecular Cancer 23: 35. https://doi.org/10.1186/s12943-024-01950-y

[484] Du, Xinyue, Weijie Luo, Hongwu Li, Qi Gu, Ping Huang, Cheng Wang, Na Li, Fanglan Liu, and Chunhua Xia. 2025. “Hsa_circ_0125356 Promotes Gemcitabine Resistance by Modulating WNT Canonical and Non-Canonical Pathways via miR-582-5p/FGF9 Axis in Non-Small Cell Lung Cancer.” Molecular Cancer 24: 59. https://doi.org/10.1186/s12943-025-02259-0

[485] Zhou, Zhi-Feng, Zhi Wei, Jin-Chan Yao, Shuo-Yan Liu, Feng Wang, Zhen Wang, Xiao-Feng Chen, et al. 2020. “CircRNA_102179 Promotes the Proliferation, Migration and Invasion in Non-Small Cell Lung Cancer Cells by Regulating miR-330-5p/HMGB3 Axis.” Pathology-Research and Practice 216: 153144. https://doi.org/10.1016/j.prp.2020.153144

[486] Xie, Hongya, Jie Yao, Yuxuan Wang, and Bin Ni. 2022. “Exosome-Transmitted circVMP1 Facilitates the Progression and Cisplatin Resistance of Non-Small Cell Lung Cancer by Targeting miR-524-5p-METTL3/SOX2 Axis.” Drug Delivery 29: 1257–71. https://doi.org/10.1080/10717544.2022.2057617

[487] Cui, Yumeng, Xiaojie Wu, Jie Jin, Weiling Man, Jie Li, Xiang Li, Yanghua Li, et al. 2023. “CircHERC1 Promotes Non-Small Cell Lung Cancer Cell Progression by Sequestering FOXO1 in the Cytoplasm and Regulating the miR-142-3p-HMGB1 Axis.” Molecular Cancer 22: 179. https://doi.org/10.1186/s12943-023-01888-7

[488] Tang, Yi-Fang, Zheng-Hua Liu, Lei-Yi Zhang, Sheng-Hao Shi, Shun Xu, Jin-An Ma, Chun-Hong Hu, and Fang-Wen Zou. 2024. “circ_PPAPDC1A Promotes Osimertinib Resistance by Sponging the miR-30a-3p/IGF1R Pathway in Non-Small Cell Lung Cancer (NSCLC).” Molecular Cancer 23: 91. https://doi.org/10.1186/s12943-024-01998-w

[489] Zhou, Ting, Zhicong Chen, Yitian Chen, Canye Li, Zhijun Xiao, Jingjing Duan, Zhen Yang, and Feng Xu. 2024. “Chronic Stress Promotes Non-Small Cell Lung Cancer (NSCLC) Progression Through circMBOAT2 Upregulation Mediated by CTCF.” Cancer Gene Therapy 31: 1721–33. https://doi.org/10.1038/s41417-024-00830-3

[490] Wang, Xueting, Rui Li, Lingxin Feng, Jing Wang, Qi Qi, Wenjie Wei, and Zhuang Yu. 2022. “Hsa_circ_0001666 Promotes Non-Small Cell Lung Cancer Migration and Invasion Through miR-1184/miR-548I/AGO1 Axis.” Molecular Therapy: Oncolytics 24: 597–611. https://doi.org/10.1016/j.omto.2022.02.011

[491] Xu, Xiaofang, Binbin Song, Qiuliang Zhang, Weibo Qi, and Yufen Xu. 2023. “Hsa_circ_0022383 Promote Non-Small Cell Lung Cancer Tumorigenesis Through Regulating the miR-495-3p/KPNA2 Axis.” Cancer Cell International 23: 282. https://doi.org/10.1186/s12935-023-03068-5

[492] Li, Dongliang, Zejun Fu, Chaoqun Dong, and Yongming Song. 2022. “Downregulation of circATXN7 Represses Non-Small Cell Lung Cancer Growth by Releasing miR-7-5p.” Thoracic Cancer 13: 1597–610. https://doi.org/10.1111/1759-7714.14426

[493] Chen, Shan, Kelin Hong, Long Zhou, Ruizhi Ran, Jinqi Huang, Yong Zheng, Maohui Xing, and Yanli Cai. 2022. “Hsa_circRNA_0017620 Regulated Cell Progression of Non-Small-Cell Lung Cancer via miR-520a-5p/KRT5 Axis.” Journal of Clinical Laboratory Analysis 36: e24347. https://doi.org/10.1002/jcla.24347

[494] Xu, Shengchao, Chengke Luo, Dikang Chen, Lu Tang, Quan Cheng, Ling Chen, and Zhixiong Liu. 2023. “circMMD Reduction Following Tumor Treating Fields Inhibits Glioblastoma Progression Through FUBP1/FIR/DVL1 and miR-15b-5p/FZD6 Signaling.” Journal of Experimental & Clinical Cancer Research 42: 64. https://doi.org/10.1186/s13046-023-02642-z

[495] Zhang, Shuai, Keman Liao, Zengli Miao, Qing Wang, Yifeng Miao, Zhongye Guo, Yun Qiu, et al. 2019. “CircFOXO3 Promotes Glioblastoma Progression by Acting as a Competing Endogenous RNA for NFAT5.” Neuro-Oncology 21: 1284–96. https://doi.org/10.1093/neuonc/noz128

[496] Zheng, Si-Qi, Yue Qi, Jun Wu, Fen-Li Zhou, Hao Yu, Lu Li, Bo Yu, Xiao-Fan Chen, and Wei Zhang. 2019. “CircPCMTD1 Acts as the Sponge of miR-224-5p to Promote Glioma Progression.” Frontiers in Oncology 9: 398. https://doi.org/10.3389/fonc.2019.00398

[497] Chen, Zide, Qicong Mai, Qi Wang, Qing Gou, Feng Shi, Zhiqiang Mo, Wei Cui, et al. 2022. “CircPOLR2A Promotes Proliferation and Impedes Apoptosis of Glioblastoma Multiforme Cells by Up-Regulating POU3F2 to Facilitate SOX9 Transcription.” Neuroscience 503: 118–30. https://doi.org/10.1016/j.neuroscience.2022.03.035

[498] Zhang, Qian, Shan Chen, Yingwei Zhen, Peng Gao, Zhenyu Zhang, Hao Guo, and Yong Wang. 2022. “Circular RNA circFGFR1 Functions as an Oncogene in Glioblastoma Cells Through Sponging to hsa-miR-224-5p.” Journal of Immunology Research 2022: 7990251. https://doi.org/10.1155/2022/7990251

[499] Wang, Xuehui, Jiaying Wang, Zihui An, Aifen Yang, Mengsheng Qiu, and Zhou Tan. 2023. “CircXPO1 Promotes Glioblastoma Malignancy by Sponging miR-7-5p.” Cells 12: 831. https://doi.org/10.3390/cells12060831

[500] Fan, Xuhui, Meng Liu, Li Fei, Zhihui Huang, and Yufeng Yan. 2022. “CircFOXM1 Promotes the Proliferation, Migration, Invasion, and Glutaminolysis of Glioblastoma by Regulating the miR-577/E2F5 Axis.” Bosnian Journal of Basic Medical Sciences 22: 205–16. https://doi.org/10.17305/bjbms.2021.6028

[501] Yao, Zhicheng, Ruiyun Xu, Lin Yuan, Mingxing Xu, Haiyun Zhuang, Yanjie Li, Yi Zhang, and Nan Lin. 2019. “Circ_0001955 Facilitates Hepatocellular Carcinoma (HCC) Tumorigenesis by Sponging miR-516a-5p to Release TRAF6 and MAPK11.” Cell Death & Disease 10: 945. https://doi.org/10.1038/s41419-019-2176-y

[502] Zhang, Bo, and Jian Zhou. 2022. “CircSEC. 24A (hsa_circ_0003528) Interference Suppresses Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells via miR-421/MMP3 Axis.” Bioengineered 13: 9049–62. https://doi.org/10.1080/21655979.2022.2057761

[503] Yang, Chuqi, Xuefei Xu, Mengting Wu, Zhengqi Zhao, Yewen Feng, Weiyu Liang, Chuyun Xu, Tao Jiang, and Guangji Zhang. 2024. “Huang-Jin-Shuang-Shen Decoction Promotes CD8⁺ T-Cell-Mediated Anti-Tumor Immunity by Regulating Chemokine CXCL10 in Gastric Cancer.” Phytomedicine 135: 156065. https://doi.org/10.1016/j.phymed.2024.156065

[504] Wu, Kun, Yuntao Li, Bo Nie, Chong Guo, Xiaobo Ma, Linyan Li, Shenju Cheng, et al. 2024. “MEF2A Is a Transcription Factor for circPVT1 and Contributes to the Malignancy of Acute Myeloid Leukemia.” International Journal of Oncology 65: 111. https://doi.org/10.3892/ijo.2024.5699

[505] Ling, Zhang, Zhi-Gang Fang, Jie-Yong Wu, and Jia-Jun Liu. 2021. “The Depletion of Circ-PRKDC Enhances Autophagy and Apoptosis in T-Cell Acute Lymphoblastic Leukemia via microRNA-653-5p/Reelin Mediation of the PI3K/AKT/mTOR Signaling Pathway.” Kaohsiung Journal of Medical Sciences 37: 392–401. https://doi.org/10.1002/kjm2.12352

[506] Wang, Jianming, Yang Liang, Yuefeng Qin, Guoyun Jiang, Yuhang Peng, and Wenli Feng. 2022. “circCRKL, a circRNA Derived from CRKL, Regulates BCR-ABL via Sponging miR-877-5p to Promote Chronic Myeloid Leukemia Cell Proliferation.” Journal of Translational Medicine 20: 395. https://doi.org/10.1186/s12967-022-03586-2

[507] Fu, Bo, Wei Liu, Cui Zhu, Peng Li, Li Wang, Li Pan, Ke Li, et al. 2021. “Circular RNA circBCBM1 Promotes Breast Cancer Brain Metastasis by Modulating miR-125a/BRD4 Axis.” International Journal of Biological Sciences 17: 3104–17. https://doi.org/10.7150/ijbs.58916

[508] Long, Fei, Liang Li, Canbin Xie, Min Ma, Zhiwei Wu, Zhixing Lu, Baiying Liu, et al. 2023. “Intergenic CircRNA Circ_0007379 Inhibits Colorectal Cancer Progression by Modulating miR-320a Biogenesis in a KSRP-Dependent Manner.” International Journal of Biological Sciences 19: 3781–803. https://doi.org/10.7150/ijbs.85063

[509] Wu, Mengqiong, Cancan Kong, Manni Cai, Weiwei Huang, Yiming Chen, Baochun Wang, and Xin Liu. 2021. “Hsa_circRNA_002144 Promotes Growth and Metastasis of Colorectal Cancer Through Regulating miR-615-5p/LARP1/mTOR Pathway.” Carcinogenesis 42: 601–10. https://doi.org/10.1093/carcin/bgaa140

[510] Zhang, Chunyu, Li Yuan, Qiaojian Zou, Caixia Shao, Yan, Jia, Jiaying Li, Yan Liao, et al. 2024. “CircMAST1 Inhibits Cervical Cancer Progression by Hindering the N4-Acetylcytidine Modification of YAP mRNA.” Cellular & Molecular Biology Letters 29: 25. https://doi.org/10.1186/s11658-024-00540-6

[511] Zhong, Peilin, Aihua Guo, Linhua Wang, Xiurong Lin, and Mei Feng. 2022. “Circular RNA CDK6 Suppresses Cervical Cancer Proliferation and Metastasis by Sponging miR-449a.” Bioengineered 13: 4885–97. https://doi.org/10.1080/21655979.2022.2036898

[512] Yu, Rui, Jie Yao, and Yu Ren. 2020. “A Novel circRNA, circNUP98, a Potential Biomarker, Acted as an Oncogene via the miR-567/PRDX3 Axis in Renal Cell Carcinoma.” Journal of Cellular and Molecular Medicine 24: 10177–88. https://doi.org/10.1111/jcmm.15629

[513] Gao, Ling, Xian Shao, Qingqing Yue, Weifei Wu, Xuejuan Yang, Xiaolei He, Limin Li, Fujun Hou, and Ruonan Zhang. 2021. “circAMOTL1L Suppresses Renal Cell Carcinoma Growth by Modulating the miR-92a-2-5p/KLLN Pathway.” Oxidative Medicine and Cellular Longevity 2021: 9970272. https://doi.org/10.1155/2021/9970272

[514] Zhang, Junxiao, Guanghua Chu, Lihua Zheng, Juandi Liu, and Juxian He. 2023. “Circular RNA circ_0000119 Promotes Cervical Cancer Cell Growth and Migration via miR-433-3p/PAK2 Axis.” Journal of Applied Genetics 64: 531–43. https://doi.org/10.1007/s13353-023-00772-w

[515] Liu, Yanhe, Hui Li, Xiaoyi Ye, Anlong Ji, Xiangwei Fu, Haishan Wu, and Xiangyong Zeng. 2020. “Hsa_circ_0000231 Knockdown Inhibits the Glycolysis and Progression of Colorectal Cancer Cells by Regulating miR-502-5p/MYO6 Axis.” World Journal of Surgical Oncology 18: 255. https://doi.org/10.1186/s12957-020-02033-0

[516] Yao, Huihui, Jiancheng Xu, Aina Zhou, Danyang Shen, Qiuchen Dong, Xiaodong Yang, Mengyu Li, et al. 2025. “Gut Microbiota-Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression.” Molecular Cancer Research 23: 202–18. https://doi.org/10.1158/1541-7786.Mcr-24-0434

[517] Wang, Yi, Yanxia Liu, Yong Wang, Peng Ren, Hui Tian, and Lin Wang. 2024. “Hsa_circ_0007718 Facilitates the Progression of Colorectal Cancer by Regulating the miR-1299/PSMC2 Axis.” International Journal of Biological Macromolecules 281: 136537. https://doi.org/10.1016/j.ijbiomac.2024.136537

[518] Wang, Li, Xiuda Peng, Xianzhou Lu, Qinglan Wei, Mingdao Chen, and Longfei Liu. 2019. “Inhibition of hsa_circ_0001313 (circCCDC66) Induction Enhances the Radio-Sensitivity of Colon Cancer Cells via Tumor Suppressor miR-338-3p.” Pathology—Research and Practice 215: 689–96. https://doi.org/10.1016/j.prp.2018.12.032

[519] Lin, Ruo-Yang, and Zhi-Ming Huang. 2023. “Hsa_circ_0079480 Enhances Cell Proliferation, Migration, and Invasion in Colorectal Cancer Through miR-498/ATP5E Axis.” Kaohsiung Journal of Medical Sciences 39: 209–20. https://doi.org/10.1002/kjm2.12616

[520] Wu, Lilan, Huiqin Xiao, Yaqin Hong, Meihua Xie, Yanxia Yu, and Lijuan Jiang. 2023. “CircRNA Circ_0000118 Regulates Malignancy of Cervical Cancer Cells by Regulating miR-211-5p/miR-377-3p/AKT2 Axis.” Biochemical Genetics 61: 1625–44. https://doi.org/10.1007/s10528-023-10332-w

[521] Shi, Bingzhe, Xiufen Lu, Wanli Ma, Chao Huang, and Junyue Huo. 2024. “hsa_circ_0000520 Serves as a Prognostic Biomarker for Colorectal Cancer and Promotes in the Disease Progression.” Turkish Journal of Gastroenterology 35: 922–32. https://doi.org/10.5152/tjg.2024.24153

[522] Wu, Dejun, Yuqin Li, Anjun Xu, Wenqing Tang, Bo Yu, et al. 2023. “CircRNA RNA hsa_circ_0008234 Promotes Colon Cancer Progression by Regulating the miR-338-3p/ETS1 Axis and PI3K/AKT/mTOR Signaling.” Cancers 15: 2068. https://doi.org/10.3390/cancers15072068

[523] Wang, Xu, Yujia Chen, Wei Liu, Tao Liu, and Di Sun. 2020. “Hsa_circ_0128846 Promotes Tumorigenesis of Colorectal Cancer by Sponging hsa-miR-1184 and Releasing AJUBA and Inactivating Hippo/YAP Signalling.” Journal of Cellular and Molecular Medicine 24: 9908–24. https://doi.org/10.1111/jcmm.15590

[524] Ma, Yue, Jing Liu, Zhuo Yang, Peng Chen, and Dan-Bo Wang. 2022. “CircRNA_400029 Promotes the Aggressive Behaviors of Cervical Cancer by Regulation of miR-1285-3p/TLN1 Axis.” Journal of Cancer 13: 541–53. https://doi.org/10.7150/jca.61437

[525] Xu, Yan-Jie, Jie-Min Zhao, Cao Gao, Xue-Feng Ni, Wei Wang, Wen-Wei Hu, and Chang-Ping Wu. 2021. “Hsa_circ_0136666 Activates Treg-Mediated Immune Escape of Colorectal Cancer via miR-497/PD-L1 Pathway.” Cellular Signalling 86: 110095. https://doi.org/10.1016/j.cellsig.2021.110095

[526] Xu, Congjie, Jiaquan Zhou, Xiaoting Zhang, Xinli Kang, Shuan Liu, Mi Song, Cheng Chang, et al. 2024. “N6-Methyladenosine-modified circ_104797 Sustains Cisplatin Resistance in Bladder Cancer Through Acting as RNA Sponges.” Cellular & Molecular Biology Letters 29: 28. https://doi.org/10.1186/s11658-024-00543-3

[527] Liu, Hua, Yifan Jiang, Jiahua Lu, Chuanhui Peng, Zhenan Ling, Yunhao Chen, Diyu Chen, et al. 2023. “m⁶A-Modification Regulated circ-CCT3 Acts as the Sponge of miR-378a-3p to Promote Hepatocellular Carcinoma Progression.” Epigenetics 18: 2204772. https://doi.org/10.1080/15592294.2023.2204772

[528] Liang, Xiaolong, Chuan Qin, Gangfeng Yu, Xiong Guo, Anqi Cheng, Han Zhang, and Ziwei Wang. 2021. “Circular RNA circRAB31 Acts as a miR-885-5p Sponge to Suppress Gastric Cancer Progression via the PTEN/PI3K/AKT Pathway.” Molecular Therapy-Oncolytics 23: 501–14. https://doi.org/10.1016/j.omto.2021.11.002

[529] Lv, Wenchang, Yufang Tan, Mingchen Xiong, Chongru Zhao, Yichen Wang, Min Wu, Yiping Wu, and Qi Zhang. 2021. “Analysis and Validation of m6A Regulatory Network: A Novel circBACH2/has-miR-944/HNRNPC Axis in Breast Cancer Progression.” Journal of Translational Medicine 19: 527. https://doi.org/10.1186/s12967-021-03196-4

[530] Liu, Jiayu, Jiaying Xie, Enwu Xu, Binhe Xu, Jiaxin Zhou, Jiazhen Zhou, and Qiaoyuan Yang. 2023. “CircRNA hsa_circ_0000043 Acts as a miR-4492 Sponge to Promote Lung Cancer Progression via BDNF and STAT3 Expression Regulation in Anti-Benzo [A] Pyrene-trans-7,8-dihydrodiol-9,10-Epoxide-transformed 16HBE Cells.” Toxicological Sciences 195: 87–102. https://doi.org/10.1093/toxsci/kfad060

[531] Liang, Yanping, Junjie Cen, Yong Huang, Yong Fang, Yunfei Wang, Guannan Shu, Yihui Pan, et al. 2022. “CircNTNG1 Inhibits Renal Cell Carcinoma Progression via HOXA5-Mediated Epigenetic Silencing of Slug.” Molecular Cancer 21: 224. https://doi.org/10.1186/s12943-022-01694-7

[532] Lu, Shangyun, Zhenou Sun, Wenli Hu, Shutao Yin, Chong Zhao, and Hongbo Hu. 2021. “PD-L1 Positively Regulates MET Phosphorylation Through Inhibiting PTP1B.” Cancer Science 112: 1878–87. https://doi.org/10.1111/cas.14844

[533] Zhang, Hao-Ling, Rui Zhao, Di Wang, Siti Nurfatimah Mohd Sapudin, Badrul Hisham Yahaya, Mohammad Syamsul Reza Harun, Zhong-Wen Zhang, et al. 2025. “Candida Albicans and Colorectal Cancer: A Paradoxical Role Revealed Through Metabolite Profiling and Prognostic Modeling.” World Journal of Clinical Oncology 16: 104182. https://doi.org/10.5306/wjco.v16.i4.104182

[534] Zhang, HaoLing, Haolong Zhang, Weifang Chen, Yong Wang, Siti Nurfatimah Mohd Sapudin, Doblin Sandai, Mohammad Syamsul Reza Harun, et al. 2024. “Construction and Validation of a Prognostic Model Based on Metabolic Characteristics of Candida Albicans in Colorectal Cancer.” Research Square https://doi.org/10.21203/rs.3.rs-4555778/v1

[535] Kabir, Tohfa, Charlotte A. Connamacher, Zara Nadeem, Matthew R. Paul, Matthew R. Smutny, Zoe K. Lawler, Annaelle M. Djomo, et al. 2025. “Short Chain Fatty Acids Regulate the Chromatin Landscape and Distinct Gene Expression Changes in Human Colorectal Cancer Cells.” bioRxiv 2025.05.07.652677. https://doi.org/10.1101/2025.05.07.652677

[536] Gates, Leah A., Bernardo Sgarbi Reis, Peder J. Lund, Matthew R. Paul, Marylene Leboeuf, Annaelle M. Djomo, Zara Nadeem, et al. 2024. “Histone Butyrylation in the Mouse Intestine Is Mediated by the Microbiota and Associated With Regulation of Gene Expression.” Nature Metabolism 6: 697–707. https://doi.org/10.1038/s42255-024-00992-2

[537] Lin, Yanchen, Ping Li, Jinliang Teng, and Chunhua Liao. 2023. “MicroRNAs: Regulators of the Host Antifungal Immune.” Perioperative Precision Medicine eISSN: 2957–544. https://doi.org/10.61189/595412fcjdhw

[538] Lin, Yanbing, Qianwen Zhou, Mengqi Li, Sucheng Hou, Jia Xu, Dongfang Dai, and Xiaoqin Yuan. 2025. “LOH12CR2 Activated by Sodium Butyrate Suppresses Tumorigenesis in Colorectal Cancer via METTL14-Mediated N6-Methyladenosine Modification of SPC24 mRNA.” Cellular Signalling 136: 112079. https://doi.org/10.1016/j.cellsig.2025.112079

[539] Huang, Huilin, Hengyou Weng, Wenju Sun, Xi Qin, Hailing Shi, Huizhe Wu, Boxuan Simen Zhao, et al. 2018. “Recognition of RNA N 6-Methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation.” Nature Cell Biology 20: 285–95. https://doi.org/10.1038/s41556-018-0045-z

[540] Sandai, Doblin, Zengkan Du, Haoling Zhang, and Qi Sun. 2025. “Regulatory Mechanisms and Emerging Diagnostic and Therapeutic Opportunities of Non-Coding RNAs in Tumorigenesis: A Pan-Cancer Perspective.” Critical Reviews in Clinical Laboratory Sciences 62: 1–57. https://doi.org/10.1080/10408363.2025.2555278

[541] Yang, Lei, Yi Chen, Ning Liu, Yanwen Lu, Xin Li, Wenliang Ma, Weidong Gan, and Dongmei Li. 2022. “5mC and H3K9me3 of TRAF3IP2 Promoter Region Accelerates the Progression of Translocation Renal Cell Carcinoma.” Biomarker Research 10: 54. https://doi.org/10.1186/s40364-022-00402-3

[542] Kim, Heesun, Yue-He Ding, Gangming Zhang, Yong-Hong Yan, Darryl Conte,, Meng-Qiu Dong, and Craig C. Mello. 2021. “HDAC1 SUMOylation Promotes Argonaute-Directed Transcriptional Silencing in C. elegans.” Elife 10: e63299. https://doi.org/10.7554/eLife.63299

[543] Cava, Claudia, Alexandros Armaos, Benjamin Lang, Gian G. Tartaglia, and Isabella Castiglioni. 2022. “Identification of Long Non-Coding RNAs and RNA Binding Proteins in Breast Cancer Subtypes.” Scientific Reports 12: 693. https://doi.org/10.1038/s41598-021-04664-z

[544] Saw, Ajay Kumar, Ayush Madhok, Anupam Bhattacharya, Soumyadeep Nandi, and Sanjeev Galande. 2025. “Integrated Promoter-Capture Hi-C and Hi-C Analysis Reveals Fine-Tuned Regulation of the 3D Chromatin Architecture in Colorectal Cancer.” Frontiers in Genetics 16: 1553469. https://doi.org/10.3389/fgene.2025.1553469

[545] Hamdan, Feda H., Amro M. Abdelrahman, Ana Patricia Kutschat, Xin Wang, Thomas L. Ekstrom, Nidhi Jalan-Sakrikar, Catherine Wegner Wippel, et al. 2023. “Interactive Enhancer Hubs (iHUBs) Mediate Transcriptional Reprogramming and Adaptive Resistance in Pancreatic Cancer.” Gut 72: 1174–85. https://doi.org/10.1136/gutjnl-2022-328154

[546] Ma, Sheng, Zixian Wang, Zezhong Xiong, Yue Ge, Meng-Yao Xu, Junbiao Zhang, Yuzheng Peng, et al. 2025. “Enhancer Transcription Profiling Reveals an Enhancer RNA-Driven Ferroptosis and New Therapeutic Opportunities in Prostate Cancer.” Signal Transduction and Targeted Therapy 10: 87. https://doi.org/10.1038/s41392-025-02170-6

[547] Wei, Zhao, Song Wang, Yaning Xu, Wenzheng Wang, Fraser Soares, Musaddeque Ahmed, Ping Su, et al. 2023. “MYC Reshapes CTCF-Mediated Chromatin Architecture in Prostate Cancer.” Nature Communications 14: 1787. https://doi.org/10.1038/s41467-023-37544-3

[548] Ramírez-Cuéllar, Julieta, Roberto Ferrari, Rosario T. Sanz, Marta Valverde-Santiago, Judith García-García, A Silvina Nacht, David Castillo, et al. 2024. “LATS1 Controls CTCF Chromatin Occupancy and Hormonal Response of 3D-Grown Breast Cancer Cells.” EMBO Journal 43: 1770–98. https://doi.org/10.1038/s44318-024-00080-x

[549] Zhao, Jingru, Yeqiao Zhou, Ilias Tzelepis, Noah G. Burget, Junwei Shi, and Robert B. Faryabi. 2024. “Oncogenic Transcription Factors Instruct Promoter-Enhancer Hubs in Individual Triple Negative Breast Cancer Cells.” Science Advances 10: eadl4043. https://doi.org/10.1126/sciadv.adl4043

[550] Zhang, Te, Wenjie Xia, Xuming Song, Qixing Mao, Xing Huang, Bing Chen, Yingkuan Liang, et al. 2022. “Super-Enhancer Hijacking LINC01977 Promotes Malignancy of Early-Stage Lung Adenocarcinoma Addicted to the Canonical TGF-β/SMAD3 Pathway.” Journal of Hematology & Oncology 15: 114. https://doi.org/10.1186/s13045-022-01331-2

[551] Xi, Yuanyin, Ruoding Wang, Man Qu, Qinwen Pan, Minghao Wang, Xiang Ai, Zihan Sun, et al. 2025. “Super-Enhancer-Hijacking RBBP7 Potentiates Metastasis and Stemness of Breast Cancer via Recruiting NuRD Complex Subunit LSD1.” Journal of Translational Medicine 23: 266. https://doi.org/10.1186/s12967-025-06270-3

[552] Feng, Yipeng, Te Zhang, Zeyu Zhang, Yingkuang Liang, Hui Wang, Yuzhong Chen, Xinnian Yu, et al. 2023. “The Super-Enhancer-Driven lncRNA LINC00880 Acts as a Scaffold Between CDK1 and PRDX1 to Sustain the Malignance of Lung Adenocarcinoma.” Cell Death & Disease 14: 551. https://doi.org/10.1038/s41419-023-06047-w

[553] Tong, Xin, Yang Gao, and Zhongjing Su. 2024. “Interaction of CTCF and CTCFL in Genome Regulation Through Chromatin Architecture During the Spermatogenesis and Carcinogenesis.” PeerJ 12: e18240. https://doi.org/10.7717/peerj.18240

[554] Tang, Ran, Yiqun Li, Fang Han, Zhenzhi Li, Xiaoyu Lin, Haoxiu Sun, Xiaoqing Zhang, et al. 2022. “A CTCF-Binding Element and Histone Deacetylation Cooperatively Maintain Chromatin Loops, Linking to Long-Range Gene Regulation in Cancer Genomes.” Frontiers in Oncology 11: 821495. https://doi.org/10.3389/fonc.2021.821495

[555] Mikulasova, Aneta, Daniel Kent, Marco Trevisan-Herraz, Nefeli Karataraki, Kent T. M. Fung, Cody Ashby, Agata Cieslak, et al. 2022. “Epigenomic Translocation of H3K4me3 Broad Domains over Oncogenes Following Hijacking of Super-Enhancers.” Genome Research 32: 1343–54. https://doi.org/10.1101/gr.276042.121

[556] Gouni-Berthold, Ioanna, Veronica J. Alexander, Qingqing Yang, Eunju Hurh, Elisabeth Steinhagen-Thiessen, Patrick M. Moriarty, Stephen G. Hughes, et al. 2021. “Efficacy and Safety of Volanesorsen in Patients With Multifactorial Chylomicronaemia (COMPASS): A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase 3 Trial.” Lancet Diabetes & Endocrinology 9: 264–75. https://doi.org/10.1016/S2213-8587(21)00046-2

[557] Li, Lijie, Jie Zeng, Sili He, Yanfei Yang, and Chen Wang. 2024. “METTL14 Decreases FTH1 mRNA Stability via m6A Methylation to Promote Sorafenib-Induced Ferroptosis of Cervical Cancer.” Cancer Biology & Therapy 25: 2349429. https://doi.org/10.1080/15384047.2024.2349429

[558] Xu, Youqin, Mu Song, Ziyang Hong, Wancheng Chen, Qianbing Zhang, Jianlong Zhou, Chao Yang, et al. 2023. “The N6-Methyladenosine METTL3 Regulates Tumorigenesis and Glycolysis by Mediating m6A Methylation of the Tumor Suppressor LATS1 in Breast Cancer.” Journal of Experimental & Clinical Cancer Research 42: 10. https://doi.org/10.1186/s13046-022-02581-1

[559] Ji, Huihui, Jian-an Zhang, Hejing Liu, Kehan Li, Zhi-wei Wang, and Xueqiong Zhu. 2022. “Comprehensive Characterization of Tumor Microenvironment and m6A RNA Methylation Regulators and Its Effects on PD-L1 and Immune Infiltrates in Cervical Cancer.” Frontiers in Immunology 13: 976107. https://doi.org/10.3389/fimmu.2022.976107

[560] Liu, Xiaoyan, Maoxiao Feng, Xiaodong Hao, Zihan Gao, Zhaoxin Wu, Yuli Wang, Lutao Du, and Chuanxin Wang. 2023. “m6A Methylation Regulates Hypoxia-Induced Pancreatic Cancer Glycolytic Metabolism Through ALKBH5-HDAC4-HIF1α Positive Feedback Loop.” Oncogene 42: 2047–60. https://doi.org/10.1038/s41388-023-02704-8

[561] Kim, Joohwan, and Gina Lee. 2021. “Metabolic Control of m(6)A RNA Modification.” Metabolites 11: 80. https://doi.org/10.3390/metabo11020080

[562] Liu, Zhi, Qingqing Zhang, Hong Zhang, Zhongyuan Yi, Huihui Ma, Xiaoyi Wang, Jingjing Wang, et al. 2024. “Colorectal Cancer Microbiome Programs DNA Methylation of Host Cells by Affecting Methyl Donor Metabolism.” Genome Medicine 16: 77. https://doi.org/10.1186/s13073-024-01344-1

[563] Giuliano, Michela, Claudia Pellerito, Adriana Celesia, Tiziana Fiore, and Sonia Emanuele. 2021. “Tributyltin (IV) Butyrate: A Novel Epigenetic Modifier With Er Stress- and Apoptosis-Inducing Properties in Colon Cancer Cells.” Molecules 26: 5010. https://doi.org/10.3390/molecules26165010

[564] Wang, Lujing, Ahmad Abdel Fat Shannar, Renyi Wu, Pochung Chou, Md Shahid Sarwar, Hsiao-chen Kuo, Rebecca Mary Peter, et al. 2022. “Butyrate Drives Metabolic Rewiring and Epigenetic Reprogramming in Human Colon Cancer Cells.” Molecular Nutrition & Food Research 66: 2200028. https://doi.org/10.1002/mnfr.202200028

[565] de Conti, Aline, Volodymyr Tryndyak, Renato Heidor, Leandro Jimenez, Fernando Salvador Moreno, Frederick A. Beland, Ivan Rusyn, and Igor P. Pogribny. 2020. “Butyrate-Containing Structured Lipids Inhibit RAC1 and Epithelial-to-Mesenchymal Transition Markers: A Chemopreventive Mechanism Against Hepatocarcinogenesis.” Journal of Nutritional Biochemistry 86: 108496. https://doi.org/10.1016/j.jnutbio.2020.108496

[566] Rodríguez-Enríquez, Sara, Diana Xochiquetzal Robledo-Cadena, Juan Carlos Gallardo-Pérez, Silvia Cecilia Pacheco-Velázquez, Citlali Vázquez, Emma Saavedra, Jorge Luis Vargas-Navarro, et al. 2021. “Acetate Promotes a Differential Energy Metabolic Response in Human HCT 116 and COLO 205 Colon Cancer Cells Impacting Cancer Cell Growth and Invasiveness.” Frontiers in Oncology 11: 697408. https://doi.org/10.3389/fonc.2021.697408

[567] Mohammadi, Parastoo, Flora Forouzesh, and Fatemeh Kouhkan. 2024. “Short Chain Fatty Acid Sodium Butyrate Increases miR-21, miR-143 and miR-145 Expression in Human Colorectal Cancer HCT-116 Cell Line.” Iranian Journal of Public Health 53: 1164. https://doi.org/10.18502/ijph.v53i5.15598

[568] Villiers, C., M. Chevallet, H. Diemer, R. Couderc, H. Freitas, A. Van Dorsselaer, P. N. Marche, and T. Rabilloud. 2009. “From Secretome Analysis to Immunology: Chitosan Induces Major Alterations in the Activation of Dendritic Cells via a TLR4-Dependent Mechanism.” Molecular & Cellular Proteomics 8: 1252–64. https://doi.org/10.1074/mcp.M800589-MCP200

[569] Kundu, Gautam, Maryam Ghasemi, Seungbin Yim, Ayanna Rohil, Cuiyan Xin, Leo Ren, Shraddha Srivastava, et al. 2024. “STAT3 Protein-Protein Interaction Analysis Finds P300 as a Regulator of STAT3 and Histone 3 Lysine 27 Acetylation in Pericytes.” Biomedicines 12: 2102. https://doi.org/10.3390/biomedicines12092102

[570] Liu, Ge, Rui Liu, Yeqi Shan, and Chaomin Sun. 2021. “Marine Bacterial Exopolysaccharide EPS11 Inhibits Migration and Invasion of Liver Cancer Cells by Directly Targeting Collagen I.” Journal of Biological Chemistry 297: 101133. https://doi.org/10.1016/j.jbc.2021.101133

[571] Cao, Ruobing, Weihua Jin, Yeqi Shan, Ju Wang, Ge Liu, Shan Kuang, and Chaomin Sun. 2018. “Marine Bacterial Polysaccharide EPS11 Inhibits Cancer Cell Growth via Blocking Cell Adhesion and Stimulating Anoikis.” Marine Drugs 16: 85. https://doi.org/10.3390/md16030085

[572] Kawanabe-Matsuda, Hirotaka, Kazuyoshi Takeda, Marie Nakamura, Seiya Makino, Takahiro Karasaki, Kazuhiro Kakimi, Megumi Nishimukai, et al. 2022. “Dietary Lactobacillus-Derived Exopolysaccharide Enhances Immune-Checkpoint Blockade Therapy.” Cancer Discovery 12: 1336–55. https://doi.org/10.1158/2159-8290.CD-21-0929

[573] Wang, Zixuan, Hengqiu Chen, Shasha Xiong, Xiaoliang Chen, Xuefeng Gao, Pengwei Huang, Jinhu Zou, and Hong Cao. 2025. “Lactobacillus plantarum SMUM211204 Exopolysaccharides Have Tumor-Suppressive Effects on Colorectal Cancer by Regulating Autophagy via the mTOR Pathway.” Journal of Agricultural and Food Chemistry 73: 5931–46. https://doi.org/10.1021/acs.jafc.4c09818

[574] Sun, Mengying, Wenwen Liu, Yinglong Song, Yanfeng Tuo, Guangqing Mu, and Fenglian Ma. 2021. “The Effects of Lactobacillus plantarum-12 Crude Exopolysaccharides on the Cell Proliferation and Apoptosis of Human Colon Cancer (HT-29) Cells.” Probiotics and Antimicrobial Proteins 13: 413–21. https://doi.org/10.1007/s12602-020-09699-8

[575] Mossmann, Dirk, Christoph Müller, Sujin Park, Brendan Ryback, Marco Colombi, Nathalie Ritter, Diana Weißenberger, et al. 2023. “Arginine Reprograms Metabolism in Liver Cancer via RBM39.” Cell 186: 5068–83. https://doi.org/10.1016/j.cell.2023.09.011

[576] Han, Xue, Chune Ren, Aifang Jiang, Yonghong Sun, Jiayi Lu, Xi Ling, Chao Lu, and Zhenhai Yu. 2024. “Arginine Methylation of ALKBH5 by PRMT6 Promotes Breast Tumorigenesis via LDHA-Mediated Glycolysis.” Frontiers of Medicine 18: 344–56. https://doi.org/10.1007/s11684-023-1028-4

[577] Crump, Nicholas T., Andreas V. Hadjinicolaou, Meng Xia, John Walsby-Tickle, Uzi Gileadi, Ji-Li Chen, Mashiko Setshedi, et al. 2021. “Chromatin Accessibility Governs the Differential Response of Cancer and T Cells to Arginine Starvation.” Cell Reports 35: 109101. https://doi.org/10.1016/j.celrep.2021.109101

[578] Croce, Michela, Patrizia Damonte, Monica Morini, Simona Pigozzi, Laura Chiossone, Paola Vacca, Vincenzo Bronte, Ottavia Barbieri, and Simonetta Astigiano. 2020. “Increased Arginase1 Expression in Tumor Microenvironment Promotes Mammary Carcinogenesis via Multiple Mechanisms.” Carcinogenesis 41: 1695–702. https://doi.org/10.1093/carcin/bgaa063

[579] Li, Tingting, Xian Wang, Enguo Ju, Suzane Ramos da Silva, Luping Chen, Xinquan Zhang, Shan Wei, and Shou-Jiang Gao. 2021. “RNF167 Activates mTORC1 and Promotes Tumorigenesis by Targeting CASTOR1 for Ubiquitination and Degradation.” Nature Communications 12: 1055. https://doi.org/10.1038/s41467-021-21206-3

[580] Feng, Dandan, Jie Gao, Ruiqiong Liu, Wei Liu, Tianyang Gao, Yunkai Yang, Die Zhang, et al. 2024. “CARM1 Drives Triple-Negative Breast Cancer Progression by Coordinating With HIF1A.” Protein & Cell 15: 744–65. https://doi.org/10.1093/procel/pwae010

[581] Abookheili, Aliakbar Rostami, Jahanbakhsh Asadi, Ayyoob Khosravi, and Ali Gorji. 2024. “Fucosyltransferase 3 and 8 Promote the Metastatic Capacity of Cancer Stem-Like Cells via CD15s and E-Cadherin in Esophageal Cancer.” Iranian Journal of Basic Medical Sciences 27: 985. https://doi.org/10.22038/IJBMS.2024.74726.16228

[582] Cuello, Hector A., Gretel M. Ferreira, Cynthia A. Gulino, Alejandro Gomez Toledo, Valeria I. Segatori, and Mariano R. Gabri. 2020. “Terminally Sialylated and Fucosylated Complex N-Glycans Are Involved in the Malignant Behavior of High-Grade Glioma.” Oncotarget 11: 4822–35. https://doi.org/10.18632/oncotarget.27850

[583] Greville, Gordon, Esther Llop, Jane Howard, Stephen F. Madden, Antoinette S. Perry, Rosa Peracaula, Pauline M. Rudd, Amanda McCann, and Radka Saldova. 2021. “5-AZA-dC Induces Epigenetic Changes Associated With Modified Glycosylation of Secreted Glycoproteins and Increased EMT and Migration in Chemo-Sensitive Cancer Cells.” Clinical Epigenetics 13: 34. https://doi.org/10.1186/s13148-021-01015-7

[584] Yang, Xiaohua, Tianzhang Kou, Hongmiao Wang, Ji Zhu, Zheng-Jiang Zhu, and Yuping Cai. 2025. “S-Adenosylmethionine Metabolism Shapes CD8⁺ T Cell Functions in Colorectal Cancer.” Cancer & Metabolism 13: 1–15. https://doi.org/10.1186/s40170-025-00394-2

[585] Sang, Xiaolin, Jiaxin Han, Zhaojing Wang, Weiji Cai, Xingming Liao, Zhuolin Kong, Zhijie Yu, Hailing Cheng, and Pixu Liu. 2024. “SGK1 Suppresses Ferroptosis in Ovarian Cancer via NRF2-dependent and -Independent Pathways.” Oncogene 43: 3335–47. https://doi.org/10.1038/s41388-024-03173-3

[586] Huang, Yuanjia, Linghua Piao, and Xiande Liu. 2024. “Enhancing Tumor-Specific Immunity With SL(dacA): A Attenuated Salmonella-Mediated c-di-AMP Delivery System Targeting the STING Pathway.” International Journal of Pharmaceutics 666: 124759. https://doi.org/10.1016/j.ijpharm.2024.124759

[587] Podyacheva, Ekaterina, and Yana Toropova. 2023. “The Role of NAD⁺, SIRTs Interactions in Stimulating and Counteracting Carcinogenesis.” International Journal of Molecular Sciences 24: 7925. https://doi.org/10.3390/ijms24097925

[588] Lv, Hongwei, Guishuai Lv, Cian Chen, Qianni Zong, Guoqing Jiang, Dan Ye, Xiuliang Cui, et al. 2021. “NAD⁺ Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion.” Cell Metabolism 33: 110–27. https://doi.org/10.1016/j.cmet.2020.10.021

[589] García-Martínez, José Manuel, Ana Chocarro-Calvo, Javier Martínez-Useros, María Jesús Fernández-Aceñero, M Carmen Fiuza, José Cáceres-Rentero, Antonio De la Vieja, et al. 2023. “Vitamin D Induces SIRT1 Activation Through K610 Deacetylation in Colon Cancer.” Elife 12: RP86913. https://doi.org/10.7554/eLife.86913.3

[590] Huang, Tianzhi, Xiao Song, Dandan Xu, Deanna Tiek, Anshika Goenka, Bingli Wu, Namratha Sastry, Bo Hu, and Shi-Yuan Cheng. 2020. “Stem Cell Programs in Cancer Initiation, Progression, and Therapy Resistance.” Theranostics 10: 8721–43. https://doi.org/10.7150/thno.41648

[591] Li, Yinglu, Elizabeth M. Goldberg, Xiao Chen, Xinjing Xu, John T. McGuire, Giuseppe Leuzzi, Dimitris Karagiannis, et al. 2022. “Histone Methylation Antagonism Drives Tumor Immune Evasion in Squamous Cell Carcinomas.” Molecular Cell 82: 3901–18. https://doi.org/10.1016/j.molcel.2022.09.007

[592] Yang, Meihua, Bo Wang, Weibin Hou, Honghui Zeng, Wang He, Xin-Ke Zhang, Dong Yan, et al. 2024. “NAD⁺ Metabolism Enzyme NNMT in Cancer-Associated Fibroblasts Drives Tumor Progression and Resistance to Immunotherapy by Modulating Macrophages in Urothelial Bladder Cancer.” Journal for Immunotherapy of Cancer 12: e009281. https://doi.org/10.1136/jitc-2024-009281

[593] Yi, Jingjie, and Jianyuan Luo. 2010. “SIRT1 and p53, Effect on Cancer, Senescence and Beyond.” Biochimica et Biophysica Acta (BBA)—Proteins and Proteomics 1804: 1684–9. https://doi.org/10.1016/j.bbapap.2010.05.002

[594] Han, Yicun, Yunzhou Pu, Xiaodie Liu, Zhiyi Liu, Yongqi Chen, Lei Tang, Jing Zhou, Qing Song, and Qing Ji. 2024. “YTHDF1 Regulates GID8-Mediated Glutamine Metabolism to Promote Colorectal Cancer Progression in m6A-Dependent Manner.” Cancer Letters 601: 217186. https://doi.org/10.1016/j.canlet.2024.217186

[595] Li, Xin, Chuanyun Li, Liping Zhang, Min Wu, Ke Cao, Feifei Jiang, Dexi Chen, Ning Li, and Weihua Li. 2020. “The Significance of Exosomes in the Development and Treatment of Hepatocellular Carcinoma.” Molecular Cancer 19: 1–18. https://doi.org/10.1186/s12943-019-1085-0

[596] Boughanem, Hatim, Pablo Hernandez-Alonso, Alberto Tinahones, Nancy Babio, Jordi Salas-Salvadó, Francisco J. Tinahones, and Manuel Macias-Gonzalez. 2020. “Association Between Serum Vitamin B12 and Global DNA Methylation in Colorectal Cancer Patients.” Nutrients 12: 3567. https://doi.org/10.3390/nu12113567

[597] Elawdan, Khaled A., Sabah Farouk, Salah Aref, Hamada Shoaib, Mohamed A. El-Razik, Nasser H. Abbas, Mohamed Younis, Abeer A. Alshambky, and Hany Khalil. 2022. “Association of Vitamin B12/Ferritin Deficiency in Cancer Patients With Methylomic Changes at Promotors of TET Methylcytosine Dioxygenases.” Biomarkers in Medicine 16: 959–70. https://doi.org/10.2217/bmm-2022-0158

[598] Sapehia, Divika, Aatish Mahajan, Parampal Singh, and Jyotdeep Kaur. 2023. “High Dietary Folate and Low Vitamin B12 in Parental Diet Disturbs the Epigenetics of Imprinted Genes MEST and PHLDA2 in Mice Placenta.” Journal of Nutritional Biochemistry 118: 109354. https://doi.org/10.1016/j.jnutbio.2023.109354

[599] Shang, Man, Huijie Yang, Ran Yang, Tao Chen, Yuan Fu, Yeyi Li, Xianlong Fang, et al. 2021. “The Folate Cycle Enzyme MTHFD2 Induces Cancer Immune Evasion Through PD-L1 Up-Regulation.” Nature Communications 12: 1940. https://doi.org/10.1038/s41467-021-22173-5

[600] Zsigrai, Sára, Alexandra Kalmár, Barbara K. Barták, Zsófia B Nagy, Krisztina A. Szigeti, Gábor Valcz, William Kothalawala, et al. 2022. “Folic Acid Treatment Directly Influences the Genetic and Epigenetic Regulation Along With the Associated Cellular Maintenance Processes of HT-29 and SW480 Colorectal Cancer Cell Lines.” Cancers 14: 1820. https://doi.org/10.3390/cancers14071820

[601] Yang, Li, Robert C. Peery, Leah M. Farmer, Xia Gao, Yiqun Zhang, Chad J. Creighton, Lanjing Zhang, and Lanlan Shen. 2024. “Dietary Folate and Cofactors Accelerate Age-Dependent p16 Epimutation to Promote Intestinal Tumorigenesis.” Cancer Research Communications 4: 164–9. https://doi.org/10.1158/2767-9764.CRC-23-0356

[602] Li, Chaoqun, Peng Teng, Shengbai Sun, Kaisa Cui, Surui Yao, Bojian Fei, Feng Ling, and Zhaohui Huang. 2023. “Acetylation of Aldehyde Dehydrogenase ALDH1L2 Regulates Cellular Redox Balance and the Chemosensitivity of Colorectal Cancer to 5-Fluorouracil.” Journal of Biological Chemistry 299: 105090. https://doi.org/10.1016/j.jbc.2023.105090

[603] Wang, Hui, Wen-Hao Wang, Wei Wang, Ji-Hong Ma, Xiao-Qiang Su, Li-Li Zhang, Yong-Li Hou, et al. 2024. “Folate Deficiency Promotes Cervical Squamous Carcinoma SiHa Cells Progression by Targeting miR-375/FZD4/β-Catenin Signaling.” Journal of Nutritional Biochemistry 124: 109489. https://doi.org/10.1016/j.jnutbio.2023.109489

[604] Tong, Dongdong, Jing Zhang, Xiaofei Wang, Qian Li, Liying Liu, Axin Lu, Bo Guo, et al. 2020. “MiR-22, Regulated by MeCP2, Suppresses Gastric Cancer Cell Proliferation by Inducing a Deficiency in Endogenous S-Adenosylmethionine.” Oncogenesis 9: 99. https://doi.org/10.1038/s41389-020-00281-z

[605] Zhang, Qingqing, Qing Zhao, Tao Li, Longya Lu, Fei Wang, Hong Zhang, Zhi Liu, et al. 2023. “Lactobacillus Plantarum-Derived Indole-3-Lactic Acid Ameliorates Colorectal Tumorigenesis via Epigenetic Regulation of CD8⁺ T Cell Immunity.” Cell Metabolism 35: 943–60. https://doi.org/10.1016/j.cmet.2023.04.015

[606] Nguyen, Nguyen T. B., Sira Gevers, Rutger N. U. Kok, Lotte M. Burgering, Hannah Neikes, Ninouk Akkerman, Max A. Betjes, et al. 2025. “Lactate Controls Cancer Stemness and Plasticity Through Epigenetic Regulation.” Cell Metabolism 37: 903–19.e10. https://doi.org/10.1016/j.cmet.2025.01.002

[607] Cheong, Yuen Jian, and Sophie Trefely. 2025. “Divergent Roles for Propionate and Butyrate in Colorectal Cancer Epigenetics.” Nature Metabolism 7: 1–3. https://doi.org/10.1038/s42255-024-01186-6

[608] Huang, Tao, Qi You, Jiawei Liu, Xuguang Shen, Dengjun Huang, Xinlu Tao, Zhijie He, et al. 2025. “WTAP Mediated m6A Modification Stabilizes PDIA3P1 and Promotes Tumor Progression Driven by Histone Lactylation in Esophageal Squamous Cell Carcinoma.” Advanced Science 12: e06529. https://doi.org/10.1002/advs.202506529

[609] Gu, Xuemei, Haoran Wei, Caixia Suo, Shengqi Shen, Chuxu Zhu, Liang Chen, Kai Yan, et al. 2023. “Itaconate Promotes Hepatocellular Carcinoma Progression by Epigenetic Induction of CD8⁺ T-Cell Exhaustion.” Nature Communications 14: 8154. https://doi.org/10.1038/s41467-023-43988-4

[610] Zhu, Chu-Xu, Kai Yan, Liang Chen, Rong-Rong Huang, Zhen-Hua Bian, Hao-Ran Wei, Xue-Mei Gu, et al. 2024. “Targeting OXCT1-Mediated Ketone Metabolism Reprograms Macrophages to Promote Antitumor Immunity via CD8⁺ T Cells in Hepatocellular Carcinoma.” Journal of Hepatology 81: 690–703. https://doi.org/10.1016/j.jhep.2024.05.007

[611] Ghare, Smita S., Benjamin T. Charpentier, Dushan T. Ghooray, Jingwen Zhang, Manicka V. Vadhanam, Sreelatha Reddy, Swati Joshi-Barve, Craig J. McClain, and Shirish S. Barve. 2023. “Tributyrin Mitigates Ethanol-Induced Lysine Acetylation of Histone-H3 and p65-NFκB Downregulating CCL2 Expression and Consequent Liver Inflammation and Injury.” Nutrients 15: 4397. https://doi.org/10.3390/nu15204397

[612] Nguyen, Anthony, Anna H. Kim, Mo K. Kang, No-Hee Park, Reuben H. Kim, Yong Kim, and Ki-Hyuk Shin. 2022. “Chronic Alcohol Exposure Promotes Cancer Stemness and Glycolysis in Oral/Oropharyngeal Squamous Cell Carcinoma Cell Lines by Activating NFAT Signaling.” International Journal of Molecular Sciences 23: 9779. https://doi.org/10.3390/ijms23179779

[613] Liu, Yufei, Jun Zhou, Yuchang Hu, Junjie Wang, and Chengfu Yuan. 2017. “Curcumin Inhibits Growth of Human Breast Cancer Cells Through Demethylation of DLC1 Promoter.” Molecular and Cellular Biochemistry 425: 47–58. https://doi.org/10.1007/s11010-016-2861-4

[614] Shi, Jia'ning, Shupeng Song, Shuangxing Li, Kaili Zhang, Yinghua Lan, and Yongguo Li. 2021. “TNF-α/NF-κB Signaling Epigenetically Represses PSD4 Transcription to Promote Alcohol-Related Hepatocellular Carcinoma Progression.” Cancer Medicine 10: 3346–57. https://doi.org/10.1002/cam4.3832

[615] Chen, Wenbo, Qisong Zhang, Ming Ding, Jingjing Yao, Yajuan Guo, Wenxin Yan, Shaofang Yu, et al. 2022. “Alcohol Triggered Bile Acid Disequilibrium by Suppressing BSEP to Sustain Hepatocellular Carcinoma Progression.” Chemico-Biological Interactions 356: 109847. https://doi.org/10.1016/j.cbi.2022.109847

[616] Attene-Ramos, Matias S., Gerardo M. Nava, Mark G. Muellner, Elizabeth D. Wagner, Michael J. Plewa, and H Rex Gaskins. 2010. “DNA Damage and Toxicogenomic Analyses of Hydrogen Sulfide in Human Intestinal Epithelial FHs 74 Int Cells.” Environmental and Molecular Mutagenesis 51: 304–14. https://doi.org/10.1002/em.20546

[617] Yang, Ruili, Cunye Qu, Yu Zhou, Joanne E. Konkel, Shihong Shi, Yi Liu, Chider Chen, et al. 2015. “Hydrogen Sulfide Promotes Tet1-and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis.” Immunity 43: 251–63. https://doi.org/10.1016/j.immuni.2015.07.017

[618] Jaiswal, Jyoti, Amit Kumar Srivastav, Manish Kushwaha, Anupam Teotia, Rajeev Singh, Anand Mohan, Govind Makharia, and Anil Kumar. 2025. “Gut Microbial Metabolite 4-Ethylphenylsulfate Is Selectively Deleterious and Anticancer to Colon Cancer Cells.” Journal of Medicinal Chemistry 68: 10425–38. https://doi.org/10.1021/acs.jmedchem.5c00609

[619] Chen, Yuting, Zhaohong Lu, Boxin Li, Huanhuan Wang, Tikeng Jiang, Mei Xuan, Hui Yang, et al. 2023. “Human CYP1B1 Enzyme-Mediated, AhR Enhanced Activation of Aflatoxin B1 for Its Genotoxicity in Human Cells.” Toxicology Letters 373: 132–40. https://doi.org/10.1016/j.toxlet.2022.11.014

[620] Bartkeviciene, Arenida, Aldona Jasukaitiene, Inga Zievyte, Darius Stukas, Sandra Ivanauskiene, Daiva Urboniene, Toivo Maimets, et al. 2023. “Association Between AHR Expression and Immune Dysregulation in Pancreatic Ductal Adenocarcinoma: Insights From Comprehensive Immune Profiling of Peripheral Blood Mononuclear Cells.” Cancers 15: 4639. https://doi.org/10.3390/cancers15184639

[621] Ozawa, Shunsuke, Ryota Ojiro, Qian Tang, Xinyu Zou, Meilan Jin, Toshinori Yoshida, and Makoto Shibutani. 2024. “Involvement of Multiple Epigenetic Mechanisms by Altered DNA Methylation from the Early Stage of Renal Carcinogenesis before Proliferative Lesion Formation Upon Repeated Administration of Ochratoxin A.” Toxicology 506: 153875. https://doi.org/10.1016/j.tox.2024.153875

[622] Arumugam, Thilona, Terisha Ghazi, and Anil Chuturgoon. 2020. “Fumonisin B1 Epigenetically Regulates PTEN Expression and Modulates DNA Damage Checkpoint Regulation in HepG2 Liver Cells.” Toxins 12: 625. https://doi.org/10.3390/toxins12100625

[623] D'Onofrio, Nunzia, Elisa Martino, Anna Balestrieri, Luigi Mele, Domenico Cautela, Domenico Castaldo, and Maria Luisa Balestrieri. 2022. “Diet-Derived Ergothioneine Induces Necroptosis in Colorectal Cancer Cells by Activating the SIRT3/MLKL Pathway.” FEBS Letters 596: 1313–29. https://doi.org/10.1002/1873-3468.14310

[624] Yoshida, Sumito, Hiroaki Shime, Misako Matsumoto, Masanori Kasahara, and Tsukasa Seya. 2019. “Anti-Oxidative Amino Acid L-Ergothioneine Modulates the Tumor Microenvironment to Facilitate Adjuvant Vaccine Immunotherapy.” Frontiers in Immunology 10: 671. https://doi.org/10.3389/fimmu.2019.00671

[625] Masuda, Junko, Chiho Umemura, Miki Yokozawa, Ken Yamauchi, Takuya Seko, Michiaki Yamashita, and Yumiko Yamashita. 2018. “Dietary Supplementation of Selenoneine-Containing Tuna Dark Muscle Extract Effectively Reduces Pathology of Experimental Colorectal Cancers in Mice.” Nutrients 10: 1380. https://doi.org/10.3390/nu10101380

[626] Liu, Wenwen, Yang Zhou, Wenzhe Duan, Jing Song, Song Wei, Shengkai Xia, Yingyan Wang, et al. 2021. “Glutathione Peroxidase 4-dependent Glutathione High-Consumption Drives Acquired Platinum Chemoresistance in Lung Cancer-Derived Brain Metastasis.” Clinical and Translational Medicine 11: e517. https://doi.org/10.1002/ctm2.517

[627] Liu, Muyun, Dan Wang, Yongde Luo, Lianghao Hu, Yawei Bi, Juntao Ji, Haojie Huang, et al. 2021. “Selective Killing of Cancer Cells Harboring Mutant RAS by Concomitant Inhibition of NADPH Oxidase and Glutathione Biosynthesis.” Cell Death & Disease 12: 189. https://doi.org/10.1038/s41419-021-03473-6

[628] Jiang, Xuejun, Brent R. Stockwell, and Marcus Conrad. 2021. “Ferroptosis: Mechanisms, Biology and Role in Disease.” Nature Reviews Molecular Cell Biology 22: 266–82. https://doi.org/10.1038/s41580-020-00324-8

[629] Jiang, Yulang, Christian Glandorff, and Mingyu Sun. 2024. “GSH and Ferroptosis: Side-by-Side Partners in the Fight Against Tumors.” Antioxidants 13: 697. https://doi.org/10.3390/antiox13060697

[630] Sun, Jing, Jianhui Zhao, Siyun Zhou, Xinxuan Li, Tengfei Li, Lijuan Wang, Shuai Yuan, et al. 2024. “Systematic Investigation of Genetically Determined Plasma and Urinary Metabolites to Discover Potential Interventional Targets for Colorectal Cancer.” Journal of the National Cancer Institute 116: 1303–12. https://doi.org/10.1093/jnci/djae089

[631] Lin, Yilong, Yue Zhang, Songsong Wang, and Qingmo Yang. 2024. “Elucidating the Relationship Between Metabolites and Breast Cancer: A Mendelian Randomization Study.” Toxicology and Applied Pharmacology 484: 116855. https://doi.org/10.1016/j.taap.2024.116855

[632] Chen, Jinyan, Xuejun Chen, and Jiong Ma. 2025. “Causal Relationships of Gut Microbiota and Blood Metabolites With Ovarian Cancer and Endometrial Cancer: A Mendelian Randomization Study.” Journal of Ovarian Research 18: 54. https://doi.org/10.1186/s13048-025-01630-5

[633] Ghosh, Sweta, Rajbir Singh, Zachary Matthew Vanwinkle, Haixun Guo, Praveen Kumar Vemula, Ajay Goel, Bodduluri Haribabu, and Venkatakrishna Rao Jala. 2022. “Microbial Metabolite Restricts 5-Fluorouracil-Resistant Colonic Tumor Progression by Sensitizing Drug Transporters via Regulation of FOXO3-FOXM1 Axis.” Theranostics 12: 5574–95. https://doi.org/10.7150/thno.70754

[634] El-Gazzar, Nashwa, Lekaa Said, Fatimah Olyan Al-Otibi, Mohamed Ragab AbdelGawwad, and Gamal Rabie. 2025. “Antimicrobial and Cytotoxic Activities of Natural (Z)-13-Docosenamide Derived From Penicillium chrysogenum.” Frontiers in Cellular and Infection Microbiology 15: 1529104. https://doi.org/10.3389/fcimb.2025.1529104

[635] Onodera, Takefumi, Isao Momose, Hayamitsu Adachi, Yohko Yamazaki, Ryuichi Sawa, Shun-ichi Ohba, and Manabu Kawada. 2020. “Human Pancreatic Cancer Cells Under Nutrient Deprivation Are Vulnerable to Redox System Inhibition.” Journal of Biological Chemistry 295: 16678–90. https://doi.org/10.1074/jbc.RA120.013893

[636] Malekinejad, Faezeh, Johanna Fink-Gremmels, and Hassan Malekinejad. 2023. “Zearalenone and Its Metabolite Exposure Directs Oestrogen Metabolism Towards Potentially Carcinogenic Metabolites in Human Breast Cancer MCF-7 Cells.” Mycotoxin Research 39: 45–56. https://doi.org/10.1007/s12550-022-00472-0

[637] Lo, Emily Kwun Kwan, Xiuwan Wang, Pui-Kei Lee, Ho-Ching Wong, Jetty Chung-Yung Lee, Carlos Gómez-Gallego, Danyue Zhao, Hani El-Nezami, and Jun Li. 2023. “Mechanistic Insights into Zearalenone-Accelerated Colorectal Cancer in Mice Using Integrative Multi-Omics Approaches.” Computational and Structural Biotechnology Journal 21: 1785–96. https://doi.org/10.1016/j.csbj.2023.02.048

[638] Anjum, Saria, Payal Mandal, Smriti Agrawal, and Kausar Mahmood Ansari. 2024. “Zearalenone Promotes Endometrial Cancer Cell Migration and Invasion via Activation of Estrogen Receptor-Mediated Rho/ROCK/PMLC Signaling Pathway.” Food and Chemical Toxicology 193: 115017. https://doi.org/10.1016/j.fct.2024.115017

[639] Kowalska, Karolina, Dominika Ewa Habrowska-Górczyńska, Kamila Domińska, Kinga Anna Urbanek, and Agnieszka Wanda Piastowska-Ciesielska. 2020. “ERβ and NFκB—Modulators of Zearalenone-Induced Oxidative Stress in Human Prostate Cancer Cells.” Toxins 12: 199. https://doi.org/10.3390/toxins12030199

[640] Ruan, Haonan, Jing Zhang, Yunyun Wang, Ying Huang, Jiashuo Wu, Chunjiao He, Tongwei Ke, Jiaoyang Luo, and Meihua Yang. 2024. “27-Hydroxycholesterol/liver X Receptor/Apolipoprotein E Mediates Zearalenone-Induced Intestinal Immunosuppression: A Key Target Potentially Linking Zearalenone and Cancer.” Journal of Pharmaceutical Analysis 14: 371–88. https://doi.org/10.1016/j.jpha.2023.08.002

[641] Lo, Emily Kwun Kwan, Jetty Chung-Yung Lee, Paul C. Turner, and Hani El-Nezami. 2021. “Low Dose of Zearalenone Elevated Colon Cancer Cell Growth Through G Protein-Coupled Estrogenic Receptor.” Scientific Reports 11: 7403. https://doi.org/10.1038/s41598-021-86788-w

[642] Nambiar, Sujisha S., Siddhartha Sankar Ghosh, and Gurvinder Kaur Saini. 2024. “Gliotoxin Triggers Cell Death Through Multifaceted Targeting of Cancer-Inducing Genes in Breast Cancer Therapy.” Computational Biology and Chemistry 112: 108170. https://doi.org/10.1016/j.compbiolchem.2024.108170

[643] Shan, Lihong, Zhaoxiang Li, Huabin Chen, Meng Ge, Yingying Sun, Ying Sun, Yaru Li, et al. 2023. “6-Heterocyclic Carboxylic Ester Derivatives of Gliotoxin Lead to LSD1 Inhibitors in Gastric Cancer Cells.” Bioorganic Chemistry 131: 106150. https://doi.org/10.1016/j.bioorg.2022.106150

[644] Pillay, Lynise C., Lucpah Nekati, Phuti J. Makhwitine, and Sizwe I. Ndlovu. 2022. “Epigenetic Activation of Silent Biosynthetic Gene Clusters in Endophytic Fungi Using Small Molecular Modifiers.” Frontiers in Microbiology 13: 815008. https://doi.org/10.3389/fmicb.2022.815008

[645] Verma, Ashish, Harshita Tiwari, Swati Singh, Priyamvada Gupta, Nilesh Rai, Santosh Kumar Singh, Bhim Pratap Singh, Sombir Rao, and Vibhav Gautam. 2023. “Epigenetic Manipulation for Secondary Metabolite Activation in Endophytic Fungi: Current Progress and Future Directions.” Mycology 14: 275–91. https://doi.org/10.1080/21501203.2023.2241486

[646] Li, Zixiang, Haoyou Wang, Bo Liu, and Wei Wang. 2025. “Bromodomain Containing Protein 4 (BRD4) and Cancer Therapy: A Glimpse at Dual-Target Drug Development.” Biochemical Pharmacology 242: 117418. https://doi.org/10.1016/j.bcp.2025.117418

[647] Shu, Shaokun, Charles Y. Lin, Housheng Hansen He, Robert M. Witwicki, Doris P. Tabassum, Justin M. Roberts, Michalina Janiszewska, et al. 2016. “Response and Resistance to BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.” Nature 529: 413–7. https://doi.org/10.1038/nature16508

[648] Yang, Guan-Jun, Yan-Jun Liu, Li-Jian Ding, Fan Tao, Ming-Hui Zhu, Zhen-Yuan Shi, Juan-Ming Wen, et al. 2022. “A State-of-The-Art Review on LSD1 and Its Inhibitors in Breast Cancer: Molecular Mechanisms and Therapeutic Significance.” Frontiers in Pharmacology 13: 989575. https://doi.org/10.3389/fphar.2022.989575

[649] Song, Yihui, Shu Wang, and Bin Yu. 2022. “Structural and Functional Landscape of FAD-Dependent Histone Lysine Demethylases for New Drug Discovery.” Journal of Medicinal Chemistry 66: 71–94. https://doi.org/10.1021/acs.jmedchem.2c01324

[650] Noce, Beatrice, Elisabetta Di Bello, Rossella Fioravanti, and Antonello Mai. 2023. “LSD1 Inhibitors for Cancer Treatment: Focus on Multi-Target Agents and Compounds in Clinical Trials.” Frontiers in Pharmacology 14: 1120911. https://doi.org/10.3389/fphar.2023.1120911

[651] Yang, Jie, Vladimir O. Talibov, Stefan Peintner, Claire Rhee, Vasanthanathan Poongavanam, Matthis Geitmann, Matteo Rossi Sebastiano, et al. 2020. “Macrocyclic Peptides Uncover a Novel Binding Mode for Reversible Inhibitors of LSD1.” ACS Omega 5: 3979–95. https://doi.org/10.1021/acsomega.9b03493

[652] Baby, Stephin, Suchita Dattatray Shinde, Neeraj Kulkarni, and Bichismita Sahu. 2023. “Lysine-Specific Demethylase 1 (LSD1) Inhibitors: Peptides as an Emerging Class of Therapeutics.” ACS Chemical Biology 18: 2144–55. https://doi.org/10.1021/acschembio.3c00386

[653] Ma, Aiai, Kan Jiang, Bin Chen, Shasha Chen, Xinge Qi, Huining Lu, Junlin Liu, et al. 2021. “Evaluation of the Anticarcinogenic Potential of the Endophyte, Streptomyces sp. LRE541 Isolated from Lilium Davidii Var. Unicolor (Hoog) Cotton.” Microbial Cell Factories 20: 217. https://doi.org/10.1186/s12934-021-01706-z

[654] Gao, Lin-Lin, Xu-Tong Fang, Shu-Hui Zhao, Chen-Xiao Hui, Wei-Wei Huang, Yu-Qi Gao, and Jin-Ming Gao. 2024. “Naphthoquinone Derivatives from the Endophytic Fungus Fusarium Solani Induce Pancreatic Cancer Cells Apoptosis via Targeting EGFR-Mediated PI3K/Akt Pathway.” Journal of Agricultural and Food Chemistry 72: 26209–23. https://doi.org/10.1021/acs.jafc.4c08652

[655] Zhang, Guihong, Jiao Liu, Sanzhong Li, Tianyu Wang, Li Chen, Huan Li, Qingkai Ding, et al. 2024. “Cytochalasin H Enhances Sensitivity to Gefitinib in Non-Small-Cell Lung Cancer Cells Through Inhibiting EGFR Activation and PD-L1 Expression.” Scientific Reports 14: 25276. https://doi.org/10.1038/s41598-024-76060-2

[656] Lu, Yi, Peng Zhang, Hongdan Chen, Qingyi Tong, Jia Wang, Qing Li, Cheng Tian, et al. 2022. “Cytochalasin Q Exerts Anti-Melanoma Effect by Inhibiting Creatine Kinase B.” Toxicology and Applied Pharmacology 441: 115971. https://doi.org/10.1016/j.taap.2022.115971

[657] Wang, Ya-Jing, Nan Ma, Yong-Fu Lu, Si-Yang Dai, Xue Song, Chang Li, Yi Sun, and Yue-Hu Pei. 2022. “Structure Elucidation and Anti-Tumor Activities of Trichothecenes from Endophytic Fungus Fusarium sporotrichioides.” Biomolecules 12: 778. https://doi.org/10.3390/biom12060778

[658] Stuhldreier, Fabian, Laura Schmitt, Thomas Lenz, Ilka Hinxlage, Marcel Zimmermann, Philipp Wollnitzke, Julian Schliehe-Diecks, et al. 2022. “The Mycotoxin Viriditoxin Induces Leukemia- and Lymphoma-Specific Apoptosis by Targeting Mitochondrial Metabolism.” Cell Death & Disease 13: 938. https://doi.org/10.1038/s41419-022-05356-w

[659] Ramírez-Villalobos, Jesica M., César I Romo-Sáenz, Karla S. Morán-Santibañez, Patricia Tamez-Guerra, Ramiro Quintanilla-Licea, Alonso A. Orozco-Flores, Ricardo Romero-Arguelles, et al. 2021. “In Vitro Tumor Cell Growth Inhibition Induced by Lophocereus Marginatus (DC.) S. Arias and Terrazas Endophytic Fungi Extracts.” International Journal of Environmental Research and Public Health 18: 9917. https://doi.org/10.3390/ijerph18189917

[660] Tang, Da, Wei Zhang, Zhenxing Zou, Yikun Wang, Shichao Yan, Sha Zhang, Wenwu Cai, et al. 2022. “Porric Acid E, a Natural Compound From Rhytidhysteron sp. BZM-9, Suppresses Colorectal Cancer Growth via an Autophagy-Dependent Pathway.” Journal of Cancer 13: 3554–65. https://doi.org/10.7150/jca.77588

[661] Huang, Yun, Hongmei Yan, Bingzhi Zhang, Ge Zhu, Jianchen Yu, Xuhan Xiao, Wenxuan He, et al. 2023. “Ascomylactam C Induces an Immunogenic Cell Death Signature via Mitochondria-Associated ER Stress in Lung Cancer and Melanoma.” Marine Drugs 21: 600. https://doi.org/10.3390/md21120600

[662] Fudulu, Alina, Carmen Cristina Diaconu, Iulia Virginia Iancu, Adriana Plesa, Adrian Albulescu, Marinela Bostan, Demetra Gabriela Socolov, et al. 2024. “Exploring the Role of E6 and E7 Oncoproteins in Cervical Oncogenesis Through MBD2/3-NuRD Complex Chromatin Remodeling.” Genes 15: 560. https://doi.org/10.3390/genes15050560

[663] Cao, Canhui, Qian Xu, Zhixian Zhu, Miaochun Xu, Ye Wei, Shitong Lin, Sheng Cheng, et al. 2024. “Three-Dimensional Chromatin Analysis Reveals Sp1 as a Mediator to Program and Reprogram HPV-host Epigenetic Architecture in Cervical Cancer.” Cancer Letters 588: 216809. https://doi.org/10.1016/j.canlet.2024.216809

[664] Nantajit, Danupon, Luana Presta, Thomas Sauter, and Mahvash Tavassoli. 2022. “EGFR-induced Suppression of HPV E6/E7 Is Mediated by microRNA-9-5p Silencing of BRD4 Protein in HPV-positive Head and Neck Squamous Cell Carcinoma.” Cell Death & Disease 13: 921. https://doi.org/10.1038/s41419-022-05269-8

[665] Kim, Min Jun, Han Ju Lee, Mee Young Choi, Sang Soo Kang, Yoon Sook Kim, Jeong Kyu Shin, and Wan Sung Choi. 2021. “UHRF1 Induces Methylation of the TXNIP Promoter and Down-Regulates Gene Expression in Cervical Cancer.” Molecules and Cells 44: 146–59. https://doi.org/10.14348/molcells.2021.0001

[666] Fontan, Christian T., Dipon Das, Molly L. Bristol, Claire D. James, Xu Wang, Hannah Lohner, Azeddine Atfi, and Iain M. Morgan. 2020. “Human Papillomavirus 16 (HPV16) E2 Repression of TWIST1 Transcription Is a Potential Mediator of HPV16 Cancer Outcomes.” mSphere 5: e00981–20. https://doi.org/10.1128/mSphere.00981-20

[667] Shi, Feng, Li Shang, Min Zhou, Cong Lv, Yueshuo Li, Cheng Luo, Na Liu, et al. 2024. “Epstein-Barr Virus-Driven Metabolic Alterations Contribute to the Viral Lytic Reactivation and Tumor Progression in Nasopharyngeal Carcinoma.” Journal of Medical Virology 96: e29634. https://doi.org/10.1002/jmv.29634

[668] Chow, Larry Ka-Yue, Dittman Lai-Shun Chung, Lihua Tao, Kui Fat Chan, Stewart Yuk Tung, Roger Kai Cheong Ngan, Wai Tong Ng, et al. 2022. “Epigenomic Landscape Study Reveals Molecular Subtypes and EBV-associated Regulatory Epigenome Reprogramming in Nasopharyngeal Carcinoma.” EBioMedicine 86: 104357. https://doi.org/10.1016/j.ebiom.2022.104357

[669] Xiang, Jin, Chang Chen, Rui Liu, Dongmei Gou, Lei Chang, Haijun Deng, Qingzhu Gao, et al. 2021. “Gluconeogenic Enzyme PCK1 Deficiency Promotes CHK2 O-GlcNAcylation and Hepatocellular Carcinoma Growth Upon Glucose Deprivation.” Journal of Clinical Investigation 131: e144703. https://doi.org/10.1172/JCI144703

[670] Walter, Lisa A., Yu Hsuan Lin, Christopher J. Halbrook, Kelly N. Chuh, Lina He, Nichole J. Pedowitz, Anna R. Batt, et al. 2019. “Inhibiting the Hexosamine Biosynthetic Pathway Lowers O-GlcNAcylation Levels and Sensitizes Cancer to Environmental Stress.” Biochemistry 59: 3169–79. https://doi.org/10.1021/acs.biochem.9b00560

[671] Eckert, Mark A., Fabian Coscia, Agnieszka Chryplewicz, Jae Won Chang, Kyle M. Hernandez, Shawn Pan, Samantha M. Tienda, et al. 2019. “Proteomics Reveals NNMT as a Master Metabolic Regulator of Cancer-Associated Fibroblasts.” Nature 569: 723–8. https://doi.org/10.1038/s41586-019-1173-8

[672] Sanchez, Erica L., Patrick A. Carroll, Angel B. Thalhofer, and Michael Lagunoff. 2015. “Latent KSHV Infected Endothelial Cells Are Glutamine Addicted and Require Glutaminolysis for Survival.” PLOS Pathogens 11: e1005052. https://doi.org/10.1371/journal.ppat.1005052

[673] Zhu, Ying, Tingting Li, Suzane Ramos da Silva, Jae-Jin Lee, Chun Lu, Hyungjin Eoh, Jae U. Jung, and Shou-Jiang Gao. 2017. “A Critical Role of Glutamine and Asparagine γ-Nitrogen in Nucleotide Biosynthesis in Cancer Cells Hijacked by an Oncogenic Virus.” mBio 8: e01179–87. https://doi.org/10.1128/mBio.01179-17

[674] Tian, Wenwen, Lewei Zhu, Yongzhou Luo, Yuhui Tang, Qingjian Tan, Yutian Zou, Kun Chen, et al. 2024. “Autophagy Deficiency Induced by SAT1 Potentiates Tumor Progression in Triple-Negative Breast Cancer.” Advanced Science 11: 2309903. https://doi.org/10.1002/advs.202309903

[675] Akinyele, Oluwaseun, and Heather M. Wallace. 2021. “Characterising the Response of Human Breast Cancer Cells to Polyamine Modulation.” Biomolecules 11: 743. https://doi.org/10.3390/biom11050743

[676] Gao, Xiaoqiang, Xiaodong Jia, Moyan Xu, Jiao Xiang, Jin Lei, Yinyin Li, Yinying Lu, and Shi Zuo. 2022. “Regulation of Gamma-Aminobutyric Acid Transaminase Expression and Its Clinical Significance in Hepatocellular Carcinoma.” Frontiers in Oncology 12: 879810. https://doi.org/10.3389/fonc.2022.879810

[677] Bonglack, Emmanuela N., Joshua E. Messinger, Jana M. Cable, James Ch'ng, K Mark Parnell, Nicolás M Reinoso-Vizcaíno, Ashley P. Barry, et al. 2021. “Monocarboxylate Transporter Antagonism Reveals Metabolic Vulnerabilities of Viral-Driven Lymphomas.” Proceedings of the National Academy of Sciences 118: e2022495118. https://doi.org/10.1073/pnas.2022495118

[678] Zhu, Zhenhan, Wenxia Jiang, Jiehao Zhou, Alexander Robert Maldeney, Jingru Liang, Jing Yang, and Wei Luo. 2024. “The Combined Inhibition of SREBP and mTORC1 Signaling Synergistically Inhibits B-Cell Lymphoma.” Cancer Medicine 13: e70342. https://doi.org/10.1002/cam4.70342

[679] Li, Hongquan, Junjiao Song, Yifei He, Yizhe Liu, Zhen Liu, Weili Sun, Weiguo Hu, et al. 2022. “CRISPR/Cas9 Screens Reveal That Hexokinase 2 Enhances Cancer Stemness and Tumorigenicity by Activating the ACSL4-fatty Acid β-oxidation Pathway.” Advanced Science 9: 2105126. https://doi.org/10.1002/advs.202105126

[680] Stäubert, Claudia, Hasanuzzaman Bhuiyan, Anna Lindahl, Oliver Jay Broom, Yafeng Zhu, Saiful Islam, Sten Linnarsson, Janne Lehtiö, and Anders Nordström. 2015. “Rewired Metabolism in Drug-Resistant Leukemia Cells.” Journal of Biological Chemistry 290: 8348–59. https://doi.org/10.1074/jbc.M114.618769

[681] Li, Minle, Ying Lu, Yakui Li, Lingfeng Tong, Xiao-Chuan Gu, Jian Meng, Yemin Zhu, et al. 2019. “Transketolase Deficiency Protects the Liver from DNA Damage by Increasing Levels of Ribose 5-phosphate and Nucleotides.” Cancer Research 79: 3689–701. https://doi.org/10.1158/0008-5472.CAN-18-3776

[682] Szigeti, Krisztina A., Alexandra Kalmár, Orsolya Galamb, Gábor Valcz, Barbara K. Barták, Zsófia B Nagy, Sára Zsigrai, et al. 2022. “Global DNA Hypomethylation of Colorectal Tumours Detected in Tissue and Liquid Biopsies May Be Related to Decreased Methyl-Donor Content.” BMC Cancer 22: 605. https://doi.org/10.1186/s12885-022-09659-1

[683] Elmer, Dominik P., Georg Stockmaier, Sandra Grund-Gröschke, Victoria Strobl, Hieu-Hoa Dang, Markus Wiederstein, David Licha, et al. 2025. “Cooperative Hedgehog/GLI and JAK/STAT Signaling Drives Immunosuppressive Tryptophan/Kynurenine Metabolism via Synergistic Induction of IDO1 in Skin Cancer.” Cell Communication and Signaling 23: 91. https://doi.org/10.1186/s12964-025-02101-6

[684] Leopizzi, Martina, Lucia Mundo, Elena Messina, Federica Campolo, Stefano Lazzi, Antonio Angeloni, Cinzia Marchese, et al. 2024. “Epstein-Barr Virus–Encoded EBNA2 Downregulates ICOSL by Inducing miR-24 in B-Cell Lymphoma.” Blood 143: 429–43. https://doi.org/10.1182/blood.2023021346

[685] Napoletani, Giorgia, Samantha S. Soldan, Toshitha Kannan, Sarah Preston-Alp, Peter Vogel, Davide Maestri, Lisa Beatrice Caruso, et al. 2023. “PARP1 Inhibition Halts EBV+ Lymphoma Progression by Disrupting the EBNA2/MYC Axis.” bioRxiv 2023.07.05.547847. https://doi.org/10.1101/2023.07.05.547847

[686] Xu, Huanzhou, Tarun E. Hutchinson, Siva Koganti, Beth A. Rousseau, Daniel Xia, Michael T. McIntosh, and Sumita Bhaduri-McIntosh. 2025. “Leveraging the Interconnected Unfolded Protein Response and NLRP3 Inflammasome Pathways to Reactivate Epstein–Barr Virus in Diffuse Large B-Cell Lymphomas.” NAR Cancer 7: zcaf017. https://doi.org/10.1093/narcan/zcaf017

[687] Shi, Feng, Ya He, Jiangjiang Li, Min Tang, Yueshuo Li, Longlong Xie, Lin Zhao, et al. 2020. “Wild-Type IDH2 Contributes to Epstein–Barr Virus-Dependent Metabolic Alterations and Tumorigenesis.” Molecular Metabolism 36: 100966. https://doi.org/10.1016/j.molmet.2020.02.009

[688] Shi, Feng, Min Zhou, Li Shang, Qianqian Du, Yueshuo Li, Longlong Xie, Xiaolan Liu, et al. 2019. “EBV (LMP1)-induced Metabolic Reprogramming Inhibits Necroptosis Through the Hypermethylation of the RIP3 Promoter.” Theranostics 9: 2424–38. https://doi.org/10.7150/thno.30941

[689] Maddocks, Oliver D. K., Christiaan F. Labuschagne, Peter D. Adams, and Karen H. Vousden. 2016. “Serine Metabolism Supports the Methionine Cycle and DNA/RNA Methylation Through De Novo ATP Synthesis in Cancer Cells.” Molecular Cell 61: 210–21. https://doi.org/10.1016/j.molcel.2015.12.014

[690] Wong, Chi Chun, Wei Kang, Jiaying Xu, Yun Qian, Simson Tsz Yat Luk, Huarong Chen, Weilin Li, et al. 2019. “Prostaglandin E2 Induces DNA Hypermethylation in Gastric Cancer In Vitro and In Vivo.” Theranostics 9: 6256–68. https://doi.org/10.7150/thno.35766

[691] Xiao, Mengtao, Hui Yang, Wei Xu, Shenghong Ma, Huaipeng Lin, Honguang Zhu, Lixia Liu, et al. 2012. “Inhibition of α-KG-dependent Histone and DNA Demethylases by Fumarate and Succinate That Are Accumulated in Mutations of FH and SDH Tumor Suppressors.” Genes & Development 26: 1326–38. https://doi.org/10.1101/gad.191056.112

[692] Cervera, Ana M., Jean-Pierre Bayley, Peter Devilee, and Kenneth J. McCreath. 2009. “Inhibition of Succinate Dehydrogenase Dysregulates Histone Modification in Mammalian Cells.” Molecular Cancer 8: 89. https://doi.org/10.1186/1476-4598-8-89

[693] Tamari, Keisuke, Masamitsu Konno, Ayumu Asai, Jun Koseki, Kazuhiko Hayashi, Koichi Kawamoto, Noriyuki Murai, et al. 2018. “Polyamine Flux Suppresses Histone Lysine Demethylases and Enhances ID1 Expression in Cancer Stem Cells.” Cell Death Discovery 4: 104. https://doi.org/10.1038/s41420-018-0117-7

[694] Wang, Chen, Meng-chu Li, Wen-ge Huang, Si-yu Huang, Maierhaba Wusiman, Zhao-yan Liu, and Hui-lian Zhu. 2025. “Betaine Inhibits the Stem Cell-Like Properties of Hepatocellular Carcinoma by Activating Autophagy via SAM/m6A/YTHDF1-mediated Enhancement on ATG3 Stability.” Theranostics 15: 1949–65. https://doi.org/10.7150/thno.102682

[695] Fang, Heng, Miaoxian Fang, Yirong Wang, Huidan Zhang, Jiaxin Li, Jingchun Chen, Qingrui Wu, et al. 2022. “Indole-3-propionic Acid as a Potential Therapeutic Agent for Sepsis-Induced Gut Microbiota Disturbance.” Microbiology Spectrum 10: e00125–22. https://doi.org/10.1128/spectrum.00125-22

[696] Antropova, E. A., T. M. Khlebodarova, P. S. Demenkov, A. S. Venzel, N. V. Ivanisenko, A. D. Gavrilenko, T. V. Ivanisenko, et al. 2022. “Computer Analysis of Regulation of Hepatocarcinoma Marker Genes Hypermethylated by HCV Proteins.” Breeding 26: 733–42. https://doi.org/10.18699/VJGB-22-89

[697] Hlady, Ryan A., Xia Zhao, Louis Y. El Khoury, Aesis Luna, Kien Pham, Qunfeng Wu, Jeong-Heon Lee, et al. 2022. “Interferon Drives HCV Scarring of the Epigenome and Creates Targetable Vulnerabilities Following Viral Clearance.” Hepatology 75: 983–96. https://doi.org/10.1002/hep.32111

[698] García-Crespo, Carlos, Irene Francisco-Recuero, Isabel Gallego, Marina Camblor-Murube, María Eugenia Soria, Ana López-López, Ana Isabel de Ávila, et al. 2023. “Hepatitis C Virus Fitness Can Influence the Extent of Infection-Mediated Epigenetic Modifications in the Host Cells.” Frontiers in Cellular and Infection Microbiology 13: 1057082. https://doi.org/10.3389/fcimb.2023.1057082

[699] Devi, Priya, Katarina Engdahl, Tanel Punga, and Anders Bergqvist. 2022. “Next-Generation Sequencing Analysis of CpG Methylation of a Tumor Suppressor Gene SHP-1 Promoter in Stable Cell Lines and HCV-Positive Patients.” Viruses 14: 2352. https://doi.org/10.3390/v14112352

[700] Kase, Koji, Motonobu Saito, Shotaro Nakajima, Daisuke Takayanagi, Katsuharu Saito, Leo Yamada, Mai Ashizawa, et al. 2021. “ARID1A Deficiency in EBV-positive Gastric Cancer Is Partially Regulated by EBV-encoded miRNAs, but Not by DNA Promotor Hypermethylation.” Carcinogenesis 42: 21–30. https://doi.org/10.1093/carcin/bgaa123

[701] Cho, Miyeon, Hyeji Byun, Sun Hee Lee, Sohyun Youn, Inuk Jung, Joohee Jung, Junho Lee, Hyosun Cho, and Hyojeung Kang. 2025. “Dihydrotestosterone-Androgen Receptor Signaling Suppresses EBV-positive Gastric Cancer Through DNA Demethylation-Mediated Viral Reactivation.” Gastric Cancer 28: 776–98. https://doi.org/10.1007/s10120-025-01626-6

[702] Zhu, Mansheng, Qixiang Liang, Tao Chen, Qian Kong, Gengtai Ye, Shitong Yu, Xunjun Li, et al. 2021. “Identification and Validation of Methylated Differentially Expressed miRNAs and Immune Infiltrate Profile in EBV-associated Gastric Cancer.” Clinical Epigenetics 13: 22. https://doi.org/10.1186/s13148-020-00989-0

[703] Mazzoccoli, Luciano, Marcela Cristina Robaina, Carlos E. Bacchi, Sheila Coelho Soares Lima, and Claudete Esteves Klumb. 2019. “miR-29 Promoter and Enhancer Methylation Identified by Pyrosequencing in Burkitt Lymhoma Cells: Interplay Between MYC and miR-29 Regulation.” Oncology Reports 42: 775–84. https://doi.org/10.3892/or.2019.7183

[704] Sanaei, Masumeh, Fraidoon Kavoosi, and Iraj Poursadgh Soufiani. 2022. “Effect of Sodium Butyrate and Epigallocatechin-3-Gallate on the Genes Expression of Intrinsic Apoptotic Pathway on PA-TU-8902, CFPAC-1, and CAPAN-1 Human Pancreatic Cancer Cell Lines: Epi-Drugs and Intrinsic Apoptotic Pathway in Pancreatic Cancer.” Galen Medical Journal 11: e2248. https://doi.org/10.31661/gmj.v11i.2248

[705] Kim, Kiyoon, Young-seok Lee, Suyun Jeong, Daehong Kim, Suk Chon, Youngmi Kim Pak, Sungsoo Kim, et al. 2020. “A Small Molecule, 4-phenylbutyric Acid, Suppresses HCV Replication via Epigenetically Induced Hepatic Hepcidin.” International Journal of Molecular Sciences 21: 5516. https://doi.org/10.3390/ijms21155516

[706] Liu, Nian, Jianglin Zhang, Mingjie Yan, Lihui Chen, Jie Wu, Qian Tao, Bei Yan, et al. 2023. “Supplementation With α-ketoglutarate Improved the Efficacy of anti-PD1 Melanoma Treatment Through Epigenetic Modulation of PD-L1.” Cell Death & Disease 14: 170. https://doi.org/10.1038/s41419-023-05692-5

[707] Stewart, Tracy Murray, Jackson R. Foley, Cassandra E. Holbert, Glynis Klinke, Gernot Poschet, Raphael R. Steimbach, Aubry K. Miller, and Robert A. Casero. 2022. “Histone deacetylase-10 Liberates Spermidine to Support Polyamine Homeostasis and Tumor Cell Growth.” Journal of Biological Chemistry 298: 102407. https://doi.org/10.1016/j.jbc.2022.102407

[708] Chen, Jiayi, Guangqin Liu, Xinzheng Wang, Hao Hong, Tingting Li, Lin Li, Hongxiang Wang, et al. 2022. “Glioblastoma Stem Cell-Specific Histamine Secretion Drives Pro-Angiogenic Tumor Microenvironment Remodeling.” Cell Stem Cell 29: 1531–46.e7. https://doi.org/10.1016/j.stem.2022.09.009

[709] Zhu, Yinghua, Ziwei Zhou, Xin Du, Xiaorong Lin, Zhi-Mei Liang, Si Chen, Yiwei Sun, et al. 2025. “Cancer Cell-Derived Arginine Fuels Polyamine Biosynthesis in Tumor-Associated Macrophages to Promote Immune Evasion.” Cancer Cell 43: 1045–60.e7. https://doi.org/10.1016/j.ccell.2025.03.015

[710] Sakamoto, Akihiko, Yusuke Terui, Takeshi Uemura, Kazuei Igarashi, and Keiko Kashiwagi. 2020. “Polyamines Regulate Gene Expression by Stimulating Translation of Histone Acetyltransferase mRNAs.” Journal of Biological Chemistry 295: 8736–45. https://doi.org/10.1074/jbc.RA120.013833

[711] Xu, Rong, QuanQiu Wang, and Li Li. 2015. “A Genome-Wide Systems Analysis Reveals Strong Link Between Colorectal Cancer and Trimethylamine N-Oxide (TMAO), a Gut Microbial Metabolite of Dietary Meat and Fat.” BMC Genomics 16: S4. https://doi.org/10.1186/1471-2164-16-S7-S4

[712] Li, Qiaqia, Kilia Y. Liu, Qipeng Liu, Guangyu Wang, Weihua Jiang, Qingshu Meng, Yang Yi, et al. 2020. “Antihistamine Drug Ebastine Inhibits Cancer Growth by Targeting Polycomb Group Protein EZH2.” Molecular Cancer Therapeutics 19: 2023–33. https://doi.org/10.1158/1535-7163.MCT-20-0250

[713] Wei, Chen, Kun Liao, Hao-jie Chen, Zi-xuan Xiao, Qi Meng, Ze-kun Liu, Yun-xin Lu, et al. 2025. “Nuclear Mitochondrial acetyl-CoA Acetyltransferase 1 Orchestrates Natural Killer Cell-Dependent Antitumor Immunity in Colorectal Cancer.” Signal Transduction and Targeted Therapy 10: 138. https://doi.org/10.1038/s41392-025-02221-y

[714] Xia, Jin-kun, Ning Tang, Xing-yu Wu, and Hao-zhen Ren. 2022. “Deregulated Bile Acids May Drive Hepatocellular Carcinoma Metastasis by Inducing an Immunosuppressive Microenvironment.” Frontiers in Oncology 12: 1033145. https://doi.org/10.3389/fonc.2022.1033145

[715] Sreekanth, Vedagopuram, Animesh Kar, Sandeep Kumar, Sanjay Pal, Poonam Yadav, Yamini Sharma, Varsha Komalla, et al. 2021. “Bile Acid Tethered Docetaxel-Based Nanomicelles Mitigate Tumor Progression Through Epigenetic Changes.” Angewandte Chemie International Edition 60: 5394–9. https://doi.org/10.1002/anie.202015173

[716] Xiong, Chen, Hong Ling, Yingdan Huang, Hanzhi Dong, Bangxiang Xie, Qian Hao, and Xiang Zhou. 2025. “AZD1775 Synergizes With SLC7A11 Inhibition to Promote Ferroptosis.” Science China Life Sciences 68: 204–18. https://doi.org/10.1007/s11427-023-2589-1

[717] Pappalardi, Melissa B., Kathryn Keenan, Mark Cockerill, Wendy A. Kellner, Alexandra Stowell, Christian Sherk, Kristen Wong, et al. 2021. “Discovery of a First-in-Class Reversible DNMT1-Selective Inhibitor With Improved Tolerability and Efficacy in Acute Myeloid Leukemia.” Nature Cancer 2: 1002–17. https://doi.org/10.1038/s43018-021-00249-x

[718] Sanaei, Masumeh, and Fraidoon Kavoosi. 2021. “Effect of Zebularine in Comparison to Trichostatin A on the Intrinsic and Extrinsic Apoptotic Pathway, Cell Viability, and Apoptosis in Hepatocellular Carcinoma SK-hep 1, Human Colorectal Cancer SW620, and Human Pancreatic Cancer PaCa-44 Cell Lines.” Iranian Journal of Pharmaceutical Research 20: 310–23. https://doi.org/10.22037/ijpr.2021.115097.15196

[719] Erfani, Mehran, Mozhdeh Zamani, Gholamhossein Tamaddon, Seyed Vahid Hosseini, and Pooneh Mokarram. 2022. “Expression and Methylation Status of BTG2, PPP1CA, and PEG3 Genes in Colon Adenocarcinoma Cell Lines: Promising Treatment Targets.” Gastroenterology and Hepatology from Bed to Bench 15: 395–405. https://doi.org/10.22037/ghfbb.v15i4.2577

[720] Yin, Yan-ping, Li-ying Ma, Guo-zhen Cao, Jing-han Hua, Xiao-tong Lv, and Wen-chu Lin. 2022. “FK228 Potentiates Topotecan Activity Against Small Cell Lung Cancer Cells via Induction of SLFN11.” Acta Pharmacologica Sinica 43: 2119–27. https://doi.org/10.1038/s41401-021-00817-y

[721] Rahnasto-Rilla, Minna, Jonna Tyni, Marjo Huovinen, Elina Jarho, Tomasz Kulikowicz, Sarangan Ravichandran, Vilhelm A. Bohr, et al. 2018. “Natural Polyphenols as Sirtuin 6 Modulators.” Scientific Reports 8: 4163. https://doi.org/10.1038/s41598-018-22388-5

[722] You, Weijie, Wei Zheng, Sandra Weiss, Katrin F. Chua, and Clemens Steegborn. 2019. “Structural Basis for the Activation and Inhibition of Sirtuin 6 by Quercetin and Its Derivatives.” Scientific Reports 9: 19176. https://doi.org/10.1038/s41598-019-55654-1

[723] Fiorentino, Francesco, Antonello Mai, and Dante Rotili. 2021. “Emerging Therapeutic Potential of SIRT6 Modulators.” Journal of Medicinal Chemistry 64: 9732–58. https://doi.org/10.1021/acs.jmedchem.1c00601

[724] Sahu, Ram Krishna, Simran Tandon, Shalini Singh, Bhudev Chandra Das, and Suresh T. Hedau. 2024. “Methyl CpG Binding Protein MBD2 Has a Regulatory Role on the BRCA1 Gene Expression and Its Modulation by Resveratrol in ER+, PR+ & Triple-Negative Breast Cancer Cells.” BMC Cancer 24: 566. https://doi.org/10.1186/s12885-024-12274-x

[725] Sakamoto, Takako, Keiji Tanimoto, Hidetaka Eguchi, Shunta Sasaki, Kouki Tsuboi, Shin-ichi Hayashi, and Sahoko Ichihara. 2023. "Resveratrol Exhibits Diverse Anti-Cancer Activities Through Epigenetic Regulation of E-cadherin and p21 in Triple-Negative Breast Cancer Cells." Breast Cancer 30: 727–38. https://doi.org/10.1007/s12282-023-01465-2

[726] Kansal, Vikash, Anshu Agarwal, Angela Harbour, Humaira Farooqi, Vijay Kumar Singh, and Ram Prasad. 2022. “Regular Intake of Green Tea Polyphenols Suppresses the Development of Nonmelanoma Skin Cancer Through miR-29-Mediated Epigenetic Modifications.” Journal of Clinical Medicine 11: 398. https://doi.org/10.3390/jcm11020398

[727] Alsadi, Nawal, Nour Yahfoufi, Carolyn Nessim, and Chantal Matar. 2024. “Role of a Polyphenol-Enriched Blueberry Preparation on Inhibition of Melanoma Cancer Stem Cells and Modulation of MicroRNAs.” Biomedicines 12: 193. https://doi.org/10.3390/biomedicines12010193

[728] Kurzava Kendall, Lucinda, Yuexi Ma, Tony Yang, Katarzyna Lubecka, and Barbara Stefanska. 2024. “Epigenetic Effects of Resveratrol on Oncogenic Signaling in Breast Cancer.” Nutrients 16: 699. https://doi.org/10.3390/nu16050699

[729] Yamada, Shoji, Yoko Takashina, Mitsuhiro Watanabe, Ryogo Nagamine, Yoshimasa Saito, Nobuhiko Kamada, and Hidetsugu Saito. 2018. “Bile Acid Metabolism Regulated by the Gut Microbiota Promotes Non-Alcoholic Steatohepatitis-Associated Hepatocellular Carcinoma in Mice.” Oncotarget 9: 9925–39. https://doi.org/10.18632/oncotarget.24066

[730] Lund, Peder J., Leah A. Gates, Marylene Leboeuf, Sarah A. Smith, Lillian Chau, Mariana Lopes, Elliot S. Friedman, et al. 2022. “Stable Isotope Tracing in Vivo Reveals a Metabolic Bridge Linking the Microbiota to Host Histone Acetylation.” Cell Reports 41: 111809. https://doi.org/10.1016/j.celrep.2022.111809

[731] Shen, Rui, Lixin Ke, Qiao Li, Xi Dang, Shunli Shen, Jianming Shen, Shaoqiang Li, et al. 2022. “Abnormal Bile Acid-Microbiota Crosstalk Promotes the Development of Hepatocellular Carcinoma.” Hepatology International 16: 396–411. https://doi.org/10.1007/s12072-022-10299-7

[732] Seymour, Brenda J., Brandon Trent, Brendan E. Allen, Adam J. Berlinberg, Jimmy Tangchittsumran, Widian K. Jubair, Meagan E. Chriswell, et al. 2024. “Microbiota-Dependent Indole Production Stimulates the Development of Collagen-Induced Arthritis in Mice.” Journal of Clinical Investigation 134: e167671. https://doi.org/10.1172/JCI167671

[733] Yu, Ya-Li, Meng Chen, Hua Zhu, Ming-Xing Zhuo, Ping Chen, Yu-Juan Mao, Lian-Yun Li, et al. 2021. “STAT1 Epigenetically Regulates LCP2 and TNFAIP2 by Recruiting EP300 to Contribute to the Pathogenesis of Inflammatory Bowel Disease.” Clinical Epigenetics 13: 127. https://doi.org/10.1186/s13148-021-01101-w

[734] Zhu, Xinhai, Ke Li, Guichao Liu, Ruan Wu, Yan Zhang, Siying Wang, and Meng Xu, et al. 2023. "Microbial Metabolite Butyrate Promotes Anti-PD-1 Antitumor Efficacy by Modulating T cell Receptor Signaling of Cytotoxic CD8 T Cell." Gut Microbes 15: 2249143. https://doi.org/10.1080/19490976.2023.2249143

[735] Wang, Rui, Bo Li, Bingyuan Huang, Yikang Li, Qiaoyan Liu, Zhuwan Lyu, and Ruiling Chen, et al. 2024. "Gut Microbiota-Derived Butyrate Induces Epigenetic and Metabolic Reprogramming in Myeloid-Derived Suppressor Cells to Alleviate Primary Biliary Cholangitis." Gastroenterology 167: 733–49. https://doi.org/10.1053/j.gastro.2024.05.014

[736] An, Yong Jin, Sihyang Jo, Jin-Mo Kim, Han Sun Kim, Hyun Young Kim, Sang-Min Jeon, Dawool Han, et al. 2023. “Lactateva Major Epigenetic Carbon Source for Histone Acetylation via Nuclear LDH Metabolism.” Experimental & Molecular Medicine 55: 2238–47. https://doi.org/10.1038/s12276-023-01095-w

[737] Gan, Weiqiang, Yanhong Kang, Yingjie Wu, Jianyun Zhu, Youming Chen, Jianyu Kuang, Jianguo Li, and Lin Yang. 2023. “Hepatitis B Virus X Protein Induces p16 Gene Promoter Methylation Through Upregulation of DNA Methylation Transferases DNMT1 and DNMT3A.” Advances in Clinical and Experimental Medicine 32: 583–92. https://doi.org/10.17219/acem/156644

[738] Mo, Hai-Ying, Qi-Yao Wei, Qiu-Hua Zhong, Xiao-Yun Zhao, Dan Guo, Jin Han, Wachiraporn Noracharttiyapot, et al. 2022. “Cytochrome P450 27C1 Level Dictates Lung Cancer Tumorigenicity and Sensitivity Towards Multiple Anticancer Agents and Its Potential Interplay With the IGF-1R/Akt/p53 Signaling Pathway.” International Journal of Molecular Sciences 23: 7853. https://doi.org/10.3390/ijms23147853

[739] Rong, Yefei, Wenchuan Wu, Xiaoling Ni, Tiantao Kuang, Dayong Jin, Dansong Wang, and Wenhui Lou. 2013. “Lactate Dehydrogenase A Is Overexpressed in Pancreatic Cancer and Promotes the Growth of Pancreatic Cancer Cells.” Tumor Biology 34: 1523–30. https://doi.org/10.1007/s13277-013-0679-1

[740] Patra, Krushna C., Qi Wang, Prashanth T. Bhaskar, Luke Miller, Zebin Wang, Will Wheaton, Navdeep Chandel, et al. 2013. “Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer.” Cancer Cell 24: 213–28. https://doi.org/10.1016/j.ccr.2013.06.014

[741] Liu, Hao, Xintian Chen, Pengfei Wang, Miaolei Chen, Chuyin Deng, Xingyou Qian, Jin Bai, et al. 2024. “PRMT1-mediated PGK1 Arginine Methylation Promotes Colorectal Cancer Glycolysis and Tumorigenesis.” Cell Death & Disease 15: 170. https://doi.org/10.1038/s41419-024-06544-6

[742] Wu, Weidong, Fengqiang Yu, Nanding Yu, Yong Zhu, Weihan Wu, Pengqiang Gao, and Chun Chen. 2022. “Glucose-6-phosphate Dehydrogenase Promotes the Proliferation and Migration of Lung Adenocarcinoma Cells via the STAT3 Signaling Pathway.” Journal of Molecular Histology 53: 215–25. https://doi.org/10.1007/s10735-021-10045-7

[743] Zhao, Haiting, Li Meng, Peng Du, Xinbin Liao, Xin Mo, Mengqi Gong, Jiaxin Chen, and Yiwei Liao. 2024. “IDH1 Mutation Produces R-2-hydroxyglutarate (R-2HG) and Induces mir-182-5p Expression to Regulate Cell Cycle and Tumor Formation in Glioma.” Biological Research 57: 30. https://doi.org/10.1186/s40659-024-00512-2

[744] Zaidi, Nousheen, Ines Royaux, Johannes V. Swinnen, and Karine Smans. 2012. “ATP Citrate Lyase Knockdown Induces Growth Arrest and Apoptosis Through Different Cell- and Environment-Dependent Mechanisms.” Molecular Cancer Therapeutics 11: 1925–35. https://doi.org/10.1158/1535-7163.MCT-12-0095

[745] Sun, Liang, Yizhou Yao, Guofeng Pan, Shenghua Zhan, Weiqiang Shi, Ting Lu, Jinfeng Yuan, et al. 2018. “Small Interfering RNA-mediated Knockdown of Fatty Acid Synthase Attenuates the Proliferation and Metastasis of Human Gastric Cancer Cells via the mTOR/Gli1 Signaling Pathway.” Oncology Letters 16: 594–602. https://doi.org/10.3892/ol.2018.8648

[746] Xi, Jianbo, Yaocheng Sun, Meiting Zhang, Zhenzhong Fa, Yanya Wan, Zhenyu Min, Hong Xu, Chengkai Xu, and Jianjun Tang. 2019. “GLS1 Promotes Proliferation in Hepatocellular Carcinoma Cells via AKT/GSK3β/CyclinD1 Pathway.” Experimental Cell Research 381: 1–9. https://doi.org/10.1016/j.yexcr.2019.04.005

[747] Sun, Liang, Ting Lu, Linhua Jiang, Huihui Yao, Qixuan Xu, Jie Sun, Xiaoqin Yang, Songbing He, and Xinguo Zhu. 2024. “ALDOA Contributes to Colorectal Tumorigenesis and Metastasis by Targeting YAP.” Cell Death Discovery 10: 489. https://doi.org/10.1038/s41420-024-02249-z

[748] Han, Jing, Menglin Nie, Cong Chen, Xiaojing Cheng, Ting Guo, Longtao Huangfu, Xiaomei Li, et al. 2022. “SDCBP-AS1 Destabilizes β-catenin by Regulating Ubiquitination and SUMOylation of hnRNP K to Suppress Gastric Tumorigenicity and Metastasis.” Cancer Communications 42: 1141–61. https://doi.org/10.1002/cac2.12367

[749] Schug, Zachary T., Barrie Peck, Dylan T. Jones, Qifeng Zhang, Shaun Grosskurth, Israt S. Alam, Louise M. Goodwin, et al. 2015. “Acetyl-CoA Synthetase 2 Promotes Acetate Utilization and Maintains Cancer Cell Growth Under Metabolic Stress.” Cancer Cell 27: 57–71. https://doi.org/10.1016/j.ccell.2014.12.002

[750] Sullivan, Mark R., Katherine R. Mattaini, Emily A. Dennstedt, Anna A. Nguyen, Sharanya Sivanand, Montana F. Reilly, Katrina Meeth, et al. 2019. “Increased Serine Synthesis Provides an Advantage for Tumors Arising in Tissues Where Serine Levels Are Limiting.” Cell Metabolism 29: 1410–21. https://doi.org/10.1016/j.cmet.2019.02.015

[751] Huang, Jun, Xing-Xing Fan, Jiaxi He, Hui Pan, Run-Ze Li, Liyan Huang, Zebo Jiang, et al. 2016. “SCD1 Is Associated With Tumor Promotion, Late Stage and Poor Survival in Lung Adenocarcinoma.” Oncotarget 7: 39970–9. https://doi.org/10.18632/oncotarget.9461

[752] Qiao, Gan, Anguo Wu, Xiaoliang Chen, Ye Tian, and Xiukun Lin. 2021. “Enolase 1, a Moonlighting Protein, as a Potential Target for Cancer Treatment.” International Journal of Biological Sciences 17: 3981–92. https://doi.org/10.7150/ijbs.63556

[753] Qiao, Rui, Mengmeng Wei, Hui Chen, Xianhong Zhang, Jie Zhang, Liyang Gao, Haijun Ma, Yujiong Wang, and Le Li. 2023. “Critical Role of 6-Phosphogluconate Dehydrogenase in TAp73-Mediated Cancer Cell Proliferation.” Molecular Cancer Research 21: 825–35. https://doi.org/10.1158/1541-7786.MCR-22-0814

[754] Cai, Zhiduan, Yulin Deng, Jianheng Ye, Yangjia Zhuo, Zezhen Liu, Yingke Liang, Hui Zhang, et al. 2020. “Aberrant Expression of Citrate Synthase Is Linked to Disease Progression and Clinical Outcome in Prostate Cancer.” Cancer Management and Research 12: 6149–63. https://doi.org/10.2147/CMAR.S255817

[755] Ye, Jiali, Xing Huang, Shuo Tian, Jichen Wang, Hanfeng Wang, Huayi Feng, Xupeng Zhao, et al. 2024. “Upregulation of Serine Metabolism Enzyme PSAT1 Predicts Poor Prognosis and Promotes Proliferation, Metastasis and Drug Resistance of Clear Cell Renal Cell Carcinoma.” Experimental Cell Research 437: 113977. https://doi.org/10.1016/j.yexcr.2024.113977

[756] Yang, Xin, Zhe Wang, Xin Li, Boya Liu, Minghui Liu, Lu Liu, Shuaiyi Chen, et al. 2018. “SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation.” Cancer Research 78: 372–86. https://doi.org/10.1158/0008-5472.CAN-17-1912

[757] Tönjes, Martje, Sebastian Barbus, Yoon Jung Park, Wei Wang, Magdalena Schlotter, Anders M. Lindroth, Sabrina V. Pleier, et al. 2013. “BCAT1 Promotes Cell Proliferation Through Amino Acid Catabolism in Gliomas Carrying Wild-Type IDH1.” Nature Medicine 19: 901–8. https://doi.org/10.1038/nm.3217

[758] Ye, Chenyang, Lina Qi, Xiaofen Li, Ji Wang, Jiekai Yu, Biting Zhou, Cheng Guo, et al. 2020. “Targeting the NAD⁺ Salvage Pathway Suppresses APC Mutation-Driven Colorectal Cancer Growth and Wnt/β-catenin Signaling via Increasing Axin Level.” Cell Communication and Signaling 18: 16. https://doi.org/10.1186/s12964-020-0513-5

[759] Zarean, Elaheh, Shuai Li, Melissa C. Southey, and Pierre-Antoine Dugué. 2025. “A Review of the Use of Tumour DNA Methylation for Breast Cancer Subtyping and Prediction of Outcomes.” Clinical Epigenetics 17: 109. https://doi.org/10.1186/s13148-025-01922-z

[760] Muse, Meghan E., Alexander J. Titus, Lucas A. Salas, Owen M. Wilkins, Chelsey Mullen, Kelly J. Gregory, Sallie S. Schneider, et al. 2020. “Enrichment of CpG Island Shore Region Hypermethylation in Epigenetic Breast Field Cancerization.” Epigenetics 15: 1093–106. https://doi.org/10.1080/15592294.2020.1747748

[761] Muse, Meghan E., Connolly D. Carroll, Lucas A. Salas, Margaret R. Karagas, and Brock C. Christensen. 2023. “Application of Novel Breast Biospecimen Cell-Type Adjustment Identifies Shared DNA Methylation Alterations in Breast Tissue and Milk With Breast Cancer–Risk Factors.” Cancer Epidemiology, Biomarkers & Prevention 32: 550–60. https://doi.org/10.1158/1055-9965.EPI-22-0405

[762] Fujiyama, Yoshiki, Yusuke Kumamoto, Nobuyuki Nishizawa, Shuji Nakamoto, Hiroki Harada, Kazuko Yokota, Yoko Tanaka, et al. 2020. “Promoter DNA Hypermethylation of the Cysteine Dioxygenase 1 (CDO1) Gene in Intraductal Papillary Mucinous Neoplasm (IPMN).” Annals of Surgical Oncology 27: 4007–16. https://doi.org/10.1245/s10434-020-08291-2

[763] Tian, Yao, Zhao-Hui Chen, Peng Wu, Di Zhang, Yue Ma, Xiao-Feng Liu, Xin Wang, et al. 2023. “MIR497HG-derived miR-195 and miR-497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in Breast Cancer.” Advanced Science 10: 2204819. https://doi.org/10.1002/advs.202204819

[764] Xiao, Xi, Mengke Chen, Ye Sang, Junyu Xue, Ke Jiang, Yulu Chen, Luyao Zhang, et al. 2023. “Methylation-Mediated Silencing of ATF3 Promotes Thyroid Cancer Progression by Regulating Prognostic Genes in the MAPK and PI3K/AKT Pathways.” Thyroid 33: 1441–54. https://doi.org/10.1089/thy.2023.0157

[765] Zhang, Peng, Yi Wan, Jinrong Ma, Jin Gong, Ziwei Zhong, Yuxin Cui, Hongli Zhang, et al. 2024. “Epigenetic Silencing of LDHB Promotes Hepatocellular Carcinoma by Remodeling the Tumor Microenvironment.” Cancer Immunology, Immunotherapy 73: 127. https://doi.org/10.1007/s00262-024-03717-2

[766] Luk, Steve T., Kai-Yu Ng, Lei Zhou, Man Tong, Tin-Lok Wong, Huajian Yu, Chung-Mau Lo, et al. 2020. “Deficiency in Embryonic Stem Cell Marker Reduced Expression 1 Activates Mitogen-Activated Protein Kinase Kinase 6–Dependent p38 Mitogen-Activated Protein Kinase Signaling to Drive Hepatocarcinogenesis.” Hepatology 72: 183–97. https://doi.org/10.1002/hep.31020

[767] Lin, Zhuoying, Wenjie Huang, Qin He, Dongxiao Li, Zhihui Wang, Yangyang Feng, Danfei Liu, et al. 2021. “FOXC1 Promotes HCC Proliferation and Metastasis by Upregulating DNMT3B to Induce DNA Hypermethylation of CTH Promoter.” Journal of Experimental & Clinical Cancer Research 40: 1–20. https://doi.org/10.1186/s13046-021-01829-6

[768] Panwalkar, Pooja, Benita Tamrazi, Derek Dang, Chan Chung, Stefan Sweha, Siva Kumar Natarajan, Matthew Pun, et al. 2021. “Targeting Integrated Epigenetic and Metabolic Pathways in Lethal Childhood PFA Ependymomas.” Science Translational Medicine 13: eabc0497. https://doi.org/10.1126/scitranslmed.abc0497

[769] Lu, Jingxin, Xia Li, Kai Tu, Yuelin Guan, Kwok-Pui Fung, and Feiyan Liu. 2019. “Verticillin A Suppresses HGF-induced Migration and Invasion via Repression of the c-Met/FAK/Src Pathway in Human Gastric and Cervical Cancer Cells.” OncoTargets and Therapy 12: 5823–33. https://doi.org/10.2147/OTT.S208683

[770] Mo, Yaqi, Yamei Han, Yang Chen, Chunling Fu, Qing Li, Zhuang Liu, Mingming Xiao, and Bo Xu. 2024. “ZDHHC20 Mediated S-Palmitoylation of Fatty Acid Synthase (FASN) Promotes Hepatocarcinogenesis.” Molecular Cancer 23: 274. https://doi.org/10.1186/s12943-024-02195-5

[771] Liu, Xiaoyu, Zhi Li, Zhongmin Wang, Fei Liu, Linling Zhang, Jingjing Ke, Xu Xu, et al. 2022. “Chromatin Remodeling Induced by ARID1A Loss in Lung Cancer Promotes Glycolysis and Confers JQ1 Vulnerability.” Cancer Research 82: 791–804. https://doi.org/10.1158/0008-5472.CAN-21-0763

[772] Chen, Yananlan, Xiao Xu, Yirui Wang, Yaodong Zhang, Tao Zhou, Wangjie Jiang, Ziyi Wang, et al. 2023. “Hypoxia-Induced SKA3 Promoted Cholangiocarcinoma Progression and Chemoresistance by Enhancing Fatty Acid Synthesis via the Regulation of PAR-dependent HIF-1a Deubiquitylation.” Journal of Experimental & Clinical Cancer Research 42: 265. https://doi.org/10.1186/s13046-023-02842-7

[773] Zheng, Zhi, Yuxi Shang, Rui Xu, Xiaosheng Yan, Xi Wang, Jun Cai, Zhigang Bai, et al. 2022. “Ubiquitin Specific Peptidase 38 Promotes the Progression of Gastric Cancer Through Upregulation of Fatty Acid Synthase.” American Journal of Cancer Research 12: 2686.

[774] Johari, Nur Amanina, Nur Anisa Sapi'i, Alvin Lu Jiunn Hieng, Nurriza Ab Latif, Syazwani Itri Amran, Rosnani Hasham, and Khairunadwa Jemon. 2024. “In Vitro and in Silico Evaluation of Andrographis Paniculata Ethanolic Crude Extracts on 3 Fatty Acid Synthase Expression on Breast Cancer Cells.” BioMedicine 14: 60–7. https://doi.org/10.37796/2211-8039.1444

[775] Liang, Yan, Yue Ban, Lei Liu, and Yanchun Li. 2024. “Inhibitory Effects of the Polyphenols from the Root of Rhizophora Apiculata Blume on Fatty Acid Synthase Activity and Human Colon Cancer Cells.” Molecules 29: 1180. https://doi.org/10.3390/molecules29051180

[776] Zhao, Xupeng, Yingjie Li, and Yong Zhou. 2019. “MicroRNA-96-3p Promotes Metastasis of Papillary Thyroid Cancer Through Targeting SDHB.” Cancer Cell International 19: 287. https://doi.org/10.1186/s12935-019-1003-y

[777] Liu, Shaojun, Zhiming Xiao, Feiyan Ai, Fen Liu, Xiong Chen, Ke Cao, Weiguo Ren, et al. 2017. “miR-142-5p Promotes Development of Colorectal Cancer Through Targeting SDHB and Facilitating Generation of Aerobic Glycolysis.” Biomedicine & Pharmacotherapy 92: 1119–27. https://doi.org/10.1016/j.biopha.2018.01.031

[778] Bian, Zehua, Fan Yang, Peiwen Xu, Ge Gao, Chunyu Yang, Yulin Cao, Surui Yao, et al. 2024. “LINC01852 Inhibits the Tumorigenesis and Chemoresistance in Colorectal Cancer by Suppressing SRSF5-mediated Alternative Splicing of PKM.” Molecular Cancer 23: 23. https://doi.org/10.1186/s12943-024-01939-7

[779] Zhang, Zhenyu, Yina Gao, Yuanyuan Qian, Bowen Wei, Kexin Jiang, Zhiwei Sun, Feifan Zhang, et al. 2025. “The Lyn/RUVBL1 Complex Promotes Colorectal Cancer Liver Metastasis by Regulating Arachidonic Acid Metabolism Through Chromatin Remodeling.” Advanced Science 12: 2406562. https://doi.org/10.1002/advs.202406562

[780] Hui, Yongfeng, Junzhi Leng, Dong Jin, Genwang Wang, Kejun Liu, Yang Bu, and Qi Wang. 2024. “BRG1 Promotes Liver Cancer Cell Proliferation and Metastasis by Enhancing Mitochondrial Function and ATP5A1 Synthesis Through TOMM40.” Cancer Biology & Therapy 25: 2375440. https://doi.org/10.1080/15384047.2024.2375440

[781] Tsuda, Motoyuki, Akihisa Fukuda, Nilotpal Roy, Yukiko Hiramatsu, Laura Leonhardt, Nobuyuki Kakiuchi, Kaja Hoyer, et al. 2018. “The BRG1/SOX9 Axis Is Critical for Acinar Cell–Derived Pancreatic Tumorigenesis.” Journal of Clinical Investigation 128: 3475–89. https://doi.org/10.1172/JCI94287

[782] Khanna, Pooja, Rushabh Mehta, Gaurav A. Mehta, Vrushank Bhatt, Jessie Y. Guo, and Michael L. Gatza. 2023 SOX4-SMARCA4 Complex Promotes Glycolysis-Dependent TNBC Cell Growth Through Transcriptional Regulation of Hexokinase 2.” bioRxiv 2023.09.10.557071. https://doi.org/10.1101/2023.09.10.557071

[783] Nie, Hao, Haixing Ju, Jiayi Fan, Xiaoliu Shi, Yaxian Cheng, Xiaohui Cang, Zhiguo Zheng, Xiaotao Duan, and Wen Yi. 2020. “O-GlcNAcylation of PGK1 Coordinates Glycolysis and TCA Cycle to Promote Tumor Growth.” Nature Communications 11: 36. https://doi.org/10.1038/s41467-019-13601-8

[784] Li, Xinjian, Yuhui Jiang, Jill Meisenhelder, Weiwei Yang, David H. Hawke, Yanhua Zheng, Yan Xia, et al. 2016. “Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis.” Molecular Cell 61: 705–19. https://doi.org/10.1016/j.molcel.2016.02.009

[785] Xiang, Wei, Hongwei Lv, Fuxue Xing, Xiaoyan Sun, Yue Ma, Lu Wu, Guishuai Lv, et al. 2023. “Inhibition of ACLY Overcomes Cancer Immunotherapy Resistance via Polyunsaturated Fatty Acids Peroxidation and cGAS-STING Activation.” Science Advances 9: eadi2465. https://doi.org/10.1126/sciadv.adi2465

[786] Han, Jang Hee, Yong Keon Kim, Hakhyun Kim, Jooyoung Lee, Myung Joon Oh, Sang Bum Kim, Minjee Kim, et al. 2022. “Snail Acetylation by Autophagy-Derived Acetyl-Coenzyme A Promotes Invasion and Metastasis of KRAS-LKB1 Co-Mutated Lung Cancer Cells.” Cancer Communications 42: 716–49. https://doi.org/10.1002/cac2.12332

[787] Wang, Yuying, Kunqi Su, Chang Wang, Tao Deng, Xiaofeng Liu, Shiqi Sun, Yang Jiang, et al. 2024. “Chemotherapy-Induced Acetylation of ACLY by NAT10 Promotes Its Nuclear Accumulation and acetyl-CoA Production to Drive Chemoresistance in Hepatocellular Carcinoma.” Cell Death & Disease 15: 545. https://doi.org/10.1038/s41419-024-06951-9

[788] Wang, Jiewen, Mingjing Peng, Linda Oyang, Mengzhou Shen, Shizhen Li, Xianjie Jiang, Zongyao Ren, et al. 2025. “Mechanism and Application of Lactylation in Cancers.” Cell & Bioscience 15: 76. https://doi.org/10.1186/s13578-025-01415-9

[789] Kalyanaraman, Balaraman, Gang Cheng, and Micael Hardy. 2024. “The Role of Short-Chain Fatty Acids in Cancer Prevention and Cancer Treatment.” Archives of Biochemistry and Biophysics 761: 110172. https://doi.org/10.1016/j.abb.2024.110172

[790] Yan, Yuanyuan, Miao He, Lin Zhao, Huizhe Wu, Yanyun Zhao, Li Han, Binbin Wei, et al. 2022. “A Novel HIF-2α Targeted Inhibitor Suppresses Hypoxia-Induced Breast Cancer Stemness via SOD2-mtROS-PDI/GPR78-UPRER Axis.” Cell Death & Differentiation 29: 1769–89. https://doi.org/10.1038/s41418-022-00963-8

[791] Wang, Ruijie, Chuwen Li, Zhongyi Cheng, Mingyu Li, Jianbo Shi, Zhiyuan Zhang, Shufang Jin, and Hailong Ma. 2024. “H3K9 Lactylation in Malignant Cells Facilitates CD8⁺ T Cell Dysfunction and Poor Immunotherapy Response.” Cell Reports 43: 114686. https://doi.org/10.1016/j.celrep.2024.114957

[792] Shi, Zhiqiang, Huiyan Zeng, Bingquan Zhao, Chen Zeng, Fan Zhang, Zhongqiu Liu, Hiu Yee Kwan, and Tao Su. 2024. “Sulforaphane Reverses the Enhanced NSCLC Metastasis by Regulating the miR-7-5p/c-Myc/LDHA Axis in the Acidic Tumor Microenvironment.” Phytomedicine 133: 155874. https://doi.org/10.1016/j.phymed.2024.155874

[793] Hu, Pei-Shan, Ting Li, Jin-Fei Lin, Miao-Zhen Qiu, De-Shen Wang, Ze-Xian Liu, Zhan-Hong Chen, et al. 2020. “VDR–SOX2 Signaling Promotes Colorectal Cancer Stemness and Malignancy in an Acidic Microenvironment.” Signal Transduction and Targeted Therapy 5: 183. https://doi.org/10.1038/s41392-020-00230-7

[794] Shinde, Rahul, and Tracy L. McGaha. 2018. “The Aryl Hydrocarbon Receptor: Connecting Immunity to the Microenvironment.” Trends in Immunology 39: 1005–20. https://doi.org/10.1016/j.it.2018.10.010

[795] Tong, Yan, and Xiaojun Lou. 2025. “Interplay Between Bile Acids, Gut Microbiota, and the Tumor Immune Microenvironment: Mechanistic Insights and Therapeutic Strategies.” Frontiers in Immunology 16: 1638352. https://doi.org/10.3389/fimmu.2025.1638352

[796] Biagioli, Michele, and Stefano Fiorucci. 2021. “Bile Acid Activated Receptors: Integrating Immune and Metabolic Regulation in Non-Alcoholic Fatty Liver Disease.” Liver Research 5: 119–41. https://doi.org/10.1016/j.livres.2021.08.003

[797] Zhou, Mengnan, Jianqi Wu, Yang Shao, Jiameng Zhang, Rui Zheng, Qi Shi, Jia Wang, and Beixing Liu. 2024. “Short-Chain Fatty Acids Reverses Gut Microbiota Dysbiosis-Promoted Progression of Glioblastoma by Up-Regulating M1 Polarization in the Tumor Microenvironment.” International Immunopharmacology 141: 112881. https://doi.org/10.1016/j.intimp.2024.112881

[798] Li, Lei, Shouhua He, Boyi Liao, Manchun Wang, Huimin Lin, Ben Hu, Xinyue Lan, et al. 2024. “Orally Administrated Hydrogel Harnessing Intratumoral Microbiome and Microbiota-Related Immune Responses for Potentiated Colorectal Cancer Treatment.” Research 7: 0364. https://doi.org/10.34133/research.0364

[799] Xie, Yongjie, Tianxing Zhou, Xueyang Li, Kaili Zhao, Weiwei Bai, Xupeng Hou, Ziyun Liu, et al. 2024. “Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2⁺ Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and Immunotherapy.” Gastroenterology 167: 281–97. https://doi.org/10.1053/j.gastro.2024.02.046

[800] He, Jing, Mingxia Zhou, Jie Yin, Junhu Wan, Jie Chu, Jinlin Jia, Jinxiu Sheng, et al. 2021. “METTL3 Restrains Papillary Thyroid Cancer Progression via m6A/c-Rel/IL-8-Mediated Neutrophil Infiltration.” Molecular Therapy 29: 1821–37. https://doi.org/10.1016/j.ymthe.2021.01.019

[801] Wang, Sen, Zhe Xuan, Zetian Chen, Penghui Xu, Lang Fang, Zheng Li, Yigang Zhang, et al. 2025. “Helicobacter pylori-Induced BRD2 m6A Modification Sensitizes Gastric Cancer Cells to Chemotherapy by Breaking FLIP/Caspase-8 Homeostasis.” International Journal of Biological Sciences 21: 346–62. https://doi.org/10.7150/ijbs.97464

[802] Ma, Zhibo, Jincui Yang, Wenlong Jia, Le Li, Yixin Li, Junjie Hu, Wei Luo, et al. 2025. “Histone Lactylation-Driven B7-H3 Expression Promotes Tumor Immune Evasion.” Theranostics 15: 2338–59. https://doi.org/10.7150/thno.105947

[803] Li, Fei, Qingyuan Huang, Troy A. Luster, Hai Hu, Hua Zhang, Wai-Lung Ng, Alireza Khodadadi-Jamayran, et al. 2020. “In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma.” Cancer Discovery 10: 270–87. https://doi.org/10.1158/2159-8290.CD-19-0780

[804] Zhang, Cai, Lijie Zhou, Mingyuan Zhang, Yue Du, Cai Li, Huijun Ren, and Lu Zheng. 2024. “H3K18 Lactylation Potentiates Immune Escape of Non–Small Cell Lung Cancer.” Cancer Research 84: 3589–601. https://doi.org/10.1158/0008-5472.CAN-23-3513

[805] Chen, Hsiao-Chi, Peihao He, Malcolm McDonald, Michael R. Williamson, Srinidhi Varadharajan, Brittney Lozzi, Junsung Woo, et al. 2024. “Histone Serotonylation Regulates Ependymoma Tumorigenesis.” Nature 632: 903–10. https://doi.org/10.1038/s41586-024-07751-z

[806] Kopczyńska, Julia, and Magdalena Kowalczyk. 2024. “The Potential of Short-Chain Fatty Acid Epigenetic Regulation in Chronic Low-Grade Inflammation and Obesity.” Frontiers in Immunology 15: 1380476. https://doi.org/10.3389/fimmu.2024.1380476

[807] Shi, Henghe, Yifei Zou, Sijie Jin, Junduo Wu, and Bin Liu. 2025. “Lactate-Induced Lactylation: from Basic Research to Clinical Perspectives.” Frontiers in Pharmacology 16: 1586973. https://doi.org/10.3389/fphar.2025.1586973

[808] Nail, Howida M., Chien-Chih Chiu, Chung-Hang Leung, Mahmoud M. M. Ahmed, and Hui-Min David Wang. 2023. “Exosomal miRNA-mediated Intercellular Communications and Immunomodulatory Effects in Tumor Microenvironments.” Journal of Biomedical Science 30: 69. https://doi.org/10.1186/s12929-023-00964-w

[809] Kang, Yongsung, Hongsup Kim, Eunhye Goo, Hyesung Jeong, Jae Hyung An, and Ingyu Hwang. 2019. “Unraveling the Role of Quorum Sensing-Dependent Metabolic Homeostasis of the Activated Methyl Cycle in a Cooperative Population of Burkholderia Glumae.” Scientific Reports 9: 11038. https://doi.org/10.1038/s41598-019-47460-6

[810] Ervin, Samantha M., Hao Li, Lauren Lim, Lee R. Roberts, Xue Liang, Sridhar Mani, and Matthew R. Redinbo. 2019. “Gut Microbial β-glucuronidases Reactivate Estrogens as Components of the Estrobolome That Reactivate Estrogens.” Journal of Biological Chemistry 294: 18586–99. https://doi.org/10.1074/jbc.RA119.010950

[811] Nagarajan, Sankari, Eva Benito, Andre Fischer, and Steven A. Johnsen. 2015. “H4K12ac Is Regulated by Estrogen Receptor-Alpha and Is Associated With BRD4 Function and Inducible Transcription.” Oncotarget 6: 7305–17. https://doi.org/10.18632/oncotarget.3439

[812] Fernández-Ramos, David, Fernando Lopitz-Otsoa, Shelly C. Lu, and José M Mato. 2025. “S-Adenosylmethionine: A Multifaceted Regulator in Cancer Pathogenesis and Therapy.” Cancers 17: 535. https://doi.org/10.3390/cancers17030535

[813] Pulous, Fadi E., Barbara Steurer, Frank W. Pun, Man Zhang, Feng Ren, and Alex Zhavoronkov. 2024. “MAT2A Inhibition Combats Metabolic and Transcriptional Reprogramming in Cancer.” Drug Discovery Today 29: 104189. https://doi.org/10.1016/j.drudis.2024.104189

[814] Marjon, Katya, Michael J. Cameron, Phong Quang, Michelle F. Clasquin, Everton Mandley, Kaiko Kunii, Michael McVay, et al. 2016. “MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis.” Cell Reports 15: 574–87. https://doi.org/10.1016/j.celrep.2016.03.043

[815] Marinkovic, Emilija, Minyi Chen, Nadja Schubert, Elif Dogan Dar, Janet Y. Leung, Jack Lohre, Jennifer M. Sahni, et al. 2024. “Selective Inflammation of the Tumor Microenvironment and Iinvigorated T Cell-Mediated Tumor Control Upon Induced Systemic Inactivation of TREX1.” bioRxiv 2024.06.09.598086. https://doi.org/10.1101/2024.06.09.598086

[816] Luo, Hui, Yizuo Song, Jian-an Zhang, Yi Liu, Fengyun Chen, Zhiwei Wang, and Xueqiong Zhu. 2022. “MAT2A Facilitates PDCD6 Methylation and Promotes Cell Growth Under Glucose Deprivation in Cervical Cancer.” Cell Death Discovery 8: 176. https://doi.org/10.1038/s41420-022-00987-6

[817] Zhu, Rongxuan, Xianglai Ye, Xiaotong Lu, Liwei Xiao, Ming Yuan, Hong Zhao, Dong Guo, et al. 2025. “ACSS2 Acts as a Lactyl-CoA Synthetase and Couples KAT2A to Function as a Lactyltransferase for Histone Lactylation and Tumor Immune Evasion.” Cell Metabolism 37: 361–76. https://doi.org/10.1016/j.cmet.2024.10.015

[818] Wu, Yeyang, Yanmei Li, Ni Yan, Jiaqi Huang, Xinyu Li, Keyan Zhang, Zhenming Lu, Ziwen Qiu, and Hong Cheng. 2024. “Nuclear-Targeted Chimeric Peptide Nanorods to Amplify Innate Anti-Tumor Immunity Through Localized DNA Damage and STING Activation.” Journal of Controlled Release 369: 531–44. https://doi.org/10.1016/j.jconrel.2024.04.008

[819] Que, Dongwen, Feimei Kuang, Rui Kang, Daolin Tang, and Jiao Liu. 2023. “ACSS2-mediated NF-κB Activation Promotes Alkaliptosis in Human Pancreatic Cancer Cells.” Scientific Reports 13: 1483. https://doi.org/10.1038/s41598-023-28261-4

[820] Saatchi, Faeze, and Ann L. Kirchmaier. 2019. “Tolerance of DNA Replication Stress Is Promoted by Fumarate Through Modulation of Histone Demethylation and Enhancement of Replicative Intermediate Processing in Saccharomyces Cerevisiae.” Genetics 212: 631–54. https://doi.org/10.1534/genetics.119.302238

[821] Yang, Chunxue, Derek Lee, Misty Shuo Zhang, Aki Pui-Wah Tse, Lai Wei, Macus Hao-Ran Bao, Bowie Po-Yee Wong, et al. 2022. “Genome-Wide CRISPR/Cas9 Library Screening Revealed Dietary Restriction of Glutamine in Combination With Inhibition of Pyruvate Metabolism as Effective Liver Cancer Treatment.” Advanced Science 9: 2202104. https://doi.org/10.1002/advs.202202104

[822] Chung, Chan, Stefan R. Sweha, Drew Pratt, Benita Tamrazi, Pooja Panwalkar, Adam Banda, Jill Bayliss, et al. 2020. “Integrated Metabolic and Epigenomic Reprograming by H3K27M Mutations in Diffuse Intrinsic Pontine Gliomas.” Cancer Cell 38: 334–49. https://doi.org/10.1016/j.ccell.2020.07.008

[823] Yoo, Hee Chan, Seung Joon Park, Miso Nam, Juwon Kang, Kibum Kim, Joo Hye Yeo, Joon-Ki Kim, et al. 2020. “A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells.” Cell Metabolism 31: 2683.e212. https://doi.org/10.1016/j.cmet.2019.11.020

[824] Xiao, Song, Wang Nai-dong, Yan Jin-Xiang, Tian Long, Lu Xiu-Rong, Gao Hong, Yan Jie-Cheng, and Zhang Fei. 2022. “ANGPTL4 Regulate Glutamine Metabolism and Fatty Acid Oxidation in Nonsmall Cell Lung Cancer Cells.” Journal of Cellular and Molecular Medicine 26: 1876–85. https://doi.org/10.1111/jcmm.16879

[825] Shi, Rongchen, Kun Zhao, Teng Wang, Jing Yuan, Dapeng Zhang, Wei Xiang, Jin Qian, et al. 2022. “5-aza-2′-deoxycytidine Potentiates Anti-Tumor Immunity in Colorectal Peritoneal Metastasis by Modulating ABC A9-mediated Cholesterol Accumulation in Macrophages.” Theranostics 12: 875–90. https://doi.org/10.7150/thno.66420

[826] Zhang, Qihong, Yun Liu, Yuheng Li, Guangdong Bai, Jiaman Pang, Miaomiao Wu, Jiawei Li, Xuan Zhao, and Yaoyao Xia. 2025. “Implications of Gut Microbiota-Mediated Epigenetic Modifications in Intestinal Diseases.” Gut Microbes 17: 2508426. https://doi.org/10.1080/19490976.2025.2508426

[827] Owens, Florida, Joseph Souchak, Valeria Nazaire, Juliet Akkaoui, Rajib Shil, Candy Carbajal, Kingshuk Panda, et al. 2025. “A Connection Between the Gut Microbiome and Epigenetic Modification in Age-Related Cancer: A Narrative Review.” Aging and Disease 17: 226–55. https://doi.org/10.14336/ad.2024.1618

[828] Rahman, Mohammad Mijanur, Huixin Wu, and Trygve O. Tollefsbol. 2024. “A Novel Combinatorial Approach Using Sulforaphane-And Withaferin A-Rich Extracts for Prevention of Estrogen Receptor-Negative Breast Cancer Through Epigenetic and Gut Microbial Mechanisms.” Scientific Reports 14: 12091. https://doi.org/10.1038/s41598-024-62084-1

[829] Li, Yuanyuan, Bingbin Dong, Wei Wu, Jiawei Wang, Hao Jin, Kangmei Chen, Kangling Huang, et al. 2022. “Metagenomic Analyses Reveal Distinct Gut Microbiota Signature for Predicting the Neoadjuvant Chemotherapy Responsiveness in Breast Cancer Patients.” Frontiers in Oncology 12: 865121. https://doi.org/10.3389/fonc.2022.865121

[830] Smith, Alyssa D., Chunwan Lu, Daniela Payne, Amy V. Paschall, John D. Klement, Priscilla S. Redd, Mohammed L. Ibrahim, et al. 2020. “Autocrine IL6-mediated Activation of the STAT3–DNMT Axis Silences the TNFα–RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells.” Cancer Research 80: 3145–56. https://doi.org/10.1158/0008-5472.CAN-19-3670

[831] Nguyen, Trang Thi Thu, Yiru Zhang, Enyuan Shang, Chang Shu, Consuelo Torrini, Junfei Zhao, Elena Bianchetti, et al. 2020. “HDAC Inhibitors Elicit Metabolic Reprogramming by Targeting Super-Enhancers in Glioblastoma Models.” Journal of Clinical Investigation 130: 3699–716. https://doi.org/10.1172/JCI129049

[832] Karagiannis, Dimitris, Warren Wu, Albert Li, Makiko Hayashi, Xiao Chen, Michaela Yip, Vaibhav Mangipudy, et al. 2024. “Metabolic Reprogramming by Histone Deacetylase Inhibition Preferentially Targets NRF2-activated Tumors.” Cell Reports 43: 113629. https://doi.org/10.1016/j.celrep.2023.113629

[833] Li, Lisi, Qi Lei, Yifan Zhen, Lixue Cao, Yujia Dong, Xifu Liu, and Meng Wang. 2024. “Lactate Dehydrogenase Inhibition Protects Against Hepatic Fibrosis by Regulating Metabolic Reprogramming of Hepatic Stellate Cells.” Journal of Agricultural and Food Chemistry 72: 27953–64. https://doi.org/10.1021/acs.jafc.4c08211

[834] Gu, Zhangyuan, Fugui Ye, Hong Luo, Xiaoguang Li, Yue Gong, Shiqi Mao, Xiaoqing Jia, et al. 2025. “Metformin Sensitizes Triple-Negative Breast Cancer to Histone Deacetylase Inhibitors by Targeting FGFR4.” Journal of Biomedical Science 32: 36. https://doi.org/10.1186/s12929-025-01129-7

[835] Hernández-Juárez, Jennifer, Orlando Vargas-Sierra, Luis A. Herrera, David Cantú De León, Jorge Fernández-Retana, Carlos Pérez-Plasencia, César López-Camarillo, et al. 2019. “Sodium-Coupled Monocarboxylate Transporter Is a Target of Epigenetic Repression in Cervical Cancer.” International Journal of Oncology 54: 1613–24. https://doi.org/10.3892/ijo.2019.4749

[836] Van Den Bijgaart, Renske J. E., Michiel Kroesen, Melissa Wassink, Ingrid C. Brok, Esther D. Kers-Rebel, Louis Boon, Torben Heise, et al. 2019. “Combined Sialic Acid and Histone Deacetylase (HDAC) Inhibitor Treatment Up-Regulates the Neuroblastoma Antigen GD2.” Journal of Biological Chemistry 294: 4437–49. https://doi.org/10.1074/jbc.RA118.002763

[837] Sharma, Manvi, and Trygve O. Tollefsbol. 2022. “Combinatorial Epigenetic Mechanisms of Sulforaphane, Genistein and Sodium Butyrate in Breast Cancer Inhibition.” Experimental Cell Research 416: 113160. https://doi.org/10.1016/j.yexcr.2022.113160

[838] Yan, Kezhi, Justine Rousseau, Keren Machol, Laura A. Cross, Katherine E. Agre, Cynthia Forster Gibson, Anne Goverde, et al. 2020. “Deficient Histone H3 Propionylation by BRPF1-KAT6 Complexes in Neurodevelopmental Disorders and Cancer.” Science Advances 6: eaax0021. https://doi.org/10.1126/sciadv.aax0021

[839] Contreras-Leal, Erika, Andrés Hernández-Oliveras, Lucía Flores-Peredo, Ángel Zarain-Herzberg, and Juan Santiago-García. 2016. “Histone Deacetylase Inhibitors Promote the Expression of ATP2A3 Gene in Breast Cancer Cell Lines.” Molecular Carcinogenesis 55: 1477–85. https://doi.org/10.1002/mc.22402

[840] Xiao, Xiaoqiang, Yanxuan Xu, and Haoyu Chen. 2020. “Sodium Butyrate-Activated TRAF6-TXNIP Pathway Affects A549 Cells Proliferation and Migration.” Cancer Medicine 9: 3477–88. https://doi.org/10.1002/cam4.2564

[841] Zhang, Hanying, Min Du, Qiyuan Yang, and Mei-Jun Zhu. 2016. “Butyrate Suppresses Murine Mast Cell Proliferation and Cytokine Production Through Inhibiting Histone Deacetylase.” Journal of Nutritional Biochemistry 27: 299–306. https://doi.org/10.1016/j.jnutbio.2015.09.020

[842] Xie, Qiu-Shi, Jia-Xin Zhang, Ming Liu, Pei-Hua Liu, Zhong-Jian Wang, Liang Zhu, Ling Jiang, et al. 2021. “Short-Chain Fatty Acids Exert Opposite Effects on the Expression and Function of P-Glycoprotein and Breast Cancer Resistance Protein in Rat Intestine.” Acta Pharmacologica Sinica 42: 470–81. https://doi.org/10.1038/s41401-020-0402-x

[843] Mekala, Janaki Ramaiah, Rohil Kumar Kurappalli, PrasannaSrinivasan Ramalingam, and Nageswara Rao Moparthi. 2021. “N-Acetyl L-Aspartate and Triacetin Modulate Tumor Suppressor MicroRNA and Class I and II HDAC Gene Expression Induce Apoptosis in Glioblastoma Cancer Cells in Vitro.” Life Sciences 286: 120024. https://doi.org/10.1016/j.lfs.2021.120024

[844] Yang, Mengdi, AiTing Wang, Changcan Li, Jing Sun, Gang Yi, Hao Cheng, Xueni Liu, et al. 2020. “Methylation-Induced Silencing of ALDH2 Facilitates Lung Adenocarcinoma Bone Metastasis by Activating the MAPK Pathway.” Frontiers in Oncology 10: 1141. https://doi.org/10.3389/fonc.2020.01141

[845] Jin, Un-Ho, Yating Cheng, Hyejin Park, Laurie A. Davidson, Evelyn S. Callaway, Robert S. Chapkin, Arul Jayaraman, et al. 2017. “Short Chain Fatty Acids Enhance Aryl Hydrocarbon (Ah) Responsiveness in Mouse Colonocytes and Caco-2 Human Colon Cancer Cells.” Scientific Reports 7: 10163. https://doi.org/10.1038/s41598-017-10824-x

[846] Wang, Zhiwei, Yuanquan Yu, Peiyao Wu, Qinghuang Ye, Yinghao Guo, Xiaoxiao Zhang, Longfu Xi, et al. 2022. “Lactate Promotes the Growth of Patient-Derived Organoids from Hepatopancreatobiliary Cancers via ENO1/HIF1α Pathway and Does Not Affect Their Drug Sensitivities.” Cell Death Discovery 8: 214. https://doi.org/10.1038/s41420-022-01014-4

[847] Chen, Baoxiang, Yanrong Deng, Yuntian Hong, Lifang Fan, Xiang Zhai, Heng Hu, Siyuan Yin, et al. 2024. “Metabolic Recoding of NSUN2-Mediated m(5)C Modification Promotes the Progression of Colorectal Cancer via the NSUN2/YBX1/m(5)C-ENO1 Positive Feedback Loop.” Advanced Science 11: e2309840. https://doi.org/10.1002/advs.202309840

[848] Tian, Chang-Qing, Lin Chen, Hua-Dong Chen, Xia-Juan Huan, Jian-Ping Hu, Jing-Kang Shen, Bing Xiong, et al. 2019. “Inhibition of the BET Family Reduces Its New Target Gene IDO1 Expression and the Production of L-Kynurenine.” Cell Death & Disease 10: 557. https://doi.org/10.1038/s41419-019-1793-9

[849] Liu, Yuanyuan, Jiguo Xie, Xiaofei Zhao, Yueyue Zhang, Zhiyuan Zhong, and Chao Deng. 2022. “A Polymeric IDO Inhibitor Based on Poly(Ethylene glycol)-b-poly(L-tyrosine-co-1-Methyl-D-tryptophan) Enables Facile Trident Cancer Immunotherapy.” Biomaterials Science 10: 5731–43. https://doi.org/10.1039/d2bm01181f

[850] Rashidi, Alireza, Somayeh Taymouri, Mahboubeh Rostami, and Mina Mirian. 2025. “Development of Folic Acid Functionalized Bilosomes for Delivery of Vorinostat to Breast Cancer Cells: Characterization and Cytocidal Effects on MCF-7 and 4T1 Breast Cancer Cell Lines.” Advanced Pharmaceutical Bulletin 15: 82–94. https://doi.org/10.34172/apb.43232

[851] Kitazawa, Satoshi, Shunsuke Ebara, Ayumi Ando, Yuji Baba, Yoshinori Satomi, Tomoyoshi Soga, and Takahito Hara. 2017. “Succinate Dehydrogenase B-Deficient Cancer Cells Are Highly Sensitive to Bromodomain and Extra-Terminal Inhibitors.” Oncotarget 8: 28922–38. https://doi.org/10.18632/oncotarget.15959

[852] Sato, Ayami, Haruka Ueno, Momoka Fusegi, Saki Kaneko, Kakeru Kohno, Nantiga Virgona, Akira Ando, et al. 2018. “A Succinate Ether Derivative of Tocotrienol Enhances Dickkopf-1 Gene Expression Through Epigenetic Alterations in Malignant Mesothelioma Cells.” Pharmacology 102: 26–36. https://doi.org/10.1159/000489128

[853] Schlörmann, W., S. Naumann, C. Renner, and M. Glei. 2015. “Influence of miRNA-106b and miRNA-135a on Butyrate-Regulated Expression of p21 and Cyclin D2 in Human Colon Adenoma Cells.” Genes & Nutrition 10: 50. https://doi.org/10.1007/s12263-015-0500-4

[854] Rauscher, Stefanie, Richard Greil, and Roland Geisberger. 2021. “Re-Sensitizing Tumor Cells to Cancer Drugs With Epigenetic Regulators.” Current Cancer Drug Targets 21: 353–9. https://doi.org/10.2174/1568009620666210108102723

[855] Mora, Yuselin, María Elena Reyes, Louise Zanella, Bárbara Mora, Kurt Buchegger, Carmen Ili, and Priscilla Brebi. 2021. “Resistance to Platinum-Based Cancer Drugs: A Special Focus on Epigenetic Mechanisms.” Pharmacogenomics 22: 777–90. https://doi.org/10.2217/pgs-2021-0020

[856] Garrett, Matthew C., Rebecca Albano, Troy Carnwath, Lubayna Elahi, Catherine A. Behrmann, Merissa Pemberton, Daniel Woo, et al. 2023. “HDAC1 and HDAC6 Are Essential for Driving Growth in IDH1 Mutant Glioma.” Scientific Reports 13: 12433. https://doi.org/10.1038/s41598-023-33889-3

[857] Wang, Huijuan, Jiaxin Chen, Xiaoyu Chen, Yingqiang Liu, Jiawei Wang, Qing Meng, Huogang Wang, et al. 2024. “Cancer-Associated Fibroblasts Expressing Sulfatase 1 Facilitate VEGFA-Dependent Microenvironmental Remodeling to Support Colorectal Cancer.” Cancer Research 84: 3371–87. https://doi.org/10.1158/0008-5472.CAN-23-3987

[858] Huang, Hui, Ying Yang, Xiaojiao Wang, Biao Wen, Xianglan Yang, Wei Zhong, Qiurong Wang, Feng He, and Jun Li. 2024. “Gut Virome Dysbiosis Impairs Antitumor Immunity and Reduces 5-fluorouracil Treatment Efficacy for Colorectal Cancer.” Frontiers in Oncology 14: 1501981. https://doi.org/10.3389/fonc.2024.1501981

[859] Ruoß, Marc, Georg Damm, Massoud Vosough, Lisa Ehret, Carl Grom-Baumgarten, Martin Petkov, Silvio Naddalin, et al. 2019. “Epigenetic Modifications of the Liver Tumor Cell Line HepG2 Increase Their Drug Metabolic Capacity.” International Journal of Molecular Sciences 20: 347. https://doi.org/10.3390/ijms20020347

[860] Saini, Anshul, and James M. Gallo. 2021. “Epigenetic Instability May Alter Cell State Transitions and Anticancer Drug Resistance.” PLoS Computational Biology 17: e1009307. https://doi.org/10.1371/journal.pcbi.1009307

[861] Roichman, Asael, Qianying Zuo, Sunghoon Hwang, Wenyun Lu, Ricardo A. Cordova, Michael R. MacArthur, Jacob A. Boyer, et al. 2025. “Microbiome Metabolism of Dietary Phytochemicals Controls the Anticancer Activity of PI3K Inhibitors.” Cell 188: 3065–80.e21. https://doi.org/10.1016/j.cell.2025.04.041

[862] Zhu, Jinghan, Juntao Li, Kexi Yang, Yuqi Chen, Jiayu Wang, Yuxin He, Kanger Shen, et al. 2024. “NR4A1 Depletion Inhibits Colorectal Cancer Progression by Promoting Necroptosis via the RIG-I-like Receptor Pathway.” Cancer Letters 585: 216693. https://doi.org/10.1016/j.canlet.2024.216693

[863] Mai, Zhensheng, Yubin Han, Dong Liang, Feihong Mai, Huimin Zheng, Pan Li, Yuan Li, et al. 2024. “Gut-Derived Metabolite 3-methylxanthine Enhances Cisplatin-Induced Apoptosis via Dopamine Receptor D1 in a Mouse Model of Ovarian Cancer.” mSystems 9: e01301–23. https://doi.org/10.1128/msystems.01301-23

[864] Hughes, Lewis, Wayne Roberts, and Donna Johnson. 2021. “The Impact of DNA Adenine Methyltransferase Knockout on the Development of Triclosan Resistance and Antibiotic Cross-Resistance in Escherichia coli.” Access Microbiology 3: acmi000178. https://doi.org/10.1099/acmi.0.000178

[865] Radpour, Ramin, Carsten Riether, Cedric Simillion, Sabine Höpner, Rémy Bruggmann, and Adrian F. Ochsenbein. 2019. “CD8⁺ T Cells Expand Stem and Progenitor Cells in Favorable but Not Adverse Risk Acute Myeloid Leukemia.” Leukemia 33: 2379–92. https://doi.org/10.1038/s41375-019-0441-9

[866] Chesnelong, Charles, Myriam M. Chaumeil, Michael D. Blough, Mohammad Al-Najjar, Owen D. Stechishin, Jennifer A. Chan, Russell O. Pieper, et al. 2014. “Lactate Dehydrogenase A Silencing in IDH Mutant Gliomas.” Neuro-oncology 16: 686–95. https://doi.org/10.1093/neuonc/not243

[867] El Helou, Rita, Julien Wicinski, Arnaud Guille, Jose Adélaïde, Pascal Finetti, François Bertucci, Max Chaffanet, et al. 2014. “Brief Reports: A Distinct DNA Methylation Signature Defines Breast Cancer Stem Cells and Predicts Cancer Outcome.” Stem Cells 32: 3031–6. https://doi.org/10.1002/stem.1792

[868] Zheng, Xiaoqi, Qian Zhao, Hua-Jun Wu, Wei Li, Haiyun Wang, Clifford A. Meyer, Qian Alvin Qin, et al. 2014. “MethylPurify: Tumor Purity Deconvolution and Differential Methylation Detection from Single Tumor DNA Methylomes.” Genome Biology 15: 419. https://doi.org/10.1186/s13059-014-0419-x

[869] El-Ayadi, Moatasem, Marc Ansari, Dominik Sturm, Gerrit H. Gielen, Monika Warmuth-Metz, Christof M. Kramm, and Andre O. von Bueren. 2017. “High-Grade Glioma in Very Young Children: a Rare and Particular Patient Population.” Oncotarget 8: 64564–78. https://doi.org/10.18632/oncotarget.18478

[870] Zhang, Jing, Jing Wang, Yangang Liu, Harwin Sidik, Ken H. Young, Harvey F. Lodish, and Mark D. Fleming. 2009. “Oncogenic Kras-Induced Leukemogeneis: Hematopoietic Stem Cells as the Initial Target and Lineage-Specific Progenitors as the Potential Targets for Final Leukemic Transformation.” Blood, The Journal of the American Society of Hematology 113: 1304–14. https://doi.org/10.1182/blood-2008-01-134262

[871] Wang, Qian, Ning Liang, Tao Yang, Yuedan Li, Jing Li, Qian Huang, Chen Wu, et al. 2021. “DNMT1-Mediated Methylation of BEX1 Regulates Stemness and Tumorigenicity in Liver Cancer.” Journal of Hepatology 75: 1142–53. https://doi.org/10.1016/j.jhep.2021.06.025

[872] Li, Yangchan, Meilin Xue, Xiaolan Deng, Lei Dong, Le Xuan Truong Nguyen, Lili Ren, Li Han, et al. 2023. “TET2-Mediated mRNA Demethylation Regulates Leukemia Stem Cell Homing and Self-Renewal.” Cell Stem Cell 30: 1072–90. https://doi.org/10.1016/j.stem.2023.07.001

[873] Zhu, Xinyu, Zinan Wang, Xiaoyi Ye, Puyang Liang, Lingling Chen, Jinzhu Chen, Chenchen Li, et al. 2025. “Short-Term Methionine Deprivation Inhibits TCA Cycle and Regulates Macrophage Polarization Through Uncharged tRNA and PDHA1 Phosphorylation.” Journal of Nutritional Biochemistry 143: 109939. https://doi.org/10.1016/j.jnutbio.2025.109939

[874] Lee, Joyce V., Corbett T. Berry, Karla Kim, Payel Sen, Taehyong Kim, Alessandro Carrer, Sophie Trefely, et al. 2018. “Acetyl-CoA Promotes Glioblastoma Cell Adhesion and Migration Through Ca²⁺–NFAT Signaling.” Genes & Development 32: 497–511. https://doi.org/10.1101/gad.311027.117

[875] He, Dejiao, Xuan Sun, Hongxia Yang, Xiaoli Li, and Dingping Yang. 2018. “TOFA Induces Cell Cycle Arrest and Apoptosis in ACHN and 786-O Cells Through Inhibiting PI3K/Akt/mTOR Pathway.” Journal of Cancer 9: 2734–42. https://doi.org/10.7150/jca.26374

[876] Li, Mei-Xin, Xiao-Ting Wu, Wen-Qiang Jing, Wen-Kui Hou, Sheng Hu, and Wei Yan. 2023. “Inosine Enhances Tumor Mitochondrial Respiration by Inducing Rag GTPases and Nascent Protein Synthesis Under Nutrient Starvation.” Cell Death & Disease 14: 492. https://doi.org/10.1038/s41419-023-06017-2

[877] Lin, An-Ping, Saman Abbas, Sang-Woo Kim, Manoela Ortega, Hakim Bouamar, Yissela Escobedo, Prakash Varadarajan, et al. 2015. “D2HGDH Regulates Alpha-Ketoglutarate Levels and Dioxygenase Function by Modulating IDH2.” Nature Communications 6: 7768. https://doi.org/10.1038/ncomms8768

[878] Lang, Fengchao, Karambir Kaur, Haiqing Fu, Javeria Zaheer, Diego Luis Ribeiro, Mirit I. Aladjem, and Chunzhang Yang. 2025. “D-2-hydroxyglutarate Impairs DNA Repair Through Epigenetic Reprogramming.” Nature Communications 16: 1431. https://doi.org/10.1038/s41467-025-56781-2

[879] Hou, Yufei, Lu Bai, Xin Wang, Shanshan Zhang, Shaojing Liu, Jiabing Hu, Jing Gao, et al. 2023. “Gut Microbiota Combined With Serum Metabolomics to Investigate the Hypoglycemic Effect of Actinidia Arguta Leaves.” Nutrients 15: 4115. https://doi.org/10.3390/nu15194115

[880] DeHaven, Corey D., Anne M. Evans, Hongping Dai, and Kay A. Lawton. 2010. “Organization of GC/MS and LC/MS Metabolomics Data into Chemical Libraries.” Journal of Cheminformatics 2: 9. https://doi.org/10.1186/1758-2946-2-9

[881] Oetjen, Janina, Kirill Veselkov, Jeramie Watrous, James S. McKenzie, Michael Becker, Lena Hauberg-Lotte, Jan Hendrik Kobarg, et al. 2015. “Benchmark Datasets for 3D MALDI- and DESI-imaging Mass Spectrometry.” GigaScience 4: 20. https://doi.org/10.1186/s13742-015-0059-4

[882] De Borre, Marie, and Miguel R. Branco. 2021. “ Oxidative Bisulfite Sequencing: An Experimental and Computational Protocol.” In DNA Modifications: Methods and Protocols, 333–48. Springer US. https://doi.org/10.1007/978-1-0716-0876-0_26

[883] Bouhaddani, Said el, Jeanine Houwing-Duistermaat, Perttu Salo, Markus Perola, Geurt Jongbloed, and Hae-Won Uh. 2016. “Evaluation of O2PLS in Omics Data Integration.” BMC Bioinformatics 17: S11. https://doi.org/10.1186/s12859-015-0854-z

[884] Chen, Panpan, Haoyuan Geng, Bangzhen Ma, Yaqi Zhang, Zihan Zhu, Min Li, Shiping Chen, et al. 2025. “Integrating Spatial Omics and Single-Cell Mass Spectrometry Imaging Reveals Tumor–Host Metabolic Interplay in Hepatocellular Carcinoma.” Proceedings of the National Academy of Sciences 122: e2505789122. https://doi.org/10.1073/pnas.2505789122

[885] Papp, Diana, Tamas Korcsmaros, and Isabelle Hautefort. 2024. “Revolutionizing Immune Research With Organoid-Based Co-Culture and Chip Systems.” Clinical and Experimental Immunology 218: 40–54. https://doi.org/10.1093/cei/uxae004

[886] Liu, Bin, Siwei Chen, Anouk La Rose, Deng Chen, Fangyuan Cao, Martijn Zwinderman, Dominik Kiemel, et al. 2019. “Inhibition of Histone Deacetylase 1 (HDAC1) and HDAC2 Enhances CRISPR/Cas9 Genome Editing.” Nucleic Acids Research 48: 517–32. https://doi.org/10.1093/nar/gkz1136

[887] Grodner, Benjamin, Hao Shi, Owen Farchione, Albert C. Vill, Ioannis Ntekas, Peter J. Diebold, David T. Wu, et al. 2024. “Spatial Mapping of Mobile Genetic Elements and Their Bacterial Hosts in Complex Microbiomes.” Nature Microbiology 9: 2262–77. https://doi.org/10.1038/s41564-024-01735-5

[888] Nomura, Motoo, Ryosuke Nagatomo, Keitaro Doi, Juko Shimizu, Kiichiro Baba, Tomoki Saito, Shigemi Matsumoto, Koichi Inoue, and Manabu Muto. 2020. “Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors.” JAMA Network Open 3: e202895. https://doi.org/10.1001/jamanetworkopen.2020.2895

[889] Tay, Rong En, Olamide Olawoyin, Paloma Cejas, Yingtian Xie, Clifford A. Meyer, Yoshinaga Ito, Qing Yu Weng, et al. 2020. “Hdac3 Is an Epigenetic Inhibitor of the Cytotoxicity Program in CD8 T Cells.” Journal of Experimental Medicine 217: e20191453. https://doi.org/10.1084/jem.20191453

[890] Hu, Mingjing, Bilal Alashkar Alhamwe, Brigitte Santner-Nanan, Sarah Miethe, Hani Harb, Harald Renz, Daniel P. Potaczek, and Ralph K. Nanan. 2022. “Short-Chain Fatty Acids Augment Differentiation and Function of Human Induced Regulatory T Cells.” International Journal of Molecular Sciences 23: 5740. https://doi.org/10.3390/ijms23105740

[891] Sayin, Sama I., Annika Wahlström, Jenny Felin, Sirkku Jäntti, Hanns-Ulrich Marschall, Krister Bamberg, Bo Angelin, et al. 2013. “Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-Beta-Muricholic Acid, a Naturally Occurring FXR Antagonist.” Cell Metabolism 17: 225–35. https://doi.org/10.1016/j.cmet.2013.01.003

[892] Huang, Ling, Junping Zheng, Guangjun Sun, Huabing Yang, Xiongjie Sun, Xiaowei Yao, Aizhen Lin, and Hongtao Liu. 2022. “5-Aminosalicylic Acid Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice by Modulating Gut Microbiota and Bile Acid Metabolism.” Cellular and Molecular Life Sciences 79: 460. https://doi.org/10.1007/s00018-022-04471-3

[893] Jin, Wen-Bing, Leyi Xiao, Mingeum Jeong, Seong-Ji Han, Wen Zhang, Hiroshi Yano, Huiqing Shi, et al. 2025. “Microbiota-Derived Bile Acids Antagonize the Host Androgen Receptor and Drive Anti-Tumor Immunity.” Cell 188: 2336–53. https://doi.org/10.1016/j.cell.2025.02.029

[894] Lutgens, Maurice WMD., Martijn G. H. van Oijen, Geert JMG. van der Heijden, Frank P. Vleggaar, Peter D. Siersema, and Bas Oldenburg. 2013. “Declining Risk of Colorectal Cancer in Inflammatory Bowel Disease: an Updated Meta-Analysis of Population-Based Cohort Studies.” Inflammatory Bowel Diseases 19: 789–99. https://doi.org/10.1097/MIB.0b013e31828029c0

[895] Paulos, Chrystal M., Claudia Wrzesinski, Andrew Kaiser, Christian S. Hinrichs, Marcello Chieppa, Lydie Cassard, Douglas C. Palmer, et al. 2007. “Microbial Translocation Augments the Function of Adoptively Transferred Self/Tumor-Specific CD8⁺ T Cells via TLR4 Signaling.” Journal of Clinical Investigation 117: 2197–204. https://doi.org/10.1172/JCI32205

[896] Zhou, Zhichao, Patricia Q. Tran, Adam M. Breister, Yang Liu, Kristopher Kieft, Elise S. Cowley, Ulas Karaoz, and Karthik Anantharaman. 2022. “METABOLIC: High-Throughput Profiling of Microbial Genomes for Functional Traits, Metabolism, Biogeochemistry, and Community-Scale Functional Networks.” Microbiome 10: 33. https://doi.org/10.1186/s40168-021-01213-8

[897] Udayasuryan, Barath, Raffae N. Ahmad, Tam T. D. Nguyen, Ariana Umaña, LaDeidra Monét Roberts, Polina Sobol, Stephen D. Jones, et al. 2022. “Fusobacterium Nucleatum Induces Proliferation and Migration in Pancreatic Cancer Cells Through Host Autocrine and Paracrine Signaling.” Science Signaling 15: eabn4948. https://doi.org/10.1126/scisignal.abn4948

[898] Collins, James, Jennifer M. Auchtung, Laura Schaefer, Kathryn A. Eaton, and Robert A. Britton. 2015. “Humanized Microbiota Mice as a Model of Recurrent Clostridium Difficile Disease.” Microbiome 3: 35. https://doi.org/10.1186/s40168-015-0097-2

[899] Patras, Kathryn A., and Kelly S. Doran. 2016. “A Murine Model of Group B Streptococcus Vaginal Colonization.” Journal of Visualized Experiments: JoVE 118: 54708. https://doi.org/10.3791/54708

[900] Staley, Christopher, Thomas Kaiser, Lalit K. Beura, Matthew J. Hamilton, Alexa R. Weingarden, Aleh Bobr, Johnthomas Kang, et al. 2017. “Stable Engraftment of Human Microbiota into Mice With a Single Oral Gavage Following Antibiotic Conditioning.” Microbiome 5: 87. https://doi.org/10.1186/s40168-017-0306-2

[901] Lima-Junior, Djalma S., Siddharth R. Krishnamurthy, Nicolas Bouladoux, Nicholas Collins, Seong-Ji Han, Erin Y. Chen, Michael G. Constantinides, et al. 2021. “Endogenous Retroviruses Promote Homeostatic and Inflammatory Responses to the Microbiota.” Cell 184: 3794–811. https://doi.org/10.1016/j.cell.2021.05.020

[902] Beura, Lalit K., Sara E. Hamilton, Kevin Bi, Jason M. Schenkel, Oludare A. Odumade, Kerry A. Casey, Emily A. Thompson, et al. 2016. “Normalizing the Environment Recapitulates Adult Human Immune Traits in Laboratory Mice.” Nature 532: 512–6. https://doi.org/10.1038/nature17655

[903] Cao, Yiyun, Joonseok Oh, Mengzhao Xue, Won Jae Huh, Jiawei Wang, Jaime A. Gonzalez-Hernandez, Tyler A. Rice, et al. 2022. “Commensal Microbiota from Patients With Inflammatory Bowel Disease Produce Genotoxic Metabolites.” Science 378: eabm3233. https://doi.org/10.1126/science.abm3233

[904] Rubinstein, Mara Roxana, Jung Eun Baik, Stephen M. Lagana, Richard P. Han, William J. Raab, Debashis Sahoo, Piero Dalerba, Timothy C. Wang, and Yiping W. Han. 2019. “Fusobacterium Nucleatum Promotes Colorectal Cancer by Inducing Wnt/β-catenin Modulator Annexin A1.” EMBO Reports 20: e47638. https://doi.org/10.15252/embr.201847638

[905] Hou, Qihang, Lulu Ye, Haofei Liu, Lulu Huang, Qian Yang, J. R. Turner, and Qinghua Yu. 2018. “Lactobacillus Accelerates ISCs Regeneration to Protect the Integrity of Intestinal Mucosa Through Activation of STAT3 Signaling Pathway Induced by LPLs Secretion of IL-22.” Cell Death & Differentiation 25: 1657–70. https://doi.org/10.1038/s41418-018-0070-2

[906] van de Wetering, Marc, Hayley E. Francies, Joshua M. Francis, Gergana Bounova, Francesco Iorio, Apollo Pronk, Winan van Houdt, et al. 2015. “Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients.” Cell 161: 933–45. https://doi.org/10.1016/j.cell.2015.03.053

[907] Heckl, Dirk, Monika S. Kowalczyk, David Yudovich, Roger Belizaire, Rishi V. Puram, Marie E. McConkey, Anne Thielke, et al. 2014. “Generation of Mouse Models of Myeloid Malignancy With Combinatorial Genetic Lesions Using CRISPR-Cas9 Genome Editing.” Nature Biotechnology 32: 941–6. https://doi.org/10.1038/nbt.2951

[908] Matano, Mami, Shoichi Date, Mariko Shimokawa, Ai Takano, Masayuki Fujii, Yuki Ohta, Toshiaki Watanabe, Takanori Kanai, and Toshiro Sato. 2015. “Modeling Colorectal Cancer Using CRISPR-Cas9–mediated Engineering of Human Intestinal Organoids.” Nature Medicine 21: 256–62. https://doi.org/10.1038/nm.3802

[909] Hansen, Stine L., Hjalte L. Larsen, Laura M. Pikkupeura, Grzegorz Maciag, Jordi Guiu, Iris Müller, Ditte L. Clement, et al. 2023. “An Organoid-Based CRISPR-Cas9 Screen for Regulators of Intestinal Epithelial Maturation and Cell Fate.” Science Advances 9: eadg4055. https://doi.org/10.1126/sciadv.adg4055

[910] Ye, Jiayu, John M. Baer, Douglas V. Faget, Vasilios A. Morikis, Qihao Ren, Anupama Melam, Ana Paula Delgado, et al. 2024. “Senescent CAFs Mediate Immunosuppression and Drive Breast Cancer Progression.” Cancer Discovery 14: 1302–23. https://doi.org/10.1158/2159-8290.CD-23-0426

[911] Fortin, Bridget M., Shannon M. Pfeiffer, Jacob Insua-Rodríguez, Hamad Alshetaiwi, Alexander Moshensky, Wei A. Song, Alisa L. Mahieu, et al. 2024. “Circadian Control of Tumor Immunosuppression Affects Efficacy of Immune Checkpoint Blockade.” Nature Immunology 25: 1257–69. https://doi.org/10.1038/s41590-024-01859-0

[912] Espinosa-Carrasco, Gabriel, Edison Chiu, Aurora Scrivo, Paul Zumbo, Asim Dave, Doron Betel, Sung Wook Kang, et al. 2024. “Intratumoral Immune Triads Are Required for Immunotherapy-Mediated Elimination of Solid Tumors.” Cancer Cell 42: 1202–16.e8. https://doi.org/10.1016/j.ccell.2024.05.025

[913] Hou, Fei, Yun Zhu, Hongbo Zhao, Haolin Cai, Yinghui Wang, Xiaoqi Peng, Lin Lu, et al. 2024. “Development and Validation of an Interpretable Machine Learning Model for Predicting the Risk of Distant Metastasis in Papillary Thyroid Cancer: a Multicenter Study.” EClinicalMedicine 77: 102913. https://doi.org/10.1016/j.eclinm.2024.102913

[914] Kong, Cheng, Lei Liang, Guang Liu, Lutao Du, Yongzhi Yang, Jianqiang Liu, Debing Shi, Xinxiang Li, and Yanlei Ma. 2023. “Integrated Metagenomic and Metabolomic Analysis Reveals Distinct Gut-Microbiome-Derived Phenotypes in Early-Onset Colorectal Cancer.” Gut 72: 1129–42. https://doi.org/10.1136/gutjnl-2022-327156

[915] Lee, Pei-Chang, Chi-Jung Wu, Ya-Wen Hung, Chieh Ju Lee, Chen-Ta Chi, I-Cheng Lee, Kuo Yu-Lun, et al. 2022. “Gut Microbiota and Metabolites Associate With Outcomes of Immune Checkpoint Inhibitor–Treated Unresectable Hepatocellular Carcinoma.” Journal for Immunotherapy of Cancer 10: e004779. https://doi.org/10.1136/jitc-2022-004779

[916] Wang, Na, Jun Yang, Wenjie Han, Mengzhen Han, Xiaolin Liu, Lei Jiang, Hui Cao, et al. 2022. “Identifying Distinctive Tissue and Fecal Microbial Signatures and the Tumor-Promoting Effects of Deoxycholic Acid on Breast Cancer.” Frontiers in Cellular and Infection Microbiology 12: 1029905. https://doi.org/10.3389/fcimb.2022.1029905

[917] Zhang, Zhan, Di Wang, Shanlei Qiao, Xinyue Wu, Shuyuan Cao, Li Wang, Xiaojian Su, and Lei Li. 2017. “Metabolic and Microbial Signatures in Rat Hepatocellular Carcinoma Treated With Caffeic Acid and Chlorogenic Acid.” Scientific Reports 7: 4508. https://doi.org/10.1038/s41598-017-04888-y

[918] He, Yao, Liuhui Fu, Yiping Li, Wenyan Wang, Mingli Gong, Jing Zhang, Xin Dong, et al. 2021. “Gut Microbial Metabolites Facilitate Anticancer Therapy Efficacy by Modulating Cytotoxic CD8⁺ T Cell Immunity.” Cell Metabolism 33: 988–1000. https://doi.org/10.1016/j.cmet.2021.03.002

[919] Hu, Mengyao, Yi Xu, Yuqing Wang, Zhenhe Huang, Lei Wang, Fanan Zeng, Bowen Qiu, et al. 2025. “Gut Microbial-Derived N-Acetylmuramic Acid Alleviates Colorectal Cancer via the AKT1 Pathway.” Gut 74: 1230–45. https://doi.org/10.1136/gutjnl-2024-332891

[920] Yan, Junling, Wenting Duan, Qinhan Gao, Tianxiao Mao, Majie Wang, Jialin Duan, and Jiankang Li. 2023. “ENPP2 Inhibitor Improves Proliferation in AOM/DSS-induced Colorectal Cancer Mice via Remodeling the Gut Barrier Function and Gut Microbiota Composition.” Pharmacological Research 195: 106877. https://doi.org/10.1016/j.phrs.2023.106877

[921] Jiang, Haixiao, Wei Zeng, Xiaoli Zhang, Yuping Li, Yilun Wang, Aijun Peng, and Demao Cao. 2024. “Gut Microbiota and Its Metabolites in Non-Small Cell Lung Cancer and Brain Metastasis: from Alteration to Potential Microbial Markers and Drug Targets.” Frontiers in Cellular and Infection Microbiology 13: 1211855. https://doi.org/10.3389/fcimb.2023.1211855

[922] Lu, Yu, Aoxi Cui, and Xiaobo Zhang. 2024. “Commensal Microbiota-Derived Metabolite Agmatine Triggers Inflammation to Promote Colorectal Tumorigenesis.” Gut Microbes 16: 2348441. https://doi.org/10.1080/19490976.2024.2348441

[923] Van den Ackerveken, Priscilla, Alison Lobbens, Dorian Pamart, Aristotelis Kotronoulas, Guillaume Rommelaere, Mark Eccleston, and Marielle Herzog. 2023. “Epigenetic Profiles of Elevated Cell Free Circulating H3. 1 Nucleosomes as Potential Biomarkers for Non-Hodgkin Lymphoma.” Scientific Reports 13: 16335. https://doi.org/10.1038/s41598-023-43520-0

[924] Gadd, Danni A., Robert F. Hillary, Daniel L. McCartney, Shaza B. Zaghlool, Anna J. Stevenson, Yipeng Cheng, Chloe Fawns-Ritchie, et al. 2022. “Epigenetic Scores for the Circulating Proteome as Tools for Disease Prediction.” Elife 11: e71802. https://doi.org/10.7554/eLife.71802

[925] Cao, Feng, Ailin Wei, Xinlei Hu, Yijing He, Jun Zhang, Lin Xia, Kailing Tu, et al. 2020. “Integrated Epigenetic Biomarkers in Circulating Cell-Free DNA as a Robust Classifier for Pancreatic Cancer.” Clinical Epigenetics 12: 112. https://doi.org/10.1186/s13148-020-00898-2

[926] Shen, Siyuan, Dongxue Huo, Chenchen Ma, Shuaiming Jiang, and Jiachao Zhang. 2021. “Expanding the Colorectal Cancer Biomarkers Based on the Human Gut Phageome.” Microbiology Spectrum 9: e0009021. https://doi.org/10.1128/Spectrum.00090-21

[927] Chen, Fangyue, Jun Yang, Youxiang Guo, Dongwei Su, Yuan Sheng, and Yanmei Wu. 2023. “Integrating Bulk and Single-Cell RNA Sequencing Data Reveals the Relationship Between Intratumor Microbiome Signature and Host Metabolic Heterogeneity in Breast Cancer.” Frontiers in Immunology 14: 1140995. https://doi.org/10.3389/fimmu.2023.1140995

[928] Ternes, Dominik, Mina Tsenkova, Vitaly Igorevich Pozdeev, Marianne Meyers, Eric Koncina, Sura Atatri, Martine Schmitz, et al. 2022. “The Gut Microbial Metabolite Formate Exacerbates Colorectal Cancer Progression.” Nature Metabolism 4: 458–75. https://doi.org/10.1038/s42255-022-00558-0

[929] Tsay, Jun-Chieh J., Benjamin G. Wu, Imran Sulaiman, Katherine Gershner, Rosemary Schluger, Yonghua Li, Ting-An Yie, et al. 2021. “Lower Airway Dysbiosis Affects Lung Cancer Progression.” Cancer Discovery 11: 293–307. https://doi.org/10.1158/2159-8290.CD-20-0263

[930] Tzeng, Alice, Naseer Sangwan, Margaret Jia, Chin-Chih Liu, Karen S. Keslar, Erinn Downs-Kelly, Robert L. Fairchild, et al. 2021. “Human Breast Microbiome Correlates With Prognostic Features and Immunological Signatures in Breast Cancer.” Genome Medicine 13: 60. https://doi.org/10.1186/s13073-021-00874-2

[931] Lee, Jonathan Wei Jie, Damian R. Plichta, Shreya Asher, Marisa Delsignore, Tiffany Jeong, Jessica McGoldrick, Kyle Staller, et al. 2023. “Association of Distinct Microbial Signatures With Premalignant Colorectal Adenomas.” Cell Host & Microbe 31: 827–38.e3. https://doi.org/10.1016/j.chom.2023.04.007

[932] Schemczssen-Graeff, Zelinda, and Marcos Pileggi. 2022. “Probiotics and Live Biotherapeutic Products Aiming at Cancer Mitigation and Patient Recover.” Frontiers in Genetics 13: 921972. https://doi.org/10.3389/fgene.2022.921972

[933] Amitay, Efrat L., Prudence R. Carr, Anton Gies, Dana Clarissa Laetsch, and Hermann Brenner. 2020. “Probiotic/Synbiotic Treatment and Postoperative Complications in Colorectal Cancer Patients: Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Clinical and Translational Gastroenterology 11: e00268. https://doi.org/10.14309/ctg.0000000000000268

[934] Xie, Li-Wei, Hai-Yan Lu, Lin-Feng Tang, Feng-Ling Tang, Rui-Qiu Zhu, Di-Fan Wang, Shang Cai, Ye Tian, and Ming Li. 2024. “Probiotic Consortia Protect the Intestine Against Radiation Injury by Improving Intestinal Epithelial Homeostasis.” International Journal of Radiation Oncology, Biology, Physics 120: 189–204. https://doi.org/10.1016/j.ijrobp.2024.03.003

[935] Wang, Kui, Suijian Wang, Xianzheng Qin, Yifei Chen, Yuhua Chen, Jiawei Wang, Yao Zhang, et al. 2024. “The Causal Relationship Between Gut Microbiota and Biliary Tract Cancer: Comprehensive Bidirectional Mendelian Randomization Analysis.” Frontiers in Cellular and Infection Microbiology 14: 1308742. https://doi.org/10.3389/fcimb.2024.1308742

[936] Zhou, Tuoyu, Jingyuan Wu, Haibo Tang, Dali Liu, Byong-Hun Jeon, Weilin Jin, Yiqing Wang, et al. 2024. “Enhancing Tumor-Specific Recognition of Programmable Synthetic Bacterial Consortium for Precision Therapy of Colorectal Cancer.” npj Biofilms and Microbiomes 10: 6. https://doi.org/10.1038/s41522-024-00479-8

[937] Zhu, Wujuan, Minghui Yu, Minghui Wang, Miaomiao Zhang, and Zijuan Hai. 2025. “Sequential Self-Assembly and Release of a Camptothecin Prodrug for Tumor-Targeting Therapy.” Nanoscale 17: 2061–7. https://doi.org/10.1039/d4nr03519d

[938] Yu, Yinglan, Xinran Shen, Xin Xiao, Lian Li, and Yuan Huang. 2023. “Butyrate Modification Promotes Intestinal Absorption and Hepatic Cancer Cells Targeting of Ferroptosis Inducer Loaded Nanoparticle for Enhanced Hepatocellular Carcinoma Therapy.” Small 19: 2301149. https://doi.org/10.1002/smll.202370287

[939] Shen, Haosheng, Changyu Zhang, Shengjie Li, Yuanmei Liang, Li Ting Lee, Nikhil Aggarwal, Kwok Soon Wun, et al. 2024. “Prodrug-Conjugated Tumor-Seeking Commensals for Targeted Cancer Therapy.” Nature Communications 15: 4343. https://doi.org/10.1038/s41467-024-48661-y

[940] Hao, Tiantian, Ying Fu, Yao Yang, Shuyan Yang, Jian Liu, Jingjing Tang, Kadir Ahmad Ridwan, et al. 2021. “Tumor Vasculature-Targeting PEGylated Peptide-Drug Conjugate Prodrug Nanoparticles Improve Chemotherapy and Prevent Tumor Metastasis.” European Journal of Medicinal Chemistry 219: 113430. https://doi.org/10.1016/j.ejmech.2021.113430

[941] Tian, Baocheng, Hong Xu, Haiyan Wang, Keke Li, Shuna Zheng, Senhao Hu, Yongjun Wang, and Qingzhi Lv. 2023. “GSH-Responsive Prodrug Nanoassembly as a Carrier-Free Nanoplatform for Tumor-Targeting Delivery and Chemo-Photothermal Therapy.” Molecular Pharmaceutics 20: 4210–8. https://doi.org/10.1021/acs.molpharmaceut.3c00319

[942] Jakubechova, Jana, Ursula Altanerova, and Cestmir Altaner. 2023. “Tumor-Targeted Suicide Gene-Directed Enzyme Prodrug Therapy Mediated by Extracellular Vesicles.” Neoplasma 70: 333–9. https://doi.org/10.4149/neo_2023_230328N172

[943] Goyal, Ashish, Jens Bauer, Joschka Hey, Dimitris N. Papageorgiou, Ekaterina Stepanova, Michael Daskalakis, Jonas Scheid, et al. 2023. “DNMT and HDAC Inhibition Induces Immunogenic Neoantigens from Human Endogenous Retroviral Element-Derived Transcripts.” Nature Communications 14: 6731. https://doi.org/10.1038/s41467-023-42417-w

[944] McDonald, James I., Noor Diab, Elisa Arthofer, Melissa Hadley, Tomas Kanholm, Uzma Rentia, Stephanie Gomez, et al. 2021. “Epigenetic Therapies in Ovarian Cancer Alter Repetitive Element Expression in a TP53-Dependent Manner.” Cancer Research 81: 5176–89. https://doi.org/10.1158/0008-5472.CAN-20-4243

[945] Donohoe, Dallas R., Darcy Holley, Leonard B. Collins, Stephanie A. Montgomery, Alan C. Whitmore, Andrew Hillhouse, Kaitlin P. Curry, et al. 2014. “A Gnotobiotic Mouse Model Demonstrates That Dietary Fiber Protects Against Colorectal Tumorigenesis in a Microbiota- and Butyrate-Dependent Manner.” Cancer Discovery 4: 1387–97. https://doi.org/10.1158/2159-8290.CD-14-0501

[946] Hu, Chupeng, Bingqing Xu, Xiaodong Wang, Wen-Hua Wan, Jinying Lu, Deyuan Kong, Yu Jin, et al. 2023. “Gut Microbiota–Derived Short-Chain Fatty Acids Regulate Group 3 Innate Lymphoid Cells in HCC.” Hepatology 77: 48–64. https://doi.org/10.1002/hep.32449

[947] Cao, Yanyan, Lijie Zhang, Fu Xiong, Xiaopeng Guo, Xuefeng Kan, Songlin Song, Bo Liang, et al. 2024. “Effect of Probiotics and Fecal Microbiota Transplantation in Dirty Rats With Established Primary Liver Cancer.” Future Microbiology 19: 117–29. https://doi.org/10.2217/fmb-2022-0234

[948] He, Zhen, Hongyu Xie, Haoyang Xu, Jinjie Wu, Wanyi Zeng, Qilang He, Christian Jobin, Sanqing Jin, and Ping Lan. 2024. “Chemotherapy-Induced Microbiota Exacerbates the Toxicity of Chemotherapy Through the Suppression of Interleukin-10 From Macrophages.” Gut Microbes 16: 2319511. https://doi.org/10.1080/19490976.2024.2319511

[949] Davar, Diwakar, Amiran K. Dzutsev, John A. McCulloch, Richard R. Rodrigues, Joe-Marc Chauvin, Robert M. Morrison, Richelle N. Deblasio, et al. 2021. “Fecal Microbiota Transplant Overcomes Resistance to Anti–PD-1 Therapy in Melanoma Patients.” Science 371: 595–602. https://doi.org/10.1126/science.abf3363

[950] Routy, Bertrand, John G. Lenehan, Wilson H. Miller,, Rahima Jamal, Meriem Messaoudene, Brendan A. Daisley, Cecilia Hes, et al. 2023. “Fecal Microbiota Transplantation Plus Anti-PD-1 Immunotherapy in Advanced Melanoma: A Phase I Trial.” Nature Medicine 29: 2121–32. https://doi.org/10.1038/s41591-023-02453-x

[951] Dizman, Nazli, Luis Meza, Paulo Bergerot, Marice Alcantara, Tanya Dorff, Yung Lyou, Paul Frankel, et al. 2022. “Nivolumab Plus Ipilimumab With or Without Live Bacterial Supplementation in Metastatic Renal Cell Carcinoma: A Randomized Phase 1 Trial.” Nature Medicine 28: 704–12. https://doi.org/10.1038/s41591-022-01694-6

[952] Sureda, Anna, Antonio Pinto, Hervé Ghesquières, Franck Morschhauser, Olivier Tournilhac, Pim Mutsaers, Josée M. Zijlstra, et al. 2025. “Safety and Efficacy of Tinostamustine in a Subpopulation of Patients With Relapsed/Refractory Hodgkin Lymphoma From a Phase I Trial.” Hematological Oncology 43: e70000. https://doi.org/10.1002/hon.70000

[953] Kiu, Raymond, Elizabeth M. Darby, Cristina Alcon-Giner, Antia Acuna-Gonzalez, Anny Camargo, Lisa E. Lamberte, Sarah Phillips, et al. 2025. “Impact of Early Life Antibiotic and Probiotic Treatment on Gut Microbiome and Resistome of Very-Low-Birth-Weight Preterm Infants.” Nature Communications 16: 7569. https://doi.org/10.1038/s41467-025-62584-2

[954] Sun, Yi, Xiang Zhang, Chuandi Jin, Kaile Yue, Dashuang Sheng, Tao Zhang, Xue Dou, et al. 2023. “Prospective, Longitudinal Analysis of the Gut Microbiome in Patients With Locally Advanced Rectal Cancer Predicts Response to Neoadjuvant Concurrent Chemoradiotherapy.” Journal of Translational Medicine 21: 221. https://doi.org/10.1186/s12967-023-04054-1

[955] Ren, Shengnan, Lingxin Feng, Haoran Liu, Yuke Mao, and Zhuang Yu. 2024. “Gut Microbiome Affects the Response to Immunotherapy in Non-Small Cell Lung Cancer.” Thoracic Cancer 15: 1149–63. https://doi.org/10.1111/1759-7714.15303

[956] Peng, Zhi, Siyuan Cheng, Yan Kou, Ziqi Wang, Rong Jin, Han Hu, Xiaotian Zhang, et al. 2020. “The Gut Microbiome Is Associated With Clinical Response to Anti–PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer.” Cancer Immunology Research 8: 1251–61. https://doi.org/10.1158/2326-6066.CIR-19-1014

[957] Zhu, Xiaoqiang, Xiaowen Huang, Muni Hu, Rongrong Sun, Jiantao Li, Hai Wang, Xuefeng Pan, et al. 2024. “A Specific Enterotype Derived from Gut Microbiome of Older Individuals Enables Favorable Responses to Immune Checkpoint Blockade Therapy.” Cell Host & Microbe 32: 489–505, e485. https://doi.org/10.1016/j.chom.2024.03.002

[958] Zhou, Han, Lei Wang, Zhiwen Lin, Chenwei Jiang, Xingte Chen, Kai Wang, Libin Liu, et al. 2023. “Methylglyoxal From Gut Microbes Boosts Radiosensitivity and Radioimmunotherapy in Rectal Cancer by Triggering Endoplasmic Reticulum Stress and cGAS-STING Activation.” Journal for Immunotherapy of Cancer 11: e007840. https://doi.org/10.1136/jitc-2023-007840

[959] Yeo, Winnie, Hyun C. Chung, Stephen L. Chan, Ling Z. Wang, Robert Lim, Joel Picus, Michael Boyer, et al. 2012. “Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group.” Journal of Clinical Oncology 30: 3361–7. https://doi.org/10.1200/JCO.2011.41.2395

[960] Weng, Rueyhung R., Hsuan-Hsuan Lu, Chien-Ting Lin, Chia-Chi Fan, Rong-Shan Lin, Tai-Chung Huang, Shu-Yung Lin, et al. 2021. “Epigenetic Modulation of Immune Synaptic-Cytoskeletal Networks Potentiates γδ T Cell-Mediated Cytotoxicity in Lung Cancer.” Nature Communications 12: 2163. https://doi.org/10.1038/s41467-021-22433-4

[961] Incorvaia, Lorena, Daniele Fanale, Giuseppe Badalamenti, Chiara Brando, Marco Bono, Ida De Luca, Laura Algeri, et al. 2020. “A “Lymphocyte MicroRNA Signature” as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients With Metastatic Renal Cell Carcinoma: Pointing Towards Epigenetic Reprogramming.” Cancers 12: 3396. https://doi.org/10.3390/cancers12113396

[962] Li, Huiping, Dujuan Li, Huiyi Chen, Xiaojie Yue, Kai Fan, Linxi Dong, and Gaofeng Wang. 2023. “Application of Silicon Nanowire Field Effect Transistor (SiNW-FET) Biosensor With High Sensitivity.” Sensors 23: 6808. https://doi.org/10.3390/s23156808

[963] Liang, Yuan, Mengni Liu, Bingyuan Liu, Benjamin Ziman, Guanjie Peng, Qiong Mao, Xingzhe Wang, et al. 2025. “Comprehensive Analysis of H3K27me3 LOCKs Under Different DNA Methylation Contexts Reveal Epigenetic Redistribution in Tumorigenesis.” Epigenetics & Chromatin 18: 6. https://doi.org/10.1186/s13072-025-00570-0

[964] Wang, Haijing, Yuanjun Wang, Libin Yang, Jiawen Feng, Shou Tian, Lingyan Chen, Wei Huang, et al. 2024. “Integrated 16S rRNA Sequencing and Metagenomics Insights into Microbial Dysbiosis and Distinct Virulence Factors in Inflammatory Bowel Disease.” Frontiers in Microbiology 15: 1375804. https://doi.org/10.3389/fmicb.2024.1375804

[965] Yashar, William M., Garth Kong, Jake VanCampen, Brittany M. Curtiss, Daniel J. Coleman, Lucia Carbone, Galip Gürkan Yardimci, et al. 2022. “GoPeaks: Histone Modification Peak Calling for CUT&Tag.” Genome Biology 23: 144. https://doi.org/10.1186/s13059-022-02707-w

[966] He, Michelle Junyi, Wenjun Pu, Xi Wang, Wei Zhang, Donge Tang, and Yong Dai. 2022. “Comparing DESI-MSI and MALDI-MSI Mediated Spatial Metabolomics and Their Applications in Cancer Studies.” Frontiers in Oncology 12: 891018. https://doi.org/10.3389/fonc.2022.891018

[967] Singh, Amrit, Casey P. Shannon, Benoît Gautier, Florian Rohart, Michaël Vacher, Scott J. Tebbutt, and Kim-Anh Lê Cao. 2019. “DIABLO: an Integrative Approach for Identifying Key Molecular Drivers From Multi-Omics Assays.” Bioinformatics 35: 3055–62. https://doi.org/10.1093/bioinformatics/bty1054

[968] Argelaguet, Ricard, Damien Arnol, Danila Bredikhin, Yonatan Deloro, Britta Velten, John C. Marioni, and Oliver Stegle. 2020. “MOFA+: A Statistical Framework for Comprehensive Integration of Multi-Modal Single-Cell Data.” Genome Biology 21: 111. https://doi.org/10.1186/s13059-020-02015-1

[969] Ali, Farman, Abdullah Almuhaimeed, Wajdi Alghamdi, Haya Aldossary, Othman Asiry, and Atef Masmoudi. 2025. “Leveraging Deep Learning for Epigenetic Protein Prediction: A Novel Approach for Early Lung Cancer Diagnosis and Drug Discovery.” Health Information Science and Systems 13: 28. https://doi.org/10.1007/s13755-025-00347-5

[970] Sobhani, Iradj, Emma Bergsten, Séverine Couffin, Aurélien Amiot, Biba Nebbad, Caroline Barau, Nicola De'angelis, et al. 2019. “Colorectal Cancer-Associated Microbiota Contributes to Oncogenic Epigenetic Signatures.” Proceedings of the National Academy of Sciences 116: 24285–95. https://doi.org/10.1073/pnas.1912129116

[971] Fellows, Rachel, Jérémy Denizot, Claudia Stellato, Alessandro Cuomo, Payal Jain, Elena Stoyanova, Szabina Balázsi, et al. 2018. “Microbiota Derived Short Chain Fatty Acids Promote Histone Crotonylation in the Colon Through Histone Deacetylases.” Nature Communications 9: 105. https://doi.org/10.1038/s41467-017-02651-5

[972] Han, Anna, Natalie Bennett, Bettaieb Ahmed, Jay Whelan, and Dallas R. Donohoe. 2018. “Butyrate Decreases Its Own Oxidation in Colorectal Cancer Cells Through Inhibition of Histone Deacetylases.” Oncotarget 9: 27280–92. https://doi.org/10.18632/oncotarget.25546

[973] Kishore, Chandra. 2021. “Epigenetic Regulation and Promising Therapies in Colorectal Cancer.” Current Molecular Pharmacology 14: 838–52. https://doi.org/10.2174/1874467214666210126105345

[974] Pan, Botao, Shuanghong Yin, Fang Peng, Chang Liu, Huiyi Liang, Jiyan Su, W. L. Wendy Hsiao, et al. 2021. “Vorinostat Targets UBE2C to Reverse Epithelial-Mesenchymal Transition and Control Cervical Cancer Growth Through the Ubiquitination Pathway.” European Journal of Pharmacology 908: 174399. https://doi.org/10.1016/j.ejphar.2021.174399

[975] Jin, Hua, Yu Zhang, Sijian Yu, Xin Du, Na Xu, Ruoyang Shao, Dongjun Lin, et al. 2023. “Venetoclax Combined With Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial.” Journal of Hematology & Oncology 16: 42. https://doi.org/10.1186/s13045-023-01437-1

[976] Tang, Yuhui, Qiaoting Cai, Zhi Tian, Wenkuan Chen, and Hailin Tang. 2025. “Crosstalk Between Gut Microbiota and Cancer Immunotherapy: Present Investigations and Future Perspective.” Research 8: 0600. https://doi.org/10.34133/research.0600

[977] Jang, H. Josh, Galen Hostetter, Alexander W. Macfarlane, Zachary Madaj, Eric A. Ross, Toshinori Hinoue, Justin R. Kulchycki, et al. 2023. “A Phase II Trial of Guadecitabine Plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing After Initial Immune Checkpoint Inhibitor Therapy.” Clinical Cancer Research 29: 2052–65. https://doi.org/10.1158/1078-0432.CCR-22-3642

[978] Demirkan, Ayşe, Jenny van Dongen, Casey T. Finnicum, Harm-Jan Westra, Soesma Jankipersadsing, Gonneke Willemsen, Richard G. Ijzerman, et al. 2024. “Linking the Gut Microbiome to Host DNA Methylation by a Discovery and Replication Epigenome-Wide Association Study.” BMC Genomics 25: 1224. https://doi.org/10.1186/s12864-024-11136-x

[979] Yaskolka Meir, Anat, Maria Keller, Anne Hoffmann, Ehud Rinott, Gal Tsaban, Alon Kaplan, Hila Zelicha, et al. 2023. “The Effect of Polyphenols on DNA Methylation-Assessed Biological Age Attenuation: The DIRECT PLUS Randomized Controlled Trial.” BMC Medicine 21: 364. https://doi.org/10.1186/s12916-023-03067-3

[980] Spencer, Christine N., Jennifer L. McQuade, Vancheswaran Gopalakrishnan, John A. McCulloch, Marie Vetizou, Alexandria P. Cogdill, Md A. Wadud Khan, et al. 2021. “Dietary Fiber and Probiotics Influence the Gut Microbiome and Melanoma Immunotherapy Response.” Science 374: 1632–40. https://doi.org/10.1126/science.aaz7015

[981] Chen, Yang, Junjie Ma, Yunze Dong, Ziyu Yang, Na Zhao, Qian Liu, Wei Zhai, et al. 2022. “Characteristics of Gut Microbiota in Patients With Clear Cell Renal Cell Carcinoma.” Frontiers in Microbiology 13: 913718. https://doi.org/10.3389/fmicb.2022.913718

[982] Yu, Jie, Sibo Meng, Tiantian Xuan, Zhanmei Wang, Linli Qu, Fangli Cao, and Jiaxin Li. 2024. “Identification of hsa-miR-193a-5p-SURF4 Axis Related to the Gut Microbiota-Metabolites-Cytokines in Lung Cancer Based on Mendelian Randomization Study and Bioinformatics Analysis.” Discover Oncology 15: 475. https://doi.org/10.1007/s12672-024-01359-5

[983] Jayakrishnan, Thejus T., Naseer Sangwan, Shimoli V. Barot, Nicole Farha, Arshiya Mariam, Shao Xiang, Federico Aucejo, et al. 2024. “Multi-Omics Machine Learning to Study Host-Microbiome Interactions in Early-Onset Colorectal Cancer.” npj Precision Oncology 8: 146. https://doi.org/10.1038/s41698-024-00647-1

[984] Zheng, Yi, Tingting Wang, Xiaoxuan Tu, Yun Huang, Hangyu Zhang, D. I. Tan, Weiqin Jiang, et al. 2019. “Gut Microbiome Affects the Response to anti-PD-1 Immunotherapy in Patients With Hepatocellular Carcinoma.” Journal for Immunotherapy of Cancer 7: 193. https://doi.org/10.1186/s40425-019-0650-9

[985] Schwaiger-Haber, Michaela, Ethan Stancliffe, Dhanalakshmi S. Anbukumar, Blake Sells, Jia Yi, Kevin Cho, Kayla Adkins-Travis, et al. 2023. “Using Mass Spectrometry Imaging to Map Fluxes Quantitatively in the Tumor Ecosystem.” Nature Communications 14: 2876. https://doi.org/10.1038/s41467-023-38403-x

[986] Björk, Johannes R., Laura A. Bolte, Andrew Maltez Thomas, Karla A. Lee, Niccolo Rossi, Thijs T. Wind, Lotte M. Smit, et al. 2024. “Longitudinal Gut Microbiome Changes in Immune Checkpoint Blockade-Treated Advanced Melanoma.” Nature Medicine 30: 785–96. https://doi.org/10.1038/s41591-024-02803-3

[987] McAndrews, Kathleen M., Fei Xiao, Antonios Chronopoulos, Valerie S. LeBleu, Fernanda G. Kugeratski, and Raghu Kalluri. 2021. “Exosome-Mediated Delivery of CRISPR/Cas9 for Targeting of Oncogenic KrasG12D in Pancreatic Cancer.” Life Science Alliance 4: e202000875. https://doi.org/10.26508/lsa.202000875

[988] Saha, Satabdi, Lubna Rehman, Abdur Rehman, Faezeh Darbaniyan, Donna M. Weber, Melody Becnel, Mahmoud Gaballa, et al. 2025. “Longitudinal Analysis of Gut Microbiome and Metabolome Correlates of Response and Toxicity With Idecabtagene Vicleucel.” Blood Advances 9: 3429–40. https://doi.org/10.1182/bloodadvances.2024014476

[989] Kumar, Mukesh, Ramanpreet Kaur, Shruthi Kanthaje, Radha K. Dhiman, and Anuradha Chakraborti. 2023. “Bacterial Metabolite Butyrate in Modulating Sorafenib-Targeted microRNAs to Curtail Its Resistance in Hepatocellular Carcinoma.” Journal of Cancer Research and Clinical Oncology 149: 5823–39. https://doi.org/10.1007/s00432-022-04544-7

[990] Zhu, Yi, Jia-li Zhang, Xue-jiao Yan, Yuan Ji, and Fang-fang Wang. 2023. “Exploring a New Mechanism Between Lactate and VSMC Calcification: PARP1/POLG/UCP2 Signaling Pathway and Imbalance of Mitochondrial Homeostasis.” Cell Death & Disease 14: 598. https://doi.org/10.1038/s41419-023-06113-3

[991] Martin-Gallausiaux, Camille, Fabienne Béguet-Crespel, Ludovica Marinelli, Alexandre Jamet, Florence Ledue, Hervé M. Blottière, and Nicolas Lapaque. 2018. “Butyrate Produced by Gut Commensal Bacteria Activates TGF-beta1 Expression Through the Transcription Factor SP1 in Human Intestinal Epithelial Cells.” Scientific Reports 8: 9742. https://doi.org/10.1038/s41598-018-28048-y

[992] Benjamin, Don, Dimitri Robay, Sravanth K. Hindupur, Jens Pohlmann, Marco Colombi, Mahmoud Y. El-Shemerly, Sauveur-Michel Maira, et al. 2018. “Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal With Metformin Due to NAD⁺ Depletion in Cancer Cells.” Cell Reports 25: 3047–58.e4. https://doi.org/10.1016/j.celrep.2018.11.043

[993] Presa, Daniela, Syed A. Khurram, Amir Z. A. Zubir, Sneha Smarakan, Patricia A. Cooper, Goreti R. Morais, Maria Sadiq, et al. 2021. “Cytochrome P450 Isoforms 1A1, 1B1 AND 2W1 as Targets for Therapeutic Intervention in Head and Neck Cancer.” Scientific Reports 11: 18930. https://doi.org/10.1038/s41598-021-98217-z

[994] . Eisenhut, M. 2019. “Stimulation of Nucleotide Oligomerization Domain and Toll-Like Receptors 2 to Enhance the Effect of Bacillus Calmette Guerin Immunization for Prevention of Mycobacterium Tuberculosis Infection: Protocol for a Series of Preclinical Randomized Controlled Trials.” JMIR Research Protocols 8: e13045. https://doi.org/10.2196/13045

[995] Bose, Shree, Haipei Yao, Qiang Huang, Regina Whitaker, Christopher D. Kontos, Rebecca A. Previs, and Xiling Shen. 2022. “Using Genetically Encoded Fluorescent Biosensors to Interrogate Ovarian Cancer Metabolism.” Journal of Ovarian Research 15: 114. https://doi.org/10.1186/s13048-022-01046-5

[996] Nobis, Max, David Herrmann, Sean C. Warren, Douglas Strathdee, Thomas R. Cox, Kurt I. Anderson, Paul Timpson, et al. 2020. “Shedding New Light on RhoA Signalling as a Drug Target in Vivo Using a Novel RhoA-FRET Biosensor Mouse.” Small GTPases 11: 240–7. https://doi.org/10.1080/21541248.2018.1438024

[997] Chen, Hai-Lin, Amel Latifi, Cheng-Cai Zhang, and Christophe Sébastien Bernard. 2018. “Biosensors-Based In Vivo Quantification of 2-Oxoglutarate in Cyanobacteria and Proteobacteria.” Life 8: 51. https://doi.org/10.3390/life8040051

[998] Liu, Tracy W., Seth T. Gammon, and David Piwnica-Worms. 2021. “Multi-Modal Multi-Spectral Intravital Microscopic Imaging of Signaling Dynamics in Real-Time During Tumor–Immune Interactions.” Cells 10: 499. https://doi.org/10.3390/cells10030499

[999] Zhao, Songyun, Pengpeng Zhang, Sen Niu, Jiaheng Xie, Yuankun Liu, Yuan Liu, Ning Zhao, et al. 2024. “Targeting Nucleotide Metabolic Pathways in Colorectal Cancer by Integrating scRNA-seq, Spatial Transcriptome, and Bulk RNA-seq Data.” Functional & Integrative Genomics 24: 72. https://doi.org/10.1007/s10142-024-01356-5

[1000] Liu, Yi-Ming, Jing-Yu Ge, Yu-Fei Chen, Tong Liu, Lie Chen, Cui-Cui Liu, Ding Ma, et al. 2023. “Combined Single-Cell and Spatial Transcriptomics Reveal the Metabolic Evolvement of Breast Cancer During Early Dissemination.” Advanced Science 10: 2205395. https://doi.org/10.1002/advs.202205395

[1001] Fan, Tianyu, Jian Lu, Delei Niu, Yue Zhang, Bin Wang, Bei Zhang, Zugui Zhang, et al. 2022. “Immune and Non-Immune Cell Subtypes Identify Novel Targets for Prognostic and Therapeutic Strategy: A Study Based on Intratumoral Heterogenicity Analysis of Multicenter scRNA-seq Datasets in Lung Adenocarcinoma.” Frontiers in Immunology 13: 1046121. https://doi.org/10.3389/fimmu.2022.1046121

[1002] Zhang, Haoling, Qilu Yan, Shuya Jiang, Dan Hu, Ping Lu, Shaowei Li, Doblin Sandai, et al. 2025. “Protein Post-Translational Modifications and Tumor Immunity: A Pan-Cancer Perspective.” Physics of Life Reviews 55: 142–209. https://doi.org/10.1016/j.plrev.2025.10.001

[1003] Ryu, Tae Young, Kwangho Kim, Tae-Su Han, Mi-Ok Lee, Jinkwon Lee, Jinhyeon Choi, Kwang Bo Jung, et al. 2022. “Human Gut-Microbiome-Derived Propionate Coordinates Proteasomal Degradation via HECTD2 Upregulation to Target EHMT2 in Colorectal Cancer.” ISME Journal 16: 1205–21. https://doi.org/10.1038/s41396-021-01119-1

[1004] Li, Jiaqi, Qingqing Zhai, Wangzheqi Zhang, Yisheng Chen, Changli Wang, Xiaoming Deng, Haoling Zhang, Zhiheng Lin, and Yalin Zhu. 2025. “The Multifunctionality of the Caspase Family of Proteases: A New Perspective Beyond Cell Death.” Molecular Aspects of Medicine 106: 101411. https://doi.org/10.1016/j.mam.2025.101411

[1005] Diao, Li-Ting, Shu-Juan Xie, Wan-Yi Xu, Hai-Hui Zhang, Ya-Rui Hou, Yan-Xia Hu, Xin-Xiang Liang, et al. 2024. “CRISPR/Cas13 sgRNA-Mediated RNA–RNA Interaction Mapping in Live Cells With APOBEC RNA Editing.” Advanced Science 11: 2409004. https://doi.org/10.1002/advs.202409004

[1006] Li, Jia-Mei, Jie Huang, Yan Liao, Ting Hu, Chang-Li Wang, Wang-Zheqi Zhang, and Chen-Wei Huang. 2025. “Gene and RNA Editing: Revolutionary Approaches to Treating Diseases.” MedComm 6: e70389. https://doi.org/10.1002/mco2.70389

[1007] Lu, Yao, Huiping Yuan, Shaojie Liang, Debing Li, Pengfei Jiang, Xian Wang, Ke Zhang, and Dechun Liu. 2025. “Microbial Metabolite-Driven Immune Reprogramming in Tumor Immunotherapy: Mechanisms and Therapeutic Perspectives.” Frontiers in Immunology 16: 1603658. https://doi.org/10.3389/fimmu.2025.1603658

[1008] Dhainaut, Maxime, Samuel A. Rose, Guray Akturk, Aleksandra Wroblewska, Sebastian R. Nielsen, Eun Sook Park, Mark Buckup, et al. 2022. “Spatial CRISPR Genomics Identifies Regulators of the Tumor Microenvironment.” Cell 185: 1223–39.e20. https://doi.org/10.1016/j.cell.2022.02.015

[1009] Migliozzi, Simona, Young Taek Oh, Mohammad Hasanain, Luciano Garofano, Fulvio D'Angelo, Ryan D. Najac, Alberto Picca, et al. 2023. “Integrative Multi-Omics Networks Identify PKCδ and DNA-PK as Master Kinases of Glioblastoma Subtypes and Guide Targeted Cancer Therapy.” Nature Cancer 4: 181–202. https://doi.org/10.1038/s43018-022-00510-x

[1010] Tao, Yuhuan, Shaozhen Xing, Shuai Zuo, Pengfei Bao, Yunfan Jin, Yu Li, Mingyang Li, et al. 2023. “Cell-Free Multi-Omics Analysis Reveals Potential Biomarkers in Gastrointestinal Cancer Patients' Blood.” Cell Reports Medicine 4: 101281. https://doi.org/10.1016/j.xcrm.2023.101281

[1011] Guo, Xiaorou, Qingwang Chen, Yuanfeng Zhang, Yujing Zhang, Yaqing Liu, Shumeng Duan, Yu Ma, et al. 2025. “Methylation Reference Datasets From Quartet DNA Materials for Benchmarking Epigenome Sequencing.” Nature Communications 16: 9202. https://doi.org/10.1038/s41467-025-64250-z

[1012] Su, Chen, Rong Yu, Xiaoquan Hong, Panpan Zhang, Yingying Guo, Jian-Chun Cai, and Jingjing Hou. 2023. “CXCR4 Expressed by Tumor-Infiltrating B Cells in Gastric Cancer Related to Survival in the Tumor Microenvironment: An Analysis Combining Single-Cell RNA Sequencing With Bulk RNA Sequencing.” International Journal of Molecular Sciences 24: 12890. https://doi.org/10.3390/ijms241612890

[1013] Canale, Fernando P., Camilla Basso, Gaia Antonini, Michela Perotti, Ning Li, Anna Sokolovska, Julia Neumann, et al. 2021. “Metabolic Modulation of Tumours With Engineered Bacteria for Immunotherapy.” Nature 598: 662–6. https://doi.org/10.1038/s41586-021-04003-2

[1014] Lim, Boon, Yutong Yin, Hua Ye, Zhanfeng Cui, Antonis Papachristodoulou, and Wei E. Huang. 2022. “Reprogramming Synthetic Cells for Targeted Cancer Therapy.” ACS Synthetic Biology 11: 1349–60. https://doi.org/10.1021/acssynbio.1c00631

[1015] Tieu, Victor, Elena Sotillo, Jeremy R. Bjelajac, Crystal Chen, Meena Malipatlolla, Justin A. Guerrero, Peng Xu, et al. 2024. “A Versatile CRISPR-Cas13d Platform for Multiplexed Transcriptomic Regulation and Metabolic Engineering in Primary Human T Cells.” Cell 187: 1278–95. https://doi.org/10.1016/j.cell.2024.01.035

[1016] Yang, Yi, Hongbing Mei, Xiaohong Han, Xintao Zhang, Jianli Cheng, Zhongfu Zhang, Han Wang, et al. 2023. “Synthetic CRISPR/dCas9-KRAB System Driven by Specific PSA Promoter Suppresses Malignant Biological Behavior of Prostate Cancer Cells Through Negative Feedback Inhibition of PSA Expression.” Cellular & Molecular Biology Letters 28: 96. https://doi.org/10.1186/s11658-023-00508-y

[1017] Ma, Yingxin, Guobin Mao, Guoqiang Wu, Zongqiang Cui, Xian-En Zhang, and Weiren Huang. 2021. “CRISPR-dCas9-guided and Telomerase-Responsive Nanosystem for Precise Anti-Cancer Drug Delivery.” ACS Applied Materials & Interfaces 13: 7890–6. https://doi.org/10.1021/acsami.0c19217

[1018] Gu, Pengfei, Jie Zhao, Wei Zhang, Xianhui Ruan, Linfei Hu, Yu Zeng, Xiukun Hou, et al. 2024. “An Inducible CRISPR-dCas9-Based Transcriptional Repression System for Cancer Therapy.” Small Methods 8: 2301310. https://doi.org/10.1002/smtd.202301310

[1019] Blanas, Athanasios, Lenneke A. M. Cornelissen, Maximilianos Kotsias, Joost C. van der Horst, Henri J. van de Vrugt, Hakan Kalay, Daniel I. R. Spencer, Rad P. Kozak, and Sandra J. van Vliet. 2019. “Transcriptional Activation of Fucosyltransferase (FUT) Genes Using the CRISPR-dCas9-VPR Technology Reveals Potent N-Glycome Alterations in Colorectal Cancer Cells.” Glycobiology 29: 137–50. https://doi.org/10.1093/glycob/cwy096

[1020] Na, Feifei, Xiangyu Pan, Jingyao Chen, Xuelan Chen, Manli Wang, Pengliang Chi, Liting You, et al. 2022. “KMT2C Deficiency Promotes Small Cell Lung Cancer Metastasis Through DNMT3A-Mediated Epigenetic Reprogramming.” Nature Cancer 3: 753–67. https://doi.org/10.1038/s43018-022-00361-6

[1021] Poirion, Olivier B., Zheng Jing, Kumardeep Chaudhary, Sijia Huang, and Lana X. Garmire. 2021. “DeepProg: An Ensemble of Deep-Learning and Machine-Learning Models for Prognosis Prediction Using Multi-Omics Data.” Genome Medicine 13: 112. https://doi.org/10.1186/s13073-021-00930-x

[1022] Casimiro-Soriguer, Carlos S., Carlos Loucera, María Peña-Chilet, and Joaquin Dopazo. 2022. “Towards a Metagenomics Machine Learning Interpretable Model for Understanding the Transition from Adenoma to Colorectal Cancer.” Scientific Reports 12: 450. https://doi.org/10.1038/s41598-021-04182-y

[1023] Gould, Michael K., Brian Z. Huang, Martin C. Tammemagi, Yaron Kinar, and Ron Shiff. 2021. “Machine Learning for Early Lung Cancer Identification Using Routine Clinical and Laboratory Data.” American Journal of Respiratory and Critical Care Medicine 204: 445–53. https://doi.org/10.1164/rccm.202007-2791OC

[1024] Ma, Mengwei, Renyi Liu, Chanjuan Wen, Weimin Xu, Zeyuan Xu, Sina Wang, Jiefang Wu, et al. 2022. “Predicting the Molecular Subtype of Breast Cancer and Identifying Interpretable Imaging Features Using Machine Learning Algorithms.” European Radiology 32: 1652–62. https://doi.org/10.1007/s00330-021-08271-4

[1025] Wang, Jue, Yunfang Yu, Yujie Tan, Huan Wan, Nafen Zheng, Zifan He, Luhui Mao, et al. 2024. “Artificial Intelligence Enables Precision Diagnosis of Cervical Cytology Grades and Cervical Cancer.” Nature Communications 15: 4369. https://doi.org/10.1038/s41467-024-48705-3

[1026] Kim, Min-Jeong, Han-Na Kim, Jonathan P. Jacobs, and Hyo-Joon Yang. 2024. “Combined DNA Methylation and Gastric Microbiome Marker Predicts Helicobacter pylori-Negative Gastric Cancer.” Gut and Liver 18: 611–20. https://doi.org/10.5009/gnl230348

[1027] Nshanian, Michael, Joshua J. Gruber, Benjamin S. Geller, Faye Chleilat, Samuel M. Lancaster, Shannon M. White, Ludmila Alexandrova, et al. 2025. “Short-Chain Fatty Acid Metabolites Propionate and Butyrate Are Unique Epigenetic Regulatory Elements Linking Diet, Metabolism and Gene Expression.” Nature Metabolism 7: 196–211. https://doi.org/10.1038/s42255-024-01191-9

[1028] Ha, Seung Yeon, Hyo Sook Song, Jin-Young Kim, Youn-Hee Choi, and Ji Ha Choi. 2025. “Effect of SLC5A8 Missense Variants on Its Tumor-Suppressive Function.” Journal of Korean Medical Science 40: e146. https://doi.org/10.3346/jkms.2025.40.e146

[1029] Hu, Thomas, Mayar Allam, Shuangyi Cai, Walter Henderson, Brian Yueh, Aybuke Garipcan, Anton V. Ievlev, et al. 2023. “Single-Cell Spatial Metabolomics With Cell-Type Specific Protein Profiling for Tissue Systems Biology.” Nature communications 14: 8260. https://doi.org/10.1038/s41467-023-43917-5

RIGHTS & PERMISSIONS

2026 The Author(s). iMeta published by John Wiley & Sons Australia, Ltd on behalf of iMeta Science.